gene_systematic_id gene_name type evidence qualifier extension reference taxon date comment SPAC1002.01 mrx11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1002.01 mrx11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1002.02 pom34 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1002.02 pom34 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC1002.02 pom34 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC1002.02 pom34 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC1002.02 pom34 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1002.04c taf11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1002.05c jmj2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC1002.05c jmj2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1002.05c jmj2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1002.06c bqt2 RNA quantitative PCR increased during(GO:0071444) PMID:16615890 4896 2014-07-14 SPAC1002.06c bqt2 RNA quantitative PCR increased during(GO:0006995) PMID:16615890 4896 2014-07-14 SPAC1002.06c bqt2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC1002.07c sat1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1002.07c sat1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1002.07c sat1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1002.07c sat1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1002.08c mtf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1002.09c dld1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1002.09c dld1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1002.09c dld1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1002.10c sgt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1002.10c sgt1 RNA Northern assay evidence increased in presence of(CHEBI:17234) PMID:16408318 4896 2021-10-04 SPAC1002.11 gaa1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1002.11 gaa1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1002.12c ssd1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1002.12c ssd1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1002.12c ssd1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1002.12c ssd1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1002.13c psu1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1002.13c psu1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC1002.13c psu1 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPAC1002.13c psu1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1002.13c psu1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1002.13c psu1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC1002.13c psu1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC1002.13c psu1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1002.13c psu1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC1002.13c psu1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1002.13c psu1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1002.13c psu1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC1002.13c psu1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1002.13c psu1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1002.14 itt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1002.16c tna1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1002.16c tna1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1002.16c tna1 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC1002.16c tna1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1002.16c tna1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1002.16c tna1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC1002.16c tna1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1002.16c tna1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1002.17c urg2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1002.17c urg2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1002.17c urg2 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC1002.17c urg2 RNA expression microarray evidence decreased in absence of(CHEBI:17568) PMID:18197241 4896 2013-09-25 SPAC1002.17c urg2 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC1002.17c urg2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC1002.17c urg2 RNA expression microarray evidence increased in presence of(CHEBI:17568) PMID:18197241 4896 2013-09-25 SPAC1002.17c urg2 RNA expression microarray evidence increased in presence of(CHEBI:3647) PMID:23695302 4896 2015-02-12 SPAC1002.17c urg2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1002.17c urg2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1002.17c urg2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC1002.17c urg2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1002.18 urg3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1002.18 urg3 RNA expression microarray evidence decreased in absence of(CHEBI:17568) PMID:18197241 4896 2013-09-25 SPAC1002.18 urg3 RNA expression microarray evidence increased in presence of(CHEBI:17568) PMID:18197241 4896 2013-09-25 SPAC1002.18 urg3 RNA expression microarray evidence increased in presence of(CHEBI:3647) PMID:23695302 4896 2015-02-12 SPAC1002.18 urg3 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1002.18 urg3 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1002.19 urg1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1002.19 urg1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1002.19 urg1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC1002.19 urg1 RNA expression microarray evidence decreased in absence of(CHEBI:17568) PMID:18197241 4896 2013-09-25 SPAC1002.19 urg1 RNA expression microarray evidence increased in presence of(CHEBI:17568) PMID:18197241 4896 2013-09-25 SPAC1002.19 urg1 RNA expression microarray evidence increased in presence of(CHEBI:3647) PMID:23695302 4896 2015-02-12 SPAC1002.19 urg1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC1002.19 urg1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1002.19 urg1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1002.19 urg1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1002.19 urg1 RNA in situ hybridization evidence used in manual assertion increased in presence of(CHEBI:17568) PMID:32059768 4896 2021-03-31 SPAC1002.20 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC1002.20 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1002.20 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1006.01 psp3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1006.01 psp3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1006.01 psp3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1006.01 psp3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1006.01 psp3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1006.01 psp3 RNA northern assay evidence used in manual assertion unchanged during(GO:0006995) PMID:21153812 4896 2016-02-03 SPAC1006.01 psp3 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:21153812 4896 2016-02-03 SPAC1006.03c red1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:23980030 4896 2013-12-02 SPAC1006.03c red1 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:23980030 4896 2013-12-02 SPAC1006.03c red1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1006.04c mcp3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1006.04c mcp3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1006.04c mcp3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1006.04c mcp3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1006.04c mcp3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1006.04c mcp3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1006.05c och1 protein Western blot evidence constant during(GO:0000278) PMID:12784644 4896 2019-11-08 SPAC1006.05c och1 RNA Northern assay evidence constant during(GO:0000278) PMID:12784644 4896 2019-11-08 SPAC1006.05c och1 RNA Northern assay evidence increased during(GO:0071472) PMID:12784644 4896 2019-11-08 SPAC1006.05c och1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1006.05c och1 RNA Northern assay evidence unchanged during(GO:0034599) PMID:12784644 4896 2019-11-08 SPAC1006.05c och1 RNA Northern assay evidence unchanged during(GO:0034605) PMID:12784644 4896 2019-11-08 SPAC1006.06 rgf2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1006.06 rgf2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1006.06 rgf2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1006.06 rgf2 RNA Northern assay evidence increased during(GO:0098765) PMID:19189958 4896 2022-01-06 SPAC1006.06 rgf2 RNA Northern assay evidence present during(GO:0072690) PMID:19189958 4896 2022-01-06 SPAC1006.07 tif1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1006.07 tif1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1006.07 tif1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1006.07 tif1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1006.07 tif1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1006.08 etd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1006.08 etd1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1006.08 etd1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1006.08 etd1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1006.09 win1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.01 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1039.01 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1039.01 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1039.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.02 efn2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1039.02 efn2 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPAC1039.02 efn2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1039.02 efn2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1039.02 efn2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1039.02 efn2 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC1039.02 efn2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1039.02 efn2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.02 efn2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC1039.02 efn2 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC1039.03 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1039.03 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1039.03 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1039.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.04 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1039.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.05c klf1 protein western blot evidence used in manual assertion increased during(GO:0006995) PMID:24167631 4896 2013-12-02 SPAC1039.05c klf1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1039.05c klf1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1039.05c klf1 RNA expression microarray evidence increased during(GO:0006995) PMID:24167631 4896 2013-12-02 SPAC1039.05c klf1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1039.05c klf1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.06 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1039.06 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1039.06 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.06 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1039.07c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1039.07c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1039.07c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.08 soa1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1039.08 soa1 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC1039.08 soa1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC1039.08 soa1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1039.08 soa1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1039.08 soa1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.09 isp5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1039.09 isp5 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1039.09 isp5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1039.09 isp5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1039.09 isp5 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:7954893 4896 2014-05-08 SPAC1039.09 isp5 RNA northern assay evidence used in manual assertion absent during(GO:0072752) PMID:15466417 4896 2014-06-09 SPAC1039.09 isp5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1039.09 isp5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1039.09 isp5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:28938) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAC1039.09 isp5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAC1039.09 isp5 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC1039.09 isp5 RNA reporter gene assay evidence increased during(GO:0006995) PMID:23934889 4896 2013-09-16 SPAC1039.09 isp5 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:7954893 4896 2014-05-08 SPAC1039.09 isp5 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:15466417 4896 2014-06-09 SPAC1039.09 isp5 RNA reporter gene assay evidence increased during(GO:0006995) PMID:27227887 4896 2017-09-27 SPAC1039.09 isp5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.10 mmf2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1039.10 mmf2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1039.10 mmf2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1039.10 mmf2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC1039.10 mmf2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1039.10 mmf2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1039.11c gto1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1039.11c gto1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1039.11c gto1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC105.01c kha1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC105.01c kha1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC105.02c ank1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC105.02c ank1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC105.02c ank1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC105.03c dal81 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC105.03c dal81 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1071.03c sil1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1071.04c spc2 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPAC1071.05 hpm1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1071.05 hpm1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1071.07c rps1502 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1071.07c rps1502 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1071.07c rps1502 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1071.07c rps1502 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1071.07c rps1502 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1071.08 rpp203 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1071.08 rpp203 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1071.09c djc9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1071.10c pma1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1071.10c pma1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1071.10c pma1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC1071.11 coq12 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1071.12c stp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1071.12c stp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1093.01 ppr5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1093.02 pdx3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1093.02 pdx3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1093.02 pdx3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1093.02 pdx3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1093.05 hca4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1093.05 hca4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1093.05 hca4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1093.05 hca4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1093.05 hca4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1093.06c dhc1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC10F6.01c sir1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC10F6.01c sir1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC10F6.01c sir1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC10F6.01c sir1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC10F6.01c sir1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC10F6.03c cts1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC10F6.03c cts1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC10F6.03c cts1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC10F6.03c cts1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC10F6.03c cts1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC10F6.03c cts1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC10F6.03c cts1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC10F6.03c cts1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC10F6.03c cts1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC10F6.03c cts1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC10F6.03c cts1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC10F6.03c cts1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC10F6.04 ats1 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC10F6.05c ubc6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC10F6.05c ubc6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC10F6.05c ubc6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC10F6.05c ubc6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC10F6.06 vip1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC10F6.06 vip1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC10F6.06 vip1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC10F6.06 vip1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC10F6.06 vip1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC10F6.06 vip1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC10F6.06 vip1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC10F6.06 vip1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC10F6.06 vip1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC10F6.06 vip1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC10F6.06 vip1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC10F6.06 vip1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC10F6.06 vip1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC10F6.07c mug94 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC10F6.08c nht1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC10F6.09c psm3 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC10F6.09c psm3 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC10F6.10 rio1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC10F6.10 rio1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC10F6.11c atg17 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC10F6.11c atg17 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC10F6.12c mam4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC10F6.12c mam4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC10F6.12c mam4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC10F6.12c mam4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC10F6.12c mam4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC10F6.12c mam4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC10F6.12c mam4 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC10F6.13c caa1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC10F6.13c caa1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC10F6.13c caa1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC10F6.13c caa1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC10F6.15 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC10F6.15 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC10F6.16 igo1 protein western blot evidence used in manual assertion increased during(GO:0006995) PMID:26776736 4896 2016-06-21 SPAC10F6.16 igo1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:26776736 4896 2016-06-21 SPAC10F6.16 igo1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC10F6.16 igo1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC10F6.17c ptc5 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC110.01 ppk1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC110.01 ppk1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC110.01 ppk1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC110.01 ppk1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0072690) PMID:23143934 4896 2014-04-01 SPAC110.01 ppk1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC110.02 pds5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC110.03 cdc42 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC110.03 cdc42 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC110.04c pss1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC110.04c pss1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC110.04c pss1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC110.04c pss1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:9524252 4896 2014-09-25 SPAC110.04c pss1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:9524252 4896 2014-09-25 SPAC110.04c pss1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC110.04c pss1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9524252 4896 2014-09-25 SPAC110.06 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1142.04 noc201 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1142.04 noc201 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1142.04 noc201 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC1142.04 noc201 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC1142.04 noc201 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1142.04 noc201 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC1142.04 noc201 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1142.04 noc201 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1142.04 noc201 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1142.05 ctr5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1142.05 ctr5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1142.05 ctr5 RNA northern assay evidence used in manual assertion decreased during(GO:0071280) PMID:11274192 4896 2015-07-14 SPAC1142.05 ctr5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1142.05 ctr5 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:11274192 4896 2015-07-14 SPAC1142.05 ctr5 RNA northern assay evidence used in manual assertion increased during(GO:0072690) PMID:28572514 4896 2017-09-16 SPAC1142.05 ctr5 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:28572514 4896 2017-09-16 SPAC1142.05 ctr5 RNA northern assay evidence used in manual assertion increased during(GO:0051328) PMID:24569997 4896 2017-09-14 SPAC1142.05 ctr5 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:24569997 4896 2017-09-14 SPAC1142.05 ctr5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1142.05 ctr5 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC1142.06 get3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1142.06 get3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1142.06 get3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1142.07c vps32 protein microscopy evidence present during(GO:0000092) PMID:37783794 4896 2023-10-05 Fig. 2 SPAC1142.07c vps32 protein microscopy evidence present during(GO:0000080) PMID:37783794 4896 2023-10-05 Fig. 2 SPAC1142.07c vps32 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1142.07c vps32 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1142.08 fhl1 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:15302827 4896 2015-10-20 SPAC1142.08 fhl1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1142.08 fhl1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11D3.01c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC11D3.01c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11D3.01c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11D3.01c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC11D3.01c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC11D3.01c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC11D3.01c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC11D3.01c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC11D3.01c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC11D3.01c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.01c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11D3.01c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.02c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC11D3.02c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11D3.02c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC11D3.02c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11D3.02c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.02c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11D3.02c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.02c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC11D3.03c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11D3.03c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC11D3.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.04c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11D3.04c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11D3.05 mfs2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC11D3.05 mfs2 RNA quantitative PCR increased in presence of(CHEBI:16240) PMID:34352089 4896 2021-10-28 SPAC11D3.05 mfs2 RNA quantitative PCR increased in presence of(CHEBI:25255) PMID:34352089 4896 2021-10-28 SPAC11D3.06 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.07c toe4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11D3.07c toe4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.08c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC11D3.08c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.08c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11D3.08c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.08c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC11D3.09 agm1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11D3.09 agm1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC11D3.09 agm1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11D3.09 agm1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11D3.09 agm1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC11D3.09 agm1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.09 agm1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC11D3.09 agm1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC11D3.10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC11D3.10 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.11c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.11c RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC11D3.13 hsp3104 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.13 hsp3104 RNA quantitative PCR increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPAC11D3.13 hsp3104 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC11D3.13 hsp3104 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC11D3.13 hsp3104 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC11D3.13 hsp3104 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC11D3.13 hsp3104 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC11D3.13 hsp3104 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC11D3.13 hsp3104 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11D3.13 hsp3104 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC11D3.13 hsp3104 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.13 hsp3104 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC11D3.14c oxp2 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11D3.14c oxp2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.14c oxp2 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC11D3.14c oxp2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.15 oxp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC11D3.16c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC11D3.16c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC11D3.16c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.16c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11D3.16c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11D3.16c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.17 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC11D3.17 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC11D3.17 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.17 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11D3.17 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11D3.17 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC11D3.18c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC11D3.18c ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11D3.18c RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC11D3.18c RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC11D3.18c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11D3.19 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11E3.02c ync13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11E3.02c ync13 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11E3.02c ync13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11E3.06 map1 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0006995) PMID:8668157 4896 2014-06-10 SPAC11E3.06 map1 RNA northern assay evidence used in manual assertion increased in(CL:0002675),during(GO:0006995) PMID:8668157 4896 2014-06-10 SPAC11E3.06 map1 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0006995) PMID:9003326 4896 2014-06-10 SPAC11E3.06 map1 RNA northern assay evidence used in manual assertion increased in(CL:0002675),during(GO:0006995) PMID:9003326 4896 2014-06-10 SPAC11E3.06 map1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC11E3.06 map1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC11E3.06 map1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11E3.06 map1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC11E3.06 map1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC11E3.06 map1 RNA northern assay evidence used in manual assertion present in(CL:0002674),during(GO:0072690) PMID:8668157 4896 2014-06-10 SPAC11E3.06 map1 RNA northern assay evidence used in manual assertion present in(CL:0002675),during(GO:0072690) PMID:8668157 4896 2014-06-10 SPAC11E3.06 map1 RNA northern assay evidence used in manual assertion present in(CL:0002675),during(GO:0072690) PMID:9003326 4896 2014-12-09 SPAC11E3.06 map1 RNA northern assay evidence used in manual assertion present in(CL:0002674),during(GO:0072690) PMID:9003326 4896 2014-12-09 SPAC11E3.09 pyp3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11E3.09 pyp3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC11E3.09 pyp3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11E3.13c gas5 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC11E3.13c gas5 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC11E3.13c gas5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11E3.13c gas5 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:21124977 4896 2015-12-15 SPAC11E3.13c gas5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11E3.14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11E3.14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11E3.14 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC11E3.14 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC11E3.14 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC11E3.14 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC11E3.14 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC11E3.14 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC11E3.14 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11E3.14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11E3.14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11E3.14 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC11E3.14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11E3.14 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC11E3.14 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC11E3.14 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC11E3.15 rpl22 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11E3.15 rpl22 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC11E3.15 rpl22 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11E3.15 rpl22 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11E3.15 rpl22 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC11E3.15 rpl22 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11E3.15 rpl22 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11G7.02 pub1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11G7.03 idh1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC11G7.03 idh1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC11G7.04 ubi1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11G7.04 ubi1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11G7.04 ubi1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC11G7.05c mct1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC11G7.05c mct1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC11G7.05c mct1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC11G7.06c mug132 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC11G7.06c mug132 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC11G7.06c mug132 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC11H11.01 sst6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11H11.01 sst6 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC11H11.01 sst6 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC11H11.01 sst6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11H11.02c mug162 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11H11.02c mug162 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC11H11.03c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC11H11.03c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11H11.03c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC11H11.04 mam2 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0006995) PMID:1657593 4896 2012-02-02 SPAC11H11.04 mam2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC11H11.05c fta6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11H11.05c fta6 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC11H11.06 arp2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC11H11.06 arp2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC11H11.06 arp2 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC1250.01 snf21 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:19168987 4896 2016-03-02 SPAC1250.01 snf21 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:19168987 4896 2016-03-02 SPAC1250.02 mug95 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1250.02 mug95 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1250.02 mug95 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1250.04c atl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1250.04c atl1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1250.04c atl1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1250.05 rpl3002 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1250.05 rpl3002 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1250.05 rpl3002 RNA Northern assay evidence increased during(GO:0034605) PMID:21981922 4896 2023-11-21 we found a 2-fold increase in rpl30-2 mRNA levels after shifting cells growing at 25C to 37C (Figure 4A, lanes 1 and 2, and Figure 4B). SPAC1296.02 cox4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1296.03c sxa2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1296.03c sxa2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1296.03c sxa2 protein microscopy evidence increased during(GO:0000084) PMID:30279276 4896 2021-03-19 SPAC1296.03c sxa2 protein microscopy evidence increased during(GO:0000088) PMID:30279276 4896 2021-03-19 SPAC1296.03c sxa2 protein microscopy evidence increased in presence of(CHEBI:26981) PMID:30279276 4896 2021-03-19 SPAC1296.03c sxa2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC1296.03c sxa2 RNA northern assay evidence used in manual assertion present in presence of(GO:0000772) PMID:1549128 4896 2018-01-24 SPAC1296.04 spo73 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1296.04 spo73 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1296.05c lcp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1296.05c lcp1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1296.06 tah18 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC12B10.01c hul6 protein Western blot evidence increased during(GO:0072690) PMID:38272226 4896 2024-12-06 (Fig. 3F) SPAC12B10.01c hul6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC12B10.01c hul6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC12B10.02c sdg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC12B10.04 pby1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC12B10.08c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC12B10.08c RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC12B10.09 pet801 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12B10.11 exg2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12B10.11 exg2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC12B10.11 exg2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC12B10.11 exg2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC12B10.11 exg2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:20852022 4896 2015-08-28 SPAC12B10.12c rhp41 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12B10.12c rhp41 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC12B10.13 gid8 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC12B10.13 gid8 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC12B10.13 gid8 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC12B10.13 gid8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC12B10.14c tea5 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC12B10.16c mug157 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12B10.16c mug157 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC12B10.16c mug157 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC12G12.01c sea4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC12G12.02 efg1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12G12.02 efg1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC12G12.02 efg1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC12G12.02 efg1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC12G12.02 efg1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC12G12.03 cip2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12G12.04 mcp60 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12G12.04 mcp60 RNA decreased during(GO:0030437) PMID:8566770 4896 2015-02-16 SPAC12G12.04 mcp60 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC12G12.04 mcp60 RNA increased during(GO:0034605) PMID:8566770 4896 2015-02-16 SPAC12G12.04 mcp60 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC12G12.05c taf9 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC12G12.06c rcl1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC12G12.06c rcl1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC12G12.06c rcl1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC12G12.07c cpn1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC12G12.07c cpn1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC12G12.08 mrpl6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12G12.09 eti1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC12G12.09 eti1 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPAC12G12.11c miy1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12G12.12 gms2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC12G12.12 gms2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC12G12.12 gms2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC12G12.12 gms2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC12G12.12 gms2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC12G12.13c cid14 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:16478992 4896 2015-05-27 SPAC12G12.13c cid14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC12G12.15 sif3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC139.01c mkt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC139.02c oac1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC139.02c oac1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC139.02c oac1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC139.02c oac1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC139.02c oac1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC139.02c oac1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC139.02c oac1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC139.04c fap2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC139.05 ssd2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC139.05 ssd2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC139.05 ssd2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC139.05 ssd2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC139.05 ssd2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC139.05 ssd2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC139.05 ssd2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC139.05 ssd2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC139.05 ssd2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC139.05 ssd2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC139.05 ssd2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC139.05 ssd2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC139.05 ssd2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC139.05 ssd2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC139.05 ssd2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC139.05 ssd2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC139.05 ssd2 RNA expression microarray evidence increased in presence of(CHEBI:69136) PMID:38415071 4896 2024-10-09 SPAC139.05 ssd2 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC1399.01c protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1399.01c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1399.01c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1399.01c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1399.01c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1399.01c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1399.01c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1399.01c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1399.02 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1399.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1399.03 fur4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1399.03 fur4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1399.03 fur4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1399.03 fur4 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1399.03 fur4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1399.03 fur4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1399.04c uck2 RNA expression microarray evidence increased in presence of(CHEBI:3647) PMID:23695302 4896 2015-02-12 SPAC1399.04c uck2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1399.04c uck2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1399.04c uck2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1399.05c toe1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1399.05c toe1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1399.05c toe1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC13A11.02c erg11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13A11.02c erg11 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC13A11.02c erg11 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC13A11.02c erg11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13A11.02c erg11 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC13A11.03 mcp7 protein western blot evidence used in manual assertion absent during(GO:0007135) PMID:15210864 4896 2015-10-20 SPAC13A11.03 mcp7 protein western blot evidence used in manual assertion decreased during(GO:0007127) PMID:15210864 4896 2015-10-20 SPAC13A11.03 mcp7 protein western blot evidence used in manual assertion increased during(GO:0051328) PMID:15210864 4896 2015-10-20 SPAC13A11.03 mcp7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13A11.03 mcp7 RNA northern assay evidence used in manual assertion increased during(GO:0051328) PMID:15210864 4896 2015-10-20 SPAC13A11.03 mcp7 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC13A11.03 mcp7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13A11.04c ubp8 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13A11.04c ubp8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13A11.05 ysp2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13A11.05 ysp2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13A11.05 ysp2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC13A11.06 pdc202 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC13A11.06 pdc202 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13A11.06 pdc202 RNA quantitative PCR increased during(GO:0036227) PMID:25102102 4896 2015-09-29 SPAC13A11.06 pdc202 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC13A11.06 pdc202 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13C5.01c pre9 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC13C5.01c pre9 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13C5.03 tht1 protein western blot evidence used in manual assertion absent during(GO:0072690) PMID:9442101 4896 2015-04-09 SPAC13C5.03 tht1 protein western blot evidence used in manual assertion increased during(GO:0000747) PMID:9442101 4896 2015-04-09 SPAC13C5.03 tht1 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:9442101 4896 2015-04-09 SPAC13C5.03 tht1 RNA expression microarray evidence increased during(GO:0071444) PMID:16615890 4896 2014-07-14 SPAC13C5.03 tht1 RNA expression microarray evidence increased during(GO:0006995) PMID:16615890 4896 2014-07-14 SPAC13C5.03 tht1 RNA northern assay evidence used in manual assertion increased during(GO:0000747) PMID:9442101 4896 2015-04-09 SPAC13C5.03 tht1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC13C5.04 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC13C5.04 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC13C5.04 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13C5.04 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC13C5.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13C5.04 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13C5.04 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13C5.04 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC13C5.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13C5.04 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC13C5.04 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC13C5.05c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC13C5.05c protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC13C5.05c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC13C5.05c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC13C5.06c mug121 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC13C5.06c mug121 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13C5.06c mug121 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13C5.06c mug121 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13C5.06c mug121 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC13D1.01c Tf2-7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13D1.01c Tf2-7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13D1.01c Tf2-7 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC13D6.01 pof14 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13D6.01 pof14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13D6.01 pof14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13D6.01 pof14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13D6.02c byr3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13D6.02c byr3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13D6.02c byr3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13D6.02c byr3 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC13D6.03c trm9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13D6.04c btb3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13D6.05 alp11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13F5.01c msh1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13F5.02c taf7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13F5.03c gld1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC13F5.03c gld1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13F5.03c gld1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC13F5.03c gld1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC13F5.03c gld1 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13F5.03c gld1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13F5.03c gld1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13F5.03c gld1 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:20396879 4896 2012-02-27 SPAC13F5.03c gld1 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPAC13F5.03c gld1 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:20396879 4896 2012-02-27 SPAC13F5.03c gld1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:16236),during(GO:0042149) PMID:22370953 4896 2016-07-06 SPAC13F5.03c gld1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13F5.03c gld1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13F5.03c gld1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13F5.05 mpd1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13F5.05 mpd1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13F5.07c hpz2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC13F5.07c hpz2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13F5.07c hpz2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13F5.07c hpz2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13F5.07c hpz2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G6.01c rad8 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G6.02c rps101 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC13G6.02c rps101 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G6.02c rps101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G6.02c rps101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC13G6.03 gpi7 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G6.03 gpi7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13G6.04 tim8 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G6.05c trs33 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13G6.06c gcv2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G6.06c gcv2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G6.06c gcv2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13G6.07c rps601 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G6.07c rps601 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G6.07c rps601 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC13G6.07c rps601 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G6.07c rps601 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC13G6.07c rps601 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13G6.07c rps601 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G6.08 fzr2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC13G6.08 fzr2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G6.08 fzr2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC13G6.08 fzr2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC13G6.08 fzr2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G6.09 tsr402 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13G6.10c asl1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G6.10c asl1 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPAC13G6.10c asl1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G6.10c asl1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G6.10c asl1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G6.10c asl1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G6.11c erg12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G6.12c chs1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G6.12c chs1 RNA northern assay evidence used in manual assertion increased during(GO:0030437) PMID:11069657 4896 2015-09-28 SPAC13G6.12c chs1 RNA Northern assay evidence increased during(GO:0030437) PMID:10632879 4896 2018-04-08 SPAC13G6.12c chs1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC13G6.12c chs1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G6.12c chs1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:11069657 4896 2015-09-28 SPAC13G6.14 aps1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC13G6.14 aps1 RNA western blot evidence used in manual assertion present during(GO:0072690) PMID:10090752 4896 2012-02-11 SPAC13G6.15c rcn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13G7.01c erg7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G7.01c erg7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G7.01c erg7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13G7.02c ssa1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G7.02c ssa1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC13G7.02c ssa1 protein Western blot evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPAC13G7.02c ssa1 protein microscopy evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPAC13G7.02c ssa1 protein Western blot evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPAC13G7.02c ssa1 protein microscopy evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPAC13G7.02c ssa1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC13G7.02c ssa1 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPAC13G7.02c ssa1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC13G7.02c ssa1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC13G7.02c ssa1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC13G7.02c ssa1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G7.02c ssa1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC13G7.02c ssa1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G7.02c ssa1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC13G7.02c ssa1 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPAC13G7.02c ssa1 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPAC13G7.02c ssa1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC13G7.03 upf3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G7.03 upf3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G7.04c mac1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G7.04c mac1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G7.05 are1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC13G7.05 are1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC13G7.05 are1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC13G7.05 are1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC13G7.05 are1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC13G7.05 are1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC13G7.05 are1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G7.05 are1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC13G7.06 met16 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G7.06 met16 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G7.07 arb2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G7.08c crb3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC13G7.10 teb1 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:23314747 4896 2015-10-01 SPAC13G7.10 teb1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G7.10 teb1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC13G7.10 teb1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G7.10 teb1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC13G7.13c msa1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC13G7.13c msa1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC13G7.13c msa1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC13G7.13c msa1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC13G7.13c msa1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC13G7.13c msa1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC13G7.13c msa1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC13G7.13c msa1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC13G7.13c msa1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC13G7.13c msa1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC13G7.13c msa1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC13G7.13c msa1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC140.01 sdh2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC140.01 sdh2 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC140.01 sdh2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC140.01 sdh2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC140.01 sdh2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC140.02 gar2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC140.02 gar2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC140.02 gar2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC140.02 gar2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC140.02 gar2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1420.01c mks1 protein Western blot evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-26 (Figure 5) SPAC1420.01c mks1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1420.01c mks1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1420.01c mks1 RNA quantitative PCR unchanged during(GO:0034605) PMID:38269097 4896 2024-03-26 (Figure 5) SPAC1420.02c cct5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1420.02c cct5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1420.03 rpn501 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1420.04c cox1101 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC144.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC144.01 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC144.02 iec1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0016036) PMID:19933844 4896 2017-09-01 SPAC144.03 ade2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC144.03 ade2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC144.03 ade2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC144.03 ade2 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC144.04c spe1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC144.06 apl5 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC144.07c gpn2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC144.08 jac1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC144.09c sfc2 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC144.09c sfc2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC144.09c sfc2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC144.09c sfc2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC144.09c sfc2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC144.10c gwt1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC144.10c gwt1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC144.10c gwt1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC144.10c gwt1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC144.11 rps1102 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC144.11 rps1102 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC144.11 rps1102 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC144.11 rps1102 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC144.11 rps1102 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC144.12 rki1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC144.12 rki1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC144.12 rki1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC144.13c srw1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC144.13c srw1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC144.13c srw1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC144.13c srw1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC144.14 klp8 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC144.15c cog1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC144.16 cia2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC144.16 cia2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1486.01 sod2 protein reporter gene assay evidence increased during(GO:0036227) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence increased during(GO:0071275) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence increased during(GO:0071287) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence increased during(GO:0071276) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence increased during(GO:0070301) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence increased during(GO:0036245) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence increased during(GO:0071732) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence increased during(GO:0034605) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein western blot evidence used in manual assertion increased during(GO:0036227) PMID:26507459 4896 2016-10-26 SPAC1486.01 sod2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1486.01 sod2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1486.01 sod2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1486.01 sod2 protein reporter gene assay evidence unchanged during(GO:0071280) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence unchanged during(GO:0071294) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 protein reporter gene assay evidence present during(GO:0072690) PMID:12442905 4896 2014-11-05 SPAC1486.01 sod2 RNA northern assay evidence used in manual assertion increased during(GO:0036245) PMID:11350071 4896 2014-11-05 SPAC1486.01 sod2 RNA northern assay evidence used in manual assertion increased during(GO:1902075) PMID:11350071 4896 2014-11-05 SPAC1486.01 sod2 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:11350071 4896 2014-11-05 SPAC1486.01 sod2 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:26507459 4896 2016-10-26 SPAC1486.01 sod2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC1486.01 sod2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1486.01 sod2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1486.01 sod2 RNA northern assay evidence used in manual assertion unchanged during(GO:0070301) PMID:11350071 4896 2014-11-05 SPAC1486.01 sod2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:11350071 4896 2014-11-05 SPAC1486.02c dsc2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1486.02c dsc2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1486.02c dsc2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1486.04c alm1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1486.06 npt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1486.07c mrpl19 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1486.07c mrpl19 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1486.09 nob1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1486.09 nob1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC1486.09 nob1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC1486.09 nob1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1486.09 nob1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC1486.09 nob1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1486.09 nob1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1486.09 nob1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1486.10 thi1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC14C4.01c atg43 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC14C4.01c atg43 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC14C4.01c atg43 protein Western blot evidence increased during(GO:0006995) PMID:33138913 4896 2021-01-07 (Figure 2A) SPAC14C4.01c atg43 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC14C4.01c atg43 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC14C4.01c atg43 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC14C4.01c atg43 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC14C4.01c atg43 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC14C4.01c atg43 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC14C4.02c smc5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC14C4.02c smc5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC14C4.03 mek1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC14C4.03 mek1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC14C4.03 mek1 RNA experimental evidence increased during(GO:0051321) PMID:12482912 4896 SPAC14C4.05c man1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC14C4.05c man1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC14C4.05c man1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC14C4.05c man1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC14C4.07 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC14C4.07 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC14C4.08 mug5 RNA quantitative PCR absent during(GO:0072690) PMID:25736293 4896 2021-01-22 SPAC14C4.08 mug5 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC14C4.08 mug5 RNA quantitative PCR present during(GO:0051321) PMID:25736293 4896 2021-01-22 SPAC14C4.09 agn1 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:15194814 4896 2015-01-08 SPAC14C4.09 agn1 protein western blot evidence used in manual assertion increased during(GO:0000080) PMID:15194814 4896 2015-01-08 SPAC14C4.09 agn1 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:15194814 4896 2015-01-08 SPAC14C4.09 agn1 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPAC14C4.09 agn1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC14C4.09 agn1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC14C4.09 agn1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC14C4.09 agn1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC14C4.09 agn1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC14C4.09 agn1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC14C4.09 agn1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC14C4.09 agn1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC14C4.09 agn1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC14C4.09 agn1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC14C4.09 agn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC14C4.09 agn1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC14C4.10c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC14C4.10c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC14C4.10c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC14C4.10c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC14C4.10c RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC14C4.11 vtc2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC14C4.11 vtc2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC14C4.11 vtc2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC14C4.12c laf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC14C4.12c laf1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC14C4.12c laf1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC14C4.13 rad17 protein western blot evidence used in manual assertion unchanged during(GO:0071480) PMID:8846774 4896 2013-03-03 SPAC14C4.13 rad17 protein western blot evidence used in manual assertion unchanged during(GO:0072711) PMID:8846774 4896 2013-03-03 SPAC14C4.13 rad17 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:8846774 4896 2013-03-03 SPAC14C4.14 atp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC14C4.15c dpp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1527.01 mok11 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1527.01 mok11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1527.01 mok11 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1527.01 mok11 RNA Northern assay evidence absent during(GO:0072690) PMID:16420355 4896 2020-10-21 SPAC1527.01 mok11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1527.01 mok11 RNA Northern assay evidence increased during(GO:0051321) PMID:16420355 4896 2020-10-21 SPAC1527.02 sft2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1527.03 slr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1527.03 slr1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1556.01c rad50 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1556.01c rad50 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1556.01c rad50 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1556.02c sdh1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1556.02c sdh1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1556.04c cdd1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1556.05c cgr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1556.05c cgr1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1556.05c cgr1 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC1556.06 meu1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1556.06 meu1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1556.06 meu1 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPAC1556.06 meu1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1556.06 meu1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1556.07 pmm1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1556.07 pmm1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1565.01 rcf2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1565.01 rcf2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1565.01 rcf2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1565.02c rga10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1565.02c rga10 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1565.03 RNA experimental evidence increased during(GO:0051321) 4896 2010-01-03 SPAC1565.03 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC1565.04c ste4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1565.04c ste4 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:1766866 4896 2013-01-30 SPAC1565.04c ste4 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC1565.04c ste4 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:1766866 4896 2013-01-30 SPAC1565.05 utp8 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1565.05 utp8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1565.05 utp8 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1565.05 utp8 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1565.06c spg1 protein northern assay evidence used in manual assertion constant during(GO:0000278) PMID:9203579 4896 2013-02-13 SPAC1565.06c spg1 protein northern assay evidence used in manual assertion present during(GO:0072690) PMID:9203579 4896 2013-02-13 SPAC1565.06c spg1 RNA western blot evidence used in manual assertion constant during(GO:0000278) PMID:9203579 4896 2013-02-13 SPAC1565.06c spg1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1565.06c spg1 RNA western blot evidence used in manual assertion present during(GO:0072690) PMID:9203579 4896 2013-02-13 SPAC1565.08 cdc48 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1565.08 cdc48 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1565.08 cdc48 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15A10.01 atm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC15A10.01 atm1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC15A10.01 atm1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC15A10.01 atm1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15A10.01 atm1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC15A10.03c rad54 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC15A10.03c rad54 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15A10.04c zpr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15A10.04c zpr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC15A10.04c zpr1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC15A10.04c zpr1 RNA expression microarray evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC15A10.04c zpr1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15A10.05c mug182 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC15A10.05c mug182 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15A10.05c mug182 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC15A10.05c mug182 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC15A10.05c mug182 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC15A10.05c mug182 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC15A10.05c mug182 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC15A10.05c mug182 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC15A10.05c mug182 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC15A10.05c mug182 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC15A10.05c mug182 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15A10.05c mug182 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC15A10.07 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC15A10.09c pun1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15A10.10 mde6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15A10.10 mde6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC15A10.10 mde6 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC15A10.10 mde6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC15A10.11 ubr11 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC15A10.13 ppk3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC15A10.13 ppk3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15A10.13 ppk3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC15A10.15 sgo2 protein Western blot evidence present during(GO:0098768) PMID:14972679 4896 2021-02-15 SPAC15E1.02c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC15E1.02c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15E1.02c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC15E1.02c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC15E1.02c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC15E1.02c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC15E1.02c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC15E1.02c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC15E1.02c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC15E1.02c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC15E1.02c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC15E1.02c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC15E1.02c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC15E1.02c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC15E1.02c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15E1.02c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC15E1.02c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC15E1.02c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC15E1.02c RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC15E1.03 rpl42 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC15E1.03 rpl42 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15E1.03 rpl42 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC15E1.03 rpl42 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC15E1.04 hal3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC15E1.06 vps29 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15E1.06 vps29 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC15E1.07c moa1 protein Western blot evidence decreased during(GO:0007133) PMID:16325576 4896 2021-05-15 SPAC15E1.07c moa1 protein Western blot evidence increased during(GO:0007128) PMID:16325576 4896 2021-05-15 SPAC15E1.07c moa1 RNA experimental evidence increased during(GO:0051321) PMID:16303567 4896 2010-01-03 SPAC15E1.08 naa10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15E1.08 naa10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC15E1.08 naa10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC15E1.08 naa10 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC15E1.09 grx2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15E1.09 grx2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC15E1.09 grx2 RNA northern assay evidence used in manual assertion unchanged during(GO:0070301) PMID:15358115 4896 2014-11-03 SPAC15E1.09 grx2 RNA northern assay evidence used in manual assertion unchanged during(GO:0036245) PMID:15358115 4896 2014-11-03 SPAC15E1.09 grx2 RNA northern assay evidence used in manual assertion unchanged during(GO:0071472) PMID:15358115 4896 2014-11-03 SPAC15E1.09 grx2 RNA northern assay evidence used in manual assertion unchanged during(GO:0034605) PMID:15358115 4896 2014-11-03 SPAC15E1.09 grx2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:15358115 4896 2014-11-03 SPAC15E1.10 fub1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC15E1.10 fub1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC15E1.10 fub1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC15E1.10 fub1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC15E1.10 fub1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC15F9.01c glm1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC15F9.03c nxt2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC15F9.03c nxt2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC16.01 rho2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC16.02c srp2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16.02c srp2 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC16.02c srp2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC16.03c ura2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16.03c ura2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC16.04 dus3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16.04 dus3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC16.04 dus3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16.05c sfp1 protein Western blot evidence decreased during(GO:0006995) PMID:38051102 4896 2023-12-15 SPAC16.05c sfp1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16.05c sfp1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16.05c sfp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16.05c sfp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC16.05c sfp1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC1610.02c mrpl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1610.02c mrpl1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1610.03c crp79 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1610.03c crp79 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1610.03c crp79 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPAC1610.03c crp79 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1610.04 mmc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1610.04 mmc1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1610.04 mmc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1635.01 por1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1635.01 por1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1635.01 por1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC1635.01 por1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1639.01c elo1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1639.01c elo1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1639.01c elo1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1639.01c elo1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1639.02c trk2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC167.03c snu66 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC167.04 pam17 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC167.05 dbs2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC167.05 dbs2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC167.05 dbs2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC167.05 dbs2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC167.06c mug143 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC167.06c mug143 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC167.06c mug143 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC167.06c mug143 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC167.06c mug143 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC167.06c mug143 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC167.06c mug143 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC167.06c mug143 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC167.06c mug143 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC167.06c mug143 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC167.06c mug143 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC167.06c mug143 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC167.06c mug143 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC167.06c mug143 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC167.06c mug143 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC167.06c mug143 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC167.06c mug143 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC167.07c hul5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC167.07c hul5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC167.07c hul5 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC167.07c hul5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC167.08 Tf2-2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC167.08 Tf2-2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC167.08 Tf2-2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC167.09 pga1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC167.09 pga1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1687.01 rpc19 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1687.01 rpc19 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.01 rpc19 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1687.01 rpc19 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.02 rce1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1687.02 rce1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.04 mcb1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:21813639 4896 2016-01-12 SPAC1687.06c rpl44 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.06c rpl44 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1687.06c rpl44 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.06c rpl44 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1687.06c rpl44 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1687.07 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1687.07 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC1687.07 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1687.07 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.07 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1687.08 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.10 mcp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1687.10 mcp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1687.11 spb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.11 spb1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.11 spb1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.11 spb1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1687.12c coq4 protein Western blot evidence decreased in presence of(CHEBI:30746) PMID:33232355 4896 2021-01-10 SPAC1687.12c coq4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1687.13c csn5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1687.14c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1687.14c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1687.14c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.14c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1687.14c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1687.15 gsk3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.15 gsk3 RNA quantitative PCR decreased in presence of(CHEBI:52289) PMID:31657618 4896 2023-06-21 (Fig. 3) SPAC1687.15 gsk3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.16c erg31 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.16c erg31 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1687.16c erg31 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.16c erg31 RNA Northern assay evidence increased during(GO:0071456) PMID:15797383 4896 2020-01-07 SPAC1687.16c erg31 RNA northern assay evidence used in manual assertion increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1687.16c erg31 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1687.16c erg31 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC1687.16c erg31 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1687.18c ssl3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.18c ssl3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1687.19c qtr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.20c mis6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.20c mis6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1687.20c mis6 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPAC1687.21 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.21 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1687.22c puf3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1687.22c puf3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1687.22c puf3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1687.22c puf3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16A10.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC16A10.01 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC16A10.01 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC16A10.01 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC16A10.01 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC16A10.01 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC16A10.01 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC16A10.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC16A10.01 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC16A10.01 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16A10.01 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC16A10.01 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16A10.01 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC16A10.01 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC16A10.04 rho4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16A10.04 rho4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC16A10.04 rho4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC16A10.04 rho4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC16A10.05c dad1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC16A10.07c taz1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16A10.08c mug74 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16A10.08c mug74 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC16C9.01c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16C9.01c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC16C9.01c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC16C9.01c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC16C9.01c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16C9.01c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC16C9.02c mta1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16C9.02c mta1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16C9.02c mta1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC16C9.03 nmd3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16C9.03 nmd3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC16C9.03 nmd3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16C9.03 nmd3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16C9.06c upf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16C9.06c upf1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC16C9.06c upf1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16C9.06c upf1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC16C9.07 pom2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC16E8.02 mpo1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC16E8.02 mpo1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC16E8.02 mpo1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC16E8.02 mpo1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC16E8.02 mpo1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16E8.02 mpo1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16E8.03 gna1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC16E8.03 gna1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC16E8.03 gna1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16E8.03 gna1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16E8.04c aro7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16E8.05c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC16E8.05c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC16E8.05c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC16E8.06c nop12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16E8.06c nop12 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC16E8.06c nop12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC16E8.06c nop12 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16E8.07c vph1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16E8.08 pos1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16E8.10c rsm7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC16E8.13 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC16E8.13 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC16E8.14c tae1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC16E8.15 tif45 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC16E8.15 tif45 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC16E8.16 sua7 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC16E8.16 sua7 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC16E8.16 sua7 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16E8.16 sua7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC16E8.16 sua7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC16E8.16 sua7 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1705.02 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1705.03c ecm33 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1705.03c ecm33 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1705.03c ecm33 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC1705.03c ecm33 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC1751.01c gti1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1751.01c gti1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC1751.01c gti1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1751.01c gti1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1751.01c gti1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1751.01c gti1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1751.02c rsm19 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1751.02c rsm19 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1751.03 tif313 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1751.03 tif313 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1751.03 tif313 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1751.03 tif313 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1751.04 loc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1751.04 loc1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1782.04 cox24 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1782.05 ypa2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1782.06c phb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1782.06c phb1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1782.07 qcr8 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1782.07 qcr8 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1782.07 qcr8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1782.08c rex3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1782.08c rex3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1782.08c rex3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1782.08c rex3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1782.09c clp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1782.09c clp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1782.10c nhp2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1782.10c nhp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1782.11 met14 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1782.11 met14 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1782.11 met14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1782.11 met14 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1782.12c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1782.12c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1783.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1783.02c vps66 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1783.04c hst4 protein Western blot evidence decreased in presence of(CHEBI:44423) PMID:34608864 4896 2021-11-05 SPAC1783.04c hst4 protein Western blot evidence decreased in presence of(CHEBI:25255) PMID:34608864 4896 2021-11-05 SPAC1783.04c hst4 protein Western blot evidence decreased during(GO:0000084) PMID:34608864 4896 2021-11-05 SPAC1783.04c hst4 RNA Northern assay evidence unchanged in presence of(CHEBI:25255) PMID:34608864 4896 2021-11-05 SPAC1783.05 hrp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1783.05 hrp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1783.06c atg12 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1783.06c atg12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1783.07c pap1 protein western blot evidence used in manual assertion increased during(GO:0070301) PMID:23115244 4896 2012-02-20 SPAC1783.07c pap1 protein reporter gene assay evidence increased during(GO:0071500) PMID:18248428 4896 2014-12-04 SPAC1783.07c pap1 protein reporter gene assay evidence increased during(GO:0006995) PMID:18248428 4896 2014-12-04 SPAC1783.07c pap1 protein reporter gene assay evidence unchanged during(GO:0042149) PMID:18248428 4896 2014-12-04 SPAC1783.07c pap1 protein reporter gene assay evidence unchanged during(GO:0036245) PMID:18248428 4896 2014-12-04 SPAC1783.07c pap1 protein reporter gene assay evidence unchanged during(GO:0070301) PMID:18248428 4896 2014-12-04 SPAC1783.07c pap1 protein reporter gene assay evidence unchanged during(GO:0071276) PMID:18248428 4896 2014-12-04 SPAC1783.07c pap1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:7769002 4896 2012-01-28 SPAC1783.07c pap1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071500) PMID:18248428 4896 2014-12-04 SPAC1783.07c pap1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0006995) PMID:18248428 4896 2014-12-04 SPAC1783.07c pap1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1783.07c pap1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1783.07c pap1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC1783.07c pap1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:7769002 4896 2012-01-28 SPAC1783.08c rpl1502 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1783.08c rpl1502 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1783.08c rpl1502 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1786.01c ptl2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1786.01c ptl2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1786.01c ptl2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1786.01c ptl2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1786.01c ptl2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1786.02 plb2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1786.02 plb2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1786.02 plb2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1786.02 plb2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1786.03 cut11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1786.03 cut11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17A2.01 bsu1 protein western blot evidence used in manual assertion absent during(GO:0071301) PMID:15701794 4896 2014-05-13 SPAC17A2.01 bsu1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17A2.01 bsu1 protein western blot evidence used in manual assertion present during(GO:0036225) PMID:15701794 4896 2014-05-13 SPAC17A2.01 bsu1 RNA northern assay evidence used in manual assertion absent during(GO:0071301) PMID:15701794 4896 2014-05-13 SPAC17A2.01 bsu1 RNA western blot evidence used in manual assertion decreased in presence of(CHEBI:26948) PMID:8675019 4896 2012-01-27 SPAC17A2.01 bsu1 RNA northern assay evidence used in manual assertion decreased during(GO:0071301) PMID:8675019 4896 2012-05-10 SPAC17A2.01 bsu1 RNA northern assay evidence used in manual assertion decreased in presence of(CHEBI:38338) PMID:8675019 4896 2012-05-10 SPAC17A2.01 bsu1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17A2.01 bsu1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17A2.01 bsu1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC17A2.01 bsu1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC17A2.01 bsu1 RNA northern assay evidence used in manual assertion present in presence of(CHEBI:43732) PMID:8675019 4896 2012-05-10 SPAC17A2.01 bsu1 RNA northern assay evidence used in manual assertion present in presence of(CHEBI:2639) PMID:8675019 4896 2012-05-10 SPAC17A2.01 bsu1 RNA northern assay evidence used in manual assertion present during(GO:0036225) PMID:15701794 4896 2014-05-13 SPAC17A2.02c tlc4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A2.02c tlc4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17A2.02c tlc4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17A2.03c vma6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A2.04c cns1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17A2.04c cns1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A2.05 osm1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17A2.05 osm1 RNA northern assay evidence used in manual assertion increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17A2.05 osm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17A2.05 osm1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC17A2.06c vps8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A2.09c csx1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A2.13c rad25 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC17A5.01 pex6 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17A5.01 pex6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A5.02c dbr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A5.02c dbr1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17A5.03 rpl301 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A5.03 rpl301 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17A5.03 rpl301 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17A5.03 rpl301 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17A5.03 rpl301 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC17A5.03 rpl301 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17A5.04c mde10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17A5.04c mde10 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A5.04c mde10 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC17A5.04c mde10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17A5.08 erp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17A5.09c glc8 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17A5.09c glc8 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17A5.09c glc8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17A5.10 hua1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17A5.10 hua1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17A5.11 rec12 RNA experimental evidence increased during(GO:0051321) PMID:8005432 4896 SPAC17A5.11 rec12 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:8005432 4896 2014-08-05 SPAC17A5.11 rec12 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC17A5.11 rec12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC17A5.13 fol2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A5.13 fol2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17A5.13 fol2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17A5.14 exo2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17A5.14 exo2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A5.14 exo2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17A5.15c gus1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17A5.15c gus1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17A5.15c gus1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17A5.15c gus1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17A5.18c rec25 protein western blot evidence used in manual assertion decreased during(GO:0007135) PMID:18514516 4896 2017-08-02 SPAC17A5.18c rec25 protein western blot evidence used in manual assertion increased during(GO:0007128) PMID:18514516 4896 2017-08-02 SPAC17A5.18c rec25 protein western blot evidence used in manual assertion present during(GO:0006279) PMID:18514516 4896 2017-08-02 SPAC17A5.18c rec25 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC17A5.18c rec25 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17C9.01c nuc2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17C9.01c nuc2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17C9.02c lys7 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC17C9.03 tif471 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17C9.06 sam50 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17C9.06 sam50 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17C9.06 sam50 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17C9.06 sam50 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC17C9.07 alg8 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17C9.07 alg8 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17C9.08 pnu1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17C9.08 pnu1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17C9.08 pnu1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17C9.09c tim13 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17C9.10 stm1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17C9.10 stm1 RNA increased during(GO:0006995) PMID:11461899 4896 2012-02-03 SPAC17C9.10 stm1 RNA increased during(GO:0042149) PMID:11461899 4896 2012-02-03 SPAC17C9.10 stm1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17C9.10 stm1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC17C9.11c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17C9.11c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17C9.11c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC17C9.11c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17C9.11c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17C9.11c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC17C9.12 scs22 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17C9.12 scs22 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC17C9.12 scs22 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17C9.14 pex19 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17C9.14 pex19 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC17C9.15c dhm2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17C9.16c mfs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17C9.16c mfs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17C9.16c mfs1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC17C9.16c mfs1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC17C9.16c mfs1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17D4.01 pex7 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17D4.01 pex7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17D4.01 pex7 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17D4.01 pex7 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17D4.01 pex7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17D4.01 pex7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17D4.02 cdc45 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:11344166 4896 2015-02-11 SPAC17D4.02 cdc45 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17D4.03c cis4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17D4.04 trm401 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC17G6.02c tco1 protein western blot evidence used in manual assertion decreased during(GO:0071456) PMID:18276645 4896 2020-09-24 SPAC17G6.02c tco1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G6.02c tco1 RNA northern assay evidence used in manual assertion decreased during(GO:0071456) PMID:18276645 4896 2020-09-24 SPAC17G6.02c tco1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17G6.02c tco1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC17G6.03 efn3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G6.03 efn3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17G6.03 efn3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC17G6.03 efn3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17G6.03 efn3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC17G6.03 efn3 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC17G6.04c cpp1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17G6.04c cpp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G6.06 rps2401 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17G6.06 rps2401 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17G6.08 pep7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17G6.08 pep7 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17G6.11c ghs2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G6.11c ghs2 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC17G6.11c ghs2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17G6.12 cul1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17G6.12 cul1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G6.13 slt1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G6.13 slt1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17G6.13 slt1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC17G6.13 slt1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17G6.13 slt1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC17G6.13 slt1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC17G6.14c uap56 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G6.14c uap56 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17G6.15c fsf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G6.16c ysh1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17G6.16c ysh1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC17G6.16c ysh1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17G6.17 pof8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G8.01c trl1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17G8.04c arc5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17G8.06c ilv3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G8.06c ilv3 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC17G8.06c ilv3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17G8.06c ilv3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC17G8.06c ilv3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC17G8.10c dma1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17G8.10c dma1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17G8.11c imt3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17G8.11c imt3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17G8.12 sec3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17G8.14c pck1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17G8.14c pck1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17H9.01 cid16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17H9.03c rdl1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17H9.03c rdl1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17H9.04c dri1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17H9.04c dri1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17H9.04c dri1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC17H9.04c dri1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC17H9.04c dri1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC17H9.04c dri1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC17H9.04c dri1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC17H9.04c dri1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17H9.04c dri1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC17H9.04c dri1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17H9.05 ebp2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17H9.05 ebp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17H9.05 ebp2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC17H9.05 ebp2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17H9.06c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17H9.06c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC17H9.06c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC17H9.07 srp21 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17H9.08 leu5 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC17H9.08 leu5 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC17H9.08 leu5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17H9.09c ras1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17H9.09c ras1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC17H9.09c ras1 RNA northern assay evidence used in manual assertion unchanged during(GO:0036227) PMID:2300054 4896 2014-06-18 SPAC17H9.09c ras1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:2300054 4896 2014-06-18 SPAC17H9.11 gmf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC17H9.12c cyc2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17H9.12c cyc2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17H9.12c cyc2 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC17H9.13c pro2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17H9.14c pdi2 protein reporter gene assay evidence increased during(GO:0036245) PMID:16850188 4896 2014-11-05 SPAC17H9.14c pdi2 protein reporter gene assay evidence increased during(GO:0070301) PMID:16850188 4896 2014-11-05 SPAC17H9.14c pdi2 protein reporter gene assay evidence increased during(GO:0042149) PMID:16850188 4896 2014-11-05 SPAC17H9.14c pdi2 protein reporter gene assay evidence increased during(GO:0006995) PMID:16850188 4896 2014-11-05 SPAC17H9.14c pdi2 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:16850188 4896 2014-11-05 SPAC17H9.14c pdi2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:16850188 4896 2014-11-05 SPAC17H9.16 tom22 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC17H9.16 tom22 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17H9.16 tom22 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC17H9.17c mdm10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC17H9.17c mdm10 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC17H9.18c RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC17H9.19c cdt2 protein western blot evidence used in manual assertion absent during(GO:0000085) PMID:16252005 4896 2014-12-12 SPAC17H9.19c cdt2 protein western blot evidence used in manual assertion increased in presence of(CHEBI:44423) PMID:16252005 4896 2014-12-12 SPAC17H9.19c cdt2 protein western blot evidence used in manual assertion increased during(GO:0071479) PMID:16252005 4896 2014-12-12 SPAC17H9.19c cdt2 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:12871901 4896 2013-12-23 SPAC17H9.19c cdt2 protein western blot evidence used in manual assertion increased during(GO:0072711) PMID:26912660 4896 2016-03-02 SPAC17H9.19c cdt2 protein western blot evidence used in manual assertion present during(GO:0000084) PMID:16252005 4896 2014-12-12 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion absent during(GO:0000087) PMID:8313888 4896 2014-09-18 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion absent during(GO:0000085) PMID:8313888 4896 2014-09-18 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion absent during(GO:0000086) PMID:8313888 4896 2014-09-18 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion absent during(GO:0000084) PMID:8313888 4896 2014-09-18 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion absent during(GO:0000087) PMID:12898217 4896 2015-06-05 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion absent during(GO:0000085) PMID:12898217 4896 2015-06-05 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion absent during(GO:0000086) PMID:12898217 4896 2015-06-05 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion absent during(GO:0000084) PMID:12898217 4896 2015-06-05 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion decreased during(GO:0000087) PMID:12871901 4896 2013-12-23 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion increased during(GO:0071479) PMID:16252005 4896 2014-12-12 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion increased during(GO:0000080) PMID:12871901 4896 2013-12-23 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion increased during(GO:0000084) PMID:12871901 4896 2013-12-23 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion increased during(GO:0051330) PMID:12871901 4896 2013-12-23 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion increased during(GO:0051332) PMID:12871901 4896 2013-12-23 SPAC17H9.19c cdt2 RNA quantitative PCR increased during(GO:0072711) PMID:26912660 4896 2016-03-02 SPAC17H9.19c cdt2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC17H9.19c cdt2 RNA northern assay evidence used in manual assertion present during(GO:0000080) PMID:8313888 4896 2014-09-18 SPAC17H9.20 psc3 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:12898217 4896 2015-06-01 SPAC17H9.20 psc3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1805.01c ppk6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1805.02c etf2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1805.02c etf2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1805.02c etf2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1805.06c hem2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1805.06c hem2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1805.08 dlc1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1805.09c fmt1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC1805.09c fmt1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1805.10 ccz1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1805.11c rps2602 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1805.11c rps2602 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1805.11c rps2602 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1805.11c rps2602 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1805.11c rps2602 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1805.12c ubi2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1805.12c ubi2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1805.12c ubi2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1805.12c ubi2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1805.13 rpl14 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1805.13 rpl14 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1805.13 rpl14 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1805.13 rpl14 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1805.15c pub2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1805.15c pub2 RNA experimental evidence increased during(GO:0006995) PMID:11956316 4896 2008-10-01 SPAC1805.15c pub2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1805.16c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1805.16c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1805.16c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1805.16c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1805.17 crm1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1805.17 crm1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1805.17 crm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1805.18 pop6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1834.01 erf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1834.01 erf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1834.02 aro1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1834.03c hhf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1834.03c hhf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1834.03c hhf1 RNA Northern assay evidence fluctuates during(GO:0098763) PMID:17452352 4896 2018-02-28 SPAC1834.03c hhf1 RNA Northern assay evidence increased during(GO:0000084) PMID:17452352 4896 2018-02-28 SPAC1834.04 hht1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1834.04 hht1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1834.04 hht1 RNA Northern assay evidence fluctuates during(GO:0098763) PMID:17452352 4896 2018-02-28 SPAC1834.04 hht1 RNA Northern assay evidence increased during(GO:0000084) PMID:17452352 4896 2018-02-28 SPAC1834.04 hht1 RNA quantitative PCR increased during(GO:0000084) PMID:30635289 4896 2024-07-23 Accordingly, the peak of septation matches with the peak of expression of the histone H3 (hht1 gene) as histones are highly expressed during S phase (Figure 1A). SPAC1834.05 alg9 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1834.06c pmo25 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:16096637 4896 2015-08-13 SPAC1834.07 klp3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1834.09 whr1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC1834.10c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1834.11c sec18 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1834.11c sec18 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1851.03 ckb1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC186.01 pfl9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC186.01 pfl9 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC186.01 pfl9 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC186.01 pfl9 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC186.02c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC186.02c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC186.03 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC186.03 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC186.03 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC186.03 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC186.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC186.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC186.04c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC186.04c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC186.04c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC186.04c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC186.05c gdt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC186.05c gdt1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC186.08c ldh1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC186.08c ldh1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC186.09 pdc102 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC186.09 pdc102 RNA quantitative PCR unchanged during(GO:0036227) PMID:25102102 4896 2015-09-29 SPAC186.09 pdc102 RNA quantitative PCR present during(GO:0072690) PMID:25102102 4896 2015-09-29 SPAC18B11.02c pus9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18B11.02c pus9 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC18B11.03c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC18B11.04 ncs1 protein western blot evidence used in manual assertion increased in presence of(CHEBI:29108) PMID:14722091 4896 2012-01-31 SPAC18B11.04 ncs1 protein western blot evidence used in manual assertion increased during(GO:0071277) PMID:14722091 4896 2012-02-09 SPAC18B11.04 ncs1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC18B11.04 ncs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC18B11.04 ncs1 RNA reporter gene assay evidence increased in presence of(CHEBI:29108) PMID:20018864 4896 2012-01-31 SPAC18B11.04 ncs1 RNA reporter gene assay evidence unchanged in presence of(CHEBI:18420) PMID:20018864 4896 2012-01-31 SPAC18B11.04 ncs1 RNA reporter gene assay evidence unchanged in presence of(CHEBI:29101) PMID:20018864 4896 2012-01-31 SPAC18B11.04 ncs1 RNA reporter gene assay evidence unchanged in presence of(CHEBI:29103) PMID:20018864 4896 2012-01-31 SPAC18B11.04 ncs1 RNA reporter gene assay evidence unchanged in presence of(CHEBI:30911) PMID:20018864 4896 2012-01-31 SPAC18B11.04 ncs1 RNA reporter gene assay evidence unchanged in presence of(CHEBI:32035) PMID:20018864 4896 2012-01-31 SPAC18B11.04 ncs1 RNA reporter gene assay evidence unchanged in presence of(CHEBI:61049) PMID:20018864 4896 2012-01-31 SPAC18B11.06 lcp5 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC18B11.06 lcp5 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC18B11.06 lcp5 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC18B11.06 lcp5 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC18B11.06 lcp5 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC18B11.06 lcp5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC18B11.06 lcp5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC18B11.06 lcp5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC18B11.07c rhp6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18B11.08c pat10 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18B11.08c pat10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC18B11.09c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC18B11.09c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC18B11.09c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC18B11.09c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC18B11.10 tup11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18B11.10 tup11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC18B11.11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18G6.01c aim18 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC18G6.01c aim18 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18G6.01c aim18 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC18G6.01c aim18 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC18G6.01c aim18 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC18G6.01c aim18 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC18G6.03 ypt3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC18G6.03 ypt3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC18G6.03 ypt3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC18G6.05c gcn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18G6.06 utp11 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC18G6.07c mra1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18G6.09c edc1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC18G6.09c edc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC18G6.09c edc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC18G6.09c edc1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC18G6.09c edc1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC18G6.09c edc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC18G6.11c rrn3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18G6.11c rrn3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC18G6.12c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18G6.12c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC18G6.12c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC18G6.12c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC18G6.14c rps7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC18G6.14c rps7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC18G6.14c rps7 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC18G6.14c rps7 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC18G6.14c rps7 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC18G6.14c rps7 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC18G6.15 mal3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1952.01 gab1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1952.02 tma23 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1952.02 tma23 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1952.02 tma23 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1952.02 tma23 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1952.02 tma23 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1952.03 otu2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1952.04c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC1952.04c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1952.04c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1952.04c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1952.05 gcn5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1952.05 gcn5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1952.05 gcn5 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1952.06c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1952.06c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1952.07 rad1 protein western blot evidence used in manual assertion decreased during(GO:0071456) PMID:31538680 4896 2019-10-14 SPAC1952.07 rad1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1952.08c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1952.09c ach1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1952.09c ach1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1952.09c ach1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1952.09c ach1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1952.09c ach1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1952.09c ach1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1952.11c ure2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1952.13 ned1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1952.13 ned1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1952.13 ned1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1952.13 ned1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1952.15c rec24 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC1952.15c rec24 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1952.17c tbc13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1952.17c tbc13 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1952.17c tbc13 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19A8.01c sec73 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19A8.02 ltc2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19A8.03 ymr1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19A8.04 erg5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19A8.04 erg5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC19A8.04 erg5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19A8.04 erg5 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC19A8.05c sst4 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19A8.05c sst4 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC19A8.05c sst4 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC19A8.05c sst4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19A8.05c sst4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19A8.05c sst4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19A8.06 pbr1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19A8.06 pbr1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19A8.07c imp4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19A8.07c imp4 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC19A8.07c imp4 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC19A8.07c imp4 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC19A8.07c imp4 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC19A8.07c imp4 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC19A8.07c imp4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19A8.07c imp4 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC19A8.07c imp4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19A8.08 upf2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC19A8.09 yos1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19A8.10 rfp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC19A8.12 dcp2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19A8.13 usp101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19A8.14 pth2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19A8.14 pth2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC19A8.15 trp2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19A8.15 trp2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19A8.15 trp2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19A8.15 trp2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19A8.15 trp2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC19A8.16 prl65 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC19A8.16 prl65 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19A8.16 prl65 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC19A8.16 prl65 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19A8.16 prl65 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19A8.16 prl65 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19A8.16 prl65 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19A8.16 prl65 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC19A8.16 prl65 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC19B12.01 ttc27 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC19B12.01 ttc27 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC19B12.01 ttc27 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC19B12.01 ttc27 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC19B12.01 ttc27 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC19B12.01 ttc27 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19B12.01 ttc27 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19B12.02c gas1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19B12.02c gas1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19B12.02c gas1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC19B12.02c gas1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19B12.02c gas1 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:21124977 4896 2015-12-15 SPAC19B12.03 bgs3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19B12.03 bgs3 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC19B12.04 rps3001 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19B12.04 rps3001 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC19B12.05c fcp1 protein western blot evidence used in manual assertion unchanged during(GO:0006995) PMID:22144909 4896 2015-11-04 SPAC19B12.05c fcp1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:22144909 4896 2015-11-04 SPAC19B12.05c fcp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19B12.06c rbd4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19B12.08 atg4 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC19B12.08 atg4 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC19B12.08 atg4 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC19B12.08 atg4 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC19B12.08 atg4 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC19B12.08 atg4 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC19B12.08 atg4 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC19B12.08 atg4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19B12.08 atg4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19B12.08 atg4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19B12.08 atg4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19B12.08 atg4 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC19B12.08 atg4 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC19B12.08 atg4 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC19B12.08 atg4 RNA quantitative PCR increased during(GO:0010438) PMID:33064910 4896 2020-10-28 SPAC19B12.09 srp14 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19B12.09 srp14 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19B12.09 srp14 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19B12.10 sst2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19B12.10 sst2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19B12.10 sst2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19B12.10 sst2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19B12.10 sst2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19B12.11c bud20 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19B12.11c bud20 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19B12.11c bud20 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19D5.01 pyp2 protein western blot evidence used in manual assertion decreased during(GO:0072752) PMID:17952063 4896 2016-01-15 SPAC19D5.01 pyp2 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:17952063 4896 2016-01-15 SPAC19D5.01 pyp2 protein Western blot evidence increased during(GO:0034605) PMID:23690545 4896 2026-04-29 (Fig. 4C, 4D) SPAC19D5.01 pyp2 protein Western blot evidence increased in presence of(CHEBI:49703) PMID:11460168 4896 2024-04-16 (Fig. 4B) SPAC19D5.01 pyp2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:17952063 4896 2016-01-15 SPAC19D5.01 pyp2 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19D5.01 pyp2 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:9450957 4896 2014-12-09 SPAC19D5.01 pyp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:8649397 4896 2013-06-04 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8649397 4896 2013-06-04 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0071470) PMID:8649397 4896 2013-06-04 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:8824587 4896 2014-02-26 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:9450957 4896 2014-12-09 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:9450957 4896 2014-12-09 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:9450957 4896 2014-12-09 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0072740) PMID:9450957 4896 2014-12-09 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:8824588 4896 2015-01-07 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8824588 4896 2015-01-07 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0072709) PMID:8824588 4896 2015-01-07 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:8824588 4896 2015-01-07 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0034644) PMID:9154834 4896 2015-05-13 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:9154834 4896 2015-05-13 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:17881729 4896 2015-12-10 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:18235227 4896 2015-12-17 SPAC19D5.01 pyp2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC19D5.01 pyp2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC19D5.01 pyp2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC19D5.01 pyp2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC19D5.01 pyp2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC19D5.01 pyp2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC19D5.01 pyp2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19D5.01 pyp2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19D5.01 pyp2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC19D5.01 pyp2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19D5.01 pyp2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC19D5.01 pyp2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC19D5.01 pyp2 RNA quantitative PCR increased during(GO:0010438) PMID:39105351 4896 2024-10-01 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:1464319 4896 2012-02-15 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8649397 4896 2013-06-04 SPAC19D5.01 pyp2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:18235227 4896 2015-12-17 SPAC19D5.02c emc10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC19D5.02c emc10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19D5.03 cid1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC19D5.03 cid1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19D5.05c imp3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19D5.05c imp3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19D5.06c din1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19D5.06c din1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC19D5.07 uga1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC19D5.07 uga1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC19D5.07 uga1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19D5.09c Tf2-8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19D5.09c Tf2-8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19E9.01c nup40 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19E9.02 fin1 protein western blot evidence used in manual assertion increased during(GO:0000087) PMID:9490640 4896 2014-08-26 SPAC19E9.02 fin1 protein Western blot evidence increased during(GO:0000085) PMID:22684255 4896 2020-12-23 (Figure 1a) SPAC19E9.02 fin1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:9490640 4896 2014-08-26 SPAC19E9.02 fin1 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:15509866 4896 2015-11-22 SPAC19E9.02 fin1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC19E9.02 fin1 RNA Northern assay evidence increased during(GO:0000093) PMID:11927555 4896 2020-12-20 SPAC19E9.02 fin1 RNA Northern assay evidence increased during(GO:0000080) PMID:11927555 4896 2020-12-20 SPAC19E9.02 fin1 RNA Northern assay evidence increased during(GO:0000090) PMID:11927555 4896 2020-12-20 SPAC19E9.02 fin1 RNA northern assay evidence used in manual assertion present during(GO:0010458) PMID:12411492 4896 2015-10-14 SPAC19E9.03 pas1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC19E9.03 pas1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19E9.03 pas1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19E9.03 pas1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC19E9.03 pas1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19E9.03 pas1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC19G12.01c cut20 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19G12.01c cut20 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC19G12.03 cda1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19G12.03 cda1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19G12.03 cda1 RNA northern assay evidence used in manual assertion increased during(GO:0030437) PMID:15862318 4896 2014-08-18 SPAC19G12.03 cda1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC19G12.04 dal1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19G12.04 dal1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC19G12.04 dal1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19G12.05 mce1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19G12.06c hta2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19G12.06c hta2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC19G12.07c rsd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19G12.08 scs7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19G12.08 scs7 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC19G12.08 scs7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19G12.08 scs7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19G12.09 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC19G12.09 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19G12.09 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC19G12.09 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC19G12.09 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC19G12.09 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC19G12.09 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC19G12.09 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC19G12.09 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC19G12.09 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19G12.09 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC19G12.09 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19G12.09 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC19G12.09 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19G12.09 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC19G12.09 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19G12.09 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC19G12.09 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC19G12.09 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC19G12.10c cpy1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19G12.11 coq9 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19G12.12 dlp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19G12.12 dlp1 protein Western blot evidence unchanged in presence of(CHEBI:30746) PMID:33232355 4896 2021-01-10 SPAC19G12.12 dlp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC19G12.13c poz1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19G12.14 its3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19G12.14 its3 RNA reverse transcription polymerase chain reaction transcription evidence unchanged in presence of(CHEBI:8273) PMID:23028742 4896 2014-02-14 SPAC19G12.14 its3 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:23028742 4896 2014-02-14 SPAC19G12.15c tpp1 protein western blot evidence used in manual assertion increased during(GO:0071472) PMID:11004189 4896 2013-09-10 SPAC19G12.15c tpp1 protein western blot evidence used in manual assertion increased during(GO:0034605) PMID:11004189 4896 2013-09-10 SPAC19G12.15c tpp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC19G12.15c tpp1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC19G12.15c tpp1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC19G12.15c tpp1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11004189 4896 2013-09-10 SPAC19G12.15c tpp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19G12.15c tpp1 RNA northern assay evidence used in manual assertion increased during(GO:0034599) PMID:11004189 4896 2013-05-08 SPAC19G12.15c tpp1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:11004189 4896 2013-05-08 SPAC19G12.15c tpp1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:11004189 4896 2013-05-08 SPAC19G12.15c tpp1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:11004189 4896 2013-09-10 SPAC19G12.15c tpp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC19G12.15c tpp1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC19G12.15c tpp1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:11004189 4896 2013-09-10 SPAC19G12.16c adg2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC19G12.16c adg2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC19G12.16c adg2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC19G12.16c adg2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC19G12.16c adg2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1A6.02 wdr55 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1A6.04c plb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1A6.04c plb1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1A6.04c plb1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1A6.05c ptl3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1A6.06c meu31 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1A6.06c meu31 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1A6.06c meu31 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1A6.06c meu31 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPAC1A6.06c meu31 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1A6.06c meu31 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1A6.07 sle1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1A6.07 sle1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC1A6.07 sle1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1A6.08c mug125 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1A6.08c mug125 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1A6.09c lag1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1A6.10 tcd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1A6.10 tcd1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1B1.02c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B1.02c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1B2.02c ugo1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1B2.03c elo2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1B2.03c elo2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B2.03c elo2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B2.03c elo2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1B2.03c elo2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1B2.03c elo2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1B2.03c elo2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1B2.04 cox6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B2.04 cox6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1B2.05 mcm5 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:9658174 4896 2015-06-10 SPAC1B2.05 mcm5 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:10888871 4896 2010-09-03 SPAC1B2.05 mcm5 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:10888871 4896 2010-09-03 SPAC1B2.06 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B3.01c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B3.03c wis2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1B3.03c wis2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B3.03c wis2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1B3.03c wis2 RNA expression microarray evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1B3.03c wis2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1B3.03c wis2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC1B3.03c wis2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B3.03c wis2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1B3.03c wis2 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC1B3.03c wis2 RNA Northern assay evidence increased PMID:8599928 4896 2025-04-05 SPAC1B3.04c guf1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B3.04c guf1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1B3.06c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1B3.06c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1B3.07c vps28 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B3.08 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1B3.08 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1B3.11c ypt4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1B3.12c rpb10 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1B3.12c rpb10 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B3.12c rpb10 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1B3.13 nan1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B3.13 nan1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B3.13 nan1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B3.13 nan1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1B3.14 vma3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B3.15c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1B3.15c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1B3.15c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B3.16c vht1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1B3.16c vht1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B3.16c vht1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1B3.16c vht1 RNA quantitative PCR fluctuates during(GO:0000278) PMID:27687771 4896 2016-12-06 SPAC1B3.16c vht1 RNA northern assay evidence used in manual assertion increased during(GO:1990383) PMID:12557275 4896 2014-05-21 SPAC1B3.16c vht1 RNA quantitative PCR increased during(GO:0071456) PMID:27053105 4896 2016-08-03 SPAC1B3.16c vht1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1B3.16c vht1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1B3.16c vht1 RNA RNA-sequencing evidence increased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAC1B3.17 clr2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1B3.18c mrps18 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1B3.20 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1B3.20 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1B3.20 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1B3.20 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1B3.21 coa3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1B3.21 coa3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1B9.02c sck1 protein Western blot evidence increased during(GO:0034605) PMID:38269097 4896 2024-03-26 (Figure 2) SPAC1B9.02c sck1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B9.03c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1B9.03c RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1B9.03c RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC1B9.03c RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC1B9.03c RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1B9.03c RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC1B9.03c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1B9.03c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1B9.03c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1D4.02c grh1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1D4.03c mon1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1D4.04 cct2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1D4.04 cct2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1D4.04 cct2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1D4.04 cct2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1D4.06c csk1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1D4.11c lkh1 protein western blot evidence used in manual assertion increased during(GO:0000087) PMID:21745468 4896 2012-01-30 SPAC1D4.11c lkh1 protein western blot evidence used in manual assertion increased during(GO:0000281) PMID:21745468 4896 2012-01-30 SPAC1D4.11c lkh1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1D4.11c lkh1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1D4.13 byr1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1D4.13 byr1 RNA northern assay evidence used in manual assertion unchanged during(GO:0036227) PMID:2300054 4896 2014-06-18 SPAC1D4.13 byr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:2300054 4896 2014-06-18 SPAC1F12.02c tma19 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F12.02c tma19 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F12.02c tma19 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC1F12.02c tma19 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F12.02c tma19 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1F12.04c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F12.05 any2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F12.06c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1F12.06c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F12.07 ser1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F12.07 ser1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F12.07 ser1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1F12.07 ser1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1F12.07 ser1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1F12.08 cab4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F12.10c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1F12.10c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1F12.10c RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC1F12.10c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F12.10c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1F12.10c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F12.10c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F12.10c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1F3.01 rrp6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F3.01 rrp6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1F3.01 rrp6 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F3.03 sro7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F3.05 gga21 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F3.05 gga21 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F3.05 gga21 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F3.06c spo15 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:15509866 4896 2015-11-22 SPAC1F3.09 mug161 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1F3.09 mug161 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1F3.09 mug161 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1F3.09 mug161 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1F3.09 mug161 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F3.09 mug161 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC1F3.09 mug161 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F3.10c oct1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1F5.04c cdc12 protein Western blot evidence decreased during(GO:0120306) PMID:32915139 4896 2020-10-26 SPAC1F5.04c cdc12 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1F5.05c mso1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F5.05c mso1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1F5.06 lsh1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1F5.07c hem14 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F5.07c hem14 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1F5.08c yam8 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC1F5.09c shk2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F5.09c shk2 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC1F5.09c shk2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC1F5.09c shk2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F5.09c shk2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F5.10 fal1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F7.02c has1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F7.02c has1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1F7.02c has1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC1F7.02c has1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC1F7.02c has1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC1F7.02c has1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC1F7.02c has1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F7.02c has1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F7.02c has1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F7.03 pkd2 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1F7.03 pkd2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F7.04 rho1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F7.05 cdc22 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1F7.05 cdc22 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F7.05 cdc22 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F7.05 cdc22 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:28640807 4896 2017-08-02 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion absent during(GO:0000087) PMID:12898217 4896 2015-06-05 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion absent during(GO:0000085) PMID:12898217 4896 2015-06-05 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion absent during(GO:0000086) PMID:12898217 4896 2015-06-05 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion absent during(GO:0000084) PMID:12898217 4896 2015-06-05 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion absent during(GO:0000087) PMID:8313888 4896 2014-09-18 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion absent during(GO:0000085) PMID:8313888 4896 2014-09-18 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion absent during(GO:0000086) PMID:8313888 4896 2014-09-18 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion absent during(GO:0000084) PMID:8313888 4896 2014-09-18 SPAC1F7.05 cdc22 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F7.05 cdc22 RNA Northern assay evidence fluctuates during(GO:0000278) PMID:1734281 4896 2019-04-29 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:14648198 4896 2019-08-07 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:44423) PMID:19750219 4896 2018-04-24 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:25255) PMID:19750219 4896 2018-04-24 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:44423) PMID:8479429 4896 2014-08-31 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion increased during(GO:0072711) PMID:24006488 4896 2013-12-05 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:16907) PMID:8842148 4896 2014-06-23 SPAC1F7.05 cdc22 RNA quantitative PCR increased during(GO:0072711) PMID:26912660 4896 2016-03-02 SPAC1F7.05 cdc22 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion unchanged during(GO:0071479) PMID:19750219 4896 2018-04-24 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion unchanged during(GO:0000085) PMID:19750219 4896 2018-04-24 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion present during(GO:0000080) PMID:8313888 4896 2014-09-18 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion present during(GO:0000082) PMID:8313888 4896 2014-09-18 SPAC1F7.05 cdc22 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:24006488 4896 2013-12-05 SPAC1F7.05 cdc22 RNA present during(GO:0000089) PMID:9755169 4896 2019-05-14 SPAC1F7.06 hsp3105 protein western blot evidence used in manual assertion increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPAC1F7.06 hsp3105 RNA quantitative PCR increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPAC1F7.06 hsp3105 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC1F7.06 hsp3105 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F7.07c fip1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1F7.07c fip1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F7.07c fip1 RNA northern assay evidence used in manual assertion absent during(GO:0071281) PMID:12888492 4896 2015-06-12 SPAC1F7.07c fip1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC1F7.07c fip1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F7.07c fip1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC1F7.07c fip1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F7.07c fip1 RNA RNA-sequencing evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC1F7.07c fip1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1F7.07c fip1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:12888492 4896 2015-06-12 SPAC1F7.07c fip1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:8995275 4896 2017-09-18 SPAC1F7.07c fip1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12888492 4896 2015-06-12 SPAC1F7.08 fio1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion absent during(GO:0071281) PMID:12888492 4896 2015-06-12 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion decreased during(GO:0071281) PMID:21531205 4896 2014-10-27 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion decreased during(GO:0071281) PMID:15866870 4896 2015-06-12 SPAC1F7.08 fio1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:16963626 4896 2019-05-24 SPAC1F7.08 fio1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F7.08 fio1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F7.08 fio1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC1F7.08 fio1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F7.08 fio1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1F7.08 fio1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:23115244 4896 2012-02-20 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:21531205 4896 2014-10-27 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:12888492 4896 2015-06-12 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:15866870 4896 2015-06-12 SPAC1F7.08 fio1 RNA RNA protection assay evidence increased during(GO:0010106) PMID:24897379 4896 2015-06-12 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:25806539 4896 2016-09-04 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:8995275 4896 2017-09-18 SPAC1F7.08 fio1 RNA RNA protection assay evidence increased during(GO:0010106) PMID:16963626 4896 2019-05-24 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23115244 4896 2012-02-20 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12888492 4896 2015-06-12 SPAC1F7.08 fio1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:15866870 4896 2015-06-12 SPAC1F7.09c dal2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F7.09c dal2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F7.09c dal2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1F7.09c dal2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F7.10 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1F7.10 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1F7.11c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC1F7.12 yak3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F7.12 yak3 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC1F7.12 yak3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1F7.13c rpl801 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F7.13c rpl801 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F7.13c rpl801 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F7.13c rpl801 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1F7.13c rpl801 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F7.13c rpl801 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC1F8.01 ght3 protein western blot evidence used in manual assertion increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPAC1F8.01 ght3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1F8.01 ght3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F8.01 ght3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F8.01 ght3 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC1F8.01 ght3 RNA quantitative PCR increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPAC1F8.01 ght3 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC1F8.01 ght3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1F8.01 ght3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F8.01 ght3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F8.01 ght3 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0071281) PMID:30730059 4896 2019-11-13 SPAC1F8.02c shu1 protein western blot evidence used in manual assertion absent during(GO:0071281) PMID:25733668 4896 2015-06-11 SPAC1F8.02c shu1 protein fusion protein localization evidence increased during(GO:0010106) PMID:25733668 4896 2015-06-11 SPAC1F8.02c shu1 protein western blot evidence used in manual assertion increased during(GO:0010106) PMID:25733668 4896 2015-06-11 SPAC1F8.02c shu1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1F8.02c shu1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F8.03c str3 RNA northern assay evidence used in manual assertion decreased during(GO:0071281) PMID:12888492 4896 2015-06-12 SPAC1F8.03c str3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC1F8.03c str3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F8.03c str3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1F8.03c str3 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1F8.03c str3 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:23115244 4896 2012-02-20 SPAC1F8.03c str3 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:12888492 4896 2015-06-12 SPAC1F8.03c str3 RNA RNA protection assay evidence increased during(GO:0010106) PMID:29549126 4896 2019-05-27 SPAC1F8.03c str3 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPAC1F8.03c str3 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPAC1F8.03c str3 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC1F8.03c str3 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12888492 4896 2015-06-12 SPAC1F8.04c hhy1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F8.04c hhy1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F8.04c hhy1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC1F8.04c hhy1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC1F8.04c hhy1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F8.04c hhy1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC1F8.05 isp3 protein western blot evidence used in manual assertion absent during(GO:0072690) PMID:23843742 4896 2013-08-08 SPAC1F8.05 isp3 protein sodium dodecyl sulfate polyacrylamide gel electrophoresis evidence decreased during(GO:0009847) PMID:24623719 4896 2015-12-09 SPAC1F8.05 isp3 protein sodium dodecyl sulfate polyacrylamide gel electrophoresis evidence increased during(GO:0030437) PMID:24623719 4896 2015-12-09 SPAC1F8.05 isp3 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:23843742 4896 2013-08-08 SPAC1F8.05 isp3 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F8.05 isp3 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:7954893 4896 2014-05-08 SPAC1F8.05 isp3 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPAC1F8.05 isp3 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:7954893 4896 2014-05-08 SPAC1F8.05 isp3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC1F8.05 isp3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC1F8.05 isp3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F8.06 pfl8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F8.06 pfl8 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F8.06 pfl8 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC1F8.06 pfl8 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC1F8.06 pfl8 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC1F8.07c pdc101 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC1F8.07c pdc101 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC1F8.07c pdc101 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC1F8.07c pdc101 RNA quantitative PCR decreased during(GO:0036227) PMID:25102102 4896 2015-09-29 SPAC1F8.07c pdc101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC1F8.07c pdc101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC1F8.07c pdc101 RNA quantitative PCR present during(GO:0072690) PMID:25102102 4896 2015-09-29 SPAC20G4.01 caf16 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20G4.01 caf16 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20G4.01 caf16 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20G4.02c fus1 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC20G4.02c fus1 RNA northern assay evidence used in manual assertion increased during(GO:0071444) PMID:7791776 4896 2014-05-13 SPAC20G4.02c fus1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC20G4.02c fus1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20G4.02c fus1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20G4.02c fus1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:7791776 4896 2014-05-13 SPAC20G4.03c hri1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20G4.03c hri1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC20G4.03c hri1 protein western blot evidence used in manual assertion present during(GO:0070314) PMID:23687372 4896 2014-02-24 SPAC20G4.03c hri1 RNA quantitative PCR decreased in presence of(CHEBI:52289) PMID:31657618 4896 2023-06-21 (Fig. 3) SPAC20G4.03c hri1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC20G4.03c hri1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC20G4.03c hri1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC20G4.03c hri1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC20G4.03c hri1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20G4.04c hus1 protein western blot evidence used in manual assertion decreased during(GO:0071456) PMID:31538680 4896 2019-10-14 SPAC20G4.04c hus1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20G4.05c sel0 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC20G4.05c sel0 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC20G4.05c sel0 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC20G4.05c sel0 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20G4.06c adf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20G4.07c erg4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC20G4.07c erg4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20G4.07c erg4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20G8.01 cdc17 RNA northern assay evidence used in manual assertion decreased during(GO:0036227) PMID:3329047 4896 2013-09-30 SPAC20G8.01 cdc17 RNA northern assay evidence used in manual assertion increased during(GO:0034644) PMID:3329047 4896 2013-09-30 SPAC20G8.02 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC20G8.03 itr2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20G8.03 itr2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC20G8.03 itr2 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC20G8.03 itr2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC20G8.03 itr2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20G8.03 itr2 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:9560432 4896 2012-05-17 SPAC20G8.03 itr2 RNA northern assay evidence used in manual assertion unchanged during(GO:0036110) PMID:9560432 4896 2012-05-17 SPAC20G8.03 itr2 RNA northern assay evidence used in manual assertion unchanged during(GO:0006995) PMID:9560432 4896 2012-05-17 SPAC20G8.03 itr2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9560432 4896 2012-05-17 SPAC20G8.04c cir2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC20G8.04c cir2 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC20G8.04c cir2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20G8.05c cdc15 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20G8.05c cdc15 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20G8.05c cdc15 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20G8.05c cdc15 RNA Northern assay evidence decreased during(GO:0000093) PMID:7634333 4896 2021-01-22 SPAC20G8.05c cdc15 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:15509866 4896 2015-11-22 SPAC20G8.05c cdc15 RNA Northern assay evidence increased during(GO:0000090) PMID:7634333 4896 2021-01-22 SPAC20G8.05c cdc15 RNA northern assay evidence used in manual assertion present during(GO:0010458) PMID:12411492 4896 2015-10-14 SPAC20G8.07c erg2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC20G8.07c erg2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC20G8.08c fft1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20G8.08c fft1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC20G8.09c nat10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20G8.09c nat10 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC20G8.09c nat10 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC20G8.09c nat10 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC20G8.09c nat10 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC20G8.09c nat10 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC20G8.09c nat10 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC20G8.09c nat10 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC20G8.10c atg6 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20G8.10c atg6 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC20G8.10c atg6 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC20G8.10c atg6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20H4.01 utp5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC20H4.01 utp5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC20H4.02 dsc3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC20H4.02 dsc3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC20H4.03c tfs1 protein Western blot evidence unchanged in presence of(CHEBI:45979) PMID:37052630 4896 2023-04-27 SPAC20H4.04 fml2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC20H4.05c mde1 RNA quantitative PCR unchanged during(GO:0042149) PMID:34086083 4896 2021-06-10 SPAC20H4.06c gpl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20H4.08 whi2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC20H4.08 whi2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20H4.08 whi2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20H4.08 whi2 RNA expression microarray evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC20H4.08 whi2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC20H4.08 whi2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC20H4.09 gih35 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC20H4.10 ufd2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC20H4.10 ufd2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC20H4.10 ufd2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC20H4.11c rho5 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC20H4.11c rho5 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC20H4.11c rho5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC20H4.11c rho5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC20H4.11c rho5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC212.01c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC212.02 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC212.02 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC212.04c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC212.04c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC212.04c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC212.04c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC212.05c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC212.05c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC212.09c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC212.09c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC212.10 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC212.11 tlh1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC21E11.03c pcr1 protein western blot evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2014-03-18 SPAC21E11.03c pcr1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC21E11.03c pcr1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:23874237 4896 2014-03-18 SPAC21E11.03c pcr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2014-03-18 SPAC21E11.03c pcr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC21E11.03c pcr1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC21E11.03c pcr1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC21E11.03c pcr1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC21E11.03c pcr1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC21E11.03c pcr1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC21E11.03c pcr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC21E11.03c pcr1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC21E11.03c pcr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC21E11.03c pcr1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC21E11.03c pcr1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC21E11.03c pcr1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC21E11.03c pcr1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC21E11.04 aca1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC21E11.04 aca1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC21E11.04 aca1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC21E11.04 aca1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC21E11.04 aca1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC21E11.05c cyp8 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC21E11.07 iba57 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC222.03c tim10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC222.03c tim10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC222.05c mss1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC222.05c mss1 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC222.06 mak16 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC222.06 mak16 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC222.06 mak16 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC222.06 mak16 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC222.06 mak16 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC222.06 mak16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC222.06 mak16 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC222.06 mak16 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC222.07c hri2 protein western blot evidence used in manual assertion present during(GO:0070314) PMID:23687372 4896 2014-02-24 SPAC222.07c hri2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC222.07c hri2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC222.07c hri2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC222.08c sno1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC222.08c sno1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC222.08c sno1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC222.08c sno1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC222.08c sno1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC222.08c sno1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC222.08c sno1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC222.09 seb1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC222.10c byr4 protein Western blot evidence decreased during(GO:0098765) PMID:24838944 4896 2025-04-15 (Fig. 3A) SPAC222.10c byr4 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC222.10c byr4 RNA northern assay evidence used in manual assertion unchanged during(GO:0006995) PMID:8682866 4896 2015-05-07 SPAC222.10c byr4 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8682866 4896 2015-05-07 SPAC222.11 hem13 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC222.11 hem13 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC222.11 hem13 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC222.11 hem13 RNA Northern assay evidence increased during(GO:0071456) PMID:15797383 4896 2020-01-07 SPAC222.11 hem13 RNA northern assay evidence used in manual assertion increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC222.11 hem13 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC222.11 hem13 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC222.12c atp2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC222.12c atp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC222.12c atp2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC222.13c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC222.14c sey1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC222.14c sey1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC222.14c sey1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC222.15 meu13 protein western blot evidence used in manual assertion absent during(GO:0007127) PMID:15210864 4896 2015-10-20 SPAC222.15 meu13 protein western blot evidence used in manual assertion absent during(GO:0007135) PMID:15210864 4896 2015-10-20 SPAC222.15 meu13 protein fusion protein localization evidence increased during(GO:0007128) PMID:11447128 4896 2015-05-27 SPAC222.15 meu13 protein western blot evidence used in manual assertion increased during(GO:0051328) PMID:15210864 4896 2015-10-20 SPAC222.15 meu13 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC222.15 meu13 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:11447128 4896 2015-05-27 SPAC222.15 meu13 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:11447128 4896 2015-05-27 SPAC222.15 meu13 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC222.18 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC222.19 lam3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC227.01c erd1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC227.02c rrp15 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC227.02c rrp15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.02c rrp15 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC227.02c rrp15 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC227.03c yea6 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC227.03c yea6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC227.04 atg10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC227.05 pfd4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.06 yip5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC227.06 yip5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.07c pab1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.08c yth1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.11c yos9 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC227.12 rna4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC227.13c isu1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.13c isu1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC227.14 yfh7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.15 reg1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC227.16c psf3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.17c rea1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC227.17c rea1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC227.17c rea1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC227.18 lys3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC227.18 lys3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC227.18 lys3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC227.18 lys3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC227.18 lys3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC227.18 lys3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC227.19c pig25 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22A12.01c pso2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22A12.01c pso2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22A12.02c mug103 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC22A12.02c mug103 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22A12.02c mug103 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22A12.03c csn4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22A12.04c rps2201 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22A12.04c rps2201 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22A12.04c rps2201 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22A12.04c rps2201 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22A12.04c rps2201 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22A12.04c rps2201 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22A12.05 rpc11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22A12.05 rpc11 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22A12.05 rpc11 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22A12.05 rpc11 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22A12.06c fsh2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC22A12.06c fsh2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22A12.06c fsh2 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC22A12.06c fsh2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22A12.06c fsh2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAC22A12.06c fsh2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22A12.06c fsh2 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC22A12.06c fsh2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22A12.08c crd1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22A12.09c sap114 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22A12.10 ept1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22A12.11 dak1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22A12.11 dak1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22A12.11 dak1 RNA quantitative PCR decreased in presence of(CHEBI:52289) PMID:31657618 4896 2023-06-21 (Fig. 3) SPAC22A12.11 dak1 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:20396879 4896 2012-02-27 SPAC22A12.11 dak1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22A12.11 dak1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC22A12.11 dak1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22A12.11 dak1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:20396879 4896 2012-02-27 SPAC22A12.12c rrp40 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22A12.12c rrp40 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22A12.13 mug84 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22A12.14c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22A12.14c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22A12.15c bip1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22A12.15c bip1 protein western blot evidence used in manual assertion increased during(GO:0034605) PMID:8227200 4896 2016-06-29 SPAC22A12.15c bip1 protein western blot evidence used in manual assertion increased during(GO:0034976) PMID:23066505 4896 2017-01-18 SPAC22A12.15c bip1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22A12.15c bip1 protein Western blot evidence unchanged in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 upon HU or DIA treatments, Bip1-GFP cortical foci decreased their number and intensity concomitantly with an increase of Bip1-GFP signal at the expanded perinuclear ER (Fig 4A), whereas the protein levels of Bip1 did not signifi- cantly change (Fig 4B). SPAC22A12.15c bip1 protein Western blot evidence unchanged in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 upon HU or DIA treatments, Bip1-GFP cortical foci decreased their number and intensity concomitantly with an increase of Bip1-GFP signal at the expanded perinuclear ER (Fig 4A), whereas the protein levels of Bip1 did not signifi- cantly change (Fig 4B). SPAC22A12.15c bip1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22A12.15c bip1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22A12.15c bip1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC22A12.15c bip1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:1373379 4896 2012-12-03 SPAC22A12.15c bip1 RNA transcript expression level evidence increased during(GO:0034976) PMID:23066505 4896 2017-01-18 SPAC22A12.15c bip1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22A12.15c bip1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22A12.16 acl2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22A12.16 acl2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22A12.16 acl2 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22A12.16 acl2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22A12.17c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC22A12.17c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC22A12.17c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC22A12.17c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC22A12.17c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC22A12.17c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC22A12.17c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC22A12.17c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22A12.17c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22A12.17c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC22A12.17c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22A12.17c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC22A12.17c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC22E12.01 pet3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22E12.02 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22E12.03c sdj1 protein western blot evidence used in manual assertion increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPAC22E12.03c sdj1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22E12.03c sdj1 RNA quantitative PCR increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPAC22E12.03c sdj1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC22E12.03c sdj1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC22E12.03c sdj1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC22E12.03c sdj1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC22E12.03c sdj1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC22E12.03c sdj1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22E12.03c sdj1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22E12.03c sdj1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22E12.03c sdj1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22E12.03c sdj1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22E12.03c sdj1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC22E12.03c sdj1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22E12.04 ccs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22E12.04 ccs1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22E12.05c rer1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22E12.05c rer1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC22E12.06c gmh3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22E12.06c gmh3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22E12.09c krp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22E12.09c krp1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22E12.09c krp1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22E12.13c rlp24 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22E12.13c rlp24 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22E12.13c rlp24 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC22E12.13c rlp24 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC22E12.13c rlp24 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC22E12.13c rlp24 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC22E12.13c rlp24 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC22E12.13c rlp24 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22E12.13c rlp24 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22E12.14c sck2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22E12.16c pik1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22E12.16c pik1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22E12.16c pik1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22E12.16c pik1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22E12.18 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22E12.18 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22F3.02 atf31 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F3.02 atf31 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC22F3.02 atf31 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22F3.02 atf31 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22F3.03c rdh54 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F3.03c rdh54 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:21084840 4896 2016-09-03 SPAC22F3.03c rdh54 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC22F3.04 mug62 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F3.04 mug62 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22F3.04 mug62 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22F3.05c alp41 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22F3.06c lon1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F3.06c lon1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22F3.07c atp20 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22F3.08c rok1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F3.09c res2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F3.09c res2 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC22F3.09c res2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC22F3.09c res2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22F3.09c res2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22F3.09c res2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22F3.09c res2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC22F3.10c gcs1 RNA northern assay evidence used in manual assertion unchanged during(GO:0070301) PMID:7608113 4896 2012-05-25 SPAC22F3.10c gcs1 RNA northern assay evidence used in manual assertion unchanged during(GO:0071276) PMID:7608113 4896 2012-05-25 SPAC22F3.10c gcs1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:7608113 4896 2012-05-25 SPAC22F3.12c rgs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22F3.12c rgs1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC22F3.12c rgs1 RNA Northern assay evidence absent during(GO:0072690) PMID:11554925 4896 2020-12-16 SPAC22F3.12c rgs1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22F3.12c rgs1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC22F3.12c rgs1 RNA Northern assay evidence present during(GO:0006995) PMID:11554925 4896 2020-12-16 SPAC22F3.13 tsc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F3.15 aim41 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F8.02c pvg5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F8.02c pvg5 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22F8.02c pvg5 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC22F8.03c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22F8.04 pet1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22F8.04 pet1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22F8.05 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC22F8.05 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F8.05 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22F8.05 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22F8.05 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22F8.05 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC22F8.05 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC22F8.05 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC22F8.05 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC22F8.05 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC22F8.05 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22F8.05 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC22F8.05 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22F8.05 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22F8.05 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22F8.05 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC22F8.05 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22F8.05 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC22F8.05 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC22F8.05 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22F8.07c rtf1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F8.07c rtf1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22F8.07c rtf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22F8.07c rtf1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22F8.09 rrp16 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F8.09 rrp16 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22F8.09 rrp16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22F8.09 rrp16 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22F8.10c sap145 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22F8.11 plc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22F8.11 plc1 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22F8.11 plc1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22F8.12c shf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22G7.02 kap111 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22G7.05 kri1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22G7.05 kri1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22G7.05 kri1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22G7.05 kri1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22G7.06c ura1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22G7.06c ura1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22G7.06c ura1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22G7.06c ura1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22G7.06c ura1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC22G7.06c ura1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22G7.07c ime4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22G7.08 ppk8 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22G7.08 ppk8 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC22G7.08 ppk8 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC22G7.08 ppk8 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22G7.08 ppk8 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22G7.08 ppk8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22G7.08 ppk8 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC22G7.09c nup45 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22G7.10 iss1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22G7.11c cum1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC22G7.11c cum1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22G7.11c cum1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC22G7.11c cum1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC22G7.11c cum1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC22G7.11c cum1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC22G7.11c cum1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC22G7.11c cum1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC22G7.11c cum1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22G7.11c cum1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22G7.11c cum1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22G7.11c cum1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC22G7.11c cum1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC22H10.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22H10.02 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22H10.03c kap114 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22H10.04 ppa3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22H10.04 ppa3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22H10.05c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22H10.05c ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC22H10.05c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22H10.05c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22H10.07 scd2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22H10.10 alp21 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22H10.12c gdi1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC22H10.12c gdi1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC22H10.12c gdi1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22H10.12c gdi1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22H10.12c gdi1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC22H10.13 zym1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC22H10.13 zym1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22H10.13 zym1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC22H10.13 zym1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC22H10.13 zym1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC22H10.13 zym1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC22H10.13 zym1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC22H10.13 zym1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC22H10.13 zym1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22H10.13 zym1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC22H10.13 zym1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22H10.13 zym1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22H10.13 zym1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22H10.13 zym1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC22H10.13 zym1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC22H10.13 zym1 RNA Northern assay evidence increased in presence of(CHEBI:35176) PMID:12050156 4896 2023-12-13 Zinc caused the accumulation of zym1 transcripts with up to 10 -20-fold increase 30 min after the addition of ZnSO4 (Fig. 3, A and C). SPAC22H10.13 zym1 RNA Northern assay evidence increased in presence of(CHEBI:50292) PMID:12050156 4896 2023-12-14 Cadmium increased the proportion of longer zym1 transcripts as observed previously following the exposure to copper (Fig. 6B). SPAC22H10.13 zym1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC22H12.01c mug35 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22H12.01c mug35 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22H12.01c mug35 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC22H12.01c mug35 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC22H12.01c mug35 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC22H12.01c mug35 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC22H12.01c mug35 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC22H12.01c mug35 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC22H12.01c mug35 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC22H12.01c mug35 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC22H12.01c mug35 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22H12.01c mug35 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22H12.01c mug35 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22H12.01c mug35 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC22H12.01c mug35 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22H12.01c mug35 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC22H12.03 pah2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22H12.03 pah2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC22H12.04c rps102 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22H12.04c rps102 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC22H12.04c rps102 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC22H12.04c rps102 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC22H12.04c rps102 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC22H12.04c rps102 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC22H12.04c rps102 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22H12.05c fsc1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC22H12.05c fsc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC22H12.05c fsc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC22H12.05c fsc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23A1.02c ted1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23A1.02c ted1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23A1.03 apt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23A1.03 apt1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23A1.03 apt1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23A1.03 apt1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23A1.03 apt1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23A1.03 apt1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23A1.03 apt1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23A1.03 apt1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC23A1.05 tsc3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23A1.06c cmk2 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:12135745 4896 2014-08-16 SPAC23A1.06c cmk2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:12135745 4896 2014-08-16 SPAC23A1.06c cmk2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23A1.07 rnf170 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23A1.08c rpl3401 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23A1.08c rpl3401 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23A1.08c rpl3401 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23A1.08c rpl3401 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23A1.08c rpl3401 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23A1.08c rpl3401 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23A1.09 rbm8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23A1.10 tef102 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23A1.10 tef102 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23A1.10 tef102 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC23A1.10 tef102 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23A1.10 tef102 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC23A1.10 tef102 RNA northern assay evidence used in manual assertion unchanged during(GO:0034644) PMID:9099890 4896 2014-10-27 SPAC23A1.10 tef102 RNA northern assay evidence used in manual assertion unchanged during(GO:0034605) PMID:9099890 4896 2014-10-27 SPAC23A1.10 tef102 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9099890 4896 2014-10-27 SPAC23A1.11 rpl1602 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23A1.11 rpl1602 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23A1.11 rpl1602 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23A1.11 rpl1602 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23A1.12c frs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23A1.12c frs1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23A1.12c frs1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC23A1.12c frs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23A1.14c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23A1.14c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23A1.14c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23A1.14c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23A1.14c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23A1.14c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23A1.14c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23A1.15c sec20 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23A1.15c sec20 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23A1.15c sec20 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23A1.17 bbc1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23A1.17 bbc1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23A1.18c mrp51 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23A1.18c mrp51 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23C11.01 ice2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C11.01 ice2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C11.01 ice2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23C11.02c rps23 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23C11.02c rps23 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC23C11.02c rps23 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23C11.02c rps23 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23C11.02c rps23 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23C11.03 mpp10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C11.03 mpp10 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23C11.03 mpp10 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23C11.04c pnk1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23C11.04c pnk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C11.04c pnk1 RNA western blot evidence used in manual assertion present during(GO:0072690) PMID:11729194 4896 2013-05-13 SPAC23C11.05 ipp1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23C11.05 ipp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C11.05 ipp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23C11.05 ipp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23C11.05 ipp1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC23C11.06c protein mass spectrometry evidence fluctuates during(GO:0000278) PMID:24763107 4896 2014-05-01 SPAC23C11.06c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23C11.06c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C11.06c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23C11.06c ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23C11.06c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23C11.06c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC23C11.06c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC23C11.06c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23C11.06c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23C11.06c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23C11.06c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23C11.06c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23C11.06c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C11.06c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23C11.06c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23C11.06c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23C11.06c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC23C11.06c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23C11.06c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC23C11.06c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23C11.06c RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC23C11.08 php3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C11.08 php3 RNA quantitative PCR increased in presence of(CHEBI:29699) PMID:38360270 4896 2024-03-14 SPAC23C11.09 ala1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23C11.11 cka1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23C11.11 cka1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C11.12 hcn1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C11.12 hcn1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C11.12 hcn1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C11.13c hpt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23C11.13c hpt1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C11.14 zhf1 RNA reverse transcription polymerase chain reaction transcription evidence unchanged in presence of(CHEBI:23336) PMID:22806344 4896 2014-07-24 SPAC23C11.16 plo1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C11.16 plo1 RNA quantitative PCR decreased during(GO:0071500) PMID:22561704 4896 2015-11-16 SPAC23C11.16 plo1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23C11.16 plo1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C11.16 plo1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C11.16 plo1 RNA northern assay evidence used in manual assertion present during(GO:0010458) PMID:12411492 4896 2015-10-14 SPAC23C11.17 mdm38 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23C4.02 crn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C4.03 hrk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C4.03 hrk1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C4.05c les1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C4.05c les1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC23C4.05c les1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23C4.05c les1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23C4.05c les1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC23C4.05c les1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23C4.05c les1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC23C4.06c efm6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C4.06c efm6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23C4.07 tht2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C4.07 tht2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C4.08 rho3 protein western blot evidence used in manual assertion unchanged during(GO:0051321) PMID:23843742 4896 2013-08-08 SPAC23C4.08 rho3 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:23843742 4896 2013-08-08 SPAC23C4.11 atp18 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23C4.11 atp18 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C4.12 hhp2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C4.12 hhp2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C4.12 hhp2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C4.13 bet1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C4.13 bet1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23C4.13 bet1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23C4.14 alg1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23C4.14 alg1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C4.15 rpb5 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPAC23C4.15 rpb5 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPAC23C4.15 rpb5 protein western blot evidence used in manual assertion decreased during(GO:0034605) PMID:11918671 4896 2015-11-26 SPAC23C4.15 rpb5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C4.15 rpb5 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPAC23C4.15 rpb5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23C4.16c atg15 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23C4.16c atg15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23C4.17 trm402 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23C4.17 trm402 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23C4.17 trm402 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23C4.17 trm402 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23C4.17 trm402 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23C4.17 trm402 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23C4.17 trm402 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23C4.17 trm402 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23C4.18c rad4 protein western blot evidence used in manual assertion unchanged during(GO:0000278) PMID:7957098 4896 2014-11-20 SPAC23C4.18c rad4 RNA northern assay evidence used in manual assertion unchanged during(GO:0000278) PMID:7957098 4896 2014-11-20 SPAC23D3.01 pdp3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23D3.04c gpd2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23D3.04c gpd2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23D3.04c gpd2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC23D3.04c gpd2 RNA northern assay evidence used in manual assertion unchanged during(GO:0071471) PMID:8825100 4896 2013-10-23 SPAC23D3.04c gpd2 RNA northern assay evidence used in manual assertion unchanged during(GO:0071472) PMID:8825100 4896 2013-10-23 SPAC23D3.04c gpd2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8825100 4896 2013-10-23 SPAC23D3.05c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC23D3.05c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23D3.05c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23D3.05c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23D3.05c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23D3.05c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23D3.05c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23D3.06c nup146 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23D3.07 pup1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23D3.08 usp108 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23D3.08 usp108 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23D3.08 usp108 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23D3.10c eng2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23D3.10c eng2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23D3.10c eng2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23D3.10c eng2 RNA experimental evidence increased during(GO:0051321) 4896 2010-11-11 SPAC23D3.10c eng2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23D3.10c eng2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC23D3.11 ayr1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23D3.11 ayr1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23D3.11 ayr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23D3.11 ayr1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23D3.11 ayr1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23D3.11 ayr1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23D3.11 ayr1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23D3.11 ayr1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC23D3.11 ayr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23D3.11 ayr1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23D3.11 ayr1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23D3.12 pho842 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23D3.12 pho842 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23D3.12 pho842 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23D3.12 pho842 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23D3.12 pho842 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23D3.12 pho842 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23D3.12 pho842 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23D3.12 pho842 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23D3.12 pho842 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23D3.12 pho842 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC23D3.12 pho842 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23D3.12 pho842 RNA RNA-sequencing evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC23D3.12 pho842 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23D3.12 pho842 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23D3.12 pho842 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23D3.12 pho842 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23D3.12 pho842 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC23D3.13c mon2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23D3.14c aah2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23D3.14c aah2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23D3.14c aah2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23D3.14c aah2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23D3.16 lam4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23D3.17 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23D3.17 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23D3.17 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23E2.01 fep1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23E2.01 fep1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:24897379 4896 2016-08-24 SPAC23E2.01 fep1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC23E2.01 fep1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23E2.01 fep1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23E2.01 fep1 RNA RNA protection assay evidence unchanged during(GO:0071281) PMID:11956219 4896 2015-06-12 SPAC23E2.01 fep1 RNA RNA protection assay evidence unchanged during(GO:0010106) PMID:11956219 4896 2015-06-12 SPAC23E2.01 fep1 RNA RNA protection assay evidence present during(GO:0072690) PMID:11956219 4896 2015-06-12 SPAC23E2.01 fep1 RNA RNA protection assay evidence present during(GO:0072690) PMID:24897379 4896 2016-08-24 SPAC23E2.01 fep1 RNA Northern assay evidence present during(GO:0072690) PMID:8799335 4896 2021-01-22 SPAC23E2.02 lsd2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23E2.02 lsd2 protein Western blot evidence increased PMID:38181050 4896 2024-05-07 Both Lsd1 (Fig 4C) and Lsd2 (Fig 4D) protein levels drastically increase after heat treatment, although the mRNA levels of Lsd1 and Lsd2 were not significantly altered between wild-type and set1Δ cells (S10 Fig), suggesting that enhanced Lsd1/2 proteins are required for cell survival under heat stress [61]. SPAC23E2.03c sms1 protein fusion protein localization evidence absent during(GO:0051321) PMID:10835379 4896 2014-09-02 SPAC23E2.03c sms1 protein fusion protein localization evidence increased during(GO:0006995) PMID:10835379 4896 2014-09-02 SPAC23E2.03c sms1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23E2.03c sms1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23E2.03c sms1 protein microscopy evidence increased during(GO:0006995) PMID:41844616 4896 2026-04-09 Tagging of Sms1 with sfGFP at the endogenous locus confirmed that Sms1 is expressed upon nitrogen starvation, and its expression is strongly increased by pheromone stimulation (Fig. S3A). SPAC23E2.03c sms1 protein fusion protein localization evidence present during(GO:0072690) PMID:10835379 4896 2014-09-02 SPAC23E2.03c sms1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:10835379 4896 2014-09-02 SPAC23E2.03c sms1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC23E2.03c sms1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23E2.03c sms1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10835379 4896 2014-09-02 SPAC23G3.01 rpb2 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPAC23G3.01 rpb2 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPAC23G3.01 rpb2 protein western blot evidence used in manual assertion unchanged during(GO:0034605) PMID:11918671 4896 2015-11-26 SPAC23G3.01 rpb2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPAC23G3.01 rpb2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23G3.01 rpb2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23G3.02c sib1 RNA RNA protection assay evidence increased during(GO:0010106) PMID:20435771 4896 2016-10-04 SPAC23G3.02c sib1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23G3.02c sib1 RNA in situ hybridization evidence used in manual assertion increased in presence of(CHEBI:30351) PMID:32059768 4896 2021-03-31 SPAC23G3.03 sib2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23G3.03 sib2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23G3.03 sib2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23G3.03 sib2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC23G3.03 sib2 RNA RNA protection assay evidence increased during(GO:0010106) PMID:20435771 4896 2016-10-04 SPAC23G3.03 sib2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23G3.03 sib2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23G3.03 sib2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23G3.03 sib2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC23G3.03 sib2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23G3.03 sib2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23G3.06 nop58 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23G3.06 nop58 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23G3.07c snf30 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23G3.09 taf4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23G3.11 rpn6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23G3.12c htr12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23G3.12c htr12 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23H3.02c ini1 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC23H3.04 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC23H3.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23H3.05c swd1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23H3.05c swd1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23H3.05c swd1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23H3.05c swd1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23H3.06 apl6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H3.06 apl6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23H3.07c mrp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23H3.07c mrp2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23H3.09c gly1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H3.09c gly1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23H3.09c gly1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23H3.11c max1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23H3.11c max1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23H3.11c max1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23H3.11c max1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC23H3.11c max1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23H3.14 avl9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H3.15c ddr48 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H3.15c ddr48 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23H3.15c ddr48 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H3.15c ddr48 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23H3.15c ddr48 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC23H3.15c ddr48 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC23H3.15c ddr48 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23H3.15c ddr48 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23H3.15c ddr48 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23H3.15c ddr48 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23H3.15c ddr48 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23H3.15c ddr48 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC23H3.15c ddr48 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23H3.15c ddr48 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC23H3.15c ddr48 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23H3.15c ddr48 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC23H3.15c ddr48 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23H3.15c ddr48 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC23H3.15c ddr48 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC23H3.15c ddr48 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC23H3.15c ddr48 RNA expression microarray evidence increased in presence of(CHEBI:69136) PMID:38415071 4896 2024-10-09 SPAC23H4.01c osh3 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC23H4.01c osh3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC23H4.03c erv25 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H4.03c erv25 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC23H4.06 gln1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC23H4.06 gln1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H4.06 gln1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23H4.06 gln1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23H4.06 gln1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23H4.06 gln1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23H4.06 gln1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23H4.06 gln1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23H4.06 gln1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23H4.06 gln1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23H4.06 gln1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC23H4.07c srp102 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC23H4.09 cdb4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H4.09 cdb4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23H4.09 cdb4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23H4.10c thi4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H4.10c thi4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23H4.10c thi4 RNA northern assay evidence used in manual assertion decreased during(GO:0071301) PMID:7961415 4896 2014-08-05 SPAC23H4.10c thi4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC23H4.10c thi4 RNA northern assay evidence used in manual assertion increased during(GO:0036225) PMID:7961415 4896 2014-08-05 SPAC23H4.12 alp13 protein Western blot evidence increased in presence of(CHEBI:50398) PMID:33468217 4896 2021-03-19 SPAC23H4.13c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC23H4.14 vam6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H4.15 tsr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC23H4.15 tsr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC23H4.15 tsr1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23H4.15 tsr1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC23H4.15 tsr1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC23H4.15 tsr1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC23H4.15 tsr1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC23H4.15 tsr1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC23H4.15 tsr1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC23H4.15 tsr1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC23H4.15 tsr1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC24B11.05 ifn1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC24B11.05 ifn1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC24B11.05 ifn1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC24B11.05 ifn1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24B11.05 ifn1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24B11.05 ifn1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC24B11.05 ifn1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC24B11.05 ifn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC24B11.05 ifn1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24B11.05 ifn1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC24B11.07c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24B11.07c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24B11.09 mpc2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC24B11.09 mpc2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC24B11.09 mpc2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24B11.11c sid2 RNA northern assay evidence used in manual assertion present during(GO:0010458) PMID:12411492 4896 2015-10-14 SPAC24B11.12c dnf2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24B11.12c dnf2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC24B11.12c dnf2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24B11.13 hem3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC24B11.13 hem3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24B11.13 hem3 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC24B11.13 hem3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24B11.13 hem3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24C9.02c cyt2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC24C9.03 mvd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24C9.03 mvd1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC24C9.05c mug70 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24C9.05c mug70 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24C9.06c aco1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC24C9.06c aco1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC24C9.06c aco1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC24C9.06c aco1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC24C9.06c aco1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24C9.06c aco1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC24C9.07c bgs2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24C9.07c bgs2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC24C9.07c bgs2 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:11069657 4896 2015-09-28 SPAC24C9.07c bgs2 RNA northern assay evidence used in manual assertion absent during(GO:0034605) PMID:11069657 4896 2015-09-28 SPAC24C9.07c bgs2 RNA northern assay evidence used in manual assertion absent during(GO:0071277) PMID:11069657 4896 2015-09-28 SPAC24C9.07c bgs2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24C9.07c bgs2 RNA experimental evidence present during(GO:0000080) PMID:11069657 4896 SPAC24C9.07c bgs2 RNA northern assay evidence used in manual assertion present during(GO:0030437) PMID:11069657 4896 2015-09-28 SPAC24C9.07c bgs2 RNA experimental evidence present during(GO:0034293) PMID:11069657 4896 SPAC24C9.08 cps1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24C9.08 cps1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC24C9.08 cps1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC24C9.09 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24C9.11 sgd1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC24C9.12c shm1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24C9.12c shm1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC24C9.12c shm1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC24C9.12c shm1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24C9.12c shm1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC24C9.12c shm1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC24C9.12c shm1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC24C9.13c mrp10 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC24C9.14 otu1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC24C9.14 otu1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24C9.14 otu1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC24C9.14 otu1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24C9.15c spn5 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC24C9.15c spn5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24C9.15c spn5 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC24C9.15c spn5 RNA experimental evidence increased during(GO:0051321) PMID:10747048 4896 SPAC24C9.15c spn5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24C9.16c cox8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24H6.01c gup1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC24H6.01c gup1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24H6.01c gup1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24H6.01c gup1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24H6.04 hxk1 RNA experimental evidence decreased in presence of(CHEBI:17234) PMID:8549830 4896 2006-11-22 SPAC24H6.04 hxk1 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion decreased during(GO:0000085) PMID:8799851 4896 2018-11-21 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion decreased during(GO:0000093) PMID:17804800 4896 2017-01-06 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:8799851 4896 2018-11-21 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion increased during(GO:0000086) PMID:8799851 4896 2018-11-21 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion increased during(GO:0000087) PMID:8799851 4896 2018-11-21 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion increased during(GO:0071277) PMID:25081204 4896 2015-02-18 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion increased during(GO:0098764) PMID:17804800 4896 2015-10-12 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion increased during(GO:0000085) PMID:17804800 4896 2017-01-06 SPAC24H6.05 cdc25 protein microscopy evidence increased during(GO:0000085) PMID:28479325 4896 2022-01-31 SPAC24H6.05 cdc25 protein reporter gene assay evidence increased during(GO:0000085) PMID:28479325 4896 2022-01-31 SPAC24H6.05 cdc25 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:25081204 4896 2015-02-18 SPAC24H6.05 cdc25 RNA western blot evidence used in manual assertion decreased during(GO:0000093) PMID:17804800 4896 2017-01-06 SPAC24H6.05 cdc25 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24H6.05 cdc25 RNA northern assay evidence used in manual assertion increased during(GO:0098764) PMID:17804800 4896 2015-10-12 SPAC24H6.05 cdc25 RNA western blot evidence used in manual assertion increased during(GO:0000085) PMID:17804800 4896 2017-01-06 SPAC24H6.05 cdc25 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24H6.05 cdc25 RNA in situ hybridization evidence used in manual assertion increased during(GO:0000085) PMID:28479325 4896 2022-01-31 During G2, the concentration of Cdc25 increases about 2 fold (Figure 1A) SPAC24H6.05 cdc25 RNA expression microarray evidence increased during(GO:0000085) PMID:28479325 4896 2022-01-31 SPAC24H6.06 sld3 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24H6.06 sld3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24H6.06 sld3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24H6.06 sld3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24H6.07 rps901 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC24H6.07 rps901 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC24H6.07 rps901 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC24H6.07 rps901 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24H6.07 rps901 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC24H6.08 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24H6.08 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC24H6.08 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24H6.08 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC24H6.09 gef1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24H6.10c aro4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24H6.10c aro4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC24H6.10c aro4 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC24H6.10c aro4 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC24H6.10c aro4 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC24H6.10c aro4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC24H6.10c aro4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC24H6.11c vsb1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC24H6.11c vsb1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC24H6.11c vsb1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC24H6.13 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC24H6.13 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC24H6.13 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25A8.01c fft3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC25A8.01c fft3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC25A8.02 atg14 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC25A8.02 atg14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC25A8.02 atg14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25B8.01 dap1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC25B8.01 dap1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC25B8.01 dap1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC25B8.01 dap1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC25B8.01 dap1 RNA Northern assay evidence increased during(GO:0071456) PMID:17276356 4896 2024-05-02 Expression of dap1+ mRNA was induced in the absence of oxygen in a Sre1-dependent manner (Figure 1A) SPAC25B8.04c mss51 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC25B8.04c mss51 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC25B8.05 deg1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25B8.06c dia4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25B8.07c rcf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25B8.08 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC25B8.08 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC25B8.08 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25B8.09 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC25B8.09 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC25B8.09 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC25B8.11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25B8.12c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC25B8.12c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25B8.12c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC25B8.12c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC25B8.12c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC25B8.12c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC25B8.12c RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC25B8.13c isp7 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC25B8.13c isp7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC25B8.13c isp7 protein western blot evidence used in manual assertion increased during(GO:0006995) PMID:24344203 4896 2014-04-02 SPAC25B8.13c isp7 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC25B8.13c isp7 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:7954893 4896 2014-05-08 SPAC25B8.13c isp7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25B8.13c isp7 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC25B8.13c isp7 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC25B8.13c isp7 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:26271) PMID:24344203 4896 2014-04-02 SPAC25B8.13c isp7 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:7954893 4896 2014-05-08 SPAC25B8.13c isp7 RNA Northern assay evidence increased during(GO:0006995) PMID:26152587 4896 2018-05-03 SPAC25B8.13c isp7 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC25B8.13c isp7 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC25B8.13c isp7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25B8.13c isp7 RNA Northern assay evidence present during(GO:0072690) PMID:26152587 4896 2018-05-03 SPAC25B8.15c tyw3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25B8.17 ypf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25B8.18 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC25B8.18 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC25B8.18 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC25B8.18 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25B8.18 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC25B8.19c loz1 RNA northern assay evidence used in manual assertion decreased during(GO:0071294) PMID:24003116 4896 2014-01-03 SPAC25B8.19c loz1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC25G10.01 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC25G10.01 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC25G10.03 zip1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC25G10.03 zip1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25G10.03 zip1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC25G10.04c rec10 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC25G10.04c rec10 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC25G10.04c rec10 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:7586030 4896 2013-10-21 SPAC25G10.04c rec10 RNA Northern assay evidence increased during(GO:0051321) PMID:9671035 4896 2019-11-07 SPAC25G10.04c rec10 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC25G10.05c his1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC25G10.05c his1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC25G10.05c his1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC25G10.05c his1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25G10.06 rps2801 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC25G10.06 rps2801 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC25G10.06 rps2801 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC25G10.06 rps2801 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25G10.06 rps2801 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC25G10.06 rps2801 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25G10.06 rps2801 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC25G10.07c cut7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25G10.07c cut7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25G10.08 tif302 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC25G10.08 tif302 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC25G10.08 tif302 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC25G10.08 tif302 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25H1.02 jmj1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC25H1.02 jmj1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC25H1.02 jmj1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC25H1.02 jmj1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC25H1.02 jmj1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC25H1.02 jmj1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC25H1.02 jmj1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC25H1.02 jmj1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC25H1.02 jmj1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC25H1.03 atg101 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC25H1.03 atg101 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC25H1.03 atg101 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC25H1.03 atg101 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25H1.03 atg101 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC25H1.04 mug105 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC25H1.04 mug105 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25H1.04 mug105 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC25H1.04 mug105 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC25H1.04 mug105 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC25H1.04 mug105 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC25H1.05 meu29 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC25H1.05 meu29 RNA experimental evidence increased during(GO:0051321) 4896 2010-01-03 SPAC25H1.05 meu29 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC25H1.07 emc1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC25H1.09 mde5 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC25H1.09 mde5 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC25H1.09 mde5 RNA experimental evidence increased during(GO:0051321) 4896 2010-01-03 SPAC25H1.09 mde5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC26A3.01 sxa1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26A3.01 sxa1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26A3.02 myh1 protein western blot evidence used in manual assertion decreased during(GO:0070301) PMID:15533944 4896 2016-03-03 SPAC26A3.02 myh1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26A3.02 myh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26A3.03c rmi1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC26A3.03c rmi1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26A3.04 rpl2002 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26A3.04 rpl2002 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26A3.04 rpl2002 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26A3.04 rpl2002 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26A3.04 rpl2002 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26A3.06 bud23 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26A3.06 bud23 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26A3.06 bud23 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26A3.07c rpl1101 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26A3.07c rpl1101 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26A3.07c rpl1101 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC26A3.07c rpl1101 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26A3.07c rpl1101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26A3.08 smb1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26A3.08 smb1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26A3.08 smb1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC26A3.08 smb1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26A3.10 cnt6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26A3.10 cnt6 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26A3.10 cnt6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26A3.11 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26A3.11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26A3.12c dhp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26A3.12c dhp1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8190062 4896 2014-06-30 SPAC26A3.13c Tf2-4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC26A3.13c Tf2-4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26A3.13c Tf2-4 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPAC26A3.14c atg44 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26A3.14c atg44 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26A3.14c atg44 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC26A3.16 dsk2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26A3.16 dsk2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26A3.16 dsk2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26A3.16 dsk2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26A3.17c rmt2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26A3.17c rmt2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26A3.17c rmt2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26F1.01 sec74 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC26F1.02 pnn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC26F1.03 pda1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC26F1.03 pda1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC26F1.04c etr1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26F1.04c etr1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26F1.04c etr1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26F1.04c etr1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC26F1.04c etr1 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC26F1.04c etr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC26F1.04c etr1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC26F1.04c etr1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC26F1.04c etr1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC26F1.04c etr1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC26F1.04c etr1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26F1.04c etr1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC26F1.04c etr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC26F1.04c etr1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26F1.04c etr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC26F1.04c etr1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26F1.04c etr1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC26F1.04c etr1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC26F1.04c etr1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC26F1.05 mug106 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC26F1.06 gpm1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26F1.06 gpm1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26F1.06 gpm1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC26F1.06 gpm1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC26F1.06 gpm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26F1.07 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26F1.07 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC26F1.07 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC26F1.07 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC26F1.07 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC26F1.07 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC26F1.07 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26F1.07 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC26F1.07 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26F1.07 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC26F1.07 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26F1.07 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC26F1.07 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC26F1.08c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC26F1.09 gyp51 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26F1.10c pyp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26F1.10c pyp1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26F1.10c pyp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26F1.10c pyp1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC26F1.10c pyp1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26F1.10c pyp1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC26F1.10c pyp1 RNA northern assay evidence used in manual assertion unchanged during(GO:0071472) PMID:9154834 4896 2015-05-13 SPAC26F1.11 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC26F1.11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC26F1.11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26F1.12c hgh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26F1.12c hgh1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26F1.12c hgh1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26F1.13c lrs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26F1.13c lrs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26F1.13c lrs1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26F1.13c lrs1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC26F1.13c lrs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26F1.14c aif1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26F1.14c aif1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26F1.14c aif1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26F1.14c aif1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC26F1.14c aif1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC26F1.14c aif1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC26F1.14c aif1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC26F1.14c aif1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC26F1.14c aif1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC26F1.14c aif1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC26F1.14c aif1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26F1.14c aif1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC26F1.14c aif1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26F1.14c aif1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC26F1.14c aif1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26F1.14c aif1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC26F1.14c aif1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC26H5.03 pcf2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26H5.04 gid5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26H5.04 gid5 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26H5.04 gid5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26H5.05 mga2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26H5.06 pot1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26H5.08c bgl2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26H5.08c bgl2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC26H5.08c bgl2 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC26H5.08c bgl2 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPAC26H5.08c bgl2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26H5.08c bgl2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC26H5.08c bgl2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26H5.09c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26H5.09c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26H5.09c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC26H5.09c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26H5.09c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC26H5.10c tif51 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26H5.10c tif51 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26H5.10c tif51 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26H5.10c tif51 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC26H5.10c tif51 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26H5.11 spo71 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC26H5.11 spo71 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC26H5.12 rpo41 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC26H5.12 rpo41 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC26H5.12 rpo41 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC26H5.13c kei1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC27D7.02c grp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27D7.03c mei2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC27D7.03c mei2 protein western blot evidence used in manual assertion increased during(GO:0006995) PMID:14745200 4896 2013-01-17 SPAC27D7.03c mei2 protein reporter gene assay evidence increased during(GO:0006995) PMID:8832415 4896 2015-01-08 SPAC27D7.03c mei2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC27D7.03c mei2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27D7.03c mei2 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC27D7.03c mei2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:14745200 4896 2013-01-17 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:19620394 4896 2014-03-06 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion decreased in presence of(CHEBI:29014) PMID:12827445 4896 2013-09-20 SPAC27D7.03c mei2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC27D7.03c mei2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC27D7.03c mei2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC27D7.03c mei2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC27D7.03c mei2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC27D7.03c mei2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC27D7.03c mei2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC27D7.03c mei2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:10467002 4896 2012-06-14 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:14745200 4896 2013-01-17 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:3025190 4896 2012-02-25 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:3025190 4896 2012-02-25 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:16624901 4896 2014-03-06 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:19620394 4896 2014-03-06 SPAC27D7.03c mei2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC27D7.03c mei2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC27D7.03c mei2 RNA quantitative PCR increased during(GO:0010438) PMID:39105351 4896 2024-10-01 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:14745200 4896 2013-01-17 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:3025190 4896 2012-02-25 SPAC27D7.03c mei2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:16624901 4896 2014-03-06 SPAC27D7.04 omt2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC27D7.04 omt2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC27D7.04 omt2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC27D7.05c apc14 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:12477395 4896 2014-07-21 SPAC27D7.05c apc14 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC27D7.05c apc14 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC27D7.06 etf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27D7.06 etf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC27D7.06 etf1 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC27D7.07c smd1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27D7.07c smd1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC27D7.08c mtl16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC27D7.09c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC27D7.09c RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC27D7.09c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC27D7.09c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC27D7.09c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC27D7.09c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC27D7.09c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC27D7.09c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC27D7.09c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC27D7.09c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC27D7.09c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC27D7.09c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC27D7.09c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC27D7.09c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC27D7.09c RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC27D7.11c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC27D7.11c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27D7.11c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC27D7.11c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC27D7.11c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC27D7.11c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC27D7.11c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC27D7.11c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC27D7.11c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC27D7.11c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC27D7.11c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC27D7.11c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC27D7.11c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC27D7.11c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC27D7.12c but1 protein reporter gene assay evidence increased during(GO:0042149) PMID:17530441 4896 2014-10-23 SPAC27D7.12c but1 protein reporter gene assay evidence increased during(GO:0006995) PMID:17530441 4896 2014-10-23 SPAC27D7.12c but1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC27D7.12c but1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC27D7.12c but1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC27D7.12c but1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0042149) PMID:17530441 4896 2014-10-23 SPAC27D7.12c but1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0006995) PMID:17530441 4896 2014-10-23 SPAC27D7.12c but1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC27D7.13c ssm4 RNA Northern assay evidence absent during(GO:0072690) PMID:9167972 4896 2021-01-22 SPAC27D7.13c ssm4 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:16823445 4896 2014-01-09 SPAC27D7.13c ssm4 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC27D7.13c ssm4 RNA Northern assay evidence present during(GO:0051321) PMID:9167972 4896 2021-01-22 SPAC27D7.14c tpr1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC27D7.14c tpr1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC27E2.01 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27E2.01 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC27E2.02 yih1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27E2.02 yih1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC27E2.03c ola1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27E2.03c ola1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC27E2.03c ola1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC27E2.03c ola1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC27E2.05 cdc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27E2.05 cdc1 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:8887553 4896 2013-02-07 SPAC27E2.05 cdc1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8887553 4896 2013-02-07 SPAC27E2.06c msm1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27E2.07 pvg2 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC27E2.07 pvg2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27E2.07 pvg2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC27E2.08 Tf2-6 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC27E2.08 Tf2-6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC27E2.11c RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC27E2.11c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC27F1.02c cdc8 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:17452625 4896 2017-08-08 SPAC27F1.05c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC27F1.05c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC27F1.05c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC27F1.06c ani2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC27F1.06c ani2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC27F1.06c ani2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC27F1.07 ost1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29A4.02c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC29A4.02c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29A4.03c mrps9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29A4.04c cbf5 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29A4.04c cbf5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29A4.05 cam2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29A4.05 cam2 RNA experimental evidence increased during(GO:0051321) PMID:17202724 4896 2007-01-15 SPAC29A4.05 cam2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC29A4.08c prp19 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29A4.10 rrn5 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29A4.12c mug108 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC29A4.12c mug108 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29A4.12c mug108 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC29A4.12c mug108 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC29A4.12c mug108 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC29A4.12c mug108 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29A4.12c mug108 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29A4.12c mug108 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29A4.14c pex3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC29A4.15 srs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC29A4.15 srs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29A4.16 hal4 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29A4.16 hal4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29A4.17c fun14 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC29A4.17c fun14 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC29A4.17c fun14 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29A4.17c fun14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC29A4.17c fun14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29A4.17c fun14 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC29A4.17c fun14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29A4.17c fun14 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC29A4.17c fun14 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC29A4.17c fun14 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC29A4.20 elp3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29A4.20 elp3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29B12.02c set2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29B12.02c set2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29B12.03 spd1 protein western blot evidence used in manual assertion decreased during(GO:0000082) PMID:8887552 4896 2013-02-05 SPAC29B12.03 spd1 protein western blot evidence used in manual assertion decreased during(GO:0000084) PMID:8887552 4896 2013-02-05 SPAC29B12.03 spd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29B12.03 spd1 protein northern assay evidence used in manual assertion present during(GO:0072690) PMID:8887552 4896 2013-02-05 SPAC29B12.03 spd1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC29B12.03 spd1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC29B12.03 spd1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29B12.03 spd1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC29B12.03 spd1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29B12.03 spd1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29B12.04 snz1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29B12.04 snz1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC29B12.04 snz1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29B12.04 snz1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC29B12.04 snz1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC29B12.05c mtq1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29B12.07 sec16 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC29B12.07 sec16 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC29B12.08 clr5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC29B12.08 clr5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29B12.08 clr5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29B12.08 clr5 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC29B12.10c pgt1 protein reporter gene assay evidence decreased during(GO:0036346) PMID:18662319 4896 2012-09-17 SPAC29B12.10c pgt1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC29B12.10c pgt1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC29B12.10c pgt1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC29B12.10c pgt1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC29B12.10c pgt1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC29B12.10c pgt1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC29B12.10c pgt1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29B12.11c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC29B12.11c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC29B12.11c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC29B12.11c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC29B12.11c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29B12.11c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29B12.11c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC29B12.11c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC29B12.13 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC29B12.13 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC29B12.13 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC29B12.13 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC29B12.13 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC29B12.13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29B12.13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC29B12.14c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC29B12.14c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC29B12.14c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC29B12.14c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC29B12.14c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29E6.01 pof11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC29E6.01 pof11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29E6.02 prp3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29E6.04 nnf1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29E6.04 nnf1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC29E6.05c mxr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:24118096 4896 2014-04-02 SPAC29E6.05c mxr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29E6.05c mxr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:24118096 4896 2014-04-02 SPAC29E6.06c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29E6.08 tbp1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC29E6.08 tbp1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC29E6.08 tbp1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC29E6.09 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC29E6.09 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC29E6.09 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.03c smd2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2C4.04c aim29 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2C4.04c aim29 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2C4.04c aim29 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2C4.04c aim29 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2C4.05 cor1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2C4.06c rcm1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.06c rcm1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2C4.07c dis32 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.07c dis32 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.07c dis32 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2C4.08 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2C4.09 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.09 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2C4.09 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.11c pno1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2C4.11c pno1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2C4.11c pno1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.11c pno1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2C4.12c tpt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2C4.12c tpt1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2C4.14c ppk11 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:20826805 4896 2016-10-18 SPAC2C4.14c ppk11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2C4.15c ubx2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2C4.15c ubx2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC2C4.15c ubx2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC2C4.15c ubx2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC2C4.15c ubx2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC2C4.15c ubx2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2C4.15c ubx2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.15c ubx2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2C4.16c rps801 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2C4.16c rps801 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.16c rps801 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2C4.16c rps801 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2C4.17c msy2 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071474) PMID:22910366 4896 2013-04-24 SPAC2C4.17c msy2 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071476) PMID:22910366 4896 2013-04-24 SPAC2C4.17c msy2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2C4.17c msy2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC2C4.17c msy2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC2C4.17c msy2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC2C4.17c msy2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC2C4.17c msy2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2C4.17c msy2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2C4.17c msy2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC2C4.17c msy2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2C4.17c msy2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC2C4.17c msy2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC2E12.02 hsf1 protein microscopy evidence increased in presence of(CHEBI:52717) PMID:39473973 4896 2025-03-27 (Fig. 4A) SPAC2E12.02 hsf1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2E12.02 hsf1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC2E12.02 hsf1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC2E12.02 hsf1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC2E12.03c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2E12.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2E12.03c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2E12.03c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2E12.03c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC2E12.05 wtf1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC2E1P3.01 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2E1P3.01 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC2E1P3.01 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC2E1P3.01 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2E1P3.01 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC2E1P3.01 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC2E1P3.01 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC2E1P3.01 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC2E1P3.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2E1P3.01 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2E1P3.01 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC2E1P3.01 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2E1P3.01 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC2E1P3.02c amt3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC2E1P3.02c amt3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2E1P3.02c amt3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2E1P3.03c Tf2-3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2E1P3.03c Tf2-3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2E1P3.04 cao1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2E1P3.04 cao1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2E1P3.04 cao1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC2E1P3.04 cao1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2E1P3.04 cao1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2E1P3.04 cao1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2E1P3.05c cbm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2E1P3.05c cbm1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC2E1P3.05c cbm1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2E1P3.05c cbm1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2E1P5.02c mug109 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2E1P5.02c mug109 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC2E1P5.02c mug109 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC2E1P5.04c cwg2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2E1P5.04c cwg2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC2E1P5.04c cwg2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2E1P5.04c cwg2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2E1P5.05 rrp9 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2E1P5.05 rrp9 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2E1P5.05 rrp9 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC2F3.01 imt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F3.02 sec67 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2F3.03c rpa49 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPAC2F3.03c rpa49 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F3.03c rpa49 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPAC2F3.03c rpa49 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2F3.03c rpa49 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC2F3.03c rpa49 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC2F3.03c rpa49 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC2F3.03c rpa49 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC2F3.03c rpa49 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2F3.03c rpa49 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F3.03c rpa49 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2F3.04c rim1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2F3.05c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2F3.05c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC2F3.05c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC2F3.05c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2F3.05c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC2F3.05c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC2F3.05c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC2F3.05c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC2F3.05c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2F3.05c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2F3.05c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2F3.05c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F3.05c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2F3.05c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC2F3.05c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC2F3.06c kap104 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F3.06c kap104 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2F3.07c RNA expression microarray evidence decreased during(GO:0042149) PMID:34460892 4896 2021-09-21 SPAC2F3.08 sut1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC2F3.08 sut1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F3.08 sut1 RNA northern assay evidence used in manual assertion decreased during(GO:0071333) PMID:11136464 4896 2012-06-19 SPAC2F3.08 sut1 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:11136464 4896 2012-06-19 SPAC2F3.08 sut1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC2F3.08 sut1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2F3.08 sut1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F3.08 sut1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC2F3.08 sut1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2F3.08 sut1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC2F3.08 sut1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC2F3.08 sut1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC2F3.09 hem1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC2F3.09 hem1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F3.09 hem1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2F3.09 hem1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2F3.09 hem1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F3.09 hem1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2F3.09 hem1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2F3.11 ppx1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2F3.13c qtr2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F3.15 lsk1 protein western blot evidence used in manual assertion unchanged during(GO:0006995) PMID:22144909 4896 2015-11-04 SPAC2F3.15 lsk1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:22144909 4896 2015-11-04 SPAC2F3.15 lsk1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2F3.16 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2F3.16 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F3.16 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2F3.16 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC2F7.05c tif5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2F7.05c tif5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F7.06c pol4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC2F7.06c pol4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F7.06c pol4 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC2F7.06c pol4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2F7.06c pol4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2F7.06c pol4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F7.09c gep3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2F7.10 akr1 protein western blot evidence used in manual assertion constant during(GO:0051321) PMID:23843742 4896 2013-08-08 SPAC2F7.11 nrd1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC2F7.11 nrd1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2F7.11 nrd1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC2F7.11 nrd1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC2F7.11 nrd1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC2F7.11 nrd1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC2F7.11 nrd1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F7.13c wrs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F7.13c wrs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2F7.13c wrs1 protein Western blot evidence unchanged in presence of(CHEBI:16240),during(GO:0034599) PMID:33313903 4896 2021-02-15 SPAC2F7.13c wrs1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC2F7.14c rrp4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2F7.15 rsm24 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F7.16c pld1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2F7.17 mrf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2F7.17 mrf1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2F7.17 mrf1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2G11.02 urb2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2G11.02 urb2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2G11.03c vps45 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC2G11.04 rbm17 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC2G11.05c alx1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2G11.07c ptc3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2G11.11c prh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2G11.11c prh1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC2G11.11c prh1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2G11.11c prh1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC2G11.11c prh1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC2G11.11c prh1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC2G11.11c prh1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC2G11.11c prh1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC2G11.11c prh1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2G11.11c prh1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC2G11.11c prh1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2G11.12 rqh1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC2G11.12 rqh1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC2G11.13 atg22 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC2G11.13 atg22 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC2G11.13 atg22 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC2G11.13 atg22 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2G11.13 atg22 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC2G11.13 atg22 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2G11.14 taf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC2G11.15c tgs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC2H10.01 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC2H10.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC2H10.01 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC2H10.01 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC2H10.01 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC30.01c sec72 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30.01c sec72 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC30.02c kti12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC30.03c tsn1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC30.04c abc4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30.04c abc4 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC30.04c abc4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC30.04c abc4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC30.04c abc4 RNA RNA protection assay evidence unchanged during(GO:0010106) PMID:19915076 4896 2019-05-27 SPAC30.04c abc4 RNA RNA protection assay evidence unchanged during(GO:0071281) PMID:19915076 4896 2019-05-27 SPAC30C2.02 mmd1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC30C2.02 mmd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30C2.02 mmd1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC30C2.02 mmd1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC30C2.02 mmd1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC30C2.02 mmd1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC30C2.02 mmd1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC30C2.02 mmd1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC30C2.02 mmd1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC30C2.02 mmd1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC30C2.02 mmd1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC30C2.02 mmd1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC30C2.02 mmd1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC30C2.04 asc1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC30C2.04 asc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30C2.04 asc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC30C2.04 asc1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC30C2.05 erv14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30C2.08 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30C2.08 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC30C2.08 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC30C2.08 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC30D11.01c gto2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30D11.01c gto2 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPAC30D11.01c gto2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC30D11.01c gto2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC30D11.01c gto2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC30D11.03 ddx27 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC30D11.03 ddx27 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC30D11.03 ddx27 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC30D11.07 nth1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC30D11.10 rad52 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30D11.11 izh3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30D11.11 izh3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC30D11.11 izh3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC30D11.12 rpl3802 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC30D11.12 rpl3802 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC30D11.12 rpl3802 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC30D11.12 rpl3802 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC30D11.12 rpl3802 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC30D11.12 rpl3802 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC30D11.12 rpl3802 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC30D11.12 rpl3802 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC30D11.12 rpl3802 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC30D11.13 hus5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC30D11.14c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31A2.02 trm112 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC31A2.02 trm112 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31A2.02 trm112 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31A2.02 trm112 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31A2.03 mrp11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31A2.03 mrp11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31A2.03 mrp11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC31A2.04c pre1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31A2.04c pre1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC31A2.05c mis4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31A2.05c mis4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31A2.07c dbp10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31A2.07c dbp10 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31A2.07c dbp10 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC31A2.08 mrp20 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31A2.10 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC31A2.10 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC31A2.11c cuf1 RNA reporter gene assay evidence decreased during(GO:0071280) PMID:17384198 4896 2012-02-28 SPAC31A2.11c cuf1 RNA reporter gene assay evidence present during(GO:0072690) PMID:17384198 4896 2012-02-28 SPAC31A2.11c cuf1 RNA northern assay evidence used in manual assertion present during(GO:0009847) PMID:28572514 4896 2017-09-16 SPAC31A2.11c cuf1 RNA northern assay evidence used in manual assertion present during(GO:0098762) PMID:24569997 4896 2017-09-14 SPAC31A2.12 rod1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC31A2.12 rod1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC31A2.12 rod1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC31A2.12 rod1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC31A2.12 rod1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC31A2.12 rod1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31A2.12 rod1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC31A2.12 rod1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC31A2.12 rod1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC31A2.13c sft1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31F12.01 zds1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC31G5.01 sap49 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31G5.01 sap49 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC31G5.01 sap49 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC31G5.02 rot1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31G5.02 rot1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC31G5.03 rps1101 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC31G5.03 rps1101 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31G5.03 rps1101 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC31G5.03 rps1101 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31G5.03 rps1101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.03 rps1101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC31G5.03 rps1101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC31G5.04 lys12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.04 lys12 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC31G5.04 lys12 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31G5.04 lys12 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC31G5.04 lys12 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC31G5.04 lys12 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.04 lys12 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC31G5.06 rrg8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.07 dni1 protein Western blot evidence increased during(GO:0006995) PMID:19627505 4896 2018-02-09 SPAC31G5.07 dni1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC31G5.08 hem4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.08 hem4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31G5.09c spk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.09c spk1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC31G5.09c spk1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC31G5.09c spk1 protein western blot evidence used in manual assertion increased during(GO:0072734) PMID:1899230 4896 2012-12-10 SPAC31G5.09c spk1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC31G5.09c spk1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC31G5.09c spk1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.09c spk1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC31G5.10 eta2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.10 eta2 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC31G5.10 eta2 RNA experimental evidence increased during(GO:0051321) 4896 2010-01-03 SPAC31G5.10 eta2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC31G5.10 eta2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31G5.11 pac2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.11 pac2 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:8536311 4896 2014-09-25 SPAC31G5.11 pac2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8536311 4896 2014-09-25 SPAC31G5.12c maf1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC31G5.12c maf1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC31G5.12c maf1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.12c maf1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31G5.12c maf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC31G5.12c maf1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC31G5.13 rpn11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.13 rpn11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC31G5.14 gcv1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC31G5.14 gcv1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.14 gcv1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31G5.14 gcv1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.15 psd3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.15 psd3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC31G5.15 psd3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.16c dpm1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31G5.17c rps1001 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC31G5.17c rps1001 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31G5.17c rps1001 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.17c rps1001 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC31G5.18c sde2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC31G5.18c sde2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.18c sde2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC31G5.18c sde2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC31G5.18c sde2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC31G5.19 abo1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC31G5.19 abo1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC31G5.21 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC31G5.21 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC31G5.21 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC323.01c pos5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC323.02c pup2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC323.04 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC323.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC323.07c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC323.07c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC323.07c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC323.07c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC323.07c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC328.02 dbl4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC328.02 dbl4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.03 tps1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC328.03 tps1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC328.03 tps1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8649397 4896 2013-06-04 SPAC328.03 tps1 RNA northern assay evidence used in manual assertion increased during(GO:0071470) PMID:8649397 4896 2013-06-04 SPAC328.03 tps1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8021171 4896 2013-09-17 SPAC328.03 tps1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:12855726 4896 2014-06-19 SPAC328.03 tps1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12855726 4896 2014-06-19 SPAC328.03 tps1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC328.03 tps1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC328.03 tps1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC328.03 tps1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC328.03 tps1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC328.03 tps1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC328.03 tps1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC328.03 tps1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC328.03 tps1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC328.03 tps1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC328.03 tps1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC328.03 tps1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.03 tps1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC328.03 tps1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC328.03 tps1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12855726 4896 2014-06-19 SPAC328.04 spg4 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC328.04 spg4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC328.04 spg4 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC328.04 spg4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.04 spg4 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC328.04 spg4 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC328.05 hrb1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC328.05 hrb1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.05 hrb1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.06 ubp2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC328.07c bsd1 protein Western blot evidence increased in presence of(CHEBI:29699) PMID:39601909 4896 2025-01-02 SPAC328.07c bsd1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC328.07c bsd1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC328.07c bsd1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.08c tbc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC328.08c tbc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC328.08c tbc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.09 odc1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC328.09 odc1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.09 odc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC328.09 odc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC328.09 odc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC328.10c rps502 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC328.10c rps502 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC328.10c rps502 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC328.10c rps502 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC328.10c rps502 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC32A11.01 mug8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC32A11.01 mug8 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC32A11.01 mug8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC32A11.01 mug8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC32A11.02c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC32A11.02c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC32A11.02c ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC32A11.02c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC32A11.02c ribosomal density ribosome profiling evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC32A11.02c ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC32A11.02c ribosomal density ribosome profiling evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC32A11.02c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC32A11.02c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC32A11.02c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC32A11.02c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC32A11.02c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC32A11.02c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC32A11.02c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC32A11.02c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC32A11.03c phx1 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA quantitative PCR increased during(GO:0006995) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA quantitative PCR increased during(GO:0042149) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA quantitative PCR increased during(GO:0070301) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA quantitative PCR increased during(GO:0072756) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA quantitative PCR increased during(GO:0036245) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA quantitative PCR increased during(GO:0072738) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA quantitative PCR increased during(GO:0034605) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC32A11.03c phx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:22646093 4896 2014-02-14 SPAC32A11.03c phx1 RNA quantitative PCR present during(GO:0072690) PMID:22646093 4896 2014-02-14 SPAC32A11.04c tif212 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC32A11.04c tif212 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC32A11.04c tif212 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC343.01c erg8 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC343.03 apc11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC343.03 apc11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC343.04c gid7 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC343.04c gid7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC343.04c gid7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC343.05 vma1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC343.06c pls1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC343.06c pls1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC343.06c pls1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC343.06c pls1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC343.07 mug28 protein western blot evidence used in manual assertion absent during(GO:0072690) PMID:20410137 4896 2015-10-08 SPAC343.07 mug28 protein western blot evidence used in manual assertion increased during(GO:0051321) PMID:20410137 4896 2015-10-08 SPAC343.07 mug28 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC343.07 mug28 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC343.07 mug28 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:20410137 4896 2015-10-08 SPAC343.07 mug28 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:20410137 4896 2015-10-08 SPAC343.07 mug28 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC343.09 ubx3 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC343.09 ubx3 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC343.09 ubx3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC343.09 ubx3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC343.10 met11 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC343.11c msc1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC343.11c msc1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC343.12 rds1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC343.12 rds1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC343.12 rds1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:28938) PMID:7565608 4896 2012-02-02 SPAC343.12 rds1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:16526) PMID:7565608 4896 2012-02-02 SPAC343.12 rds1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:17234) PMID:7565608 4896 2012-02-02 SPAC343.12 rds1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:35780) PMID:7565608 4896 2012-02-02 SPAC343.12 rds1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:7565608 4896 2012-02-02 SPAC343.12 rds1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC343.12 rds1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC343.12 rds1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC343.12 rds1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC343.12 rds1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC343.12 rds1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC343.12 rds1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC343.12 rds1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC343.12 rds1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC343.12 rds1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC343.12 rds1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC343.12 rds1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC343.12 rds1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC343.12 rds1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC343.12 rds1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC343.13 gta2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC343.16 lys2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC343.16 lys2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC343.16 lys2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC343.16 lys2 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC343.16 lys2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC343.16 lys2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC343.16 lys2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC343.20 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC343.20 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC343.20 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC343.20 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3A11.02 cps3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC3A11.02 cps3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3A11.03 efm3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3A11.04 sei1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3A11.05c kms1 RNA experimental evidence increased during(GO:0051321) 4896 SPAC3A11.05c kms1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A11.05c kms1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A11.06 mvp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3A11.06 mvp1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC3A11.06 mvp1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC3A11.06 mvp1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC3A11.06 mvp1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC3A11.06 mvp1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC3A11.06 mvp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A11.06 mvp1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3A11.06 mvp1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3A11.06 mvp1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3A11.06 mvp1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A11.06 mvp1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC3A11.06 mvp1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3A11.07 nde1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3A11.07 nde1 RNA northern assay evidence used in manual assertion decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3A11.07 nde1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3A11.07 nde1 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC3A11.07 nde1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A11.09 sod22 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3A11.09 sod22 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A11.10c dpe1 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC3A11.10c dpe1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3A11.10c dpe1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3A11.10c dpe1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3A11.10c dpe1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC3A11.10c dpe1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC3A11.10c dpe1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A11.10c dpe1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3A11.10c dpe1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A11.10c dpe1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3A11.11c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3A11.12c rpt5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3A11.12c rpt5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3A11.12c rpt5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3A11.12c rpt5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A12.02 ceo2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC3A12.03c meu34 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3A12.04c rpp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3A12.06c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC3A12.06c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3A12.06c ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A12.06c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3A12.06c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A12.06c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A12.07 rpb11 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPAC3A12.07 rpb11 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3A12.07 rpb11 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPAC3A12.07 rpb11 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A12.08 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3A12.08 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3A12.08 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3A12.08 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A12.09c ure4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3A12.09c ure4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3A12.09c ure4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A12.09c ure4 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3A12.10 rpl2001 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3A12.10 rpl2001 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3A12.10 rpl2001 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A12.10 rpl2001 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A12.12 atp11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A12.13c tif310 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3A12.13c tif310 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3A12.13c tif310 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3A12.14 cam1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC3A12.14 cam1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3A12.14 cam1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:3035538 4896 2012-08-15 SPAC3A12.15 vps53 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3A12.16c tim17 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A12.17c cys12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3A12.17c cys12 RNA northern assay evidence used in manual assertion increased during(GO:0006979) PMID:14981292 4896 2014-08-06 SPAC3A12.18 zwf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3A12.18 zwf1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC3A12.18 zwf1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC3A12.18 zwf1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC3A12.18 zwf1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC3A12.18 zwf1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC3A12.18 zwf1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3A12.18 zwf1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3A12.18 zwf1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3A12.18 zwf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3A12.18 zwf1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC3A12.18 zwf1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3A12.18 zwf1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3A12.19 mrpl27 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3C7.01c sac12 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3C7.02c pil2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3C7.02c pil2 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3C7.02c pil2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC3C7.02c pil2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC3C7.02c pil2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3C7.02c pil2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3C7.03c rad55 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:10430583 4896 2014-09-19 SPAC3C7.03c rad55 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10430583 4896 2014-09-19 SPAC3C7.04 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3C7.05c mug191 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3C7.05c mug191 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3C7.05c mug191 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3C7.05c mug191 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC3C7.05c mug191 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC3C7.05c mug191 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC3C7.05c mug191 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC3C7.05c mug191 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC3C7.05c mug191 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC3C7.05c mug191 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC3C7.05c mug191 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3C7.05c mug191 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3C7.05c mug191 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3C7.05c mug191 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3C7.05c mug191 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3C7.05c mug191 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC3C7.05c mug191 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3C7.07c ate1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3C7.07c ate1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3C7.08c elf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3C7.08c elf1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3C7.08c elf1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3C7.08c elf1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3C7.11c cnx1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3C7.11c cnx1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC3C7.11c cnx1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3C7.11c cnx1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC3C7.11c cnx1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:7876257 4896 2013-01-02 SPAC3C7.11c cnx1 RNA northern assay evidence used in manual assertion increased during(GO:0035967) PMID:7876257 4896 2013-01-02 SPAC3C7.11c cnx1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3C7.11c cnx1 RNA northern assay evidence used in manual assertion unchanged in presence of(CHEBI:29699) PMID:7876257 4896 2015-03-19 SPAC3C7.12 tip1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3C7.13c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3C7.13c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3C7.13c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3C7.13c protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC3C7.13c ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3C7.13c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3C7.13c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC3C7.13c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC3C7.13c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC3C7.13c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC3C7.13c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC3C7.13c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC3C7.13c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3C7.13c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC3C7.13c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3C7.13c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3C7.13c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3C7.13c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3C7.13c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3C7.13c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC3C7.13c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3C7.13c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3C7.14c obr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3C7.14c obr1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:7769002 4896 2012-01-28 SPAC3C7.14c obr1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3C7.14c obr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:9585505 4896 2012-02-29 SPAC3C7.14c obr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23115244 4896 2012-02-20 SPAC3C7.14c obr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC3C7.14c obr1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC3C7.14c obr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3C7.14c obr1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC3C7.14c obr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9585505 4896 2012-02-29 SPAC3C7.14c obr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:7769002 4896 2012-01-28 SPAC3F10.02c trk1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3F10.03 grs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3F10.03 grs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3F10.03 grs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3F10.04 gsa1 protein reporter gene assay evidence increased during(GO:0042149) PMID:15529002 4896 2014-11-20 SPAC3F10.04 gsa1 protein reporter gene assay evidence increased during(GO:0036245) PMID:15529002 4896 2014-11-20 SPAC3F10.04 gsa1 RNA reporter gene assay evidence increased during(GO:0042149) PMID:15529002 4896 2014-11-20 SPAC3F10.04 gsa1 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC3F10.05c mug113 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3F10.05c mug113 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3F10.05c mug113 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3F10.06c rit1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3F10.06c rit1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3F10.07c erf4 protein western blot evidence used in manual assertion increased during(GO:0051321) PMID:23843742 4896 2013-08-08 SPAC3F10.07c erf4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3F10.07c erf4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC3F10.07c erf4 RNA quantitative PCR increased during(GO:0051321) PMID:23843742 4896 2013-08-08 SPAC3F10.07c erf4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3F10.08c faf1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3F10.08c faf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3F10.08c faf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3F10.10c map3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3F10.10c map3 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC3F10.10c map3 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC3F10.10c map3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3F10.11c abc2 RNA RNA protection assay evidence unchanged during(GO:0010106) PMID:19915076 4896 2019-05-27 SPAC3F10.11c abc2 RNA RNA protection assay evidence unchanged during(GO:0071281) PMID:19915076 4896 2019-05-27 SPAC3F10.12c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3F10.13 ucp6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3F10.13 ucp6 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3F10.13 ucp6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3F10.15c spo12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3F10.15c spo12 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3F10.15c spo12 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3F10.15c spo12 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3F10.15c spo12 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:11085271 4896 2015-07-15 SPAC3F10.15c spo12 RNA northern assay evidence used in manual assertion increased during(GO:0044839) PMID:11085271 4896 2015-07-15 SPAC3F10.15c spo12 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3F10.15c spo12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3F10.15c spo12 RNA northern assay evidence used in manual assertion present during(GO:0010458) PMID:12411492 4896 2015-10-14 SPAC3F10.15c spo12 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:11085271 4896 2015-07-15 SPAC3F10.16c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3F10.16c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3F10.16c RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3F10.16c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3F10.17 ltv1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3F10.18c rpl4102 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3F10.18c rpl4102 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3F10.19 spd2 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:24652833 4896 2016-10-27 SPAC3F10.19 spd2 protein western blot evidence used in manual assertion decreased during(GO:0072711) PMID:24652833 4896 2016-10-27 SPAC3F10.19 spd2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3F10.19 spd2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:24652833 4896 2016-10-27 SPAC3F10.19 spd2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3F10.19 spd2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3F10.19 spd2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3G6.02 dss1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G6.03c ifs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G6.03c ifs1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC3G6.03c ifs1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3G6.03c ifs1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC3G6.04 rnp24 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G6.04 rnp24 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3G6.04 rnp24 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3G6.04 rnp24 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3G6.05 mpv17 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3G6.05 mpv17 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3G6.05 mpv17 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3G6.05 mpv17 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3G6.05 mpv17 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3G6.06c rad2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3G6.06c rad2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3G6.07 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3G6.07 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC3G6.07 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC3G6.07 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3G6.07 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3G6.07 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3G6.07 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3G6.09c tps2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G6.09c tps2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3G6.11 chl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G6.11 chl1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3G6.11 chl1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3G6.13c rpl4101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3G6.13c rpl4101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3G9.03 rpl2301 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3G9.03 rpl2301 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3G9.03 rpl2301 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3G9.03 rpl2301 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3G9.03 rpl2301 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC3G9.05 spa2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G9.06 frs2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G9.06 frs2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3G9.08 png1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3G9.08 png1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3G9.08 png1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3G9.09c tif211 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G9.09c tif211 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3G9.09c tif211 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3G9.10c rrp41 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3G9.10c rrp41 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3G9.11c pdc201 protein mass spectrometry evidence fluctuates during(GO:0000278) PMID:24763107 4896 2014-05-01 SPAC3G9.11c pdc201 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3G9.11c pdc201 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G9.11c pdc201 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3G9.11c pdc201 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC3G9.11c pdc201 RNA quantitative PCR increased during(GO:0036227) PMID:25102102 4896 2015-09-29 SPAC3G9.11c pdc201 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC3G9.11c pdc201 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3G9.11c pdc201 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC3G9.11c pdc201 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC3G9.12 peg1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC3G9.13c msw1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G9.13c msw1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3G9.13c msw1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC3G9.15c fcf2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3G9.15c fcf2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3G9.16c bet5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H1.01c orc3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H1.03 mug151 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3H1.05 ste24 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H1.05 ste24 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H1.06c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3H1.06c RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3H1.06c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC3H1.06c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H1.07 aru1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC3H1.07 aru1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H1.07 aru1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3H1.07 aru1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC3H1.07 aru1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H1.07 aru1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H1.07 aru1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3H1.07 aru1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC3H1.07 aru1 RNA expression microarray evidence increased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC3H1.08c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H1.10 pcs2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H1.11 hsr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H1.11 hsr1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H1.11 hsr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H1.11 hsr1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC3H1.13 ppk13 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H1.14 gid4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H5.04 aar2 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAC3H5.05c rps1401 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3H5.05c rps1401 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3H5.05c rps1401 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H5.05c rps1401 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H5.05c rps1401 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3H5.05c rps1401 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H5.05c rps1401 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3H5.06c pol1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:11344166 4896 2015-02-11 SPAC3H5.06c pol1 protein western blot evidence used in manual assertion unchanged during(GO:0000278) PMID:8443413 4896 2014-09-15 SPAC3H5.06c pol1 RNA northern assay evidence used in manual assertion increased during(GO:0000080) PMID:1291234 4896 2013-08-13 SPAC3H5.06c pol1 RNA northern assay evidence used in manual assertion increased during(GO:0000084) PMID:1291234 4896 2013-08-13 SPAC3H5.06c pol1 RNA northern assay evidence used in manual assertion unchanged during(GO:0000278) PMID:8443413 4896 2014-09-15 SPAC3H5.07 rpl702 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H5.07 rpl702 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3H5.07 rpl702 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3H5.07 rpl702 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3H5.07 rpl702 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H5.07 rpl702 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3H5.07 rpl702 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H5.08c wdr44 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC3H5.09c hob2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H5.09c hob2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC3H5.09c hob2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H5.10 rpl3202 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H5.10 rpl3202 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3H5.10 rpl3202 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC3H5.10 rpl3202 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3H5.10 rpl3202 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H5.10 rpl3202 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H5.10 rpl3202 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H5.11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H5.12c rpl501 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H5.12c rpl501 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC3H5.12c rpl501 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3H5.12c rpl501 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H5.12c rpl501 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC3H5.12c rpl501 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H8.02 csr102 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC3H8.03 img2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H8.03 img2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H8.04 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H8.04 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC3H8.04 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC3H8.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H8.06 aur1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H8.06 aur1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H8.07c pfd3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H8.07c pfd3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC3H8.09c nab3 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC3H8.09c nab3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC3H8.09c nab3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC3H8.10 spo20 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC3H8.10 spo20 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC458.02c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC458.02c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC458.02c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC458.02c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC458.02c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC458.03 tel2 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:17189249 4896 2013-05-01 SPAC458.03 tel2 RNA northern assay evidence used in manual assertion unchanged during(GO:0034644) PMID:17189249 4896 2013-05-01 SPAC458.03 tel2 RNA northern assay evidence used in manual assertion unchanged during(GO:0072711) PMID:17189249 4896 2013-05-01 SPAC458.03 tel2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:17189249 4896 2013-05-01 SPAC458.04c dli1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC458.04c dli1 RNA Northern assay evidence absent during(GO:0072690) PMID:20298435 4896 2021-01-22 SPAC458.04c dli1 RNA experimental evidence increased during(GO:0051321) 4896 2007-10-11 SPAC458.04c dli1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC458.04c dli1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC458.04c dli1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC458.04c dli1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC458.04c dli1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC458.04c dli1 RNA Northern assay evidence present during(GO:0051321) PMID:20298435 4896 2021-01-22 SPAC458.05 pik3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC458.05 pik3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC458.06 atg1803 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC458.06 atg1803 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC458.06 atg1803 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC458.07 tfa1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC458.07 tfa1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4A8.02c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4A8.02c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4A8.02c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4A8.03c ptc4 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC4A8.03c ptc4 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC4A8.03c ptc4 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC4A8.03c ptc4 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC4A8.03c ptc4 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC4A8.03c ptc4 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC4A8.04 isp6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4A8.04 isp6 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4A8.04 isp6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4A8.04 isp6 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:7954893 4896 2014-05-08 SPAC4A8.04 isp6 RNA experimental evidence increased during(GO:0006995) PMID:11872168 4896 2006-05-16 SPAC4A8.04 isp6 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:7954893 4896 2014-05-08 SPAC4A8.04 isp6 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:11872168 4896 2017-01-10 SPAC4A8.04 isp6 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC4A8.04 isp6 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC4A8.04 isp6 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC4A8.04 isp6 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC4A8.04 isp6 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC4A8.04 isp6 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC4A8.04 isp6 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC4A8.04 isp6 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4A8.04 isp6 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4A8.04 isp6 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4A8.04 isp6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4A8.04 isp6 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC4A8.04 isp6 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC4A8.04 isp6 RNA northern assay evidence used in manual assertion unchanged during(GO:0006995) PMID:21153812 4896 2016-02-03 SPAC4A8.04 isp6 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:21153812 4896 2016-02-03 SPAC4A8.05c myp2 RNA transcript expression level evidence present during(GO:0072690) PMID:9398685 4896 2015-09-28 SPAC4A8.06c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4A8.06c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4A8.06c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4A8.07c lcb4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4A8.07c lcb4 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC4A8.08c vrs2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4A8.08c vrs2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4A8.10 rog1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4A8.11c fas2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4A8.11c fas2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4A8.11c fas2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4A8.11c fas2 RNA quantitative PCR increased during(GO:0071456) PMID:27053105 4896 2016-08-03 SPAC4A8.11c fas2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4A8.12c sds22 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4A8.12c sds22 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:1846086 4896 2013-02-22 SPAC4A8.13c pts1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4A8.14 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4A8.15c cdc3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4A8.15c cdc3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4A8.15c cdc3 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC4A8.16c tif303 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4A8.16c tif303 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4A8.16c tif303 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4A8.16c tif303 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4A8.16c tif303 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4C5.01 pud1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4C5.01 pud1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4C5.01 pud1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4C5.01 pud1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC4C5.02c ryh1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4C5.02c ryh1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4C5.04 rad31 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4C5.04 rad31 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4D7.02c pgc1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4D7.02c pgc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4D7.02c pgc1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4D7.02c pgc1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC4D7.02c pgc1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC4D7.02c pgc1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC4D7.02c pgc1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC4D7.02c pgc1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC4D7.02c pgc1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC4D7.02c pgc1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC4D7.02c pgc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4D7.02c pgc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4D7.02c pgc1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4D7.02c pgc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4D7.02c pgc1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC4D7.02c pgc1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC4D7.02c pgc1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4D7.03 pop2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4D7.05 sum1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4D7.05 sum1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4D7.05 sum1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4D7.05 sum1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4D7.05 sum1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4D7.06c met8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4D7.08c ade4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4D7.08c ade4 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4D7.08c ade4 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8082193 4896 2013-05-20 SPAC4D7.09 tif223 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4D7.09 tif223 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4D7.09 tif223 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4D7.09 tif223 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4D7.11 dsc4 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC4D7.12c fet5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.02 ape4 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4F10.04 ypa1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.05c lip2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.06 bud22 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F10.06 bud22 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.06 bud22 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4F10.07c atg13 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4F10.07c atg13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F10.07c atg13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4F10.07c atg13 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4F10.07c atg13 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC4F10.07c atg13 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4F10.07c atg13 RNA quantitative PCR increased during(GO:0010438) PMID:33064910 4896 2020-10-28 SPAC4F10.08 mug126 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4F10.08 mug126 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC4F10.08 mug126 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4F10.08 mug126 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4F10.09c noc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F10.09c noc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.09c noc1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4F10.09c noc1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4F10.10c mnn9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F10.10c mnn9 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC4F10.10c mnn9 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.11 spn1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4F10.12 fta1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.13c mpd2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F10.13c mpd2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.13c mpd2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4F10.14c btf3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F10.14c btf3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4F10.14c btf3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F10.14c btf3 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4F10.15c wsp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.16c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC4F10.16c ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4F10.16c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4F10.16c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F10.17 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4F10.17 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC4F10.17 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC4F10.17 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F10.17 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4F10.17 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4F10.17 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC4F10.18 nup37 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F10.20 grx1 protein reporter gene assay evidence increased during(GO:0071294) PMID:11118633 4896 2014-11-03 SPAC4F10.20 grx1 protein reporter gene assay evidence increased during(GO:0071732) PMID:11118633 4896 2014-11-03 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion decreased during(GO:0071288) PMID:12297001 4896 2014-11-05 SPAC4F10.20 grx1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion increased during(GO:0071248) PMID:12297001 4896 2013-05-08 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion increased during(GO:0034599) PMID:12297001 4896 2013-05-08 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:12297001 4896 2013-05-08 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:15358115 4896 2014-11-03 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion increased during(GO:0036245) PMID:15358115 4896 2014-11-03 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:15358115 4896 2014-11-03 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:15358115 4896 2014-11-03 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion increased during(GO:0071294) PMID:12297001 4896 2014-11-05 SPAC4F10.20 grx1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC4F10.20 grx1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC4F10.20 grx1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC4F10.20 grx1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC4F10.20 grx1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC4F10.20 grx1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4F10.20 grx1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC4F10.20 grx1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion unchanged during(GO:0034605) PMID:12297001 4896 2014-11-05 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion unchanged during(GO:0071276) PMID:12297001 4896 2014-11-05 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion unchanged during(GO:0070301) PMID:12297001 4896 2014-11-05 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:15358115 4896 2014-11-03 SPAC4F10.20 grx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12297001 4896 2014-11-05 SPAC4F10.22 cmc4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F8.01 did4 protein microscopy evidence present during(GO:0000080) PMID:37783794 4896 2023-10-05 Fig. 2 SPAC4F8.01 did4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4F8.02c mrpl40 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F8.02c mrpl40 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F8.03 sdo1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F8.03 sdo1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F8.03 sdo1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F8.04 rpf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F8.04 rpf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F8.04 rpf1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4F8.04 rpf1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4F8.05c mrpl28 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4F8.05c mrpl28 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F8.06 mrps12 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4F8.07c hxk2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC4F8.07c hxk2 RNA experimental evidence decreased in presence of(CHEBI:17234) PMID:8549830 4896 2006-11-22 SPAC4F8.07c hxk2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F8.07c hxk2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F8.08 mug114 RNA expression microarray evidence decreased during(GO:0042149) PMID:34460892 4896 2021-09-20 SPAC4F8.08 mug114 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4F8.08 mug114 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC4F8.10c stg1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4F8.10c stg1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4F8.14c hcs1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4F8.14c hcs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4F8.14c hcs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4F8.14c hcs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4F8.15 itr1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4F8.15 itr1 RNA northern assay evidence used in manual assertion unchanged during(GO:0036110) PMID:9560432 4896 2012-05-17 SPAC4F8.15 itr1 RNA northern assay evidence used in manual assertion unchanged during(GO:0042149) PMID:9560432 4896 2012-05-17 SPAC4F8.15 itr1 RNA northern assay evidence used in manual assertion unchanged during(GO:0006995) PMID:9560432 4896 2012-05-17 SPAC4F8.15 itr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9560432 4896 2012-05-17 SPAC4G8.02c sss1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G8.02c sss1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G8.02c sss1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4G8.03c puf5 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4G8.03c puf5 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC4G8.03c puf5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4G8.03c puf5 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4G8.04 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G8.04 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4G8.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G8.06c trm12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G8.07c trm2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G8.07c trm2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4G8.08 mrs4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC4G8.08 mrs4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G8.10 gos1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G8.10 gos1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G8.10 gos1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G8.10 gos1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4G8.10 gos1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4G8.10 gos1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4G8.10 gos1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC4G8.11c atp10 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4G8.12c smp3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4G8.12c smp3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G8.12c smp3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC4G8.13c prz1 protein western blot evidence used in manual assertion increased during(GO:0042149) PMID:27756188 4896 2017-01-09 SPAC4G8.13c prz1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC4G8.13c prz1 RNA northern assay evidence used in manual assertion increased during(GO:0071277) PMID:27756188 4896 2017-01-09 SPAC4G8.13c prz1 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:27756188 4896 2017-01-09 SPAC4G9.02 rnh201 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.02 rnh201 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G9.03 adk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.03 adk1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4G9.03 adk1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G9.05 mpf1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4G9.05 mpf1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC4G9.05 mpf1 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:16896214 4896 2014-07-17 SPAC4G9.05 mpf1 RNA quantitative PCR increased during(GO:0051321) PMID:16896214 4896 2014-07-17 SPAC4G9.05 mpf1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4G9.06c chz1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4G9.07 mug133 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.07 mug133 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC4G9.07 mug133 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4G9.07 mug133 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G9.09c arg11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G9.09c arg11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4G9.10 arg3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.10 arg3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G9.10 arg3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4G9.10 arg3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4G9.11c cmb1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4G9.11c cmb1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.11c cmb1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4G9.11c cmb1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC4G9.11c cmb1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC4G9.11c cmb1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC4G9.11c cmb1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC4G9.11c cmb1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC4G9.11c cmb1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4G9.11c cmb1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4G9.11c cmb1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4G9.11c cmb1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC4G9.12 idn1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4G9.12 idn1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4G9.12 idn1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G9.12 idn1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4G9.12 idn1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G9.13c vps26 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.13c vps26 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4G9.14 sym1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.14 sym1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G9.15 ifa38 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.16c rpl901 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.16c rpl901 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4G9.16c rpl901 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4G9.16c rpl901 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4G9.16c rpl901 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G9.16c rpl901 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G9.17c mrp5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.19 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.19 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G9.19 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4G9.19 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4G9.20c ymc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4G9.20c ymc1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4G9.20c ymc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4G9.20c ymc1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4G9.20c ymc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G9.22 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4G9.22 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4G9.22 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC4G9.22 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4G9.22 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC4G9.22 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC4H3.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4H3.03c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4H3.03c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC4H3.03c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC4H3.03c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC4H3.03c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC4H3.03c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC4H3.03c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC4H3.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4H3.03c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4H3.03c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4H3.03c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC4H3.03c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4H3.03c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC4H3.03c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC4H3.03c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC4H3.04c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4H3.04c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4H3.04c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC4H3.04c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4H3.04c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4H3.04c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4H3.04c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4H3.06 rss1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4H3.07c rdl2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC4H3.07c rdl2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4H3.08 fox2 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC4H3.08 fox2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4H3.08 fox2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC4H3.08 fox2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC4H3.08 fox2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC4H3.08 fox2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC4H3.08 fox2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC4H3.08 fox2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC4H3.08 fox2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC4H3.08 fox2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4H3.08 fox2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC4H3.08 fox2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4H3.08 fox2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4H3.08 fox2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC4H3.08 fox2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC4H3.08 fox2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC4H3.09 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4H3.09 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC4H3.10c pyk1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC4H3.10c pyk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC4H3.10c pyk1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4H3.10c pyk1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4H3.11c ppc89 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC4H3.11c ppc89 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC4H3.13 pcc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC4H3.17 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC4H3.17 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC513.01c eft201 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC513.01c eft201 protein western blot evidence used in manual assertion unchanged during(GO:0071470) PMID:18065650 4896 2017-09-29 SPAC513.01c eft201 protein western blot evidence used in manual assertion unchanged during(GO:0034599) PMID:18065650 4896 2017-09-29 SPAC513.01c eft201 protein western blot evidence used in manual assertion unchanged during(GO:0006995) PMID:18065650 4896 2017-09-29 SPAC513.01c eft201 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC513.01c eft201 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC513.01c eft201 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC513.01c eft201 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC513.02 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC513.02 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC513.02 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC513.02 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC513.02 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC513.02 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC513.02 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC513.02 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC513.02 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC513.02 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC513.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC513.02 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC513.02 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC513.02 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC513.02 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC513.02 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC513.02 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC513.03 mfm2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC513.03 mfm2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC513.03 mfm2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC513.03 mfm2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC513.03 mfm2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC513.03 mfm2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC513.03 mfm2 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0006995) PMID:8196631 4896 2012-02-08 SPAC513.03 mfm2 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0071444) PMID:8196631 4896 2012-02-08 SPAC513.03 mfm2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC513.05 ams1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC513.05 ams1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC513.05 ams1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC513.05 ams1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC513.05 ams1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC513.06c dhd1 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC513.06c dhd1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC513.06c dhd1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC513.07 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC513.07 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC513.07 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC513.07 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC513.07 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC513.07 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC513.07 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC513.07 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC513.07 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC513.07 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC513.07 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC513.07 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC513.07 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC513.07 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC513.07 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC513.07 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC521.02 wss1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC521.03 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC521.03 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC521.03 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC521.03 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC521.03 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC521.03 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC521.03 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC521.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC521.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC521.04c sst1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC521.04c sst1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC521.04c sst1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC521.05 rps802 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC521.05 rps802 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC521.05 rps802 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56E4.02c alg13 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56E4.02c alg13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC56E4.03 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC56E4.03 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC56E4.03 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC56E4.03 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC56E4.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC56E4.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC56E4.03 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC56E4.04c cut6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC56E4.04c cut6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC56E4.04c cut6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56E4.04c cut6 RNA quantitative PCR fluctuates during(GO:0000278) PMID:27687771 4896 2016-12-06 SPAC56E4.04c cut6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56E4.04c cut6 RNA RNA-sequencing evidence increased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAC56E4.05 snd2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC56E4.05 snd2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56E4.05 snd2 RNA experimental evidence increased during(GO:0051321) PMID:16303567 4896 2010-01-03 SPAC56E4.05 snd2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC56E4.06c ggt2 protein reporter gene assay evidence increased during(GO:0071500) PMID:16202243 4896 2014-08-06 SPAC56E4.06c ggt2 protein reporter gene assay evidence increased during(GO:0034599) PMID:16202243 4896 2014-08-06 SPAC56E4.06c ggt2 protein reporter gene assay evidence increased in presence of(CHEBI:29321) PMID:16202243 4896 2014-08-06 SPAC56E4.06c ggt2 protein reporter gene assay evidence increased during(GO:0070301) PMID:16202243 4896 2014-08-06 SPAC56E4.06c ggt2 protein reporter gene assay evidence increased during(GO:0042149) PMID:16202243 4896 2014-08-06 SPAC56E4.06c ggt2 protein reporter gene assay evidence increased during(GO:0006995) PMID:16202243 4896 2014-08-06 SPAC56E4.06c ggt2 RNA northern assay evidence used in manual assertion increased during(GO:0071500) PMID:16202243 4896 2014-08-06 SPAC56E4.06c ggt2 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:29321) PMID:16202243 4896 2014-08-06 SPAC56E4.06c ggt2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56E4.07 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56F8.03 tif52 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC56F8.03 tif52 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56F8.05c mug64 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC56F8.05c mug64 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56F8.05c mug64 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56F8.05c mug64 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC56F8.06c alg10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC56F8.06c alg10 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC56F8.07 ema19 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC56F8.07 ema19 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56F8.08 mud1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC56F8.09 rrp8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC56F8.09 rrp8 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC56F8.09 rrp8 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC56F8.09 rrp8 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC56F8.09 rrp8 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC56F8.09 rrp8 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC56F8.09 rrp8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56F8.09 rrp8 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC56F8.09 rrp8 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC56F8.10 met9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC56F8.10 met9 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC56F8.10 met9 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56F8.11 spc3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC56F8.11 spc3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC56F8.12 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56F8.13 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56F8.13 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56F8.14c mug115 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56F8.14c mug115 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC56F8.14c mug115 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC56F8.14c mug115 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC56F8.15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC56F8.16 esc1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:8381348 4896 2016-10-11 SPAC56F8.16 esc1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC56F8.16 esc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC56F8.16 esc1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC57A10.02 cdr2 protein western blot evidence used in manual assertion absent during(GO:0006995) PMID:9843572 4896 2017-04-28 SPAC57A10.02 cdr2 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:24508166 4896 2015-02-23 SPAC57A10.02 cdr2 protein western blot evidence used in manual assertion decreased during(GO:0006995) PMID:9843577 4896 2019-11-06 SPAC57A10.02 cdr2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A10.02 cdr2 protein western blot evidence used in manual assertion present during(GO:0000278) PMID:24508166 4896 2015-02-23 SPAC57A10.02 cdr2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A10.02 cdr2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC57A10.03 cyp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC57A10.04 mug10 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC57A10.04 mug10 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A10.05c pof1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC57A10.05c pof1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A10.06 mug15 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A10.06 mug15 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC57A10.07 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC57A10.07 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC57A10.08c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC57A10.08c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A10.08c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A10.08c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC57A10.09c nhp6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A10.09c nhp6 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC57A10.09c nhp6 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC57A10.09c nhp6 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC57A10.09c nhp6 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC57A10.09c nhp6 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC57A10.09c nhp6 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC57A10.09c nhp6 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC57A10.09c nhp6 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A10.09c nhp6 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC57A10.09c nhp6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC57A10.09c nhp6 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC57A10.10c sla1 protein western blot evidence used in manual assertion decreased during(GO:0006279) PMID:14665462 4896 2015-01-12 SPAC57A10.10c sla1 protein western blot evidence used in manual assertion decreased during(GO:0007127) PMID:14665462 4896 2015-01-12 SPAC57A10.10c sla1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A10.10c sla1 protein western blot evidence used in manual assertion increased during(GO:0007135) PMID:14665462 4896 2015-01-12 SPAC57A10.10c sla1 protein western blot evidence used in manual assertion present during(GO:0022620) PMID:14665462 4896 2015-01-12 SPAC57A10.10c sla1 RNA northern assay evidence used in manual assertion constant during(GO:0051321) PMID:14665462 4896 2015-01-12 SPAC57A10.10c sla1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC57A10.10c sla1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A10.10c sla1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A10.10c sla1 RNA northern assay evidence used in manual assertion unchanged during(GO:0051321) PMID:14665462 4896 2015-01-12 SPAC57A10.10c sla1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:14665462 4896 2015-01-12 SPAC57A10.11c mia40 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A10.11c mia40 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC57A10.12c ura3 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC57A10.12c ura3 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC57A10.12c ura3 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC57A10.12c ura3 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC57A10.12c ura3 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC57A10.12c ura3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A10.12c ura3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A7.04c pabp protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A7.04c pabp protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC57A7.04c pabp ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A7.04c pabp ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC57A7.04c pabp RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A7.04c pabp RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC57A7.05 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A7.05 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC57A7.05 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC57A7.05 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC57A7.05 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC57A7.05 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC57A7.05 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC57A7.05 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC57A7.05 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A7.05 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC57A7.05 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A7.05 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC57A7.05 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC57A7.05 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC57A7.05 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC57A7.06 utp14 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A7.06 utp14 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A7.06 utp14 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC57A7.07c mht1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC57A7.08 pzh1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A7.08 pzh1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC57A7.08 pzh1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC57A7.08 pzh1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC57A7.09 rnf13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A7.09 rnf13 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A7.09 rnf13 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC57A7.11 mip1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A7.11 mip1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC57A7.12 ssz1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC57A7.12 ssz1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC57A7.12 ssz1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC57A7.12 ssz1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC57A7.12 ssz1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC57A7.12 ssz1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC57A7.12 ssz1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC57A7.13 rbm10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC589.02c med13 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC589.02c med13 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPAC589.02c med13 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC589.06c snd302 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC589.06c snd302 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC589.06c snd302 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC589.06c snd302 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC589.07c atg1801 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC589.07c atg1801 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC589.07c atg1801 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC589.07c atg1801 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC589.07c atg1801 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC589.07c atg1801 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC589.08c dam1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC589.08c dam1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC589.08c dam1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC589.09 csr101 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC589.09 csr101 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC589.10c ubi5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC589.10c ubi5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC589.10c ubi5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC589.10c ubi5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC589.11 pth4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC589.12 cwh43 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC589.12 cwh43 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC589.12 cwh43 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC589.12 cwh43 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC5D6.01 rps2202 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5D6.01 rps2202 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC5D6.01 rps2202 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC5D6.01 rps2202 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC5D6.01 rps2202 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC5D6.02c mug165 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC5D6.04 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5D6.04 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC5D6.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC5D6.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC5D6.05 med18 RNA northern assay evidence used in manual assertion increased during(GO:0000917) PMID:10491317 4896 2014-07-01 SPAC5D6.05 med18 RNA northern assay evidence used in manual assertion present during(GO:0000278) PMID:10491317 4896 2014-07-01 SPAC5D6.06c alg14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5D6.07c pxa1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5D6.07c pxa1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC5D6.07c pxa1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC5D6.07c pxa1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC5D6.07c pxa1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC5D6.07c pxa1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC5D6.08c mes1 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:8082199 4896 2014-08-08 SPAC5D6.08c mes1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:8082199 4896 2014-08-08 SPAC5D6.08c mes1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC5D6.09c mug86 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC5D6.09c mug86 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5D6.09c mug86 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC5D6.09c mug86 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC5D6.09c mug86 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC5D6.09c mug86 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC5D6.10c mug116 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC5D6.12 mtf2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC5D6.12 mtf2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC5H10.01 dgc1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC5H10.01 dgc1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC5H10.01 dgc1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC5H10.01 dgc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5H10.01 dgc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC5H10.01 dgc1 RNA expression microarray evidence increased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC5H10.02c hsp3102 protein western blot evidence used in manual assertion increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPAC5H10.02c hsp3102 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC5H10.02c hsp3102 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC5H10.02c hsp3102 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC5H10.02c hsp3102 RNA quantitative PCR increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPAC5H10.02c hsp3102 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC5H10.02c hsp3102 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC5H10.02c hsp3102 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC5H10.02c hsp3102 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC5H10.02c hsp3102 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC5H10.02c hsp3102 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC5H10.02c hsp3102 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC5H10.02c hsp3102 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC5H10.02c hsp3102 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC5H10.03 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC5H10.03 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5H10.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC5H10.04 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC5H10.05c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5H10.05c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC5H10.06c adh4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC5H10.06c adh4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5H10.06c adh4 RNA northern assay evidence used in manual assertion decreased during(GO:0071294) PMID:24003116 4896 2014-01-03 SPAC5H10.06c adh4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC5H10.06c adh4 RNA transcript expression level evidence increased during(GO:0071276) PMID:18203864 4896 2015-07-14 SPAC5H10.06c adh4 RNA transcript expression level evidence increased during(GO:0071280) PMID:18203864 4896 2015-07-14 SPAC5H10.06c adh4 RNA transcript expression level evidence increased during(GO:0034224) PMID:18203864 4896 2015-07-14 SPAC5H10.06c adh4 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC5H10.06c adh4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC5H10.06c adh4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC5H10.07 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC5H10.08c pan6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5H10.08c pan6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC5H10.08c pan6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC5H10.09c ecm31 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC5H10.10 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC5H10.10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5H10.10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC5H10.10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC5H10.10 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC5H10.10 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC5H10.11 gmh1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC5H10.11 gmh1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC5H10.11 gmh1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC5H10.11 gmh1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC5H10.12c otg1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC5H10.12c otg1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC5H10.13c gmh2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC5H10.13c gmh2 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC5H10.13c gmh2 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC5H10.13c gmh2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC5H10.13c gmh2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC607.02c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC607.02c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC607.02c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC607.03c snu13 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC607.03c snu13 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC607.03c snu13 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC607.03c snu13 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC607.04 arg82 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC607.04 arg82 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC607.05 rpn9 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC607.06c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC607.07c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC607.08c mil1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC607.08c mil1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC607.08c mil1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC607.08c mil1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC607.08c mil1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC607.08c mil1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC607.08c mil1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC607.08c mil1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC607.08c mil1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC607.08c mil1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC607.08c mil1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC607.08c mil1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC607.09c btn1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC607.09c btn1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC607.09c btn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC607.09c btn1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC607.09c btn1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC607.09c btn1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC607.09c btn1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC607.10 spo3 protein western blot evidence used in manual assertion absent during(GO:0072690) PMID:11739793 4896 2015-01-31 SPAC607.10 spo3 protein western blot evidence used in manual assertion absent during(GO:0007127) PMID:11739793 4896 2015-01-31 SPAC607.10 spo3 protein western blot evidence used in manual assertion increased during(GO:0007135) PMID:11739793 4896 2015-01-31 SPAC607.10 spo3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC607.10 spo3 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:11739793 4896 2015-01-31 SPAC607.10 spo3 RNA northern assay evidence used in manual assertion absent during(GO:0007127) PMID:11739793 4896 2015-01-31 SPAC607.10 spo3 RNA experimental evidence increased during(GO:0034293) 4896 SPAC607.10 spo3 RNA experimental evidence increased during(GO:0000080) 4896 SPAC607.10 spo3 RNA northern assay evidence used in manual assertion increased during(GO:0007135) PMID:11739793 4896 2015-01-31 SPAC607.10 spo3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC630.03 arp3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC630.04c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC630.04c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC630.04c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC630.05 gyp7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC630.05 gyp7 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC630.05 gyp7 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC630.05 gyp7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC630.05 gyp7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC630.06c sni445 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC630.06c sni445 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC630.07c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC630.07c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC630.07c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC630.07c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC630.07c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC630.07c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC630.08c erg25 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC630.08c erg25 RNA Northern assay evidence increased during(GO:0071456) PMID:15797383 4896 2020-01-07 SPAC630.08c erg25 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC630.08c erg25 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC630.09c mug58 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC630.10 bmt2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC630.10 bmt2 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC630.11 vps55 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC630.11 vps55 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC630.11 vps55 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC630.13c tsc2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC630.14c tup12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC630.14c tup12 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC630.15 mug177 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC630.15 mug177 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC631.02 bdf2 protein western blot evidence used in manual assertion decreased during(GO:0000087) PMID:22095079 4896 2018-06-26 SPAC631.02 bdf2 protein western blot evidence used in manual assertion decreased during(GO:0000080) PMID:22095079 4896 2018-06-26 SPAC631.02 bdf2 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:22095079 4896 2018-06-26 SPAC631.02 bdf2 protein western blot evidence used in manual assertion increased during(GO:0000085) PMID:22095079 4896 2018-06-26 SPAC631.02 bdf2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC631.02 bdf2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC631.02 bdf2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC631.02 bdf2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC637.03 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC637.03 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC637.03 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC637.03 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC637.03 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC637.03 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC637.03 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC637.03 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC637.03 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC637.03 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC637.03 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC637.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC637.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC637.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC637.03 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC637.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC637.03 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC637.03 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC637.03 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC637.04 ypp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC637.05c vma2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC637.06 gmh5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC637.07 moe1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC637.07 moe1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC637.07 moe1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC637.07 moe1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC637.07 moe1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC637.09 rex1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC637.09 rex1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC637.09 rex1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC637.10c rpn10 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC637.10c rpn10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC637.13c slm1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC637.13c slm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC637.13c slm1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC637.13c slm1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC637.13c slm1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC637.13c slm1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC637.13c slm1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC644.05c dut1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC644.05c dut1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC644.05c dut1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC644.06c cdr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC644.07 bcs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC644.08 utr4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC644.09 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC644.09 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC644.09 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC644.11c pkp1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC644.13c yip4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC644.14c rad51 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:25165823 4896 2014-10-22 SPAC644.14c rad51 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC644.14c rad51 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:25165823 4896 2014-10-22 SPAC644.14c rad51 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC644.14c rad51 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC644.15 rpp101 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC644.15 rpp101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC644.15 rpp101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC644.16 rna15 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC644.16 rna15 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC644.16 rna15 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC644.18c bet3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC652.01 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC664.01c swi6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC664.01c swi6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC664.02c arp8 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC664.04c rps1602 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC664.04c rps1602 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC664.04c rps1602 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC664.04c rps1602 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC664.04c rps1602 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC664.05 rpl13 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC664.05 rpl13 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC664.05 rpl13 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC664.05 rpl13 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC664.05 rpl13 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC664.05 rpl13 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC664.06 rlp7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC664.06 rlp7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC664.06 rlp7 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC664.06 rlp7 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC664.06 rlp7 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC664.06 rlp7 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC664.06 rlp7 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC664.06 rlp7 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC664.06 rlp7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC664.06 rlp7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC664.06 rlp7 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC664.06 rlp7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC664.07c rad9 protein western blot evidence used in manual assertion decreased during(GO:0071456) PMID:31538680 4896 2019-10-14 SPAC664.07c rad9 protein reporter gene assay evidence increased during(GO:0006995) PMID:17725619 4896 2014-12-03 SPAC664.07c rad9 protein reporter gene assay evidence increased during(GO:0071500) PMID:17725619 4896 2014-12-03 SPAC664.07c rad9 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC664.07c rad9 RNA quantitative PCR increased during(GO:0006995) PMID:17725619 4896 2014-12-03 SPAC664.07c rad9 RNA quantitative PCR increased during(GO:0071500) PMID:17725619 4896 2014-12-03 SPAC664.07c rad9 RNA quantitative PCR increased during(GO:1902112) PMID:17725619 4896 2014-12-03 SPAC664.07c rad9 RNA quantitative PCR present during(GO:0072690) PMID:17725619 4896 2014-12-03 SPAC664.08c bfr2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC664.08c bfr2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC664.08c bfr2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC664.08c bfr2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC664.08c bfr2 RNA RNA-sequencing evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC664.09 ggt1 protein reporter gene assay evidence increased during(GO:0006995) PMID:15765057 4896 2014-11-26 SPAC664.09 ggt1 protein reporter gene assay evidence increased during(GO:0071361) PMID:15765057 4896 2014-11-26 SPAC664.09 ggt1 protein reporter gene assay evidence increased during(GO:0071311) PMID:15765057 4896 2014-11-26 SPAC664.09 ggt1 protein reporter gene assay evidence increased during(GO:0071500) PMID:15052323 4896 2014-12-03 SPAC664.09 ggt1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC664.09 ggt1 RNA quantitative PCR increased during(GO:0071500) PMID:15052323 4896 2014-12-03 SPAC664.09 ggt1 RNA quantitative PCR present during(GO:0072690) PMID:15052323 4896 2014-12-03 SPAC664.11 ssc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC664.11 ssc1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC664.11 ssc1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC664.11 ssc1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:2123810 4896 2013-01-31 SPAC664.11 ssc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC664.11 ssc1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC664.11 ssc1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:2123810 4896 2013-01-31 SPAC664.12c sdh6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC664.13 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC664.13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC664.13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC664.13 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC664.13 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC664.14 amt2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC664.14 amt2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC664.14 amt2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC683.02c RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC683.02c RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC683.02c RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC683.02c RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC683.02c RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC683.02c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC683.02c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC683.02c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC688.02c mis14 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC688.02c mis14 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC688.02c mis14 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC688.03c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC688.03c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC688.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC688.03c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC688.03c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC688.03c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC688.04c gst3 protein reporter gene assay evidence increased during(GO:0071276) PMID:12151111 4896 2014-11-03 SPAC688.04c gst3 protein reporter gene assay evidence increased during(GO:0071288) PMID:12151111 4896 2014-11-03 SPAC688.04c gst3 protein reporter gene assay evidence increased during(GO:0071275) PMID:12151111 4896 2014-11-03 SPAC688.04c gst3 protein reporter gene assay evidence increased during(GO:0071294) PMID:12151111 4896 2014-11-03 SPAC688.04c gst3 protein reporter gene assay evidence increased during(GO:0071280) PMID:12151111 4896 2014-11-03 SPAC688.04c gst3 protein reporter gene assay evidence increased during(GO:0042149) PMID:15650330 4896 2014-11-20 SPAC688.04c gst3 protein reporter gene assay evidence increased during(GO:0071500) PMID:15650330 4896 2014-11-20 SPAC688.04c gst3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC688.04c gst3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC688.04c gst3 protein reporter gene assay evidence unchanged during(GO:0071732) PMID:12151111 4896 2014-11-03 SPAC688.04c gst3 protein reporter gene assay evidence unchanged during(GO:0070301) PMID:12151111 4896 2014-11-03 SPAC688.04c gst3 protein reporter gene assay evidence unchanged during(GO:0036245) PMID:12151111 4896 2014-11-03 SPAC688.04c gst3 protein reporter gene assay evidence present during(GO:0072690) PMID:15650330 4896 2014-11-20 SPAC688.04c gst3 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC688.04c gst3 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:15650330 4896 2014-11-20 SPAC688.04c gst3 RNA northern assay evidence used in manual assertion increased during(GO:0071500) PMID:15650330 4896 2014-11-20 SPAC688.04c gst3 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:12063243 4896 2014-11-20 SPAC688.04c gst3 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12063243 4896 2014-11-20 SPAC688.04c gst3 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC688.04c gst3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC688.04c gst3 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC688.04c gst3 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC688.04c gst3 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC688.04c gst3 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC688.04c gst3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC688.04c gst3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC688.04c gst3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC688.04c gst3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC688.04c gst3 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC688.04c gst3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC688.04c gst3 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC688.04c gst3 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC688.06c slx4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC688.06c slx4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC688.06c slx4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC688.07c rng10 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC688.12c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC688.13 scn3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC688.13 scn3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC688.13 scn3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC688.13 scn3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC688.14 set13 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC688.14 set13 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC694.02 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC694.02 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC694.03 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC694.03 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC694.04c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC694.04c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC694.04c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC694.04c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC694.05c rps2502 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC694.05c rps2502 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC694.05c rps2502 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC694.05c rps2502 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC694.05c rps2502 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC694.05c rps2502 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC694.05c rps2502 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC694.06c mrc1 protein western blot evidence used in manual assertion increased in presence of(CHEBI:44423) PMID:19422421 4896 2018-04-12 SPAC694.06c mrc1 protein western blot evidence used in manual assertion increased during(GO:0000082) PMID:16618806 4896 2018-04-11 SPAC694.06c mrc1 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:11715017 4896 2018-03-21 SPAC694.06c mrc1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC694.06c mrc1 RNA northern assay evidence used in manual assertion increased during(GO:0000082) PMID:16618806 4896 2018-04-11 SPAC694.06c mrc1 RNA northern assay evidence used in manual assertion increased during(GO:0000084) PMID:11715017 4896 2018-03-21 SPAC6B12.03c bit2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6B12.03c bit2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC6B12.03c bit2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC6B12.03c bit2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6B12.03c bit2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6B12.03c bit2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6B12.03c bit2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6B12.03c bit2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC6B12.06c rrg9 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6B12.06c rrg9 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6B12.07c pqr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6B12.07c pqr1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6B12.07c pqr1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC6B12.07c pqr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6B12.07c pqr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC6B12.07c pqr1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6B12.07c pqr1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC6B12.08 epr1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC6B12.08 epr1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6B12.08 epr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6B12.09 trm10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6B12.09 trm10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6B12.10c spp1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:11160827 4896 2015-02-09 SPAC6B12.10c spp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6B12.12 tom70 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6B12.12 tom70 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6B12.13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6B12.13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6B12.15 cpc2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6B12.15 cpc2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6B12.15 cpc2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6B12.16 meu26 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6B12.16 meu26 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC6B12.16 meu26 RNA experimental evidence increased during(GO:0051321) 4896 2010-01-03 SPAC6B12.18 gon7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6B12.18 gon7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6B12.18 gon7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6C3.02c mix17 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6C3.02c mix17 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6C3.03c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6C3.04 cit1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6C3.04 cit1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6C3.04 cit1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6C3.04 cit1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6C3.04 cit1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC6C3.05 meu43 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6C3.05 meu43 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC6C3.06c neo1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC6C3.06c neo1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC6C3.06c neo1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6C3.07 mug68 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6C3.07 mug68 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6C3.08 nas6 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6F12.02 rst2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6F12.02 rst2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC6F12.02 rst2 RNA northern assay evidence used in manual assertion unchanged during(GO:0042149) PMID:11739717 4896 2017-07-14 SPAC6F12.02 rst2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10982411 4896 2017-07-28 SPAC6F12.03c fsv1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC6F12.03c fsv1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6F12.03c fsv1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6F12.03c fsv1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6F12.03c fsv1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6F12.03c fsv1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC6F12.04 tvp15 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC6F12.04 tvp15 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F12.04 tvp15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6F12.07 tom20 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F12.07 tom20 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6F12.10c ade3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F12.10c ade3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6F12.10c ade3 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC6F12.10c ade3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6F12.10c ade3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC6F12.11c sfc1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6F12.12 par2 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:10757751 4896 2015-01-14 SPAC6F12.12 par2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:10757751 4896 2015-01-14 SPAC6F12.13c fps1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6F12.13c fps1 RNA northern assay evidence used in manual assertion decreased during(GO:0006995) PMID:17596513 4896 2015-07-30 SPAC6F12.13c fps1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6F12.13c fps1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6F12.13c fps1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:17596513 4896 2015-07-30 SPAC6F12.14 cut23 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F12.14 cut23 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC6F12.14 cut23 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6F12.15c cut9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F12.15c cut9 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6F12.15c cut9 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6F12.16c mtr4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F12.16c mtr4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6F12.16c mtr4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6F12.16c mtr4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6F6.02c pof5 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC6F6.02c pof5 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6F6.02c pof5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6F6.03c nog2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F6.03c nog2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6F6.03c nog2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6F6.03c nog2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6F6.05 ost2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F6.05 ost2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6F6.06c rax2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F6.06c rax2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6F6.07c rps13 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F6.07c rps13 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6F6.07c rps13 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6F6.07c rps13 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6F6.07c rps13 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6F6.07c rps13 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC6F6.07c rps13 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC6F6.10c arc2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6F6.11c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F6.11c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6F6.12 atg24 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F6.12 atg24 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC6F6.12 atg24 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6F6.12 atg24 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6F6.12 atg24 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6F6.12 atg24 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6F6.13c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC6F6.13c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC6F6.15 ypt5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6F6.15 ypt5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6F6.16c tpz1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6F6.16c tpz1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6F6.16c tpz1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6F6.19 sap34 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC6G10.02c tea3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6G10.03c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC6G10.03c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6G10.03c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC6G10.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G10.03c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6G10.03c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6G10.04c pre5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6G10.05c trs120 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6G10.06 btn3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G10.06 btn3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6G10.08 idp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6G10.08 idp1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC6G10.08 idp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G10.08 idp1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC6G10.08 idp1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC6G10.09 gls1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G10.09 gls1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6G10.10c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6G10.11c ubi3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC6G10.11c ubi3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G10.12c ace2 protein Western blot evidence increased during(GO:0000090) PMID:16317047 4896 2024-07-22 Ace2p-Myc13 was periodically produced through the cell cycle (Fig. 4A). It began to accumulate during anaphase as determined by the coincidence of binucleate formation, and it peaked in abundance concomitantly with the peak of septation. SPAC6G10.12c ace2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC6G10.12c ace2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC6G10.12c ace2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC6G10.12c ace2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC6G10.12c ace2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC6G10.12c ace2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G10.12c ace2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6G10.12c ace2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6G10.12c ace2 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:15509866 4896 2015-11-22 SPAC6G10.12c ace2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPAC6G9.01c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6G9.01c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G9.02c nop9 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC6G9.02c nop9 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC6G9.02c nop9 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC6G9.02c nop9 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC6G9.02c nop9 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC6G9.02c nop9 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6G9.02c nop9 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G9.02c nop9 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6G9.03c rtt106 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6G9.03c rtt106 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6G9.04 spo7 RNA experimental evidence absent during(GO:0098763) PMID:21775631 4896 2016-09-07 SPAC6G9.04 spo7 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6G9.04 spo7 RNA experimental evidence present during(GO:0098762) PMID:21775631 4896 2016-09-07 SPAC6G9.05 pcd1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC6G9.06c pcp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6G9.09c rpl2401 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC6G9.09c rpl2401 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC6G9.09c rpl2401 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC6G9.10c sen1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6G9.10c sen1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6G9.10c sen1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC6G9.10c sen1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC6G9.10c sen1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC6G9.10c sen1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC6G9.10c sen1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC6G9.10c sen1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6G9.10c sen1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6G9.11 syb1 protein microscopy evidence constant PMID:23709180 4896 2026-05-27 Unexpectedly, the abun- dance of GFP-Syb1 remained essentially constant after the induc- tion of sporulation (Fig. 1B and C; see Fig. S2A in the supplemen- tal material). Furthermore, Psy1 protein also showed a pattern similar to that of Syb1 protein. SPAC6G9.11 syb1 protein reporter gene assay evidence increased during(GO:0000090) PMID:21148300 4896 2021-03-19 SPAC6G9.11 syb1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC6G9.11 syb1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC6G9.11 syb1 RNA Northern assay evidence increased during(GO:0098762) PMID:23709180 4896 2026-05-27 mRNA was detected in vegetative cells and was found to increase during sporulation (Fig. 1A). SPAC6G9.11 syb1 RNA Northern assay evidence increased during(GO:0098765) PMID:23709180 4896 2026-05-27 mRNA was detected in vegetative cells and was found to increase during sporulation (Fig. 1A). The level of syb1 mRNA began to increase about 6 h after induction of meiosis and peaked at about 9 h when the cells were in meiosis II (see Fig. S1A and B in the supplemental material). SPAC6G9.11 syb1 RNA Northern assay evidence present PMID:23709180 4896 2026-05-27 mRNA was detected in vegetative cells and was found to increase during sporulation (Fig. 1A). SPAC6G9.12 cfr1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC6G9.13c bqt1 RNA expression microarray evidence increased during(GO:0071444) PMID:16615890 4896 2014-07-14 SPAC6G9.13c bqt1 RNA expression microarray evidence increased during(GO:0006995) PMID:16615890 4896 2014-07-14 SPAC6G9.13c bqt1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC6G9.14 puf4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC6G9.14 puf4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC6G9.14 puf4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC6G9.14 puf4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC6G9.15c ebp1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC6G9.16c xrc4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC732.01 vma11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC732.01 vma11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC750.01 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC750.01 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC750.01 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC750.01 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC750.02c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC750.04c ftm3 RNA expression microarray evidence decreased during(GO:0042149) PMID:34460892 4896 2021-09-20 SPAC750.05c ftm4 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC750.05c ftm4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC750.05c ftm4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC750.05c ftm4 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC750.06c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC750.06c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC750.06c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC750.08c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC750.08c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC767.01c vps1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC767.01c vps1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC767.01c vps1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC7D4.03c ahk1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC7D4.04 atg11 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC7D4.05 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC7D4.06c alg3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC7D4.06c alg3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC7D4.06c alg3 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC7D4.07c trx1 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:28640807 4896 2017-08-02 SPAC7D4.07c trx1 protein reporter gene assay evidence increased during(GO:0070301) PMID:11267679 4896 2014-11-03 SPAC7D4.07c trx1 protein reporter gene assay evidence increased during(GO:0036245) PMID:11267679 4896 2014-11-03 SPAC7D4.07c trx1 protein reporter gene assay evidence increased during(GO:0071276) PMID:12018855 4896 2014-11-05 SPAC7D4.07c trx1 protein reporter gene assay evidence increased during(GO:0071294) PMID:12018855 4896 2014-11-05 SPAC7D4.07c trx1 protein reporter gene assay evidence increased during(GO:0071288) PMID:12018855 4896 2014-11-05 SPAC7D4.07c trx1 protein reporter gene assay evidence unchanged during(GO:0071470) PMID:12018855 4896 2014-11-05 SPAC7D4.07c trx1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC7D4.07c trx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23115244 4896 2012-02-20 SPAC7D4.07c trx1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0034605) PMID:21091378 4896 2013-08-28 SPAC7D4.07c trx1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0070301) PMID:21091378 4896 2013-08-28 SPAC7D4.07c trx1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0072709) PMID:21091378 4896 2013-08-28 SPAC7D4.07c trx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:18758731 4896 2013-09-17 SPAC7D4.07c trx1 RNA northern assay evidence used in manual assertion increased during(GO:0036245) PMID:18758731 4896 2013-09-17 SPAC7D4.07c trx1 RNA northern assay evidence used in manual assertion increased during(GO:0071447) PMID:18758731 4896 2013-09-17 SPAC7D4.07c trx1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC7D4.07c trx1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC7D4.07c trx1 RNA northern assay evidence used in manual assertion unchanged during(GO:0072711) PMID:28640807 4896 2017-08-02 SPAC7D4.07c trx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23115244 4896 2012-02-20 SPAC7D4.07c trx1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:21091378 4896 2013-08-28 SPAC7D4.07c trx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:18758731 4896 2013-09-17 SPAC7D4.11c sec39 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC7D4.11c sec39 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC7D4.12c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC7D4.14c iss10 protein western blot evidence used in manual assertion decreased during(GO:0051321) PMID:23980030 4896 2013-12-02 SPAC7D4.14c iss10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC7D4.14c iss10 protein Western blot evidence decreased during(GO:0098764) PMID:33574613 4896 2021-03-15 Notably, Pir1 was depleted during early meiosis (Fig. 5a) but gradually recovered by middle meiosis. SPAC7D4.14c iss10 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:23980030 4896 2013-12-02 SPAC7D4.14c iss10 RNA northern assay evidence used in manual assertion unchanged during(GO:0051321) PMID:23980030 4896 2013-12-02 SPAC7D4.14c iss10 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23980030 4896 2013-12-02 SPAC806.02c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC806.03c rps2601 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC806.03c rps2601 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC806.03c rps2601 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC806.03c rps2601 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC806.03c rps2601 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC806.04c duf8901 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC806.05 lyr3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC806.06c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC806.07 ndk1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC806.07 ndk1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC806.07 ndk1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:7499258 4896 2013-02-20 SPAC806.07 ndk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC806.07 ndk1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:7499258 4896 2013-02-20 SPAC806.08c mod21 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC806.11 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC821.03c slf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC821.04c cid13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC821.04c cid13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC821.04c cid13 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC821.05 tif308 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC821.05 tif308 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC821.05 tif308 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC821.05 tif308 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC821.06 spn2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC821.06 spn2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC821.08c slp1 protein western blot evidence used in manual assertion absent during(GO:0051329) PMID:11058086 4896 2015-12-14 SPAC821.08c slp1 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:11058086 4896 2015-12-14 SPAC821.08c slp1 protein western blot evidence used in manual assertion present during(GO:0000087) PMID:11058086 4896 2015-12-14 SPAC821.08c slp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC821.08c slp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC821.08c slp1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC821.08c slp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC821.08c slp1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC821.08c slp1 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:15509866 4896 2015-11-22 SPAC821.08c slp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC821.08c slp1 RNA northern assay evidence used in manual assertion present during(GO:0000087) PMID:11058086 4896 2015-12-14 SPAC821.08c slp1 RNA northern assay evidence used in manual assertion present during(GO:0051329) PMID:11058086 4896 2015-12-14 SPAC821.09 eng1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC821.09 eng1 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:15194814 4896 2015-01-08 SPAC821.09 eng1 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPAC821.09 eng1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC821.09 eng1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC821.09 eng1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC821.09 eng1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC821.09 eng1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC821.09 eng1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC821.09 eng1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC821.09 eng1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC821.09 eng1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC821.09 eng1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC821.09 eng1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC821.09 eng1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC821.10c sod1 protein Western blot evidence decreased during(GO:0034224) PMID:39761853 4896 2025-07-08 (Fig. 4A) SPAC821.10c sod1 protein reporter gene assay evidence increased during(GO:0071280) PMID:12243351 4896 2014-11-20 SPAC821.10c sod1 protein reporter gene assay evidence increased during(GO:0071294) PMID:12243351 4896 2014-11-20 SPAC821.10c sod1 protein reporter gene assay evidence increased during(GO:0071276) PMID:12243351 4896 2014-11-20 SPAC821.10c sod1 protein reporter gene assay evidence increased during(GO:0071275) PMID:12243351 4896 2014-11-20 SPAC821.10c sod1 protein reporter gene assay evidence increased during(GO:0071288) PMID:12243351 4896 2014-11-20 SPAC821.10c sod1 protein reporter gene assay evidence increased during(GO:0070301) PMID:12243351 4896 2014-11-20 SPAC821.10c sod1 protein western blot evidence used in manual assertion increased during(GO:0036227) PMID:26507459 4896 2016-10-26 SPAC821.10c sod1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC821.10c sod1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC821.10c sod1 protein reporter gene assay evidence unchanged during(GO:0036245) PMID:12243351 4896 2014-11-20 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion decreased during(GO:0036227) PMID:12359231 4896 2014-11-04 SPAC821.10c sod1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC821.10c sod1 RNA Northern assay evidence decreased during(GO:0034224) PMID:39761853 4896 2025-07-08 (Fig. 1) SPAC821.10c sod1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12359231 4896 2014-11-04 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion increased during(GO:0036245) PMID:12359231 4896 2014-11-04 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12073089 4896 2015-07-15 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion increased during(GO:0036245) PMID:12073089 4896 2015-07-15 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:26507459 4896 2016-10-26 SPAC821.10c sod1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion unchanged during(GO:0072709) PMID:12073089 4896 2015-07-15 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion unchanged during(GO:0034605) PMID:12073089 4896 2015-07-15 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12359231 4896 2014-11-04 SPAC821.10c sod1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12073089 4896 2015-07-15 SPAC821.11 pro1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC821.11 pro1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC821.11 pro1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC821.11 pro1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC821.12 orb6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC823.03 ppk15 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC823.03 ppk15 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC823.03 ppk15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC823.03 ppk15 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC823.03 ppk15 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC823.03 ppk15 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC823.03 ppk15 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC823.03 ppk15 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC823.04 rrp36 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC823.04 rrp36 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC823.06 taf3 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPAC823.07 pga3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC823.08c rrp3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC823.08c rrp3 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC823.08c rrp3 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC823.08c rrp3 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC823.08c rrp3 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC823.08c rrp3 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC823.08c rrp3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC823.08c rrp3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC823.08c rrp3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC823.08c rrp3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC823.09c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC823.10c hem25 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC823.10c hem25 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC823.10c hem25 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC823.11 sgp1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC823.11 sgp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC823.11 sgp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC823.12 vps11 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC823.12 vps11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC823.13c she9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC823.14 ptf1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAC823.15 ppa1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC823.16c atg1802 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC823.16c atg1802 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC823.16c atg1802 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC823.16c atg1802 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC824.02 bst1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC824.02 bst1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC824.02 bst1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC824.03c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC824.04 swd22 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC824.05 vps16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC824.07 glo2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC824.07 glo2 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:16141205 4896 2015-01-25 SPAC824.07 glo2 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:16141205 4896 2015-01-25 SPAC824.07 glo2 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:16141205 4896 2015-01-25 SPAC824.07 glo2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC824.07 glo2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC824.07 glo2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC824.08 gda1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC869.01 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC869.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.02c yhb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC869.02c yhb1 protein Western blot evidence increased during(GO:0071500) PMID:22840777 4896 2018-02-23 SPAC869.02c yhb1 protein Western blot evidence unchanged during(GO:0036227) PMID:22840777 4896 2018-02-23 SPAC869.02c yhb1 protein Western blot evidence present during(GO:0072690) PMID:22840777 4896 2018-02-23 SPAC869.02c yhb1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC869.02c yhb1 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC869.02c yhb1 RNA expression microarray evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC869.02c yhb1 RNA quantitative PCR increased during(GO:0071500) PMID:22840777 4896 2018-02-23 SPAC869.02c yhb1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC869.02c yhb1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.02c yhb1 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPAC869.03c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC869.03c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC869.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.04 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC869.04 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC869.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.05c sul2 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC869.05c sul2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.05c sul2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC869.05c sul2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC869.05c sul2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC869.05c sul2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC869.06c hry1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC869.06c hry1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC869.06c hry1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.07c mel1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC869.07c mel1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC869.07c mel1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.07c mel1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC869.07c mel1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC869.08 pcm2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC869.08 pcm2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC869.08 pcm2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.09 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC869.09 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC869.09 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC869.09 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC869.09 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC869.09 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC869.09 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC869.09 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.09 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC869.10c put4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC869.10c put4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC869.10c put4 RNA northern assay evidence used in manual assertion decreased during(GO:0072752) PMID:15466417 4896 2014-06-09 SPAC869.10c put4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC869.10c put4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:28938) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAC869.10c put4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAC869.10c put4 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAC869.10c put4 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:15466417 4896 2014-06-09 SPAC869.10c put4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.11 cat1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC869.11 cat1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC869.11 cat1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC890.03 ppk16 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC890.03 ppk16 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC890.05 pxr1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC890.05 pxr1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC890.05 pxr1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC890.05 pxr1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC890.05 pxr1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC890.05 pxr1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC890.05 pxr1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC890.05 pxr1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC890.05 pxr1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC890.05 pxr1 RNA RNA-sequencing evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC890.06 nup155 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC890.06 nup155 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC890.07c rmt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC890.07c rmt1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC890.08 rpl31 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC890.08 rpl31 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC890.08 rpl31 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC890.08 rpl31 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC890.08 rpl31 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC890.08 rpl31 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC890.08 rpl31 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC8C9.03 cgs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8C9.03 cgs1 protein western blot evidence used in manual assertion increased during(GO:0071277) PMID:27756188 4896 2017-01-09 SPAC8C9.03 cgs1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC8C9.03 cgs1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC8C9.03 cgs1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC8C9.03 cgs1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC8C9.03 cgs1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC8C9.03 cgs1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC8C9.03 cgs1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC8C9.03 cgs1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC8C9.03 cgs1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC8C9.03 cgs1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC8C9.03 cgs1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC8C9.03 cgs1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC8C9.03 cgs1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC8C9.03 cgs1 RNA Northern assay evidence increased during(GO:0042149) PMID:15189983 4896 2022-11-09 (Fig. 7) (lanes 1 and 2), we observed that both cgs1Δ and pka1Δ are transcriptionally induced by glucose starvation. SPAC8C9.06c ppr4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8C9.06c ppr4 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC8C9.06c ppr4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC8C9.07 fyv7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8C9.07 fyv7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC8C9.08 rps5 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC8C9.08 rps5 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC8C9.08 rps5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC8C9.08 rps5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC8C9.09c mug129 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC8C9.10c rrp14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC8C9.10c rrp14 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC8C9.10c rrp14 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC8C9.11 fra2 RNA RNA protection assay evidence unchanged during(GO:0010106) PMID:24897379 4896 2016-08-24 SPAC8C9.11 fra2 RNA RNA protection assay evidence present during(GO:0072690) PMID:24897379 4896 2016-08-24 SPAC8C9.12c mrs3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC8C9.14 prr1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC8C9.16c oxr1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC8C9.16c oxr1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC8C9.16c oxr1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC8C9.16c oxr1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC8C9.17c spc34 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC8C9.17c spc34 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC8C9.17c spc34 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC8E11.01c inv2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8E11.02c rad24 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8E11.02c rad24 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC8E11.02c rad24 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC8E11.03c dmc1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC8E11.03c dmc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8E11.03c dmc1 RNA experimental evidence increased during(GO:0051321) 4896 SPAC8E11.03c dmc1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAC8E11.05c laa2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC8E11.07c alp31 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC8E11.08c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC8E11.10 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC8E11.10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8E11.10 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC8E11.10 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC8E11.10 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC8E11.10 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC8E11.10 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC8E11.10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC8E11.10 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC8E11.10 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC8E11.10 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC8F11.03 msh3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8F11.04 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC8F11.04 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8F11.04 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC8F11.04 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC8F11.04 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC8F11.04 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC8F11.04 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC8F11.04 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC8F11.04 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC8F11.04 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC8F11.04 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC8F11.04 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC8F11.05c mug130 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC8F11.06 brr6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC8F11.07c cdc24 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:9649516 4896 2015-04-22 SPAC8F11.08c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC8F11.09c efm7 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC8F11.09c efm7 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC8F11.10c pvg1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC8F11.10c pvg1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC8F11.10c pvg1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAC8F11.10c pvg1 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAC8F11.10c pvg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9.02c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9.02c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9.02c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9.04 Tf2-1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9.04 Tf2-1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC9.04 Tf2-1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9.04 Tf2-1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC9.05 fml1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC9.06c mta3 RNA quantitative PCR unchanged during(GO:0042149) PMID:34086083 4896 2021-06-10 SPAC9.07c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9.07c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9.07c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9.08c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9.08c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC9.09 met26 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9.09 met26 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9.09 met26 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9.09 met26 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9.09 met26 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC9.09 met26 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9.09 met26 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC9.10 thi9 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9.10 thi9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9.10 thi9 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9.10 thi9 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9.10 thi9 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9.10 thi9 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC9.10 thi9 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC9.11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9.13c cwf16 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC922.03 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC922.03 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC922.03 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC922.03 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC922.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC922.05c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC922.05c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC922.06 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC922.06 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC922.06 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC922.06 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC922.07c atd2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC922.07c atd2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC922.07c atd2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC922.07c atd2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC926.02 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC926.03 rlc1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC926.04c hsp90 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC926.04c hsp90 protein western blot evidence used in manual assertion increased during(GO:0034605) PMID:7813446 4896 2014-11-24 SPAC926.04c hsp90 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC926.04c hsp90 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC926.04c hsp90 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAC926.04c hsp90 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC926.04c hsp90 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC926.04c hsp90 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC926.06c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC926.08c rpf2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC926.08c rpf2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC926.08c rpf2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC926.08c rpf2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC926.08c rpf2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC926.08c rpf2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC926.08c rpf2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC926.08c rpf2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC926.08c rpf2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC926.09c fas1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC926.09c fas1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC926.09c fas1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC926.09c fas1 RNA quantitative PCR increased during(GO:0071456) PMID:27053105 4896 2016-08-03 SPAC926.09c fas1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC926.09c fas1 RNA RNA-sequencing evidence increased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAC959.03c utp7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC959.03c utp7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC959.04c omh6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC959.05c pdi4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC959.05c pdi4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC959.05c pdi4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC959.06c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC959.06c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC959.06c RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-21 SPAC959.07 rps403 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC959.07 rps403 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC959.07 rps403 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC959.07 rps403 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC959.08 rpl2102 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC959.08 rpl2102 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC959.08 rpl2102 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC959.08 rpl2102 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC959.08 rpl2102 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC959.09c apc5 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC959.09c apc5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC959.11 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC959.11 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPAC977.01 ftm1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC977.01 ftm1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAC977.01 ftm1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC977.01 ftm1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC977.02 ftm2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC977.05c RNA northern assay evidence used in manual assertion decreased during(GO:0071294) PMID:24003116 4896 2014-01-03 SPAC977.05c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC977.05c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC977.05c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC977.06 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC977.09c plb4 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAC977.10 nhe1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC977.10 nhe1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC977.10 nhe1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC977.10 nhe1 RNA northern assay evidence used in manual assertion unchanged during(GO:0071475) PMID:1314171 4896 2012-11-26 SPAC977.11 fex1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC977.11 fex1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC977.11 fex1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC977.12 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC977.12 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC977.12 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC977.12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC977.12 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC977.12 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC977.12 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC977.13c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAC977.13c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC977.13c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC977.13c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC977.13c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC977.13c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC977.13c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC977.13c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC977.13c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC977.13c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC977.13c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC977.13c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC977.13c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC977.14c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC977.14c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC977.14c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC977.14c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC977.14c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC977.14c RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC977.15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC977.16c dak2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC977.16c dak2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC977.16c dak2 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:20396879 4896 2012-02-27 SPAC977.16c dak2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC977.16c dak2 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC977.16c dak2 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:20396879 4896 2012-02-27 SPAC977.16c dak2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAC977.16c dak2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC977.16c dak2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC977.16c dak2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC977.16c dak2 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC977.17 aqp1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC977.17 aqp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPAC977.17 aqp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC977.17 aqp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC977.18 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC9E9.02 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC9E9.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9E9.03 leu2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9E9.03 leu2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9E9.03 leu2 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAC9E9.03 leu2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9E9.03 leu2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC9E9.04 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9E9.04 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9E9.04 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC9E9.04 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC9E9.04 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC9E9.04 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC9E9.04 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC9E9.04 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9E9.04 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC9E9.04 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9E9.04 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC9E9.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9E9.04 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC9E9.04 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAC9E9.05 sor1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9E9.06c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9E9.06c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9E9.06c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9E9.07c ypt2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9E9.07c ypt2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9E9.09c atd1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9E9.09c atd1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9E9.09c atd1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9E9.10c cbh1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9E9.10c cbh1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9E9.11 plr1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC9E9.11 plr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAC9E9.11 plr1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAC9E9.11 plr1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAC9E9.11 plr1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAC9E9.11 plr1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAC9E9.11 plr1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAC9E9.11 plr1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9E9.11 plr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC9E9.11 plr1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9E9.11 plr1 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPAC9E9.11 plr1 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPAC9E9.12c abc1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC9E9.12c abc1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC9E9.12c abc1 RNA RNA protection assay evidence unchanged during(GO:0010106) PMID:19915076 4896 2019-05-27 SPAC9E9.12c abc1 RNA RNA protection assay evidence unchanged during(GO:0071281) PMID:19915076 4896 2019-05-27 SPAC9E9.12c abc1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9037770 4896 2012-04-27 SPAC9E9.12c abc1 RNA northern assay evidence used in manual assertion present during(GO:0006995) PMID:9037770 4896 2012-04-27 SPAC9E9.13 wos2 protein Western blot evidence constant during(GO:0000278) PMID:10581266 4896 2019-06-07 SPAC9E9.13 wos2 protein Western blot evidence decreased during(GO:0036227) PMID:10581266 4896 2019-06-07 SPAC9E9.13 wos2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9E9.13 wos2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9E9.13 wos2 RNA Northern assay evidence decreased during(GO:0036227) PMID:10581266 4896 2019-06-07 SPAC9E9.13 wos2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9E9.13 wos2 RNA expression microarray evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC9E9.13 wos2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC9E9.13 wos2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9E9.13 wos2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9E9.13 wos2 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAC9E9.14 vps24 protein microscopy evidence present during(GO:0000080) PMID:37783794 4896 2023-10-05 Fig. 2 SPAC9E9.14 vps24 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9E9.14 vps24 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC9E9.14 vps24 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9E9.14 vps24 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9E9.15 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9E9.15 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9E9.15 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC9E9.15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9E9.15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC9E9.15 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9E9.15 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAC9E9.15 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9E9.15 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAC9E9.17c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9G1.02 wis4 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9G1.02 wis4 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAC9G1.02 wis4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC9G1.03c rpl3001 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAC9G1.03c rpl3001 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9G1.03c rpl3001 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAC9G1.03c rpl3001 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9G1.03c rpl3001 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9G1.03c rpl3001 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAC9G1.03c rpl3001 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAC9G1.04 oxa101 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10712694 4896 2014-10-21 SPAC9G1.05 aip1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9G1.06c cyk3 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAC9G1.06c cyk3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9G1.07 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9G1.07 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAC9G1.08c phi1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9G1.10c inp53 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAC9G1.11c spn4 RNA quantitative PCR decreased during(GO:0071500) PMID:22561704 4896 2015-11-16 SPAC9G1.13c swc4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAC9G1.14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAC9G1.14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAC9G1.14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPACUNK12.02c cmk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPACUNK12.02c cmk1 protein western blot evidence used in manual assertion increased during(GO:0071277) PMID:25081204 4896 2015-02-18 SPACUNK12.02c cmk1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:25081204 4896 2015-02-18 SPACUNK12.02c cmk1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPACUNK12.02c cmk1 RNA northern assay evidence used in manual assertion increased during(GO:0000084) PMID:10617667 4896 2014-09-24 SPACUNK12.02c cmk1 RNA quantitative PCR increased during(GO:0071277) PMID:25081204 4896 2015-02-18 SPACUNK12.02c cmk1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPACUNK12.02c cmk1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPACUNK12.02c cmk1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPACUNK12.02c cmk1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPACUNK12.02c cmk1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10617667 4896 2014-09-24 SPACUNK12.02c cmk1 RNA quantitative PCR present during(GO:0072690) PMID:25081204 4896 2015-02-18 SPACUNK4.06c rpb7 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPACUNK4.06c rpb7 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPACUNK4.06c rpb7 protein western blot evidence used in manual assertion decreased during(GO:0034605) PMID:11918671 4896 2015-11-26 SPACUNK4.06c rpb7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPACUNK4.06c rpb7 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPACUNK4.07c cta4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPACUNK4.07c cta4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPACUNK4.07c cta4 RNA experimental evidence increased during(GO:0051321) PMID:16394583 4896 2009-04-29 SPACUNK4.09 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPACUNK4.09 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPACUNK4.09 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPACUNK4.09 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPACUNK4.10 gor1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPACUNK4.10 gor1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPACUNK4.10 gor1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPACUNK4.12c iph1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPACUNK4.12c iph1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPACUNK4.15 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPACUNK4.15 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPACUNK4.15 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPACUNK4.15 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPACUNK4.15 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPACUNK4.15 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPACUNK4.15 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPACUNK4.15 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPACUNK4.15 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPACUNK4.15 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPACUNK4.15 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPACUNK4.15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPACUNK4.15 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPACUNK4.15 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPACUNK4.15 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPACUNK4.15 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPACUNK4.15 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPACUNK4.15 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPACUNK4.16c tps3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPACUNK4.16c tps3 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPACUNK4.16c tps3 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPACUNK4.16c tps3 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPACUNK4.16c tps3 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPACUNK4.16c tps3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPACUNK4.16c tps3 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPACUNK4.16c tps3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPACUNK4.16c tps3 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPACUNK4.16c tps3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPACUNK4.16c tps3 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPACUNK4.17 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPACUNK4.17 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPACUNK4.17 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPACUNK4.17 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPACUNK4.17 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPACUNK4.17 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPACUNK4.17 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPACUNK4.17 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPACUNK4.17 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPACUNK4.17 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPACUNK4.17 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPACUNK4.17 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPACUNK4.17 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPACUNK4.17 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPACUNK4.17 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPACUNK4.17 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPACUNK4.17 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPACUNK4.17 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPACUNK4.17 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPACUNK4.19 mug153 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPACUNK4.19 mug153 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAP11E10.01 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP11E10.01 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP11E10.01 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAP11E10.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP11E10.01 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAP11E10.02c mam3 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAP11E10.02c mam3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP11E10.02c mam3 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPAP14E8.02 tos4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP14E8.02 tos4 protein western blot evidence used in manual assertion increased during(GO:0000082) PMID:16618806 4896 2018-04-11 SPAP14E8.02 tos4 protein western blot evidence used in manual assertion increased during(GO:0000082) PMID:31719112 4896 2020-03-30 SPAP14E8.02 tos4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAP14E8.02 tos4 RNA northern assay evidence used in manual assertion increased during(GO:0000082) PMID:16618806 4896 2018-04-11 SPAP14E8.02 tos4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP14E8.03 bos1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP14E8.03 bos1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAP14E8.03 bos1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP14E8.03 bos1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAP14E8.03 bos1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAP14E8.04 oma1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAP14E8.04 oma1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP14E8.04 oma1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAP14E8.04 oma1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP14E8.05c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP14E8.05c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAP27G11.03 cdc123 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAP27G11.04c tad3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP27G11.07c bud32 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP27G11.08c meu32 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAP27G11.08c meu32 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP27G11.08c meu32 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAP27G11.08c meu32 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP27G11.09c rib1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP27G11.09c rib1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAP27G11.12 hid3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP27G11.12 hid3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAP27G11.12 hid3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP27G11.12 hid3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAP27G11.13c nop10 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAP27G11.13c nop10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP27G11.13c nop10 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAP27G11.13c nop10 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAP27G11.16 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAP32A8.02 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP32A8.02 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP32A8.02 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAP32A8.02 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAP32A8.02 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAP32A8.02 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAP32A8.02 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAP32A8.02 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAP32A8.03c bop1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP4C9.02 emc5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP7G5.02c gua2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP7G5.02c gua2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP7G5.02c gua2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAP7G5.02c gua2 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAP7G5.02c gua2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAP7G5.02c gua2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAP7G5.03 prm1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP7G5.03 prm1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0006995) PMID:24514900 4896 2014-12-10 SPAP7G5.03 prm1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:24514900 4896 2014-12-10 SPAP7G5.04c lys1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP7G5.04c lys1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP7G5.04c lys1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP7G5.04c lys1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAP7G5.04c lys1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAP7G5.05 rpl1002 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP7G5.05 rpl1002 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP7G5.05 rpl1002 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP7G5.06 per1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAP7G5.06 per1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAP7G5.06 per1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP7G5.06 per1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP7G5.06 per1 RNA northern assay evidence used in manual assertion absent during(GO:0072752) PMID:15466417 4896 2014-06-09 SPAP7G5.06 per1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAP7G5.06 per1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAP7G5.06 per1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:28938) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAP7G5.06 per1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPAP7G5.06 per1 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAP7G5.06 per1 RNA increased in presence of(CHEBI:26271) PMID:20404084 4896 2010-05-04 SPAP7G5.06 per1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:15466417 4896 2014-06-09 SPAP7G5.06 per1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAP7G5.06 per1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP8A3.02c ofd2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP8A3.02c ofd2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP8A3.03 zip3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP8A3.04c hsp9 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAP8A3.04c hsp9 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2013-03-18 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:8654972 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8654972 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:8654972 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:8679693 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8679693 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:8679693 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:22182414 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:22182414 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion increased during(GO:0009267) PMID:22182414 4896 2015-05-07 SPAP8A3.04c hsp9 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAP8A3.04c hsp9 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAP8A3.04c hsp9 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAP8A3.04c hsp9 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAP8A3.04c hsp9 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAP8A3.04c hsp9 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAP8A3.04c hsp9 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAP8A3.04c hsp9 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAP8A3.04c hsp9 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAP8A3.04c hsp9 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAP8A3.04c hsp9 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAP8A3.04c hsp9 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAP8A3.04c hsp9 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAP8A3.04c hsp9 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAP8A3.04c hsp9 RNA quantitative PCR increased during(GO:0071447) PMID:33410907 4896 2021-01-12 (Figure 1) SPAP8A3.04c hsp9 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23874237 4896 2013-03-18 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8654972 4896 2015-05-07 SPAP8A3.04c hsp9 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8679693 4896 2015-05-07 SPAP8A3.06 uaf2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP8A3.06 uaf2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP8A3.06 uaf2 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPAP8A3.07c aro3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAP8A3.07c aro3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP8A3.07c aro3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP8A3.07c aro3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAP8A3.07c aro3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP8A3.07c aro3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP8A3.07c aro3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAP8A3.08 cdc4 RNA Northern assay evidence decreased during(GO:0000085) PMID:19279143 4896 2020-01-07 SPAP8A3.08 cdc4 RNA Northern assay evidence fluctuates during(GO:0000278) PMID:19279143 4896 2020-01-07 SPAP8A3.08 cdc4 RNA Northern assay evidence increased during(GO:0000087) PMID:19279143 4896 2020-01-07 SPAP8A3.10 ups1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP8A3.10 ups1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP8A3.10 ups1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAP8A3.11c mtg2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAP8A3.12c tpp2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAP8A3.12c tpp2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAP8A3.13c gid10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAP8A3.14c sls1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB15E9.01c pfl2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAPB15E9.01c pfl2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPB15E9.01c pfl2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAPB15E9.01c pfl2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB15E9.02c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB15E9.02c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAPB15E9.02c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB15E9.03c Tf2-5 RNA expression microarray evidence decreased during(GO:0042149) PMID:34460892 4896 2021-09-22 SPAPB15E9.03c Tf2-5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB15E9.03c Tf2-5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB17E12.03 pex12 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB17E12.04c csn2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB17E12.05 rpl3703 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB17E12.05 rpl3703 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB17E12.05 rpl3703 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB17E12.05 rpl3703 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB17E12.06 sos7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB17E12.06 sos7 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAPB17E12.07c sen2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB17E12.08 eos1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB17E12.09 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB17E12.09 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAPB17E12.10c mrm202 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB17E12.10c mrm202 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB17E12.10c mrm202 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB17E12.11 ost3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB17E12.13 rpl1802 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB17E12.13 rpl1802 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPAPB17E12.13 rpl1802 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB17E12.13 rpl1802 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB17E12.13 rpl1802 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB17E12.13 rpl1802 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPB18E9.02c ppk18 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB18E9.04c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB18E9.04c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB18E9.05c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAPB18E9.05c RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPB18E9.05c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1A10.02 scm3 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAPB1A10.02 scm3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1A10.02 scm3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1A10.04c cwp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1A10.05 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAPB1A10.05 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAPB1A10.05 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1A10.05 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAPB1A10.05 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1A10.05 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAPB1A10.06c dhx37 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1A10.06c dhx37 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1A10.06c dhx37 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1A10.07c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1A10.08 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAPB1A10.08 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAPB1A10.08 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAPB1A10.08 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB1A10.08 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1A10.08 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAPB1A10.08 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1A10.08 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAPB1A10.09 ase1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1A10.10c ypt71 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1A10.10c ypt71 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1A10.11c mse1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1A10.11c mse1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1A10.11c mse1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1A10.12c alo1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB1A10.12c alo1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1A10.14 pof15 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAPB1A10.14 pof15 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAPB1A10.14 pof15 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAPB1A10.14 pof15 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAPB1A10.14 pof15 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAPB1A10.14 pof15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1A10.14 pof15 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1A10.14 pof15 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1A10.14 pof15 RNA RNA-sequencing evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAPB1A10.14 pof15 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAPB1A10.14 pof15 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAPB1A10.14 pof15 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1A10.15 arv1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1A11.01 mfc1 RNA experimental evidence decreased during(GO:0046688) PMID:21828039 4896 2012-03-22 SPAPB1A11.01 mfc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB1A11.01 mfc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1A11.01 mfc1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAPB1A11.02 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB1A11.02 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPAPB1A11.03 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPAPB1A11.03 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAPB1A11.03 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB1A11.03 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAPB1A11.03 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAPB1A11.03 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAPB1A11.03 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAPB1A11.03 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAPB1A11.03 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAPB1A11.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1A11.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB1A11.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1A11.03 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAPB1A11.04c mca1 protein Western blot evidence increased in presence of(CHEBI:45979) PMID:41984257 4896 2026-05-01 Fig. 4b, c SPAPB1A11.04c mca1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAPB1E7.04c cts2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB1E7.04c cts2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1E7.04c cts2 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPAPB1E7.04c cts2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1E7.04c cts2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1E7.04c cts2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1E7.04c cts2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPB1E7.04c cts2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB1E7.05 gde1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1E7.05 gde1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAPB1E7.05 gde1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPAPB1E7.06c eme1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1E7.06c eme1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAPB1E7.07 glt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1E7.07 glt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB1E7.07 glt1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPAPB1E7.08c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB1E7.08c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1E7.08c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1E7.08c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1E7.08c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1E7.09 ogm2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1E7.10 rpc17 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB1E7.10 rpc17 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1E7.10 rpc17 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1E7.10 rpc17 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1E7.11c mpa1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1E7.11c mpa1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB1E7.12 rps602 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB1E7.12 rps602 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB1E7.12 rps602 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB1E7.12 rps602 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB1E7.12 rps602 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB1E7.12 rps602 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPB21F2.02 dop1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB21F2.03 slx9 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB24D3.02c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB24D3.02c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAPB24D3.02c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB24D3.03 agm2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPAPB24D3.04c mag1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB24D3.04c mag1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB24D3.04c mag1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB24D3.05c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB24D3.06c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB24D3.07c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB24D3.07c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB24D3.07c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB24D3.07c RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAPB24D3.07c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAPB24D3.07c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB24D3.07c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB24D3.07c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB24D3.08c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB24D3.08c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB24D3.08c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB24D3.08c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAPB24D3.08c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPAPB24D3.08c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPAPB24D3.08c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPAPB24D3.08c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPAPB24D3.08c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB24D3.08c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB24D3.09c pdr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAPB24D3.09c pdr1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAPB24D3.09c pdr1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPAPB24D3.10c agl1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB24D3.10c agl1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB24D3.10c agl1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB24D3.10c agl1 RNA expression microarray evidence decreased during(GO:1904547) PMID:34460892 4896 2021-09-20 SPAPB24D3.10c agl1 RNA quantitative PCR increased in presence of(CHEBI:17306),during(GO:0042149) PMID:24224056 4896 2013-11-25 SPAPB24D3.10c agl1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAPB24D3.10c agl1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB24D3.10c agl1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB24D3.10c agl1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB24D3.10c agl1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB2B4.01c gpi12 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB2B4.01c gpi12 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAPB2B4.01c gpi12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB2B4.02 grx5 protein reporter gene assay evidence decreased during(GO:0071288) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 protein reporter gene assay evidence decreased during(GO:0071276) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 protein reporter gene assay evidence decreased during(GO:0070301) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 protein reporter gene assay evidence decreased during(GO:0036245) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB2B4.02 grx5 protein reporter gene assay evidence increased during(GO:0071732) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 protein reporter gene assay evidence increased during(GO:0071472) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 RNA northern assay evidence used in manual assertion decreased during(GO:0036227) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 RNA northern assay evidence used in manual assertion increased during(GO:0071732) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:16258240 4896 2013-10-10 SPAPB2B4.02 grx5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB2B4.02 grx5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB2B4.02 grx5 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:16258240 4896 2013-10-10 SPAPB2B4.03 cig2 protein western blot evidence used in manual assertion decreased during(GO:0000085) PMID:17531813 4896 2017-11-19 SPAPB2B4.03 cig2 protein western blot evidence used in manual assertion decreased during(GO:0000087) PMID:17531813 4896 2017-11-19 SPAPB2B4.03 cig2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB2B4.03 cig2 protein western blot evidence used in manual assertion increased during(GO:0072711) PMID:26912660 4896 2016-03-02 SPAPB2B4.03 cig2 protein western blot evidence used in manual assertion increased during(GO:0072711) PMID:12093738 4896 2017-11-16 SPAPB2B4.03 cig2 protein western blot evidence used in manual assertion increased during(GO:0098763) PMID:12093738 4896 2017-11-16 SPAPB2B4.03 cig2 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:17531813 4896 2017-11-19 SPAPB2B4.03 cig2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:19366728 4896 2012-04-24 SPAPB2B4.03 cig2 RNA western blot evidence used in manual assertion absent during(GO:0006995) PMID:19366728 4896 2012-04-24 SPAPB2B4.03 cig2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB2B4.03 cig2 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:14648198 4896 2019-08-07 SPAPB2B4.03 cig2 RNA increased during(GO:0000084) PMID:8264644 4896 2014-06-20 SPAPB2B4.03 cig2 RNA northern assay evidence used in manual assertion increased during(GO:0071444) PMID:9034336 4896 2014-11-25 SPAPB2B4.03 cig2 RNA quantitative PCR increased during(GO:0072711) PMID:26912660 4896 2016-03-02 SPAPB2B4.03 cig2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPAPB2B4.03 cig2 RNA northern assay evidence used in manual assertion unchanged during(GO:0034644) PMID:12960401 4896 2015-10-19 SPAPB2B4.03 cig2 RNA western blot evidence used in manual assertion present during(GO:0000278) PMID:1829983 4896 2014-06-06 SPAPB2B4.03 cig2 RNA present during(GO:0000080) PMID:7909513 4896 2014-07-29 SPAPB2B4.03 cig2 RNA present during(GO:0000084) PMID:7909513 4896 2014-07-29 SPAPB2B4.04c pmc1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB2B4.04c pmc1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPAPB2B4.04c pmc1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAPB2B4.04c pmc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB2B4.04c pmc1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB2B4.04c pmc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB2B4.04c pmc1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPAPB2B4.06 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB2B4.06 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB2B4.06 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB2B4.06 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB2B4.06 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB2B4.07 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB2B4.07 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB2C8.01 pfl10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB2C8.01 pfl10 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAPB8E5.02c rpn502 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB8E5.02c rpn502 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPB8E5.03 mae1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB8E5.03 mae1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB8E5.03 mae1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB8E5.03 mae1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPB8E5.03 mae1 RNA northern assay evidence used in manual assertion present during(GO:0071333) PMID:8750236 4896 2012-10-26 SPAPB8E5.03 mae1 RNA northern assay evidence used in manual assertion present during(GO:0071332) PMID:8750236 4896 2012-10-26 SPAPB8E5.03 mae1 RNA northern assay evidence used in manual assertion present during(GO:0097403) PMID:8750236 4896 2012-10-26 SPAPB8E5.03 mae1 RNA northern assay evidence used in manual assertion present in presence of(CHEBI:15741) PMID:8750236 4896 2012-10-26 SPAPB8E5.04c npc2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB8E5.04c npc2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB8E5.04c npc2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB8E5.04c npc2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAPB8E5.04c npc2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPAPB8E5.04c npc2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAPB8E5.04c npc2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB8E5.04c npc2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPB8E5.05 mfm1 RNA northern assay evidence used in manual assertion increased in(CL:0002674) PMID:8196631 4896 2012-02-08 SPAPB8E5.05 mfm1 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0006995) PMID:8196631 4896 2012-02-08 SPAPB8E5.05 mfm1 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0071444) PMID:8196631 4896 2012-02-08 SPAPB8E5.05 mfm1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAPB8E5.05 mfm1 RNA expression microarray evidence increased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPAPB8E5.06c rpl302 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB8E5.06c rpl302 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB8E5.06c rpl302 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPAPB8E5.06c rpl302 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB8E5.06c rpl302 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAPB8E5.06c rpl302 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPB8E5.06c rpl302 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPB8E5.07c rrp12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB8E5.07c rrp12 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPB8E5.07c rrp12 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB8E5.07c rrp12 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPB8E5.07c rrp12 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPB8E5.07c rrp12 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPB8E5.09 rvb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPB8E5.10 min8 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPB8E5.10 min8 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPAPB8E5.10 min8 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPJ691.02 moh1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPAPJ691.02 moh1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPJ691.02 moh1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPAPJ691.02 moh1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPAPJ691.02 moh1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPJ691.02 moh1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPJ691.02 moh1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPJ691.03 mic10 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPJ691.03 mic10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPJ695.01c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPJ695.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPJ698.02c rps002 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPJ698.02c rps002 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPAPJ698.02c rps002 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPJ698.02c rps002 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPJ698.02c rps002 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAPJ698.02c rps002 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPJ698.02c rps002 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPAPJ698.03c prp12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPJ760.02c abp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPJ760.03c adg1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPJ760.03c adg1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPJ760.03c adg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPJ760.03c adg1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPYUG7.02c sin1 protein western blot evidence used in manual assertion unchanged during(GO:0042149) PMID:25590601 4896 2015-07-28 SPAPYUG7.02c sin1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:25590601 4896 2015-07-28 SPAPYUG7.02c sin1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPAPYUG7.03c mid2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPYUG7.03c mid2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPAPYUG7.03c mid2 RNA transcript expression level evidence increased during(GO:0000087) PMID:12668659 4896 2019-07-30 SPAPYUG7.03c mid2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPAPYUG7.03c mid2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPAPYUG7.04c rpb9 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPAPYUG7.04c rpb9 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPAPYUG7.04c rpb9 protein western blot evidence used in manual assertion decreased during(GO:0034605) PMID:11918671 4896 2015-11-26 SPAPYUG7.04c rpb9 protein microscopy evidence unchanged during(GO:0000278) PMID:32059768 4896 2021-03-31 SPAPYUG7.04c rpb9 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPAPYUG7.04c rpb9 RNA quantitative PCR increased during(GO:0036227) PMID:35618649 4896 2022-07-13 SPAPYUG7.05 pro3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPAPYUG7.05 pro3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPAPYUG7.06 sdu1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPAPYUG7.06 sdu1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPAPYUG7.06 sdu1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPAPYUG7.06 sdu1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:24313451 4896 2014-02-13 SPAPYUK71.03c tcb3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPATRNAILE.02 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPATRNAPRO.02 spl1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC106.01 mph1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC106.02c srx1 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC106.02c srx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:22245228 4896 2012-05-24 SPBC106.02c srx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2013-03-18 SPBC106.02c srx1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC106.02c srx1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC106.02c srx1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC106.02c srx1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC106.02c srx1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC106.02c srx1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC106.02c srx1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC106.02c srx1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC106.02c srx1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC106.02c srx1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC106.02c srx1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC106.02c srx1 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPBC106.02c srx1 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPBC106.03 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC106.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC106.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC106.04 ada1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC106.05c tim11 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC106.05c tim11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC106.06 cct4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC106.06 cct4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC106.06 cct4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC106.07c nat2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC106.08c mug2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC106.08c mug2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC106.09 cut4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC106.09 cut4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC106.09 cut4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC106.10 pka1 protein western blot evidence used in manual assertion increased during(GO:0071277) PMID:27756188 4896 2017-01-09 SPBC106.10 pka1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC106.10 pka1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC106.10 pka1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC106.10 pka1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC106.10 pka1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC106.10 pka1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC106.10 pka1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC106.10 pka1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC106.10 pka1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC106.10 pka1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC106.10 pka1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC106.10 pka1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC106.10 pka1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC106.10 pka1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC106.10 pka1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC106.10 pka1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC106.10 pka1 RNA Northern assay evidence increased during(GO:0042149) PMID:15189983 4896 2022-11-09 (Fig. 7) (lanes 1 and 2), we observed that both cgs1Δ and pka1Δ are transcriptionally induced by glucose starvation. SPBC106.11c plg7 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC106.11c plg7 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC106.11c plg7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC106.12c tho4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC106.12c tho4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC106.13 gid9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC106.13 gid9 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC106.13 gid9 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC106.13 gid9 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC106.13 gid9 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC106.13 gid9 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC106.14c sda1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC106.14c sda1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC106.14c sda1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC106.14c sda1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC106.14c sda1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC106.14c sda1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC106.14c sda1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC106.14c sda1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC106.14c sda1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC106.15 idi1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC106.15 idi1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC106.16 pre6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC106.16 pre6 protein western blot evidence used in manual assertion unchanged during(GO:0044838) PMID:20133687 4896 2014-10-02 SPBC106.16 pre6 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:20133687 4896 2014-10-02 SPBC106.16 pre6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC106.17c cys2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC106.17c cys2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC106.17c cys2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC106.17c cys2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC106.18 rpl2501 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC106.18 rpl2501 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC106.18 rpl2501 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC106.18 rpl2501 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC106.18 rpl2501 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC106.18 rpl2501 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC106.18 rpl2501 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC106.18 rpl2501 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC106.20 exo70 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1105.01 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1105.02c lys4 protein western blot evidence used in manual assertion decreased in presence of(CHEBI:28786) PMID:16299000 4896 2012-11-12 SPBC1105.02c lys4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1105.02c lys4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1105.02c lys4 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:16299000 4896 2012-11-12 SPBC1105.02c lys4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1105.02c lys4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1105.02c lys4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1105.02c lys4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1105.02c lys4 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1105.02c lys4 RNA northern assay evidence used in manual assertion unchanged in presence of(CHEBI:28786) PMID:16299000 4896 2012-11-12 SPBC1105.02c lys4 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:16299000 4896 2012-11-12 SPBC1105.03c mrpl16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1105.04c cbp1 protein Western blot evidence unchanged during(GO:0042149) PMID:40132111 4896 2025-08-12 (Fig. 5B) SPBC1105.05 exg1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1105.05 exg1 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPBC1105.05 exg1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1105.05 exg1 RNA northern assay evidence used in manual assertion increased during(GO:0000281) PMID:20852022 4896 2015-08-28 SPBC1105.05 exg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1105.05 exg1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC1105.05 exg1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:20852022 4896 2015-08-28 SPBC1105.07c pci2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1105.08 emp70 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1105.09 ubc15 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1105.10 rav1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1105.11c hht3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1105.11c hht3 RNA Northern assay evidence fluctuates during(GO:0098763) PMID:17452352 4896 2018-02-28 SPBC1105.11c hht3 RNA Northern assay evidence increased during(GO:0000084) PMID:17452352 4896 2018-02-28 SPBC1105.12 hhf3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1105.12 hhf3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1105.12 hhf3 RNA Northern assay evidence fluctuates during(GO:0098763) PMID:17452352 4896 2018-02-28 SPBC1105.12 hhf3 RNA Northern assay evidence increased during(GO:0000084) PMID:17452352 4896 2018-02-28 SPBC1105.12 hhf3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1105.13c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1105.13c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1105.13c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1105.13c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1105.13c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1105.13c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1105.13c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1105.13c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1105.13c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1105.14 rsv2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1105.14 rsv2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC1105.14 rsv2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC1105.14 rsv2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1105.14 rsv2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1105.14 rsv2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1105.14 rsv2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1105.14 rsv2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1105.14 rsv2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1105.14 rsv2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1105.14 rsv2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1105.14 rsv2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1105.14 rsv2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1105.14 rsv2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC1105.14 rsv2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1105.14 rsv2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1105.14 rsv2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC1105.15c htd2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1105.15c htd2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1105.17 cnp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1105.17 cnp1 protein Western blot evidence increased PMID:30635289 4896 2024-07-23 Cnp1-GFP protein increases approximately twofold at 165-min postelutriation. This resulindicates that the mRNA increase in G1 results in augmentation of the Cnp1 protein level in S phase. SPBC1105.17 cnp1 RNA northern assay evidence used in manual assertion increased during(GO:0000080) PMID:10864871 4896 2015-01-15 SPBC1105.17 cnp1 RNA northern assay evidence used in manual assertion increased during(GO:0000084) PMID:10864871 4896 2015-01-15 SPBC1105.17 cnp1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC1105.17 cnp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1105.17 cnp1 RNA quantitative PCR increased during(GO:0000080) PMID:30635289 4896 2024-07-23 Consistent with the previous report (Takahashi et al. 2000), cnp1 mRNA peaks before the transcription of histone H3, $120 min after elutriation, showing an approximately twofold increase. This pattern of expression coincides with the expression of cdc18, a well-known cell cycle-regulated gene expressed specifically in G1 phase (Figure 1A). SPBC1105.19 tam12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1105.19 tam12 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1105.19 tam12 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC115.01c rrp46 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC115.01c rrp46 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC115.02c afg1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC115.02c afg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC115.03 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC115.03 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC119.01 rpn3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC119.03 cmt1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC119.03 cmt1 RNA transcript expression level evidence increased during(GO:0010446) PMID:31053915 4896 2019-05-17 SPBC119.03 cmt1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC119.03 cmt1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC119.03 cmt1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC119.03 cmt1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC119.03 cmt1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC119.03 cmt1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC119.03 cmt1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC119.03 cmt1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC119.03 cmt1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC119.03 cmt1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC119.03 cmt1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC119.03 cmt1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC119.04 mei3 protein northern assay evidence used in manual assertion present during(GO:0051321) PMID:3034608 4896 2013-02-25 SPBC119.04 mei3 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:3034608 4896 2013-02-25 SPBC119.04 mei3 RNA northern assay evidence used in manual assertion absent during(GO:0036227) PMID:3034608 4896 2013-02-25 SPBC119.04 mei3 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:2300054 4896 2014-06-18 SPBC119.04 mei3 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:2840284 4896 2014-05-02 SPBC119.04 mei3 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:2300054 4896 2014-06-18 SPBC119.04 mei3 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC119.04 mei3 RNA northern assay evidence used in manual assertion present during(GO:0051321) PMID:3034608 4896 2013-02-25 SPBC119.05c lsb1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC119.05c lsb1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC119.05c lsb1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC119.05c lsb1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC119.06 sco1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC119.06 sco1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC119.06 sco1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC119.07 vps15 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC119.07 vps15 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC119.08 pmk1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC119.08 pmk1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:8943330 4896 2014-07-08 SPBC119.08 pmk1 RNA increased during(GO:0033554) PMID:9135147 4896 SPBC119.09c orm1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC119.09c orm1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC119.10 asn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC119.10 asn1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC119.10 asn1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC119.10 asn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC119.10 asn1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC119.10 asn1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC119.11c pac1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC119.11c pac1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC119.12 rud3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC119.12 rud3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC119.12 rud3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC119.14 rti1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC119.14 rti1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC119.16c den11 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC119.16c den11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC119.17 cym1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC119.17 cym1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC119.17 cym1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1198.01 fmd2 protein Western blot evidence absent during(GO:0072690) PMID:22840777 4896 2018-02-23 SPBC1198.01 fmd2 protein Western blot evidence increased during(GO:0071500) PMID:22840777 4896 2018-02-23 SPBC1198.01 fmd2 protein Western blot evidence increased during(GO:0036227) PMID:22840777 4896 2018-02-23 SPBC1198.01 fmd2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1198.01 fmd2 RNA quantitative PCR increased during(GO:0071500) PMID:22840777 4896 2018-02-23 SPBC1198.01 fmd2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC1198.01 fmd2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1198.01 fmd2 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC1198.02 dea2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1198.02 dea2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1198.02 dea2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1198.02 dea2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1198.02 dea2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1198.02 dea2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1198.02 dea2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1198.02 dea2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1198.02 dea2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1198.03c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1198.05 guk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1198.05 guk1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1198.05 guk1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1198.05 guk1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1198.05 guk1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1198.05 guk1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1198.05 guk1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1198.06c dfg501 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1198.06c dfg501 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1198.07c dfg502 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1198.07c dfg502 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1198.07c dfg502 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1198.08 dug1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1198.09 pex4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1198.09 pex4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1198.09 pex4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1198.11c reb1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1198.12 mfr1 protein western blot evidence used in manual assertion absent during(GO:0072690) PMID:11493649 4896 2015-07-16 SPBC1198.12 mfr1 protein western blot evidence used in manual assertion decreased during(GO:0043934) PMID:11493649 4896 2015-07-16 SPBC1198.12 mfr1 protein western blot evidence used in manual assertion increased during(GO:0098765) PMID:11493649 4896 2015-07-16 SPBC1198.12 mfr1 protein western blot evidence used in manual assertion increased during(GO:0098764) PMID:11493649 4896 2015-07-16 SPBC1198.12 mfr1 protein western blot evidence used in manual assertion increased during(GO:0007133) PMID:21389117 4896 2016-04-22 SPBC1198.12 mfr1 protein Western blot evidence increased during(GO:0098765) PMID:23628763 4896 2019-10-11 SPBC1198.12 mfr1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1198.12 mfr1 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:11405625 4896 2014-05-14 SPBC1198.12 mfr1 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:11405625 4896 2014-05-14 SPBC1198.12 mfr1 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:11493649 4896 2015-07-16 SPBC1198.12 mfr1 RNA northern assay evidence used in manual assertion decreased during(GO:0043934) PMID:11493649 4896 2015-07-16 SPBC1198.12 mfr1 RNA northern assay evidence used in manual assertion increased during(GO:0098765) PMID:11493649 4896 2015-07-16 SPBC1198.12 mfr1 RNA northern assay evidence used in manual assertion increased during(GO:0098764) PMID:11493649 4896 2015-07-16 SPBC1198.12 mfr1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1198.12 mfr1 RNA northern assay evidence used in manual assertion present during(GO:0007135) PMID:11405625 4896 2014-05-14 SPBC1198.13c tfg2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1198.14c fbp1 protein reporter gene assay evidence increased during(GO:0042149) PMID:19266076 4896 2014-12-07 SPBC1198.14c fbp1 protein reporter gene assay evidence increased during(GO:0042149) PMID:8832415 4896 2015-01-08 SPBC1198.14c fbp1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1198.14c fbp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1198.14c fbp1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1198.14c fbp1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1198.14c fbp1 RNA reporter gene assay evidence decreased in presence of(CHEBI:17489) PMID:1849107 4896 2012-01-27 SPBC1198.14c fbp1 RNA northern assay evidence used in manual assertion decreased during(GO:0071320) PMID:9829945 4896 2013-09-20 SPBC1198.14c fbp1 RNA northern assay evidence used in manual assertion increased during(GO:0042149) PMID:28674280 4896 2018-02-08 SPBC1198.14c fbp1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC1198.14c fbp1 RNA northern assay evidence used in manual assertion increased during(GO:0061431) PMID:9829945 4896 2013-09-20 SPBC1198.14c fbp1 RNA quantitative PCR increased in presence of(CHEBI:17306),during(GO:0042149) PMID:24224056 4896 2013-11-25 SPBC1198.14c fbp1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:16236),during(GO:0042149) PMID:22370953 4896 2016-07-06 SPBC1198.14c fbp1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC1198.14c fbp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1198.14c fbp1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1198.14c fbp1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1198.14c fbp1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1198.14c fbp1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC11B10.02c his3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC11B10.02c his3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11B10.02c his3 RNA northern assay evidence used in manual assertion decreased during(GO:0006995) PMID:8159167 4896 2013-10-22 SPBC11B10.02c his3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC11B10.02c his3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC11B10.02c his3 RNA northern assay evidence used in manual assertion unchanged in presence of(CHEBI:27570) PMID:8159167 4896 2013-10-22 SPBC11B10.02c his3 RNA northern assay evidence used in manual assertion unchanged in absence of(CHEBI:27570) PMID:8159167 4896 2013-10-22 SPBC11B10.02c his3 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8159167 4896 2013-10-22 SPBC11B10.03 cog8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC11B10.03 cog8 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC11B10.05c rsp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11B10.06 sws1 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC11B10.08 wwm1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC11B10.09 cdc2 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:2569363 4896 2013-02-19 SPBC11B10.09 cdc2 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:3516412 4896 2014-08-13 SPBC11B10.09 cdc2 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:10888871 4896 2010-09-03 SPBC11B10.09 cdc2 protein western blot evidence used in manual assertion unchanged during(GO:0072734) PMID:1899230 4896 2012-12-10 SPBC11B10.09 cdc2 protein Western blot evidence unchanged in presence of(CHEBI:49703) PMID:11460168 4896 2024-04-16 (Fig. 3B) SPBC11B10.09 cdc2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:2569363 4896 2013-02-19 SPBC11B10.09 cdc2 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:10888871 4896 2010-09-03 SPBC11B10.09 cdc2 RNA expression microarray evidence unchanged during(GO:0000085) PMID:28479325 4896 2022-01-31 SPBC11B10.10c pht1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC11C11.01 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC11C11.02 imp2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC11C11.03 ndc80 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC11C11.05 knh1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC11C11.06c mom14 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC11C11.06c mom14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11C11.06c mom14 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC11C11.06c mom14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC11C11.06c mom14 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC11C11.06c mom14 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC11C11.06c mom14 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC11C11.06c mom14 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC11C11.06c mom14 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC11C11.06c mom14 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC11C11.06c mom14 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC11C11.06c mom14 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC11C11.06c mom14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC11C11.06c mom14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC11C11.06c mom14 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC11C11.06c mom14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC11C11.06c mom14 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC11C11.06c mom14 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC11C11.06c mom14 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC11C11.07 rpl1801 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11C11.07 rpl1801 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC11C11.07 rpl1801 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC11C11.07 rpl1801 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC11C11.07 rpl1801 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC11C11.07 rpl1801 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC11C11.07 rpl1801 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC11C11.08 srp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC11C11.08 srp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC11C11.09c rpl502 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC11C11.09c rpl502 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC11C11.09c rpl502 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC11C11.09c rpl502 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC11C11.09c rpl502 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC11C11.09c rpl502 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC11C11.10 pus4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11C11.10 pus4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC11C11.11c irc3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC11G11.01 fis1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11G11.01 fis1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC11G11.01 fis1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC11G11.02c end3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11G11.03 mrt4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC11G11.03 mrt4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11G11.03 mrt4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC11G11.03 mrt4 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC11G11.03 mrt4 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC11G11.03 mrt4 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC11G11.03 mrt4 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC11G11.03 mrt4 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC11G11.03 mrt4 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC11G11.03 mrt4 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC11G11.03 mrt4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC11G11.03 mrt4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC11G11.05 rpa34 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC11G11.05 rpa34 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC11G11.05 rpa34 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC11G11.05 rpa34 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1215.01 shy1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1215.01 shy1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1215.02c naa25 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1271.01c pof13 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1271.02 stt3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1271.02 stt3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1271.03c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC1271.04c dys1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1271.04c dys1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1271.04c dys1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1271.05c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1271.05c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC1271.05c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1271.05c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1271.05c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1271.05c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1271.05c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1271.06c mug96 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1271.06c mug96 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1271.07c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1271.07c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1271.07c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC1271.07c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1271.07c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1271.07c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1271.07c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1271.08c ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1271.08c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1271.08c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC1271.08c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1271.08c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1271.08c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1271.08c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1271.08c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1271.08c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1271.08c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1271.08c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1271.08c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1271.08c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1271.09 tgp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1271.09 tgp1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:27641),during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 3A) SPBC1271.09 tgp1 RNA quantitative polymerase chain reaction evidence used in manual assertion increased during(GO:0016036) PMID:32499400 4896 2020-06-24 SPBC1271.09 tgp1 RNA quantitative polymerase chain reaction evidence used in manual assertion increased in presence of(CHEBI:53745) PMID:32499400 4896 2020-06-24 SPBC1271.09 tgp1 RNA quantitative polymerase chain reaction evidence used in manual assertion increased in presence of(CHEBI:168396) PMID:32499400 4896 2020-06-24 SPBC1271.09 tgp1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1271.09 tgp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1271.09 tgp1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC1271.09 tgp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1271.09 tgp1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1271.09 tgp1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC1271.10c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1271.10c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1271.10c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1271.11 pet802 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1271.11 pet802 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1271.12 osh41 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1271.12 osh41 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1271.14 aga1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1289.01c chr4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1289.01c chr4 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC1289.02c uap2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1289.03c spi1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1289.03c spi1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1289.03c spi1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1289.04c pob1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1289.06c ppr8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1289.06c ppr8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1289.06c ppr8 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1289.06c ppr8 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1289.06c ppr8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1289.06c ppr8 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1289.07c rpc40 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPBC1289.07c rpc40 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1289.07c rpc40 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1289.07c rpc40 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPBC1289.07c rpc40 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1289.07c rpc40 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1289.08 uap1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1289.10c adn2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1289.12 usp109 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1289.13c gmh6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1289.13c gmh6 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1289.13c gmh6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1289.14 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1289.14 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1289.14 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1289.14 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1289.14 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1289.14 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1289.14 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1289.14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1289.14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1289.14 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1289.14 RNA quantitative PCR increased during(GO:0010438) PMID:39105351 4896 2024-10-01 SPBC1289.14 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC1289.15 pfl5 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1289.15 pfl5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1289.16c cao2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1289.16c cao2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1289.16c cao2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1289.16c cao2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC1289.16c cao2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1289.16c cao2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1289.17 Tf2-11 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1289.17 Tf2-11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1289.17 Tf2-11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC12C2.02c ste20 protein western blot evidence used in manual assertion unchanged during(GO:0042149) PMID:25590601 4896 2015-07-28 SPBC12C2.02c ste20 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:25590601 4896 2015-07-28 SPBC12C2.03c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC12C2.03c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC12C2.04 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC12C2.04 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC12C2.04 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC12C2.04 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC12C2.04 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC12C2.04 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC12C2.04 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC12C2.04 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC12C2.04 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC12C2.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC12C2.04 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC12C2.04 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC12C2.06 dbp5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC12C2.07c srm1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC12C2.07c srm1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC12C2.07c srm1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC12C2.08 dnm1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC12C2.08 dnm1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC12C2.09c izh2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC12C2.09c izh2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC12C2.12c glo1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC12C2.12c glo1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC12C2.12c glo1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC12C2.12c glo1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC12C2.12c glo1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC12C2.12c glo1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC12C2.13c fnx1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:9710608 4896 2012-05-23 SPBC12C2.13c fnx1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:9710608 4896 2012-05-23 SPBC12C2.13c fnx1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:16624901 4896 2014-03-06 SPBC12C2.13c fnx1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC12C2.13c fnx1 RNA northern assay evidence used in manual assertion unchanged during(GO:0042149) PMID:9710608 4896 2012-05-23 SPBC12C2.13c fnx1 RNA northern assay evidence used in manual assertion unchanged during(GO:0016036) PMID:9710608 4896 2012-05-23 SPBC12C2.13c fnx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:16624901 4896 2014-03-06 SPBC12C2.14c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC12D12.01 sad1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC12D12.01 sad1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC12D12.02c cdm1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC12D12.02c cdm1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC12D12.02c cdm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC12D12.02c cdm1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC12D12.02c cdm1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC12D12.02c cdm1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC12D12.03 cct1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC12D12.03 cct1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC12D12.03 cct1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC12D12.05c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC12D12.05c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC12D12.05c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC12D12.07c trx2 protein reporter gene assay evidence decreased during(GO:0036227) PMID:12020831 4896 2014-11-03 SPBC12D12.07c trx2 protein reporter gene assay evidence increased during(GO:0071275) PMID:12020831 4896 2014-11-03 SPBC12D12.07c trx2 protein reporter gene assay evidence increased during(GO:0071282) PMID:12020831 4896 2014-11-03 SPBC12D12.07c trx2 protein reporter gene assay evidence present during(GO:0072690) PMID:12020831 4896 2014-11-03 SPBC12D12.07c trx2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC12D12.07c trx2 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:9585505 4896 2012-02-29 SPBC12D12.07c trx2 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:18758731 4896 2013-09-17 SPBC12D12.07c trx2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC12D12.07c trx2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC12D12.07c trx2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC12D12.07c trx2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC12D12.07c trx2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC12D12.07c trx2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9585505 4896 2012-02-29 SPBC12D12.07c trx2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:18758731 4896 2013-09-17 SPBC12D12.09 rev7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC12D12.09 rev7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1306.01c gfm1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1306.01c gfm1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1306.02 trm734 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1347.01c rev1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1347.02 ani1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1347.02 ani1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1347.02 ani1 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC1347.02 ani1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC1347.02 ani1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1347.02 ani1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1347.02 ani1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1347.02 ani1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1347.02 ani1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1347.02 ani1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1347.02 ani1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1347.02 ani1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1347.02 ani1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1347.02 ani1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1347.03 meu14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1347.03 meu14 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPBC1347.03 meu14 RNA experimental evidence increased during(GO:0051321) PMID:12759375 4896 2015-03-11 SPBC1347.03 meu14 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1347.05c scj1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1347.06c cki1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1347.06c cki1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1347.07 rex2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1347.07 rex2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1347.09 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1347.09 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1347.09 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1347.10 cdc23 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:12185500 4896 2015-06-15 SPBC1347.10 cdc23 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1347.11 sro1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1347.11 sro1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1347.11 sro1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1347.11 sro1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1347.11 sro1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1347.11 sro1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1347.12 arp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1347.12 arp1 RNA quantitative PCR absent during(GO:0072690) PMID:25736293 4896 2021-01-22 SPBC1347.12 arp1 RNA quantitative PCR present during(GO:0051321) PMID:25736293 4896 2021-01-22 SPBC1347.13c mrm1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1347.13c mrm1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1347.13c mrm1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1348.01 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1348.02 ftm5 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC1348.02 ftm5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1348.02 ftm5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1348.02 ftm5 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1348.06c RNA northern assay evidence used in manual assertion decreased during(GO:0071294) PMID:24003116 4896 2014-01-03 SPBC1348.06c RNA transcript expression level evidence increased during(GO:0071276) PMID:18203864 4896 2015-07-14 SPBC1348.06c RNA transcript expression level evidence increased during(GO:0034224) PMID:18203864 4896 2015-07-14 SPBC1348.06c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1348.06c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1348.06c RNA transcript expression level evidence unchanged during(GO:0071280) PMID:18203864 4896 2015-07-14 SPBC1348.07 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1348.08c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1348.12 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1348.12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1348.12 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC1348.14c ght7 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1348.14c ght7 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0071281) PMID:30730059 4896 2019-11-13 SPBC13A2.03 bbl1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC13A2.03 bbl1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC13A2.04c ptr2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC13A2.04c ptr2 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC13A2.04c ptr2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC13A2.04c ptr2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC13A2.04c ptr2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC13A2.04c ptr2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC13A2.04c ptr2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC13A2.04c ptr2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC13E7.04 atp16 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC13E7.04 atp16 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC13E7.04 atp16 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC13E7.04 atp16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC13E7.04 atp16 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC13E7.05 gpi14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC13E7.05 gpi14 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC13E7.05 gpi14 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC13E7.05 gpi14 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC13E7.06 msd1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC13E7.10c brf1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC13E7.10c brf1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC13E7.11 rbd1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC13G1.01c nam9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC13G1.02 mpg2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC13G1.03c pex14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC13G1.04c abh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC13G1.04c abh1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC13G1.05 emp65 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC13G1.06c isd11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC13G1.06c isd11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC13G1.07 swf1 protein western blot evidence used in manual assertion constant during(GO:0051321) PMID:23843742 4896 2013-08-08 SPBC13G1.07 swf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC13G1.08c ash2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC13G1.08c ash2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC13G1.08c ash2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC13G1.09 enp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC13G1.09 enp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC13G1.09 enp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC13G1.09 enp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC13G1.10c rqt2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC13G1.11 ykt6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC13G1.16 smp2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC146.01 med15 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC146.02 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC146.02 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC146.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC146.03c cut3 protein western blot evidence used in manual assertion unchanged during(GO:0000278) PMID:7957061 4896 2014-11-28 SPBC146.03c cut3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC146.04 erv2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC146.05c cwf25 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC146.06c fan1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC146.06c fan1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC146.06c fan1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC146.07 prp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC146.08c tif1102 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC146.09c lsd1 protein Western blot evidence increased PMID:38181050 4896 2024-05-07 Both Lsd1 (Fig 4C) and Lsd2 (Fig 4D) protein levels drastically increase after heat treatment, although the mRNA levels of Lsd1 and Lsd2 were not significantly altered between wild-type and set1Δ cells (S10 Fig), suggesting that enhanced Lsd1/2 proteins are required for cell survival under heat stress [61]. SPBC146.09c lsd1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC146.10 mug57 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC146.11c mug97 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC146.11c mug97 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2008-09-08 SPBC146.11c mug97 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC146.12 coq6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC146.12 coq6 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC146.12 coq6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC146.13c myo1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:19808887 4896 2017-07-14 SPBC146.13c myo1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC146.14c sec26 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14C8.01c cut2 protein decreased during(GO:0000090) PMID:8632802 4896 2016-03-03 SPBC14C8.01c cut2 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC14C8.01c cut2 protein Western blot evidence decreased in presence of(CHEBI:49703) PMID:11460168 4896 2024-04-16 (Fig. 3B) SPBC14C8.01c cut2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14C8.01c cut2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC14C8.01c cut2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14C8.01c cut2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14C8.01c cut2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC14C8.02 tim44 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14C8.02 tim44 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC14C8.03 fma2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14C8.03 fma2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14C8.04 ilv6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14C8.04 ilv6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14C8.04 ilv6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14C8.05c meu17 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC14C8.05c meu17 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC14C8.05c meu17 RNA experimental evidence increased during(GO:0034293) 4896 SPBC14C8.05c meu17 RNA experimental evidence increased during(GO:0000080) 4896 SPBC14C8.05c meu17 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion absent during(GO:0007127) PMID:15278909 4896 2015-02-23 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion absent during(GO:0007135) PMID:15278909 4896 2015-02-23 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion absent during(GO:0000087) PMID:8521469 4896 2014-11-24 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion absent during(GO:0000085) PMID:8521469 4896 2014-11-24 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion absent during(GO:0000087) PMID:8643672 4896 2014-09-15 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion absent during(GO:0000085) PMID:8643672 4896 2014-09-15 SPBC14C8.07c cdc18 protein absent during(GO:0000087) PMID:9755169 4896 2019-05-14 SPBC14C8.07c cdc18 protein absent during(GO:0000085) PMID:9755169 4896 2019-05-14 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion increased during(GO:0000093) PMID:10766248 4896 2015-04-24 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:17531813 4896 2017-11-19 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion increased during(GO:0000085) PMID:17531813 4896 2017-11-19 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion increased during(GO:0072711) PMID:17531813 4896 2017-11-19 SPBC14C8.07c cdc18 protein increased during(GO:0000080) PMID:9755169 4896 2019-05-14 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion present during(GO:0006279) PMID:15278909 4896 2015-02-23 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion present during(GO:0000080) PMID:8521469 4896 2014-11-24 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion present during(GO:0000080) PMID:8643672 4896 2014-09-15 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion present during(GO:0000084) PMID:8643672 4896 2014-09-15 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion present during(GO:0000084) PMID:8521469 4896 2014-11-24 SPBC14C8.07c cdc18 protein western blot evidence used in manual assertion present during(GO:0000084) PMID:17531813 4896 2017-11-19 SPBC14C8.07c cdc18 RNA northern assay evidence used in manual assertion decreased during(GO:0000085) PMID:7916658 4896 2019-11-23 SPBC14C8.07c cdc18 RNA Northern assay evidence decreased during(GO:0000085) PMID:10589835 4896 2019-06-07 SPBC14C8.07c cdc18 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC14C8.07c cdc18 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC14C8.07c cdc18 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC14C8.07c cdc18 RNA Northern assay evidence fluctuates during(GO:0072690) PMID:9303312 4896 2024-07-23 (Fig. 4B) SPBC14C8.07c cdc18 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:14648198 4896 2019-08-07 SPBC14C8.07c cdc18 RNA northern assay evidence used in manual assertion increased during(GO:0000082) PMID:7916658 4896 2019-11-23 SPBC14C8.07c cdc18 RNA experimental evidence increased during(GO:0000084) 4896 SPBC14C8.07c cdc18 RNA northern assay evidence used in manual assertion increased during(GO:0072711) PMID:24006488 4896 2013-12-05 SPBC14C8.07c cdc18 RNA northern assay evidence used in manual assertion increased during(GO:0071444) PMID:9034336 4896 2014-11-25 SPBC14C8.07c cdc18 RNA quantitative PCR increased during(GO:0072711) PMID:26912660 4896 2016-03-02 SPBC14C8.07c cdc18 RNA experimental evidence increased during(GO:0000080) 4896 SPBC14C8.07c cdc18 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC14C8.07c cdc18 RNA quantitative PCR increased during(GO:0000080) PMID:30635289 4896 2024-07-23 Consistent with the previous report (Takahashi et al. 2000), cnp1 mRNA peaks before the transcription of histone H3, $120 min after elutriation, showing an approximately twofold increase. This pattern of expression coincides with the expression of cdc18, a well-known cell cycle-regulated gene expressed specifically in G1 phase (Figure 1A). SPBC14C8.07c cdc18 RNA northern assay evidence used in manual assertion unchanged during(GO:0034644) PMID:12960401 4896 2015-10-19 SPBC14C8.07c cdc18 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:24006488 4896 2013-12-05 SPBC14C8.07c cdc18 RNA present during(GO:0000089) PMID:9755169 4896 2019-05-14 SPBC14C8.10 mrpl24 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14C8.11c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14C8.11c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC14C8.11c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14C8.12 rpb8 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPBC14C8.12 rpb8 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPBC14C8.12 rpb8 protein western blot evidence used in manual assertion decreased during(GO:0034605) PMID:11918671 4896 2015-11-26 SPBC14C8.12 rpb8 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPBC14C8.12 rpb8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14C8.12 rpb8 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC14C8.13 srr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14C8.13 srr1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14C8.14c pol5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14C8.14c pol5 RNA Northern assay evidence constant during(GO:0000278) PMID:16816948 4896 2021-01-22 SPBC14C8.14c pol5 RNA Northern assay evidence constant during(GO:0051321) PMID:16816948 4896 2021-01-22 SPBC14C8.14c pol5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC14C8.16c bot1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14C8.17c spt8 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC14C8.19 tam10 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC14F5.01 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14F5.02 trs65 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14F5.03c kap123 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14F5.03c kap123 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC14F5.03c kap123 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC14F5.03c kap123 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC14F5.03c kap123 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC14F5.03c kap123 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC14F5.03c kap123 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC14F5.03c kap123 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14F5.03c kap123 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC14F5.04c pgk1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC14F5.04c pgk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14F5.04c pgk1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC14F5.04c pgk1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14F5.04c pgk1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC14F5.04c pgk1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC14F5.05c sam1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14F5.05c sam1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC14F5.05c sam1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14F5.06 rli1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14F5.06 rli1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC14F5.06 rli1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC14F5.06 rli1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC14F5.06 rli1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC14F5.06 rli1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC14F5.06 rli1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC14F5.06 rli1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14F5.09c ade8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14F5.09c ade8 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC14F5.09c ade8 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC14F5.09c ade8 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC14F5.09c ade8 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC14F5.09c ade8 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC14F5.09c ade8 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC14F5.10c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC14F5.10c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14F5.10c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC14F5.10c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC14F5.10c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC14F5.10c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC14F5.11c snx41 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14F5.11c snx41 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC14F5.11c snx41 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC14F5.11c snx41 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC14F5.12c cbh2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC14F5.12c cbh2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC14F5.13c pho8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC14F5.13c pho8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC14F5.13c pho8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC14F5.13c pho8 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC14F5.13c pho8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC14F5.13c pho8 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC1539.01c mrpl15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1539.02 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1539.03c arg41 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1539.04 tts1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1539.04 tts1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1539.04 tts1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1539.04 tts1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1539.04 tts1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1539.04 tts1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1539.04 tts1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1539.04 tts1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1539.04 tts1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1539.04 tts1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1539.05 cog3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1539.05 cog3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1539.06 acb1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1539.07c fmd1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1539.09c trp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1539.09c trp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1539.09c trp1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1539.09c trp1 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC1539.10 nop16 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1539.10 nop16 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1539.10 nop16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1539.10 nop16 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC15C4.04c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC15C4.04c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC15C4.06c rnf181 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC15C4.06c rnf181 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC15C4.06c rnf181 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC15D4.01c klp9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC15D4.01c klp9 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC15D4.02 gsf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC15D4.02 gsf1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC15D4.02 gsf1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC15D4.02 gsf1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC15D4.02 gsf1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC15D4.03 slm9 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC15D4.04 alg7 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC15D4.04 alg7 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:7893167 4896 2012-05-04 SPBC15D4.05 zng1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC15D4.07c atg9 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC15D4.07c atg9 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC15D4.07c atg9 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC15D4.08c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC15D4.08c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC15D4.09c met3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC15D4.09c met3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC15D4.10c amo1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC15D4.11c mam3302 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC15D4.12c mug98 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC15D4.12c mug98 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC15D4.15 pho2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC15D4.15 pho2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC15D4.15 pho2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC15D4.15 pho2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC15D4.15 pho2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC1604.01 egt1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1604.01 egt1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1604.01 egt1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC1604.01 egt1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1604.01 egt1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1604.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1604.04 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1604.04 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1604.05 pgi1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1604.05 pgi1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC1604.05 pgi1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1604.06c noc4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1604.06c noc4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1604.06c noc4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1604.07 atp4 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1604.07 atp4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1604.09c rex4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1604.09c rex4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1604.09c rex4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1604.10 srb7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1604.11 atp17 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1604.11 atp17 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1604.14c shk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1604.14c shk1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1604.16c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1604.16c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1604.17c tti2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1604.17c tti2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1604.18c cmp7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1604.18c cmp7 protein microscopy evidence present during(GO:0000092) PMID:37783794 4896 2023-10-05 Fig. 2 SPBC1604.18c cmp7 protein microscopy evidence present during(GO:0000080) PMID:37783794 4896 2023-10-05 Fig. 2 SPBC1604.18c cmp7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1604.20c tea2 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPBC1652.01 stb3 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1652.01 stb3 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC1652.01 stb3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1652.01 stb3 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC1652.01 stb3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1652.01 stb3 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC1652.02 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1652.02 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1677.02 dpm3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1677.02 dpm3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1677.03c tda1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1677.03c tda1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1677.03c tda1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1677.03c tda1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1677.03c tda1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1677.03c tda1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1683.01 pho841 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1683.01 pho841 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1683.01 pho841 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1683.01 pho841 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1683.01 pho841 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1683.01 pho841 ribosomal density ribosome profiling evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC1683.01 pho841 ribosomal density ribosome profiling evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1683.01 pho841 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1683.01 pho841 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1683.01 pho841 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1683.01 pho841 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1683.01 pho841 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1683.01 pho841 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1683.01 pho841 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1683.01 pho841 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1683.01 pho841 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC1683.02 dea3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1683.02 dea3 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPBC1683.02 dea3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1683.03c amf1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1683.03c amf1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1683.03c amf1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1683.03c amf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1683.03c amf1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1683.04 ghf3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1683.04 ghf3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1683.04 ghf3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1683.04 ghf3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1683.05 thi7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1683.05 thi7 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1683.05 thi7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1683.06c urh1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1683.06c urh1 RNA expression microarray evidence increased in presence of(CHEBI:3647) PMID:23695302 4896 2015-02-12 SPBC1683.06c urh1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1683.06c urh1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1683.06c urh1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1683.06c urh1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1683.07 mal1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1683.07 mal1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1683.07 mal1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC1683.07 mal1 RNA northern assay evidence used in manual assertion increased during(GO:1902141) PMID:16496115 4896 2013-05-21 SPBC1683.07 mal1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1683.07 mal1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1683.08 ght4 protein western blot evidence used in manual assertion increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPBC1683.08 ght4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1683.08 ght4 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1683.08 ght4 RNA quantitative PCR increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPBC1683.08 ght4 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC1683.08 ght4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1683.08 ght4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1683.08 ght4 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0071281) PMID:30730059 4896 2019-11-13 SPBC1683.09c frp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1683.09c frp1 RNA northern assay evidence used in manual assertion absent during(GO:0071281) PMID:8321236 4896 2012-12-13 SPBC1683.09c frp1 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:10593913 4896 2014-11-25 SPBC1683.09c frp1 RNA northern assay evidence used in manual assertion absent during(GO:0035874) PMID:10593913 4896 2014-11-25 SPBC1683.09c frp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1683.09c frp1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1683.09c frp1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1683.09c frp1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC1683.09c frp1 RNA northern assay evidence used in manual assertion increased during(GO:0071280) PMID:10593913 4896 2014-11-25 SPBC1683.09c frp1 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPBC1683.09c frp1 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPBC1683.09c frp1 RNA quantitative PCR increased in presence of(CHEBI:30351) PMID:37923140 4896 2024-06-19 (Fig. 5) SPBC1683.09c frp1 RNA northern assay evidence used in manual assertion present during(GO:0010106) PMID:8321236 4896 2012-12-13 SPBC1683.10c pcl1 RNA northern assay evidence used in manual assertion decreased during(GO:0010106) PMID:23115244 4896 2012-02-20 SPBC1683.10c pcl1 RNA northern assay evidence used in manual assertion decreased during(GO:0010106) PMID:21531205 4896 2014-10-27 SPBC1683.10c pcl1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:16963626 4896 2019-05-24 SPBC1683.10c pcl1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1683.10c pcl1 RNA northern assay evidence used in manual assertion increased during(GO:0071281) PMID:21531205 4896 2014-10-27 SPBC1683.10c pcl1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23115244 4896 2012-02-20 SPBC1683.11c icl1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1683.11c icl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1683.11c icl1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1683.11c icl1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1683.12 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1683.12 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1683.12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1683.12 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1683.12 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1683.13c cha4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1685.01 pmp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1685.02c rps1202 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1685.02c rps1202 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1685.02c rps1202 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1685.02c rps1202 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1685.02c rps1202 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC1685.03 sec11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1685.04 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1685.05 htr11 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1685.05 htr11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1685.05 htr11 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC1685.05 htr11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1685.05 htr11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1685.06 cid11 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1685.06 cid11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1685.07c avt5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1685.09 rps29 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1685.09 rps29 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1685.09 rps29 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1685.10 rps27 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1685.10 rps27 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1685.10 rps27 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1685.10 rps27 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1685.10 rps27 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1685.10 rps27 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC1685.11 rlp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1685.11 rlp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1685.11 rlp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1685.13 fhn1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1685.13 fhn1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1685.13 fhn1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC1685.13 fhn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1685.13 fhn1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1685.13 fhn1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1685.13 fhn1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1685.13 fhn1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC1685.13 fhn1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1685.14c vid27 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC1685.14c vid27 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC1685.14c vid27 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1685.14c vid27 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1685.15c klp6 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1685.15c klp6 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1685.15c klp6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1685.15c klp6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16A3.01 spn3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16A3.02c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16A3.02c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC16A3.02c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC16A3.02c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC16A3.02c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC16A3.02c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC16A3.02c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC16A3.02c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC16A3.02c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16A3.02c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC16A3.02c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16A3.02c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC16A3.02c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16A3.02c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC16A3.02c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC16A3.02c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC16A3.03c ppr7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16A3.06 tad1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC16A3.07c nrm1 RNA Northern assay evidence present during(GO:0000080) PMID:16916637 4896 2024-07-24 Analysis of nrm1+ transcript abundance in temperature-sensitive cdc25-22 cells arrested in G2/M and, subsequently, released into the cell cycle revealed that nrm1+, like the well-established G1-specific targetscdc18+ and ste9+, is a G1-specific transcript (Figure 6D). SPBC16A3.08c oga1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16A3.08c oga1 RNA reverse transcription polymerase chain reaction transcription evidence decreased during(GO:0006995) PMID:23640107 4896 2013-05-07 SPBC16A3.08c oga1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16A3.08c oga1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:23640107 4896 2013-05-07 SPBC16A3.09c ufd1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16A3.09c ufd1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16A3.09c ufd1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16A3.10 ale1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC16A3.10 ale1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16A3.10 ale1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16A3.13 meu7 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC16A3.13 meu7 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC16A3.13 meu7 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2008-09-08 SPBC16A3.13 meu7 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC16A3.13 meu7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16A3.15c nda2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16A3.15c nda2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16A3.15c nda2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:6327053 4896 2013-09-30 SPBC16A3.15c nda2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:3785193 4896 2013-10-16 SPBC16A3.16 coa5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16A3.17c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC16A3.17c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC16A3.17c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC16A3.17c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC16A3.18 cip1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC16A3.18 cip1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16C6.01c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16C6.02c vps1302 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16C6.02c vps1302 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16C6.03c rsa1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16C6.04 dbl6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16C6.04 dbl6 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16C6.04 dbl6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16C6.05 tma22 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16C6.05 tma22 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16C6.07c rpt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16C6.07c rpt1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16C6.08c qcr6 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC16C6.08c qcr6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16C6.08c qcr6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16C6.09 ogm4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC16C6.10 chp2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16C6.10 chp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16C6.10 chp2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16C6.10 chp2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC16C6.11 rpl3201 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16C6.11 rpl3201 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16C6.11 rpl3201 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16C6.11 rpl3201 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16C6.11 rpl3201 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC16C6.12c las1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16C6.12c las1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC16C6.12c las1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC16C6.12c las1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC16C6.12c las1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC16C6.12c las1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC16C6.12c las1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16C6.12c las1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16C6.14 spo2 RNA experimental evidence absent during(GO:0000278) PMID:18367542 4896 2010-10-20 SPBC16C6.14 spo2 RNA experimental evidence decreased during(GO:0007135) PMID:18367542 4896 2010-10-20 SPBC16C6.14 spo2 RNA experimental evidence increased during(GO:0007127) PMID:18367542 4896 2010-10-20 SPBC16C6.14 spo2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16D10.01c acl4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16D10.01c acl4 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC16D10.01c acl4 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC16D10.01c acl4 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC16D10.01c acl4 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC16D10.01c acl4 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC16D10.01c acl4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16D10.01c acl4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16D10.01c acl4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16D10.02 trm11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16D10.02 trm11 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16D10.02 trm11 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16D10.03 kae1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16D10.03 kae1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16D10.04c dna2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16D10.04c dna2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC16D10.04c dna2 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16D10.05 mok13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16D10.05 mok13 RNA Northern assay evidence absent during(GO:0072690) PMID:16420355 4896 2020-10-21 SPBC16D10.05 mok13 RNA experimental evidence increased during(GO:0034293) PMID:16420355 4896 2008-04-30 SPBC16D10.05 mok13 RNA experimental evidence increased during(GO:0000080) PMID:16420355 4896 2008-04-30 SPBC16D10.05 mok13 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC16D10.05 mok13 RNA Northern assay evidence increased during(GO:0051321) PMID:16420355 4896 2020-10-21 SPBC16D10.06 zrt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16D10.06 zrt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16D10.06 zrt1 RNA northern assay evidence used in manual assertion decreased during(GO:0071294) PMID:24003116 4896 2014-01-03 SPBC16D10.06 zrt1 RNA reverse transcription polymerase chain reaction transcription evidence decreased during(GO:0071294) PMID:18637840 4896 2012-09-11 SPBC16D10.06 zrt1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16D10.06 zrt1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16D10.06 zrt1 RNA expression microarray evidence increased during(GO:0071276) PMID:18637840 4896 2012-09-11 SPBC16D10.06 zrt1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071276) PMID:18637840 4896 2012-09-11 SPBC16D10.06 zrt1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0034224) PMID:18637840 4896 2012-09-11 SPBC16D10.06 zrt1 RNA transcript expression level evidence increased during(GO:0071276) PMID:18203864 4896 2015-07-14 SPBC16D10.06 zrt1 RNA transcript expression level evidence increased during(GO:0071280) PMID:18203864 4896 2015-07-14 SPBC16D10.06 zrt1 RNA transcript expression level evidence increased during(GO:0034224) PMID:18203864 4896 2015-07-14 SPBC16D10.06 zrt1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC16D10.06 zrt1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16D10.06 zrt1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16D10.06 zrt1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC16D10.07c sir2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16D10.08c hsp104 protein western blot evidence used in manual assertion increased during(GO:0034605) PMID:19759825 4896 2015-11-24 SPBC16D10.08c hsp104 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16D10.08c hsp104 protein Western blot evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPBC16D10.08c hsp104 protein microscopy evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPBC16D10.08c hsp104 protein Western blot evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPBC16D10.08c hsp104 protein microscopy evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPBC16D10.08c hsp104 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16D10.08c hsp104 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC16D10.08c hsp104 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBC16D10.08c hsp104 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC16D10.08c hsp104 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC16D10.08c hsp104 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16D10.08c hsp104 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC16D10.08c hsp104 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16D10.08c hsp104 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPBC16D10.08c hsp104 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPBC16D10.08c hsp104 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC16D10.09 pcn1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:1361173 4896 2014-08-22 SPBC16D10.09 pcn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16D10.10 tad2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16D10.11c rps1801 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16D10.11c rps1801 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16D10.11c rps1801 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC16D10.11c rps1801 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16D10.11c rps1801 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC16E9.01c php4 protein Western blot evidence decreased during(GO:0072690) PMID:38272226 4896 2024-12-06 Php4 degraded in stationary phase (Fig. 1A) SPBC16E9.01c php4 protein Western blot evidence increased in presence of(CHEBI:52717),during(GO:0072690) PMID:38272226 4896 2024-12-06 (Fig. 1B) SPBC16E9.01c php4 protein Western blot evidence increased in presence of(CHEBI:30351),during(GO:0072690) PMID:38272226 4896 2024-12-06 (Fig. 7A) SPBC16E9.01c php4 RNA RNA protection assay evidence decreased during(GO:0071281) PMID:16963626 4896 2019-05-24 SPBC16E9.01c php4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16E9.01c php4 RNA RNA protection assay evidence increased during(GO:0010106) PMID:16963626 4896 2019-05-24 SPBC16E9.01c php4 RNA quantitative PCR increased in presence of(CHEBI:29699) PMID:38360270 4896 2024-03-14 SPBC16E9.01c php4 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC16E9.05 erg6 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC16E9.05 erg6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.05 erg6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16E9.05 erg6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16E9.05 erg6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16E9.06c uvi31 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.06c uvi31 RNA Northern assay evidence increased during(GO:0034644) PMID:8048925 4896 2019-04-27 SPBC16E9.07 mug100 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.07 mug100 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC16E9.07 mug100 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16E9.07 mug100 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC16E9.08 mcp4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.08 mcp4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC16E9.08 mcp4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC16E9.10c rix7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.10c rix7 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC16E9.10c rix7 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC16E9.10c rix7 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC16E9.10c rix7 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC16E9.10c rix7 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC16E9.10c rix7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16E9.10c rix7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16E9.12c pab2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.12c pab2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16E9.13 ksp1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16E9.13 ksp1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16E9.13 ksp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC16E9.13 ksp1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16E9.13 ksp1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16E9.14c zrg17 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.16c lsd90 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.16c lsd90 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC16E9.16c lsd90 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16E9.16c lsd90 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16E9.16c lsd90 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC16E9.16c lsd90 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC16E9.16c lsd90 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC16E9.16c lsd90 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC16E9.16c lsd90 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC16E9.16c lsd90 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC16E9.16c lsd90 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC16E9.16c lsd90 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC16E9.16c lsd90 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16E9.16c lsd90 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC16E9.16c lsd90 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16E9.16c lsd90 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC16E9.16c lsd90 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16E9.16c lsd90 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC16E9.16c lsd90 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC16E9.16c lsd90 RNA expression microarray evidence increased in presence of(CHEBI:69136) PMID:38415071 4896 2024-10-09 SPBC16E9.16c lsd90 RNA quantitative PCR increased in presence of(CHEBI:142517) PMID:35416247 4896 2022-07-04 SPBC16E9.16c lsd90 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC16E9.17c rem1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC16E9.18 psd1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC16E9.20 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16E9.20 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16G5.02c rbk1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC16G5.03 mrz1 protein Western blot evidence decreased during(GO:0072690),during(GO:0042149) PMID:36088506 4896 2023-11-10 As shown in Fig. 2A, Mrz1 expression was decreased during the stationary phase grown on YES. SPBC16G5.03 mrz1 protein Western blot evidence increased in presence of(CHEBI:75142),during(GO:0072690),during(GO:0042149) PMID:36088506 4896 2023-11-10 SPBC16G5.03 mrz1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16G5.04 mrpl23 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16G5.06 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16G5.07c sto1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16G5.08 trp4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16G5.09 kex1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16G5.09 kex1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16G5.09 kex1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16G5.14c rps3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16G5.14c rps3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16G5.14c rps3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16G5.14c rps3 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC16G5.14c rps3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16G5.14c rps3 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC16G5.14c rps3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16G5.15c fkh2 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:15302827 4896 2015-10-20 SPBC16G5.15c fkh2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16G5.15c fkh2 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:15302827 4896 2015-10-20 SPBC16G5.15c fkh2 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:15509866 4896 2015-11-22 SPBC16G5.15c fkh2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC16G5.17 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16G5.17 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16G5.18 erg24 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16H5.02 pfk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16H5.02 pfk1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16H5.02 pfk1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC16H5.03c uba2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16H5.04 snd301 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16H5.04 snd301 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16H5.06 rip1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC16H5.06 rip1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16H5.06 rip1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16H5.06 rip1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC16H5.08c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16H5.08c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC16H5.08c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16H5.09c omh2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC16H5.10c prp43 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16H5.10c prp43 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16H5.11c skb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC16H5.11c skb1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC16H5.11c skb1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC16H5.11c skb1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC16H5.14c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1703.03c syo2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1703.03c syo2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1703.05 rio2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1703.05 rio2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1703.05 rio2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1703.06 pof10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1703.06 pof10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1703.07 acl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1703.07 acl1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1703.07 acl1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1703.07 acl1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1703.07 acl1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1703.08c fau1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1703.08c fau1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1703.08c fau1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1703.10 ypt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1703.10 ypt1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1703.10 ypt1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1703.11 opa3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1703.11 opa3 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC1703.13c mir1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1703.13c mir1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1703.13c mir1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1703.13c mir1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC1703.14c top1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1706.01 tea4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1706.01 tea4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1706.01 tea4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1706.03 fzo1 protein Western blot evidence decreased during(GO:0072690) PMID:35075549 4896 2022-04-01 the protein level of Fzo1 is unstable during the stationary phase. SPBC1706.03 fzo1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1706.03 fzo1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1706.03 fzo1 RNA quantitative PCR unchanged during(GO:0072690) PMID:35075549 4896 2022-04-01 SPBC1709.01 chs2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1709.01 chs2 protein western blot evidence used in manual assertion increased during(GO:0000917) PMID:15277753 4896 2015-10-20 SPBC1709.01 chs2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1709.01 chs2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1709.01 chs2 RNA northern assay evidence used in manual assertion present during(GO:0000917) PMID:15277753 4896 2015-10-20 SPBC1709.02c vrs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1709.02c vrs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1709.02c vrs1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1709.02c vrs1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1709.02c vrs1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1709.02c vrs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1709.03 vps3844 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1709.05 sks2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1709.05 sks2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1709.05 sks2 protein western blot evidence used in manual assertion unchanged during(GO:0034605) PMID:8973306 4896 2013-10-29 SPBC1709.05 sks2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:8973306 4896 2013-10-29 SPBC1709.05 sks2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1709.05 sks2 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1709.05 sks2 RNA northern assay evidence used in manual assertion decreased during(GO:0034605) PMID:8973306 4896 2013-10-29 SPBC1709.05 sks2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1709.05 sks2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8973306 4896 2013-10-29 SPBC1709.06 dus2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1709.06 dus2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1709.07 erg27 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1709.07 erg27 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1709.08 cft1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1709.10c atx1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1709.10c atx1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1709.10c atx1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1709.11c png2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1709.11c png2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1709.12 rid1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1709.12 rid1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1709.12 rid1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1709.12 rid1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1709.13c set10 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1709.13c set10 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1709.16c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1709.17 met7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1709.19c nfu1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1711.02 mat3-Mc RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC1711.04 mtd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1711.04 mtd1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.04 mtd1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.04 mtd1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1711.05 srp40 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1711.05 srp40 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1711.05 srp40 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1711.05 srp40 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1711.06 rpl401 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1711.06 rpl401 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.06 rpl401 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1711.07 rrb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1711.07 rrb1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.07 rrb1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1711.07 rrb1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1711.07 rrb1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1711.07 rrb1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1711.07 rrb1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1711.07 rrb1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1711.07 rrb1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.07 rrb1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1711.07 rrb1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.08 aha1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1711.08 aha1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1711.08 aha1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1711.08 aha1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1711.08 aha1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.08 aha1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.08 aha1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC1711.09c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.10c npl4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1711.10c npl4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.11 atg2402 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1711.11 atg2402 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1711.11 atg2402 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1711.11 atg2402 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1711.11 atg2402 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.11 atg2402 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.11 atg2402 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC1711.12 ppp16 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.12 ppp16 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.12 ppp16 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC1711.12 ppp16 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1711.12 ppp16 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1711.12 ppp16 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.12 ppp16 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1711.12 ppp16 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.13 his2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1711.13 his2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1711.13 his2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1711.13 his2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1711.13 his2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1711.13 his2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1711.14 rec15 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC1711.14 rec15 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:14648198 4896 2019-08-07 SPBC1711.14 rec15 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:8559063 4896 2014-09-24 SPBC1711.14 rec15 RNA Northern assay evidence increased during(GO:0051321) PMID:9671035 4896 2019-11-07 SPBC1711.14 rec15 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC1711.15c RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC1711.16 pwp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1711.16 pwp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1711.16 pwp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1711.16 pwp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1711.18 tam9 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1711.18 tam9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1718.01 pop1 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:9203581 4896 2015-05-05 SPBC1718.02 hop1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1718.02 hop1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC1718.02 hop1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1718.03 ker1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1718.03 ker1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1718.04 sct1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1718.05 trs31 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPBC1718.06 msp1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1718.06 msp1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1718.06 msp1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1718.06 msp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1718.07c zfs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1718.07c zfs1 RNA experimental evidence increased during(GO:0006995) PMID:8534915 4896 SPBC1718.07c zfs1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:8534915 4896 2014-07-31 SPBC1718.07c zfs1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1718.07c zfs1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8534915 4896 2014-07-31 SPBC1734.01c esf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1734.01c esf1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1734.01c esf1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1734.01c esf1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1734.01c esf1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1734.01c esf1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1734.01c esf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1734.01c esf1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1734.01c esf1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC1734.01c esf1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1734.02c cdc27 RNA Northern assay evidence constant during(GO:0000278) PMID:1538696 4896 2021-01-22 SPBC1734.03 fol1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1734.04 anp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1734.04 anp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1734.04 anp1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC1734.05c spf31 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1734.07c trs8502 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1734.08 hse1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1734.08 hse1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1734.09 yea4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1734.11 mas5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1734.11 mas5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1734.11 mas5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1734.11 mas5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1734.11 mas5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1734.12c alg12 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1734.14c suc1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:3322810 4896 2013-09-30 SPBC1734.14c suc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1734.15 rsc4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1773.02c bcp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1773.02c bcp1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC1773.02c bcp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.02c bcp1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1773.02c bcp1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1773.03c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.03c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1773.03c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1773.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.03c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1773.04 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.04 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1773.05c tms1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1773.05c tms1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.05c tms1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1773.05c tms1 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC1773.05c tms1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC1773.05c tms1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1773.05c tms1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1773.05c tms1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1773.05c tms1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1773.05c tms1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1773.05c tms1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1773.05c tms1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.05c tms1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1773.05c tms1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1773.05c tms1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1773.06c adh8 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1773.06c adh8 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1773.06c adh8 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1773.06c adh8 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC1773.06c adh8 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1773.06c adh8 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1773.06c adh8 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1773.06c adh8 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1773.06c adh8 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1773.06c adh8 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1773.07c sbp1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1773.07c sbp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.07c sbp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1773.07c sbp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1773.07c sbp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.08c omh4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1773.08c omh4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1773.08c omh4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1773.08c omh4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1773.09c mug184 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1773.09c mug184 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1773.10c nrs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.10c nrs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1773.10c nrs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.11c mug89 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1773.11c mug89 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.11c mug89 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1773.11c mug89 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1773.11c mug89 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1773.12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1773.12 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1773.12 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1773.13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1773.14 arg7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.14 arg7 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1773.15 dal52 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.15 dal52 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1773.16c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.16c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1773.16c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1773.16c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.17c gor2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1773.17c gor2 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1773.17c gor2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1773.17c gor2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1773.17c gor2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1773.17c gor2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1773.17c gor2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1773.17c gor2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1773.17c gor2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1773.17c gor2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1773.17c gor2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1778.01c zuo1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1778.01c zuo1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1778.01c zuo1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1778.01c zuo1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1778.01c zuo1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1778.01c zuo1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1778.01c zuo1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1778.01c zuo1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1778.01c zuo1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1778.01c zuo1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1778.02 rap1 protein western blot evidence used in manual assertion constant during(GO:0051321) PMID:26058898 4896 2015-08-20 SPBC1778.02 rap1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1778.02 rap1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1778.03c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1778.03c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1778.03c RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC1778.04 spo6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1778.04 spo6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1778.04 spo6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1778.04 spo6 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9528784 4896 2015-05-05 SPBC1778.05c lam2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1778.05c lam2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1778.05c lam2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1778.06c fim1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1778.07 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1778.08c arc3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1778.09 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1778.09 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1778.10c pdk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1778.10c pdk1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC17A3.01c tim50 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17A3.02 aim19 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17A3.02 aim19 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC17A3.03c siw14 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17A3.03c siw14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC17A3.03c siw14 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17A3.03c siw14 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC17A3.04c rar1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17A3.04c rar1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17A3.04c rar1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17A3.04c rar1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC17A3.05c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17A3.05c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17A3.06 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC17A3.07 pgr1 RNA northern assay evidence used in manual assertion increased in presence of(GO:0036245) PMID:9287302 4896 2012-05-30 SPBC17A3.07 pgr1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:48958) PMID:9287302 4896 2012-05-30 SPBC17A3.07 pgr1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:34656) PMID:9287302 4896 2012-05-30 SPBC17A3.07 pgr1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:9287302 4896 2012-05-30 SPBC17A3.07 pgr1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:9287302 4896 2012-05-30 SPBC17A3.07 pgr1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC17A3.07 pgr1 RNA northern assay evidence used in manual assertion unchanged during(GO:0070301) PMID:9287302 4896 2012-05-30 SPBC17A3.07 pgr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9287302 4896 2012-05-30 SPBC17A3.08 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17A3.09c aim22 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17D1.01 spp41 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC17D1.01 spp41 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17D1.01 spp41 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC17D1.02 dph2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17D1.02 dph2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC17D1.02 dph2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17D1.03c rrp43 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17D1.03c rrp43 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC17D1.04 acr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17D1.04 acr1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17D1.05 rhs1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17D1.05 rhs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17D1.06 dbp3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC17D1.06 dbp3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17D1.06 dbp3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17D1.06 dbp3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17D1.06 dbp3 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC17D1.06 dbp3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17D1.07c npg1 protein western blot evidence used in manual assertion increased during(GO:0007127) PMID:25146394 4896 2014-09-05 SPBC17D1.07c npg1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17D1.07c npg1 protein western blot evidence used in manual assertion present during(GO:0007135) PMID:25146394 4896 2014-09-05 SPBC17D1.07c npg1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC17D1.17 tam11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC17D1.17 tam11 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17D1.17 tam11 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC17D1.17 tam11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17D1.17 tam11 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC17D11.01 nep1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17D11.01 nep1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC17D11.01 nep1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17D11.02c hrd1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17D11.03c pxp2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC17D11.05 tif301 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17D11.05 tif301 protein western blot evidence used in manual assertion unchanged during(GO:0071470) PMID:18065650 4896 2017-09-29 SPBC17D11.05 tif301 protein western blot evidence used in manual assertion unchanged during(GO:0034599) PMID:18065650 4896 2017-09-29 SPBC17D11.05 tif301 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17D11.05 tif301 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17D11.05 tif301 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17D11.07c rpn2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17D11.07c rpn2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC17D11.08 dca7 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17D11.08 dca7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17D11.08 dca7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC17D11.08 dca7 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17D11.08 dca7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17D11.08 dca7 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC17F3.01c rga5 RNA quantitative PCR increased during(GO:0071500) PMID:22561704 4896 2015-11-16 SPBC17F3.01c rga5 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC17F3.01c rga5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC17F3.01c rga5 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC17F3.02 nak1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:15731009 4896 2017-07-14 SPBC17F3.02 nak1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17G9.02c cdc73 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17G9.03c krs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17G9.03c krs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17G9.03c krs1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17G9.03c krs1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC17G9.03c krs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17G9.03c krs1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC17G9.04c nup85 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17G9.04c nup85 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC17G9.05 rct1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC17G9.06c sib3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC17G9.07 rps2402 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17G9.07 rps2402 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17G9.07 rps2402 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17G9.07 rps2402 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC17G9.07 rps2402 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17G9.07 rps2402 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17G9.08c cnt5 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC17G9.09 tif213 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC17G9.09 tif213 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17G9.09 tif213 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17G9.10 rpl1102 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17G9.10 rpl1102 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC17G9.10 rpl1102 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC17G9.10 rpl1102 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC17G9.10 rpl1102 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC17G9.10 rpl1102 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17G9.10 rpl1102 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC17G9.10 rpl1102 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC17G9.11c pyr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC17G9.11c pyr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC17G9.11c pyr1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC17G9.12c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC17G9.13c cup1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1815.01 eno101 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1815.01 eno101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1815.01 eno101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1815.01 eno101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC1815.01 eno101 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1815.01 eno101 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC1826.01c mot1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1861.01c cnp3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1861.01c cnp3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1861.01c cnp3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1861.02 abp2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC1861.02 abp2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC1861.02 abp2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC1861.02 abp2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC1861.02 abp2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC1861.02 abp2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1861.02 abp2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1861.05 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC1861.05 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1861.06c mug131 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1861.06c mug131 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1861.06c mug131 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1861.06c mug131 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1861.07 elc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1861.07 elc1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1861.08c lea1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1861.08c lea1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1861.09 ppk22 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18A7.01 xpa1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPBC18A7.01 xpa1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18A7.01 xpa1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC18A7.02c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18E5.01 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC18E5.01 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18E5.01 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC18E5.02c lcb1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18E5.02c lcb1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC18E5.03c sim4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC18E5.03c sim4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC18E5.04 rpl1001 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18E5.04 rpl1001 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18E5.06 rps21 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18E5.06 rps21 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC18E5.06 rps21 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC18E5.06 rps21 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18E5.06 rps21 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC18E5.07 aim21 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC18E5.08 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC18E5.12c mas2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18E5.13 mti3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18E5.15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC18H10.02 lcf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18H10.02 lcf1 RNA quantitative PCR increased during(GO:0071456) PMID:27053105 4896 2016-08-03 SPBC18H10.02 lcf1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC18H10.02 lcf1 RNA RNA-sequencing evidence increased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPBC18H10.02 lcf1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12684881 4896 2014-10-06 SPBC18H10.03 tif307 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18H10.03 tif307 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC18H10.03 tif307 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18H10.04c sce3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC18H10.04c sce3 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:9254700 4896 2015-12-10 SPBC18H10.04c sce3 RNA northern assay evidence used in manual assertion decreased during(GO:0006995) PMID:9254700 4896 2015-12-10 SPBC18H10.04c sce3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18H10.05 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC18H10.05 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18H10.05 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC18H10.05 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC18H10.05 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC18H10.09 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC18H10.11c ppr2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18H10.11c ppr2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18H10.12c rpl701 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC18H10.12c rpl701 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC18H10.12c rpl701 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC18H10.12c rpl701 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18H10.12c rpl701 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC18H10.13 rps1402 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC18H10.13 rps1402 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC18H10.13 rps1402 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC18H10.13 rps1402 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC18H10.13 rps1402 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18H10.13 rps1402 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC18H10.13 rps1402 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC18H10.14 rps1601 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC18H10.14 rps1601 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC18H10.14 rps1601 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC18H10.14 rps1601 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC18H10.14 rps1601 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC18H10.15 cdk11 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC18H10.18c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC18H10.18c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC18H10.20c any1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1921.01c rpl35A02 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1921.03c mex67 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1921.04c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1921.05 ape2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1921.05 ape2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1921.06c pvg3 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1921.06c pvg3 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC1921.06c pvg3 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC1921.06c pvg3 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC1921.07c sgf29 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19C2.01 cdc28 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC19C2.01 cdc28 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19C2.02 pmt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C2.02 pmt1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:23074192 4896 2012-11-13 SPBC19C2.02 pmt1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C2.02 pmt1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23074192 4896 2012-11-13 SPBC19C2.03 rpc10 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19C2.04c ubp11 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC19C2.04c ubp11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19C2.04c ubp11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19C2.05 pat1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC19C2.05 pat1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C2.05 pat1 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:3830131 4896 2013-01-31 SPBC19C2.05 pat1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC19C2.05 pat1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19C2.05 pat1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19C2.05 pat1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19C2.05 pat1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:3830131 4896 2013-01-31 SPBC19C2.06c mug124 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC19C2.06c mug124 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C2.07 fba1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C2.07 fba1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC19C2.07 fba1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19C2.07 fba1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC19C2.07 fba1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C2.07 fba1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8286404 4896 2012-09-06 SPBC19C2.08 prp38 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPBC19C2.09 sre1 protein western blot evidence used in manual assertion decreased during(GO:0071238) PMID:28202541 4896 2017-06-08 SPBC19C2.09 sre1 protein western blot evidence used in manual assertion increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C2.09 sre1 RNA Northern assay evidence increased during(GO:0071456) PMID:15797383 4896 2020-01-07 SPBC19C2.09 sre1 RNA northern assay evidence used in manual assertion increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C2.09 sre1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C2.09 sre1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC19C2.09 sre1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19C2.09 sre1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC19C2.11c mdm34 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C2.11c mdm34 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC19C2.11c mdm34 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC19C2.11c mdm34 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19C2.11c mdm34 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19C2.11c mdm34 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC19C2.11c mdm34 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19C2.13c ctu2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C2.13c ctu2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C2.13c ctu2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19C2.13c ctu2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19C2.13c ctu2 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPBC19C2.15c phs1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C7.01 mni1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C7.03 cyr1 protein reporter gene assay evidence increased during(GO:0000088) PMID:26443240 4896 2021-03-19 SPBC19C7.04c gsr1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19C7.04c gsr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C7.04c gsr1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19C7.04c gsr1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC19C7.04c gsr1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC19C7.04c gsr1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC19C7.04c gsr1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC19C7.04c gsr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19C7.04c gsr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19C7.04c gsr1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19C7.04c gsr1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC19C7.05 rcr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C7.05 rcr1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC19C7.06 prs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C7.06 prs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC19C7.07c sen34 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19C7.07c sen34 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC19C7.09c uve1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19C7.09c uve1 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19C7.09c uve1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19C7.09c uve1 ribosomal density ribosome profiling evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC19C7.09c uve1 RNA Northern assay evidence increased during(GO:0034644) PMID:9023111 4896 2018-06-07 SPBC19C7.09c uve1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC19C7.10 bqt4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC19C7.10 bqt4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C7.10 bqt4 RNA expression microarray evidence increased during(GO:0006995) PMID:19948484 4896 2015-09-25 SPBC19C7.10 bqt4 RNA expression microarray evidence increased during(GO:0071444),during(GO:0006995) PMID:19948484 4896 2015-09-25 SPBC19C7.10 bqt4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19C7.10 bqt4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19C7.10 bqt4 RNA expression microarray evidence present during(GO:0072690) PMID:19948484 4896 2015-09-25 SPBC19C7.11 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19C7.12c omh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19C7.12c omh1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19F5.01c puc1 RNA Northern assay evidence increased during(GO:0006995) PMID:8006074 4896 2018-06-09 SPBC19F5.01c puc1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC19F5.01c puc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19F5.01c puc1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19F5.02c utp4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19F5.02c utp4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19F5.02c utp4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19F5.03 sac11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19F5.04 hom3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19F5.04 hom3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC19F5.04 hom3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19F5.04 hom3 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC19F5.04 hom3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19F5.04 hom3 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC19F5.04 hom3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19F5.04 hom3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19F5.04 hom3 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC19F5.04 hom3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19F5.04 hom3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19F5.04 hom3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC19F5.05c ppp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19F5.05c ppp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC19F5.05c ppp1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC19F5.05c ppp1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC19F5.05c ppp1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC19F5.05c ppp1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC19F5.05c ppp1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC19F5.05c ppp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19F5.05c ppp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19F5.05c ppp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19F5.05c ppp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19F8.01c spn7 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19F8.01c spn7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19F8.01c spn7 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC19F8.01c spn7 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC19F8.02 nud3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19F8.04c lcl3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19F8.04c lcl3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19F8.04c lcl3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC19F8.06c meu22 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19F8.06c meu22 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC19F8.06c meu22 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPBC19F8.06c meu22 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC19F8.06c meu22 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19F8.07 mcs6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC19F8.07 mcs6 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19F8.08 rps401 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19F8.08 rps401 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC19F8.08 rps401 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19F8.08 rps401 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19G7.01c msh2 RNA Northern assay evidence present during(GO:0098763) PMID:9858548 4896 2018-07-13 SPBC19G7.01c msh2 RNA Northern assay evidence present during(GO:0098762) PMID:9858548 4896 2018-07-13 SPBC19G7.02 abz2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC19G7.02 abz2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19G7.03c rps3002 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19G7.03c rps3002 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19G7.03c rps3002 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC19G7.03c rps3002 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19G7.03c rps3002 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19G7.03c rps3002 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC19G7.04 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19G7.04 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC19G7.04 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19G7.04 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19G7.04 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC19G7.05c bgs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19G7.05c bgs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC19G7.05c bgs1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC19G7.05c bgs1 RNA expression microarray evidence increased PMID:21148300 4896 2021-03-19 SPBC19G7.05c bgs1 RNA expression microarray evidence increased during(GO:0000088) PMID:21148300 4896 2021-03-19 SPBC19G7.05c bgs1 RNA in situ hybridization evidence used in manual assertion increased in presence of(CHEBI:26981) PMID:21148300 4896 2021-03-19 SPBC19G7.06 mbx1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19G7.06 mbx1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC19G7.06 mbx1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC19G7.06 mbx1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC19G7.10c pdc2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19G7.16 iws1 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19G7.16 iws1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC19G7.16 iws1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19G7.16 iws1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC19G7.16 iws1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC19G7.17 ssh1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC19G7.18c mrx17 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19G7.18c mrx17 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC19G7.19 tom5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC19G7.19 tom5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1A4.01 apc10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1A4.01 apc10 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC1A4.01 apc10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1A4.02c leu1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1A4.02c leu1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1A4.02c leu1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC1A4.02c leu1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1A4.02c leu1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1A4.02c leu1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC1A4.02c leu1 RNA northern assay evidence used in manual assertion unchanged during(GO:0006995) PMID:14745200 4896 2013-01-17 SPBC1A4.02c leu1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:14745200 4896 2013-01-17 SPBC1A4.03c top2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1A4.04 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1A4.04 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1A4.04 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1A4.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1A4.05 blt1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1A4.05 blt1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1A4.07c sof1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1A4.08c cct3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1A4.09 pus7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1A4.09 pus7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1A4.10c med14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1A4.11c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1D7.01 pfd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC1D7.02c scr1 RNA quantitative PCR increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPBC1D7.02c scr1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC1D7.03 clg1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1D7.03 clg1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC1D7.03 clg1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC1D7.04 mlo3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1D7.05 byr2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC1D7.05 byr2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1D7.05 byr2 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:1435723 4896 2013-02-19 SPBC1D7.05 byr2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC1D7.05 byr2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1D7.05 byr2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC1D7.05 byr2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:1435723 4896 2013-02-19 SPBC1E8.03c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC1E8.03c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC1E8.04 Tf2-10 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC1E8.04 Tf2-10 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC20F10.01 gar1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC20F10.01 gar1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC20F10.01 gar1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC20F10.01 gar1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC20F10.01 gar1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC20F10.01 gar1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC20F10.01 gar1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC20F10.01 gar1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC20F10.02c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC20F10.03 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC20F10.03 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC20F10.03 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC20F10.03 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC20F10.03 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC20F10.03 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC20F10.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC20F10.03 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC20F10.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC20F10.03 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC20F10.03 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC20F10.04c nse4 protein western blot evidence used in manual assertion constant during(GO:0098763) PMID:17005570 4896 2016-08-22 SPBC20F10.04c nse4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC20F10.05 nrl1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC20F10.06 mad2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC20F10.07 ltc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC20F10.07 ltc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC20F10.07 ltc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC20F10.10 psl1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC20F10.10 psl1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC20F10.10 psl1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC20F10.10 psl1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC20F10.10 psl1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC20F10.10 psl1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC20F10.10 psl1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC20F10.10 psl1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC20F10.10 psl1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC20F10.10 psl1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC20F10.10 psl1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC20F10.10 psl1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC21.01 mis17 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21.01 mis17 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC21.06c cdc7 protein Western blot evidence decreased during(GO:0098765) PMID:24838944 4896 2025-04-16 (Fig. 4A) SPBC21.06c cdc7 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC21.07c ppk24 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC21.07c ppk24 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC211.01 rsm10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC211.02c cwf3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC211.03c gea1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC211.03c gea1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC211.04c mcm6 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:9658174 4896 2015-06-10 SPBC211.04c mcm6 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:11344166 4896 2015-02-11 SPBC211.04c mcm6 protein western blot evidence used in manual assertion decreased during(GO:0045023) PMID:16899242 4896 2014-11-06 SPBC211.04c mcm6 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:10888871 4896 2010-09-03 SPBC211.04c mcm6 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:10888871 4896 2010-09-03 SPBC211.04c mcm6 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC211.04c mcm6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC211.05 sap10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC211.06 gfh1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC211.07c ubc8 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC211.07c ubc8 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC211.07c ubc8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC211.07c ubc8 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC211.07c ubc8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC211.07c ubc8 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC211.08c mtr3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC211.08c mtr3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC211.08c mtr3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC211.08c mtr3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC215.01 gyp4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC215.03c csn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC215.04 git11 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC215.04 git11 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC215.04 git11 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC215.04 git11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC215.04 git11 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC215.05 gpd1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC215.05 gpd1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC215.05 gpd1 RNA quantitative PCR increased in presence of(CHEBI:142517) PMID:29900664 4896 2018-11-13 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0071470) PMID:8649397 4896 2013-06-04 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8649397 4896 2013-06-04 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:8649397 4896 2013-06-04 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:7498541 4896 2013-10-21 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:8824587 4896 2014-02-26 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2013-03-18 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:9560390 4896 2014-05-22 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:12715160 4896 2014-06-23 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:8824588 4896 2015-01-07 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:18235227 4896 2015-12-17 SPBC215.05 gpd1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC215.05 gpd1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC215.05 gpd1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC215.05 gpd1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC215.05 gpd1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC215.05 gpd1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC215.05 gpd1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC215.05 gpd1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC215.05 gpd1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC215.05 gpd1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC215.05 gpd1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC215.05 gpd1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC215.05 gpd1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC215.05 gpd1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC215.05 gpd1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC215.05 gpd1 RNA quantitative PCR increased during(GO:0071447) PMID:33410907 4896 2021-01-12 (Figure 1) SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:7498541 4896 2013-10-21 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23874237 4896 2013-03-18 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12715160 4896 2014-06-23 SPBC215.05 gpd1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:18235227 4896 2015-12-17 SPBC215.06c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC215.06c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC215.06c RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC215.06c RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC215.06c RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC215.06c RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC215.06c RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC215.06c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC215.06c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC215.06c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC215.07c pdp2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC215.07c pdp2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC215.07c pdp2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC215.07c pdp2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC215.08c arg4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC215.08c arg4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC215.08c arg4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC215.08c arg4 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC215.09c erg10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC215.09c erg10 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC215.09c erg10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC215.09c erg10 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC215.09c erg10 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC215.10 odr1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC215.11c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC215.11c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC215.11c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC215.11c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC215.11c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC215.11c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC215.11c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC215.11c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC215.11c RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC215.11c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC215.11c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC215.11c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC215.11c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC215.11c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC215.11c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC215.11c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC215.11c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC215.12 cwf10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC215.13 mtl3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC215.14c vps20 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC215.14c vps20 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC216.01c psy2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC216.01c psy2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC216.02 num1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC216.02 num1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC216.02 num1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC216.03 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC216.03 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC216.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC216.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC216.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC216.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC216.04c mxr2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC216.04c mxr2 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:24118096 4896 2014-04-02 SPBC216.04c mxr2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC216.04c mxr2 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:23456650 4896 2014-02-13 SPBC216.04c mxr2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:24118096 4896 2014-04-02 SPBC216.05 rad3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC216.05 rad3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC216.06c swi1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC216.07c tor2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21B10.02 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21B10.03c ath1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC21B10.03c ath1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC21B10.03c ath1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21B10.03c ath1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC21B10.03c ath1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21B10.04c vtc1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC21B10.04c vtc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21B10.04c vtc1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC21B10.04c vtc1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC21B10.07 crr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21B10.07 crr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21B10.08c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC21B10.08c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC21B10.08c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21B10.10 rps402 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC21B10.10 rps402 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21B10.11 dpm2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC21B10.11 dpm2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21B10.12 rec6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21B10.12 rec6 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:8005432 4896 2014-08-05 SPBC21B10.12 rec6 RNA Northern assay evidence increased during(GO:0051321) PMID:9671035 4896 2019-11-07 SPBC21B10.12 rec6 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC21B10.12 rec6 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC21B10.12 rec6 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21B10.13c yox1 protein Western blot evidence increased during(GO:0000084) PMID:19714215 4896 2024-07-24 the Yox1p levels were low during M/G1-phase but then strongly increased during S-phase (Figure 2D, top), peaking about 40 minutes after the peak of yox1 mRNA levels. SPBC21B10.13c yox1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC21B10.14 kgd4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC21B10.14 kgd4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21B10.15 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21C3.01c vps1301 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC21C3.02c dep1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21C3.07c trm140 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21C3.08c car2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21C3.08c car2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC21C3.08c car2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC21C3.08c car2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC21C3.08c car2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC21C3.08c car2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC21C3.08c car2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21C3.08c car2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21C3.08c car2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC21C3.08c car2 RNA expression microarray evidence increased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPBC21C3.09c oaa1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC21C3.11 ubx4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21C3.11 ubx4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC21C3.11 ubx4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21C3.11 ubx4 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC21C3.13 rps1901 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC21C3.13 rps1901 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC21C3.13 rps1901 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21C3.13 rps1901 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21C3.13 rps1901 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC21C3.14c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21C3.14c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21C3.15c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21C3.15c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21C3.17c psg1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21C3.17c psg1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC21C3.18 spo4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21C3.18 spo4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC21C3.18 spo4 protein Western blot evidence present during(GO:0098765) PMID:11739743 4896 2026-01-04 SPBC21C3.18 spo4 RNA Northern assay evidence absent during(GO:0098763) PMID:11739743 4896 2026-01-04 the spo4 mRNA levels were mon- itored by Northern blot analysis. spo4 mRNA was barely de- tectable in vegetative cells, though it abruptly increased during meiosis. SPBC21C3.18 spo4 RNA quantitative PCR decreased in presence of(CHEBI:52289) PMID:31657618 4896 2023-06-21 (Fig. 3) SPBC21C3.18 spo4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC21C3.18 spo4 RNA Northern assay evidence increased during(GO:0098764) PMID:11739743 4896 2026-01-04 the spo4 mRNA levels were mon- itored by Northern blot analysis. spo4 mRNA was barely de- tectable in vegetative cells, though it abruptly increased during meiosis. SPBC21C3.19 rtc3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC21C3.19 rtc3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21C3.19 rtc3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC21C3.19 rtc3 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-21 SPBC21C3.19 rtc3 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC21C3.19 rtc3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC21C3.19 rtc3 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC21C3.19 rtc3 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC21C3.19 rtc3 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC21C3.19 rtc3 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC21C3.19 rtc3 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC21C3.19 rtc3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC21C3.19 rtc3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC21C3.19 rtc3 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC21C3.19 rtc3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21C3.19 rtc3 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC21C3.19 rtc3 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC21C3.19 rtc3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC21C3.19 rtc3 RNA expression microarray evidence increased in presence of(CHEBI:69136) PMID:38415071 4896 2024-10-09 SPBC21C3.20c git1 protein western blot evidence used in manual assertion increased during(GO:0042149) PMID:16489217 4896 2017-09-28 SPBC21C3.20c git1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21C3.20c git1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21C3.20c git1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21D10.05c ucp3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21D10.06c map4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC21D10.06c map4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21D10.06c map4 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC21D10.06c map4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21D10.06c map4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21D10.08c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21D10.08c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC21D10.09c rkr1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21D10.09c rkr1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21D10.09c rkr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21D10.11c nfs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21D10.12 hob1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC21H7.02 taf10 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC21H7.03c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC21H7.03c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC21H7.03c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21H7.03c RNA expression microarray evidence decreased in presence of(CHEBI:18385) PMID:16278451 4896 2014-06-02 SPBC21H7.03c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC21H7.03c RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC21H7.04 dbp7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC21H7.04 dbp7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC21H7.04 dbp7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21H7.05 sfc6 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21H7.06c opi10 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC21H7.06c opi10 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC21H7.06c opi10 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC21H7.06c opi10 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC21H7.06c opi10 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC21H7.06c opi10 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC21H7.06c opi10 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC21H7.06c opi10 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC21H7.06c opi10 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC21H7.06c opi10 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC21H7.06c opi10 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC21H7.06c opi10 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC21H7.06c opi10 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC21H7.07c his5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC21H7.07c his5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC23E6.01c cxr1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC23E6.01c cxr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23E6.01c cxr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC23E6.02 rrp2 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23E6.02 rrp2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC23E6.03c nta1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC23E6.03c nta1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23E6.04c utp10 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23E6.04c utp10 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC23E6.04c utp10 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23E6.04c utp10 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23E6.05 arx1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23E6.05 arx1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23E6.05 arx1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC23E6.05 arx1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC23E6.05 arx1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC23E6.05 arx1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC23E6.05 arx1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC23E6.05 arx1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23E6.05 arx1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23E6.06c rib3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC23E6.06c rib3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23E6.06c rib3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC23E6.07c rfc1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23E6.09 ssn6 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC23E6.09 ssn6 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC23E6.09 ssn6 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC23E6.09 ssn6 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC23E6.09 ssn6 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC23E6.09 ssn6 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23E6.09 ssn6 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23E6.09 ssn6 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC23E6.10c mri1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23E6.10c mri1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC23E6.10c mri1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC23E6.10c mri1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23G7.04c nif1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23G7.05 sui1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC23G7.06c nvj2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC23G7.06c nvj2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23G7.06c nvj2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC23G7.06c nvj2 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23G7.06c nvj2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC23G7.06c nvj2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC23G7.06c nvj2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC23G7.06c nvj2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC23G7.06c nvj2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC23G7.06c nvj2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23G7.06c nvj2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC23G7.06c nvj2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23G7.06c nvj2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC23G7.06c nvj2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23G7.06c nvj2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC23G7.07c cms1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23G7.07c cms1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC23G7.07c cms1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23G7.09 mat1-Mc RNA RNA protection assay evidence increased during(GO:0006995) PMID:2900761 4896 2014-06-18 SPBC23G7.09 mat1-Mc RNA expression microarray evidence increased during(GO:0042149) PMID:34460892 4896 2021-09-20 SPBC23G7.09 mat1-Mc RNA RNA protection assay evidence present during(GO:0072690) PMID:2900761 4896 2014-06-18 SPBC23G7.10c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC23G7.10c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC23G7.10c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC23G7.10c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC23G7.10c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC23G7.10c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC23G7.10c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC23G7.10c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23G7.10c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC23G7.10c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC23G7.10c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC23G7.11 mag2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC23G7.11 mag2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC23G7.11 mag2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC23G7.11 mag2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC23G7.11 mag2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC23G7.11 mag2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC23G7.11 mag2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC23G7.11 mag2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC23G7.11 mag2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC23G7.11 mag2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23G7.12c rpt6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23G7.12c rpt6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23G7.13c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC23G7.13c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23G7.13c RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPBC23G7.13c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23G7.13c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23G7.13c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC23G7.14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC23G7.14 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23G7.14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC23G7.15c rpp202 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC23G7.15c rpp202 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23G7.15c rpp202 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC23G7.15c rpp202 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC23G7.16 ctr6 protein western blot evidence used in manual assertion decreased during(GO:0071280) PMID:12244050 4896 2014-04-03 SPBC23G7.16 ctr6 protein western blot evidence used in manual assertion increased during(GO:0035874) PMID:12244050 4896 2014-04-03 SPBC23G7.16 ctr6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC23G7.16 ctr6 RNA northern assay evidence used in manual assertion decreased during(GO:0071280) PMID:12244050 4896 2014-04-03 SPBC23G7.16 ctr6 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:12244050 4896 2014-04-03 SPBC23G7.16 ctr6 RNA northern assay evidence used in manual assertion increased during(GO:0098762) PMID:24569997 4896 2017-09-14 SPBC23G7.16 ctr6 RNA northern assay evidence used in manual assertion increased during(GO:0072690) PMID:28572514 4896 2017-09-16 SPBC23G7.16 ctr6 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:28572514 4896 2017-09-16 SPBC23G7.16 ctr6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC23G7.16 ctr6 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC23G7.16 ctr6 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC23G7.16 ctr6 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC23G7.16 ctr6 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12244050 4896 2014-04-03 SPBC23G7.17c mat1-Mi RNA RNA protection assay evidence absent during(GO:0072690) PMID:2900761 4896 2014-06-18 SPBC23G7.17c mat1-Mi RNA northern assay evidence used in manual assertion increased during(GO:0071444) PMID:7651414 4896 2012-02-24 SPBC23G7.17c mat1-Mi RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:7651414 4896 2012-02-24 SPBC23G7.17c mat1-Mi RNA expression microarray evidence increased during(GO:0071444) PMID:16615890 4896 2014-07-14 SPBC23G7.17c mat1-Mi RNA expression microarray evidence increased during(GO:0006995) PMID:16615890 4896 2014-07-14 SPBC23G7.17c mat1-Mi RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC23G7.17c mat1-Mi RNA RNA protection assay evidence present during(GO:0006995) PMID:2900761 4896 2014-06-18 SPBC244.01c sid4 protein Western blot evidence decreased during(GO:0098765) PMID:24838944 4896 2025-04-16 (Fig. 4C) SPBC244.02c utp6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC244.02c utp6 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC244.02c utp6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC244.02c utp6 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC244.02c utp6 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC24C6.02 spb4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC24C6.02 spb4 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC24C6.02 spb4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC24C6.02 spb4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC24C6.02 spb4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC24C6.02 spb4 RNA RNA-sequencing evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC24C6.03 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC24C6.04 put2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC24C6.04 put2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC24C6.04 put2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC24C6.06 gpa1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC24C6.06 gpa1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC24C6.06 gpa1 RNA western blot evidence used in manual assertion increased during(GO:0006995) PMID:1905818 4896 2013-02-01 SPBC24C6.06 gpa1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC24C6.06 gpa1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC24C6.09c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC24C6.09c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC24C6.09c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC24C6.09c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC24C6.09c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC24C6.09c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC24C6.09c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC24C6.09c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC24C6.09c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC24C6.09c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC24C6.09c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC24C6.09c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC24C6.09c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC24C6.09c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC24C6.09c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC24C6.09c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC24C6.09c RNA expression microarray evidence increased in presence of(CHEBI:69136) PMID:38415071 4896 2024-10-09 SPBC24C6.10c dip1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC24C6.10c dip1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC24C6.10c dip1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC24C6.10c dip1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC24C6.11 cwf14 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC25B2.01 hbs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC25B2.01 hbs1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC25B2.01 hbs1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC25B2.02c mam1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25B2.02c mam1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC25B2.02c mam1 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0006995) PMID:9191268 4896 2012-01-30 SPBC25B2.02c mam1 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0000749) PMID:9191268 4896 2012-01-30 SPBC25B2.02c mam1 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0006995) PMID:9236781 4896 2012-02-15 SPBC25B2.02c mam1 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0000749) PMID:9236781 4896 2012-02-15 SPBC25B2.02c mam1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC25B2.03 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC25B2.03 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC25B2.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC25B2.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC25B2.03 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC25B2.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC25B2.03 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC25B2.05 mis3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25B2.05 mis3 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC25B2.05 mis3 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC25B2.05 mis3 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC25B2.05 mis3 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC25B2.05 mis3 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC25B2.05 mis3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC25B2.05 mis3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC25B2.05 mis3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC25B2.06c btb2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25B2.06c btb2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC25B2.07c mmb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25B2.07c mmb1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC25B2.07c mmb1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC25B2.08 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC25B2.08 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25B2.08 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC25B2.08 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC25B2.08 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC25B2.09c msr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC25B2.09c msr1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC25B2.09c msr1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC25B2.09c msr1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC25B2.09c msr1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC25B2.09c msr1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC25B2.09c msr1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC25B2.10 cru1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25B2.10 cru1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC25B2.10 cru1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC25B2.11 pof2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25D12.02c dnt1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:22809626 4896 2013-12-03 SPBC25D12.03c mcm7 protein western blot evidence used in manual assertion absent during(GO:0006995) PMID:11606526 4896 2012-09-11 SPBC25D12.03c mcm7 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:11854402 4896 2015-06-12 SPBC25D12.03c mcm7 protein western blot evidence used in manual assertion decreased during(GO:0045023) PMID:16899242 4896 2014-11-06 SPBC25D12.03c mcm7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25D12.03c mcm7 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC25D12.04 suc22 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC25D12.04 suc22 RNA northern assay evidence used in manual assertion increased during(GO:0044843) PMID:8842148 4896 2014-06-23 SPBC25D12.04 suc22 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:16907) PMID:8842148 4896 2014-06-23 SPBC25D12.04 suc22 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8842148 4896 2014-06-23 SPBC25D12.04 suc22 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC25D12.04 suc22 RNA Northern assay evidence increased during(GO:0072711) PMID:12062100 4896 2021-09-24 SPBC25D12.05 trm1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25D12.05 trm1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC25D12.06 mrh5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC25D12.06 mrh5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC25H2.02 trs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25H2.02 trs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC25H2.03 vac14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25H2.04c tim22 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC25H2.04c tim22 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC25H2.04c tim22 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC25H2.05 egd2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25H2.05 egd2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC25H2.05 egd2 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC25H2.05 egd2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC25H2.05 egd2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC25H2.07 tif11 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC25H2.07 tif11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25H2.07 tif11 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC25H2.07 tif11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC25H2.07 tif11 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC25H2.08c mrs2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC25H2.09 mic19 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC25H2.09 mic19 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC25H2.11c spt7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC25H2.12c cct7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25H2.12c cct7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC25H2.13c cdc20 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:9605404 4896 2015-03-19 SPBC25H2.13c cdc20 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC25H2.14 mug16 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC25H2.14 mug16 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC25H2.14 mug16 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC25H2.15 tsr401 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC26H8.01 thi2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC26H8.01 thi2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC26H8.01 thi2 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC26H8.01 thi2 RNA northern assay evidence used in manual assertion absent during(GO:0071301) PMID:1644306 4896 2015-01-07 SPBC26H8.01 thi2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC26H8.01 thi2 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC26H8.02c sec9 protein microscopy evidence increased during(GO:0098762) PMID:23709180 4896 2026-05-27 In contrast, Sec9 protein levels increased in a manner similar to that of sec9 transcript levels (Fig. 1B and C). SPBC26H8.02c sec9 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC26H8.02c sec9 RNA Northern assay evidence increased during(GO:0007136) PMID:16272747 4896 2023-12-11 The level of sec9 mRNA began to increase about 6 hr after induction and peaked at about 9 hr, when cells were in early meiosis II (Fig. 2A, 2B). SPBC26H8.03 cho2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC26H8.03 cho2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC26H8.03 cho2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC26H8.03 cho2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC26H8.04c iml1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC26H8.05c pph3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC26H8.05c pph3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC26H8.06 grx4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC26H8.06 grx4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC26H8.06 grx4 protein reporter gene assay evidence increased during(GO:0071275) PMID:16175211 4896 2014-11-06 SPBC26H8.06 grx4 protein reporter gene assay evidence increased during(GO:0071732) PMID:16175211 4896 2014-11-06 SPBC26H8.06 grx4 protein reporter gene assay evidence increased during(GO:0042149) PMID:16175211 4896 2014-11-06 SPBC26H8.06 grx4 protein reporter gene assay evidence increased during(GO:0071276) PMID:16175211 4896 2014-11-06 SPBC26H8.06 grx4 protein reporter gene assay evidence increased during(GO:0070301) PMID:16175211 4896 2014-11-06 SPBC26H8.06 grx4 protein reporter gene assay evidence increased during(GO:0071472) PMID:16175211 4896 2014-11-06 SPBC26H8.06 grx4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC26H8.06 grx4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC26H8.07c nda3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC26H8.08c grn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC26H8.08c grn1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC26H8.08c grn1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC26H8.08c grn1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC26H8.09c snf59 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC26H8.11c the4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC26H8.11c the4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC26H8.11c the4 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC26H8.11c the4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC26H8.12 cyc3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC26H8.12 cyc3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC26H8.13c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC26H8.14c cox17 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC26H8.16 sdh8 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC27.02c ask1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC27.03 meu25 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC27.03 meu25 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC27.03 meu25 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPBC27.03 meu25 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC27.04 uds1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC27.04 uds1 protein mass spectrometry evidence fluctuates during(GO:0000278) PMID:24763107 4896 2014-05-01 SPBC27.04 uds1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC27.04 uds1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC27.04 uds1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC27.05 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC27.05 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC27.06c mgr2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC27.08c sua1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC27.08c sua1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC27.08c sua1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC27.08c sua1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC27.08c sua1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC27.08c sua1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC27B12.01c mmm1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC27B12.01c mmm1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC27B12.03c erg32 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC27B12.03c erg32 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC27B12.03c erg32 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC27B12.05 crt10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC27B12.05 crt10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC27B12.06 gpi13 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC27B12.06 gpi13 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC27B12.09c flx1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC27B12.11c pho7 protein Western blot evidence unchanged during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC27B12.11c pho7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC27B12.11c pho7 RNA expression microarray evidence unchanged during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC27B12.12c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC27B12.12c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC27B12.12c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC27B12.13 tom40 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC27B12.13 tom40 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC28E12.01c apc13 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:12477395 4896 2014-07-21 SPBC28E12.01c apc13 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC28E12.01c apc13 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBC28E12.02 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC28E12.02 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC28E12.02 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC28E12.03 rga4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC28E12.04 cbp7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC28E12.04 cbp7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC28E12.04 cbp7 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC28E12.05 esf2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC28E12.05 esf2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC28E12.05 esf2 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPBC28E12.06c lvs1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC28E12.06c lvs1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC28F2.03 ppi1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC28F2.05c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC28F2.05c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC28F2.07 sfr1 protein Western blot evidence increased during(GO:0007128) PMID:39174851 4896 2024-09-25 EGFP-Sfr1 protein was clearly detected from the end of S-phase (2.5 h after meiotic induction) to the entry into the first chromosome segregation (meiosis I, 4.5 h), with the highest levels during meiotic prophase (Fig. 1A). SPBC28F2.07 sfr1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC28F2.09 toa1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC28F2.11 hmo1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC28F2.12 rpb1 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPBC28F2.12 rpb1 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPBC28F2.12 rpb1 protein western blot evidence used in manual assertion unchanged during(GO:0034605) PMID:11918671 4896 2015-11-26 SPBC28F2.12 rpb1 protein microscopy evidence unchanged during(GO:0000278) PMID:32059768 4896 2021-03-31 SPBC28F2.12 rpb1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPBC28F2.12 rpb1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC28F2.12 rpb1 RNA in situ hybridization evidence used in manual assertion unchanged during(GO:0000085) PMID:28479325 4896 2022-01-31 SPBC29A10.01 ccr1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC29A10.01 ccr1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A10.02 spo5 protein western blot evidence used in manual assertion absent during(GO:0007138) PMID:16896214 4896 2014-07-17 SPBC29A10.02 spo5 protein western blot evidence used in manual assertion decreased during(GO:0007136) PMID:16896214 4896 2014-07-17 SPBC29A10.02 spo5 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC29A10.02 spo5 protein western blot evidence used in manual assertion increased during(GO:0007128) PMID:16896214 4896 2014-07-17 SPBC29A10.02 spo5 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC29A10.02 spo5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A10.02 spo5 protein western blot evidence used in manual assertion present during(GO:0007132) PMID:16896214 4896 2014-07-17 SPBC29A10.02 spo5 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:16823445 4896 2014-01-09 SPBC29A10.02 spo5 RNA northern assay evidence used in manual assertion increased during(GO:0007127) PMID:16896214 4896 2014-07-17 SPBC29A10.02 spo5 RNA quantitative PCR increased during(GO:0007127) PMID:16896214 4896 2014-07-17 SPBC29A10.02 spo5 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC29A10.02 spo5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A10.03c pcf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A10.04 psm1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC29A10.05 exo1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29A10.05 exo1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC29A10.07 pom152 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29A10.08 gas2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A10.08 gas2 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPBC29A10.08 gas2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A10.08 gas2 RNA quantitative PCR decreased in presence of(CHEBI:29699) PMID:38360270 4896 2024-03-14 SPBC29A10.08 gas2 RNA northern assay evidence used in manual assertion fluctuates during(GO:0000278) PMID:21124977 4896 2015-12-15 SPBC29A10.08 gas2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29A10.08 gas2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC29A10.09c tri1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A10.10c dbl8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A10.11c muk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC29A10.12 oxs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29A10.13 atp7 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC29A10.14 rec8 protein western blot evidence used in manual assertion absent during(GO:0000278) PMID:10440376 4896 2014-07-29 SPBC29A10.14 rec8 protein western blot evidence used in manual assertion absent during(GO:0007138) PMID:10440376 4896 2014-07-29 SPBC29A10.14 rec8 protein western blot evidence used in manual assertion absent during(GO:0072690) PMID:14532136 4896 2014-07-30 SPBC29A10.14 rec8 protein western blot evidence used in manual assertion decreased during(GO:0007135) PMID:10440376 4896 2014-07-29 SPBC29A10.14 rec8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A10.14 rec8 protein western blot evidence used in manual assertion present during(GO:0051332) PMID:10440376 4896 2014-07-29 SPBC29A10.14 rec8 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:10440376 4896 2014-07-29 SPBC29A10.14 rec8 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:14532136 4896 2014-07-30 SPBC29A10.14 rec8 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:14648198 4896 2019-08-07 SPBC29A10.14 rec8 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:16823445 4896 2014-01-09 SPBC29A10.14 rec8 RNA expression microarray evidence increased during(GO:0071444) PMID:16615890 4896 2014-07-14 SPBC29A10.14 rec8 RNA expression microarray evidence increased during(GO:0006995) PMID:16615890 4896 2014-07-14 SPBC29A10.14 rec8 RNA Northern assay evidence increased during(GO:0051321) PMID:9671035 4896 2019-11-07 SPBC29A10.14 rec8 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC29A10.14 rec8 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A10.14 rec8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC29A10.14 rec8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29A10.14 rec8 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC29A10.14 rec8 RNA northern assay evidence used in manual assertion present during(GO:0007127) PMID:1339382 4896 2013-08-12 SPBC29A10.15 orc1 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:10888871 4896 2010-09-03 SPBC29A10.15 orc1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC29A10.15 orc1 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:10888871 4896 2010-09-03 SPBC29A10.15 orc1 RNA Northern assay evidence constant during(GO:0000278) PMID:8618924 4896 2021-01-22 SPBC29A10.16c cyb502 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC29A10.17 lam1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC29A3.01 ccc2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC29A3.01 ccc2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29A3.02c his7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A3.03c gid2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A3.03c gid2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC29A3.03c gid2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29A3.03c gid2 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBC29A3.04 rpl8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A3.04 rpl8 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC29A3.04 rpl8 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC29A3.04 rpl8 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A3.04 rpl8 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC29A3.06 utp18 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A3.06 utp18 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC29A3.06 utp18 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC29A3.06 utp18 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC29A3.06 utp18 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC29A3.06 utp18 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC29A3.06 utp18 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC29A3.06 utp18 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29A3.08 pof4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29A3.08 pof4 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC29A3.08 pof4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A3.08 pof4 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC29A3.09c gcn20 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A3.10c atp14 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29A3.10c atp14 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC29A3.11c ort1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A3.11c ort1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29A3.11c ort1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29A3.11c ort1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC29A3.12 rps902 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC29A3.12 rps902 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A3.13 pdp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29A3.15c rsm23 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC29A3.15c rsm23 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29A3.16 rrs1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC29A3.16 rrs1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC29A3.16 rrs1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC29A3.16 rrs1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC29A3.16 rrs1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC29A3.16 rrs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29A3.16 rrs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29A3.16 rrs1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC29A3.16 rrs1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29A3.18 cyt1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC29A3.18 cyt1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29A3.18 cyt1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC29A3.18 cyt1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPBC29A3.18 cyt1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29B5.01 atf1 protein western blot evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2014-03-18 SPBC29B5.01 atf1 protein immunofluorescence evidence increased during(GO:0071472) PMID:9585506 4896 2014-11-21 SPBC29B5.01 atf1 protein reporter gene assay evidence increased during(GO:0071500) PMID:19940942 4896 2014-12-03 SPBC29B5.01 atf1 protein reporter gene assay evidence increased during(GO:0006995) PMID:19940942 4896 2014-12-03 SPBC29B5.01 atf1 protein reporter gene assay evidence increased during(GO:0042149) PMID:19940942 4896 2014-12-03 SPBC29B5.01 atf1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:8824587 4896 2014-02-26 SPBC29B5.01 atf1 protein immunofluorescence evidence present during(GO:0072690) PMID:9585506 4896 2014-11-21 SPBC29B5.01 atf1 RNA quantitative PCR decreased during(GO:1905308) PMID:26108447 4896 2016-07-06 SPBC29B5.01 atf1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:8824587 4896 2014-02-26 SPBC29B5.01 atf1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2014-03-18 SPBC29B5.01 atf1 RNA quantitative PCR increased during(GO:0070301) PMID:17612531 4896 2014-08-14 SPBC29B5.01 atf1 RNA quantitative PCR increased during(GO:0071500) PMID:19940942 4896 2014-12-03 SPBC29B5.01 atf1 RNA quantitative PCR increased during(GO:0006995) PMID:19940942 4896 2014-12-03 SPBC29B5.01 atf1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC29B5.01 atf1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC29B5.01 atf1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC29B5.01 atf1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC29B5.01 atf1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC29B5.01 atf1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29B5.01 atf1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC29B5.01 atf1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC29B5.01 atf1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC29B5.01 atf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29B5.01 atf1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC29B5.01 atf1 RNA quantitative PCR unchanged during(GO:0006995) PMID:8557039 4896 2015-01-07 SPBC29B5.01 atf1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8824587 4896 2014-02-26 SPBC29B5.01 atf1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23874237 4896 2014-03-18 SPBC29B5.01 atf1 RNA quantitative PCR present during(GO:0072690) PMID:19940942 4896 2014-12-03 SPBC29B5.01 atf1 RNA quantitative PCR present during(GO:0072690) PMID:8557039 4896 2015-01-07 SPBC29B5.02c isp4 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC29B5.02c isp4 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC29B5.02c isp4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC29B5.02c isp4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29B5.02c isp4 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC29B5.02c isp4 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:7954893 4896 2014-05-08 SPBC29B5.02c isp4 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC29B5.02c isp4 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC29B5.02c isp4 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC29B5.02c isp4 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC29B5.02c isp4 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC29B5.02c isp4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29B5.02c isp4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC29B5.02c isp4 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPBC29B5.02c isp4 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC29B5.02c isp4 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:7954893 4896 2014-05-08 SPBC29B5.02c isp4 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC29B5.02c isp4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29B5.03c rpl26 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29B5.03c rpl26 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC29B5.03c rpl26 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC29B5.03c rpl26 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC29B5.03c rpl26 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC29B5.03c rpl26 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC29B5.03c rpl26 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC29B5.04c app1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC29B5.04c app1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2A9.02 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2A9.02 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2A9.02 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC2A9.02 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC2A9.02 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC2A9.02 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC2A9.02 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC2A9.02 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2A9.02 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC2A9.02 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC2A9.02 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2A9.02 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC2A9.02 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2A9.02 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC2A9.04c san1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2A9.04c san1 protein western blot evidence used in manual assertion unchanged during(GO:0034605) PMID:21324894 4896 2012-03-13 SPBC2A9.04c san1 protein western blot evidence used in manual assertion unchanged during(GO:0000084) PMID:21324894 4896 2012-03-13 SPBC2A9.04c san1 protein western blot evidence used in manual assertion unchanged during(GO:0000085) PMID:21324894 4896 2012-03-13 SPBC2A9.04c san1 protein western blot evidence used in manual assertion unchanged during(GO:0000087) PMID:21324894 4896 2012-03-13 SPBC2A9.04c san1 protein western blot evidence used in manual assertion unchanged during(GO:0000080) PMID:21324894 4896 2012-03-13 SPBC2A9.04c san1 protein western blot evidence used in manual assertion unchanged during(GO:0000281) PMID:21324894 4896 2012-03-13 SPBC2A9.04c san1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:21324894 4896 2012-03-13 SPBC2A9.04c san1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2A9.04c san1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2A9.04c san1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC2A9.04c san1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2A9.07c hpz1 protein western blot evidence used in manual assertion decreased during(GO:0000084) PMID:22970243 4896 2014-07-01 SPBC2A9.07c hpz1 protein western blot evidence used in manual assertion increased during(GO:0000092) PMID:22970243 4896 2014-07-01 SPBC2A9.07c hpz1 protein western blot evidence used in manual assertion present during(GO:0000080) PMID:22970243 4896 2014-07-01 SPBC2A9.08c sec22 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2A9.10 bmc1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2D10.03c ess1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2D10.04 aly2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2D10.04 aly2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2D10.05 exg3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC2D10.05 exg3 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC2D10.05 exg3 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC2D10.05 exg3 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC2D10.05 exg3 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC2D10.05 exg3 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC2D10.05 exg3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC2D10.05 exg3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2D10.05 exg3 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC2D10.05 exg3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2D10.05 exg3 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC2D10.05 exg3 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:20852022 4896 2015-08-28 SPBC2D10.06 rep1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2D10.06 rep1 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:14648198 4896 2019-08-07 SPBC2D10.06 rep1 RNA Northern assay evidence increased during(GO:0051321) PMID:9671035 4896 2019-11-07 SPBC2D10.06 rep1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC2D10.06 rep1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC2D10.08c yml6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2D10.09 snr1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2D10.09 snr1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC2D10.10c fib1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2D10.10c fib1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2D10.10c fib1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2D10.10c fib1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC2D10.10c fib1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2D10.10c fib1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2D10.11c nap2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2D10.12 rhp23 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2D10.12 rhp23 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC2D10.13 est1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2D10.13 est1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2D10.14c myo51 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2D10.14c myo51 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC2D10.15c pth1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2D10.15c pth1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2D10.18 coq8 protein Western blot evidence decreased in presence of(CHEBI:30746) PMID:33232355 4896 2021-01-10 SPBC2D10.18 coq8 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2D10.19c alb1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2D10.19c alb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2D10.19c alb1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2D10.19c alb1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2D10.20 ubc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2D10.20 ubc1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2F12.02c mrpl7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2F12.02c mrpl7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2F12.04 rpl1701 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2F12.04 rpl1701 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2F12.04 rpl1701 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2F12.04 rpl1701 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2F12.04 rpl1701 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC2F12.04 rpl1701 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC2F12.05c osh2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2F12.05c osh2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2F12.07c rpl802 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2F12.07c rpl802 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2F12.09c atf21 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2F12.09c atf21 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC2F12.09c atf21 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071474) PMID:22910366 4896 2013-04-24 SPBC2F12.09c atf21 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC2F12.09c atf21 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC2F12.09c atf21 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC2F12.09c atf21 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2F12.09c atf21 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2F12.09c atf21 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC2F12.09c atf21 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC2F12.09c atf21 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC2F12.09c atf21 RNA quantitative PCR increased during(GO:0010438) PMID:39105351 4896 2024-10-01 SPBC2F12.09c atf21 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0071476) PMID:22910366 4896 2013-04-24 SPBC2F12.10 mrpl35 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2F12.10 mrpl35 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2F12.11c rep2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2F12.11c rep2 RNA northern assay evidence used in manual assertion decreased during(GO:0006995) PMID:7588609 4896 2013-03-13 SPBC2F12.11c rep2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2F12.11c rep2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC2F12.11c rep2 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:51143) PMID:7588609 4896 2013-03-13 SPBC2F12.12c cay1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2F12.13 klp5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC2F12.14c gua1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2F12.14c gua1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2F12.14c gua1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC2F12.14c gua1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2F12.14c gua1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC2F12.14c gua1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2F12.14c gua1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2F12.14c gua1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2F12.15c pfa3 protein western blot evidence used in manual assertion constant during(GO:0051321) PMID:23843742 4896 2013-08-08 SPBC2F12.15c pfa3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2F12.15c pfa3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2F12.15c pfa3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC2F12.15c pfa3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2F12.15c pfa3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2F12.17 cox7 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2F12.17 cox7 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2F12.17 cox7 RNA quantitative PCR decreased in presence of(CHEBI:142517) PMID:35416247 4896 2022-07-04 SPBC2G2.01c liz1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2G2.01c liz1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC2G2.01c liz1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC2G2.01c liz1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2G2.01c liz1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC2G2.02 syj1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2G2.03c sbh1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC2G2.04c mmf1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2G2.04c mmf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G2.04c mmf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2G2.04c mmf1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC2G2.04c mmf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2G2.05 rpl1603 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2G2.05 rpl1603 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G2.05 rpl1603 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2G2.05 rpl1603 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC2G2.06c apl1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G2.06c apl1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2G2.07c mug178 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G2.07c mug178 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC2G2.07c mug178 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2G2.08 ade9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G2.08 ade9 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC2G2.08 ade9 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC2G2.08 ade9 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC2G2.08 ade9 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC2G2.08 ade9 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC2G2.08 ade9 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2G2.08 ade9 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2G2.09c crs1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G2.09c crs1 protein Western blot evidence increased during(GO:0007128) PMID:34067465 4896 2024-09-26 (Fig. 1C) SPBC2G2.09c crs1 protein Western blot evidence increased during(GO:0051332) PMID:34067465 4896 2024-10-09 (Fig. 1C) SPBC2G2.09c crs1 protein Western blot evidence increased during(GO:0098764) PMID:34067465 4896 2024-10-09 (Fig. 1C) SPBC2G2.09c crs1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC2G2.09c crs1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2G2.10c mug110 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC2G2.10c mug110 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC2G2.11 myr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G2.12 hrs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G2.12 hrs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2G2.12 hrs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2G2.13c dcd1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2G2.14 csi1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC2G2.15c mrm2 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPBC2G2.16 mpi1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC2G2.17c psu2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC2G2.17c psu2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2G2.17c psu2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2G2.17c psu2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC2G2.17c psu2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2G5.01 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2G5.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2G5.01 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2G5.03 ctu1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC2G5.03 ctu1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2G5.03 ctu1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC2G5.03 ctu1 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPBC2G5.06c hmt2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC2G5.06c hmt2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC2G5.06c hmt2 RNA northern assay evidence used in manual assertion increased during(GO:0071276) PMID:10224084 4896 2012-08-15 SPBC2G5.06c hmt2 RNA expression microarray evidence increased during(GO:0071276) PMID:18637840 4896 2012-09-11 SPBC2G5.06c hmt2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC2G5.06c hmt2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC2G5.06c hmt2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC2G5.06c hmt2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10224084 4896 2012-08-15 SPBC2G5.07c rpc25 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC30B4.06c ips1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30B4.06c ips1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC30B4.08 eri1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC30B4.09 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC30B4.09 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC30B4.09 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC30B4.09 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC30B4.09 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC30B4.09 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC30B4.09 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC30B4.09 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC30D10.02 ncb2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC30D10.03c isn1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC30D10.05c nre1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC30D10.06 lsm4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.07c bpl1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC30D10.07c bpl1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC30D10.07c bpl1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC30D10.08 mgm101 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.08 mgm101 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC30D10.08 mgm101 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC30D10.09c hva22 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC30D10.09c hva22 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.09c hva22 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC30D10.11 gpi1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.11 gpi1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC30D10.11 gpi1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC30D10.12c rsm27 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.13c pdb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.13c pdb1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC30D10.13c pdb1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC30D10.14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.14 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC30D10.14 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC30D10.14 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC30D10.14 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC30D10.14 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC30D10.14 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC30D10.14 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC30D10.14 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC30D10.14 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC30D10.14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC30D10.14 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC30D10.14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC30D10.14 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC30D10.15 naf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.15 naf1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC30D10.15 naf1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC30D10.16 pha2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC30D10.16 pha2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC30D10.17c smi1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC30D10.17c smi1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC30D10.18c rpl102 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC30D10.18c rpl102 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC30D10.18c rpl102 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC30D10.18c rpl102 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC317.01 mbx2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC317.01 mbx2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC317.01 mbx2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC31A8.01c rtn1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC31A8.01c rtn1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC31A8.01c rtn1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC31A8.01c rtn1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8873452 4896 2013-02-01 SPBC31A8.02 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC31E1.01c atg2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC31E1.02c pmr1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC31E1.02c pmr1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC31E1.02c pmr1 RNA Northern assay evidence increased during(GO:0071277) PMID:14723709 4896 2020-01-22 SPBC31E1.03 hub1 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPBC31E1.04 pep12 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC31E1.06 bms1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC31F10.02 the13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC31F10.03 ggg1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC31F10.03 ggg1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC31F10.05 mug37 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC31F10.05 mug37 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC31F10.05 mug37 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC31F10.05 mug37 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC31F10.06c sar1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC31F10.08 mde2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC31F10.08 mde2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC31F10.09c med10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC31F10.10c mub1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC31F10.10c mub1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC31F10.10c mub1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC31F10.14c hip3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC31F10.14c hip3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC31F10.16 bch1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC31F10.16 bch1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC31F10.17c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32C12.02 ste11 protein western blot evidence used in manual assertion increased during(GO:0006995) PMID:22375066 4896 2015-02-19 SPBC32C12.02 ste11 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC32C12.02 ste11 protein Western blot evidence increased during(GO:0006995) PMID:37788281 4896 2023-12-13 SPBC32C12.02 ste11 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:22375066 4896 2015-02-19 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion absent during(GO:0071320) PMID:1657709 4896 2013-02-19 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion decreased during(GO:0071320) PMID:9560432 4896 2012-05-17 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion decreased during(GO:0071320) PMID:9829945 4896 2013-09-20 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion decreased in presence of(CHEBI:29014) PMID:12827445 4896 2013-09-20 SPBC32C12.02 ste11 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC32C12.02 ste11 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC32C12.02 ste11 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC32C12.02 ste11 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:9560432 4896 2012-05-17 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:10467002 4896 2012-06-14 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:14745200 4896 2013-01-17 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:1657709 4896 2013-02-19 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion increased during(GO:0061431) PMID:9829945 4896 2013-09-20 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:8824587 4896 2014-02-26 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:22375066 4896 2015-02-19 SPBC32C12.02 ste11 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9560432 4896 2012-05-17 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:14745200 4896 2013-01-17 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:1657709 4896 2013-02-19 SPBC32C12.02 ste11 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:22375066 4896 2015-02-19 SPBC32F12.01c css1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32F12.01c css1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC32F12.01c css1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32F12.01c css1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC32F12.01c css1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC32F12.02 rec14 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:9258671 4896 2012-05-31 SPBC32F12.02 rec14 RNA Northern assay evidence increased during(GO:0051321) PMID:9671035 4896 2019-11-07 SPBC32F12.03c gpx1 protein western blot evidence used in manual assertion increased during(GO:0036227) PMID:18162174 4896 2014-10-24 SPBC32F12.03c gpx1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC32F12.03c gpx1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC32F12.03c gpx1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:18162174 4896 2014-10-24 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:10455235 4896 2012-05-31 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion increased during(GO:0072709) PMID:10455235 4896 2012-05-31 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:10455235 4896 2012-05-31 SPBC32F12.03c gpx1 RNA quantitative PCR increased in presence of(CHEBI:17306),during(GO:0042149) PMID:24224056 4896 2013-11-25 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2013-03-18 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:18162174 4896 2014-10-24 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:12221110 4896 2015-12-16 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12221110 4896 2015-12-16 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:12221110 4896 2015-12-16 SPBC32F12.03c gpx1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC32F12.03c gpx1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC32F12.03c gpx1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC32F12.03c gpx1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC32F12.03c gpx1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC32F12.03c gpx1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC32F12.03c gpx1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC32F12.03c gpx1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC32F12.03c gpx1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC32F12.03c gpx1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC32F12.03c gpx1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC32F12.03c gpx1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC32F12.03c gpx1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC32F12.03c gpx1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC32F12.03c gpx1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion unchanged in presence of(CHEBI:64090) PMID:10455235 4896 2012-05-31 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10455235 4896 2012-05-31 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23874237 4896 2013-03-18 SPBC32F12.03c gpx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:18162174 4896 2014-10-24 SPBC32F12.05c cwf12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC32F12.06 pch1 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:9115279 4896 2013-10-28 SPBC32F12.06 pch1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9115279 4896 2013-10-28 SPBC32F12.08c duo1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32F12.08c duo1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32F12.09 rum1 protein western blot evidence used in manual assertion absent during(GO:0000084) PMID:19033384 4896 2013-12-10 SPBC32F12.09 rum1 protein Western blot evidence decreased during(GO:0000084) PMID:9430640 4896 2021-05-10 (Fig. 1B) SPBC32F12.09 rum1 protein western blot evidence used in manual assertion increased during(GO:0006995) PMID:19366728 4896 2012-04-24 SPBC32F12.09 rum1 protein Western blot evidence increased during(GO:0000080) PMID:9614176 4896 2018-06-08 SPBC32F12.09 rum1 protein Western blot evidence increased during(GO:0006995) PMID:9614176 4896 2018-06-08 SPBC32F12.09 rum1 protein Western blot evidence increased during(GO:0016036) PMID:36779416 4896 2023-03-02 SPBC32F12.09 rum1 protein Western blot evidence increased during(GO:0000090) PMID:9430640 4896 2021-03-02 (Fig. 1B) SPBC32F12.09 rum1 protein western blot evidence used in manual assertion present during(GO:0000080) PMID:19033384 4896 2013-12-10 SPBC32F12.09 rum1 protein Western blot evidence present during(GO:0000080) PMID:9430640 4896 2021-03-02 (Fig. 1B) SPBC32F12.09 rum1 RNA Northern assay evidence fluctuates during(GO:0000085) PMID:9430640 4896 2021-03-02 (Fig. 1C) Peaks at the end of G2 40 min before peak of rum1 protein SPBC32F12.09 rum1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC32F12.10 pgm1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32F12.10 pgm1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC32F12.10 pgm1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC32F12.10 pgm1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC32F12.10 pgm1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32F12.10 pgm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC32F12.11 tdh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32F12.11 tdh1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC32F12.11 tdh1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC32F12.11 tdh1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC32F12.11 tdh1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC32F12.12c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32F12.12c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32F12.12c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC32H8.01c vfa1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32H8.02c nep2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC32H8.02c nep2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32H8.02c nep2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC32H8.02c nep2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC32H8.03 bem46 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC32H8.03 bem46 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC32H8.03 bem46 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC32H8.04c utp24 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC32H8.04c utp24 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC32H8.04c utp24 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC32H8.04c utp24 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32H8.05 llp1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC32H8.05 llp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32H8.05 llp1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC32H8.05 llp1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC32H8.05 llp1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC32H8.05 llp1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC32H8.05 llp1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC32H8.05 llp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC32H8.05 llp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC32H8.05 llp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC32H8.06 mug93 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32H8.06 mug93 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32H8.07 git5 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC32H8.07 git5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32H8.07 git5 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC32H8.07 git5 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC32H8.07 git5 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC32H8.07 git5 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC32H8.07 git5 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC32H8.07 git5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC32H8.07 git5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC32H8.07 git5 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC32H8.07 git5 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC32H8.07 git5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC32H8.07 git5 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC32H8.07 git5 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC32H8.07 git5 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8804400 4896 2013-02-01 SPBC32H8.08c omh5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC32H8.08c omh5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC32H8.09 wdr8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32H8.09 wdr8 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32H8.10 cdk9 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC32H8.11 mei4 protein western blot evidence used in manual assertion increased during(GO:0051332) PMID:29123917 4896 2018-02-07 SPBC32H8.11 mei4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC32H8.11 mei4 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:7498766 4896 2014-05-20 SPBC32H8.11 mei4 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:9528784 4896 2015-05-05 SPBC32H8.11 mei4 RNA northern assay evidence used in manual assertion increased during(GO:0007128) PMID:9528784 4896 2015-05-05 SPBC32H8.11 mei4 RNA northern assay evidence used in manual assertion increased during(GO:0007127) PMID:24569997 4896 2017-09-14 SPBC32H8.11 mei4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC32H8.11 mei4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC32H8.11 mei4 RNA northern assay evidence used in manual assertion present during(GO:0051321) PMID:7498766 4896 2014-05-20 SPBC32H8.12c act1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC32H8.12c act1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC32H8.13c mok12 RNA Northern assay evidence absent during(GO:0072690) PMID:16420355 4896 2020-10-21 SPBC32H8.13c mok12 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC32H8.13c mok12 RNA Northern assay evidence increased during(GO:0030437) PMID:16420355 4896 2020-10-21 SPBC336.01 fbh1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC336.02 cdh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC336.02 cdh1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC336.02 cdh1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC336.02 cdh1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC336.03 efc25 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC336.03 efc25 protein Western blot evidence unchanged during(GO:0006995) PMID:12052869 4896 2018-04-29 SPBC336.03 efc25 protein Western blot evidence present during(GO:0072690) PMID:12052869 4896 2018-04-29 SPBC336.03 efc25 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC336.03 efc25 RNA Northern assay evidence unchanged during(GO:0006995) PMID:12052869 4896 2018-04-29 SPBC336.03 efc25 RNA Northern assay evidence present during(GO:0072690) PMID:12052869 4896 2018-04-29 SPBC336.04 cdc6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC336.04 cdc6 protein western blot evidence used in manual assertion unchanged during(GO:0070301) PMID:15533944 4896 2016-03-03 SPBC336.04 cdc6 protein western blot evidence used in manual assertion unchanged during(GO:0000278) PMID:8443413 4896 2014-09-15 SPBC336.04 cdc6 RNA northern assay evidence used in manual assertion increased during(GO:0000080) PMID:1291234 4896 2013-08-13 SPBC336.04 cdc6 RNA northern assay evidence used in manual assertion increased during(GO:0000084) PMID:1291234 4896 2013-08-13 SPBC336.04 cdc6 RNA northern assay evidence used in manual assertion unchanged during(GO:0000278) PMID:8443413 4896 2014-09-15 SPBC336.05c hen1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC336.06c rnh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC336.07 sfc3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC336.07 sfc3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC336.08 spc24 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC336.10c tif512 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC336.10c tif512 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC336.10c tif512 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC336.12c cdc10 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC336.12c cdc10 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC336.12c cdc10 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC336.12c cdc10 RNA northern assay evidence used in manual assertion unchanged during(GO:0006279) PMID:14648198 4896 2019-08-07 SPBC336.12c cdc10 RNA northern assay evidence used in manual assertion unchanged during(GO:0036227) PMID:4018034 4896 2013-09-30 SPBC336.12c cdc10 RNA northern assay evidence used in manual assertion unchanged during(GO:0000084) PMID:4018034 4896 2013-09-30 SPBC336.12c cdc10 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:4018034 4896 2013-09-30 SPBC336.12c cdc10 RNA present during(GO:0000089) PMID:9755169 4896 2019-05-14 SPBC336.15 pic1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC336.15 pic1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC337.02c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC337.02c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC337.02c protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC337.02c protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC337.02c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC337.02c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC337.02c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC337.04 ppk27 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC337.05c cct8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC337.05c cct8 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC337.05c cct8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC337.05c cct8 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC337.06c cwf15 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC337.06c cwf15 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC337.07c ecm14 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC337.07c ecm14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC337.08c ubi4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC337.08c ubi4 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC337.08c ubi4 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:10623474 4896 2014-09-24 SPBC337.08c ubi4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC337.08c ubi4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC337.08c ubi4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC337.08c ubi4 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC337.08c ubi4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC337.08c ubi4 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC337.08c ubi4 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10623474 4896 2014-09-24 SPBC337.09 erg28 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC337.10c dre2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC337.10c dre2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC337.12 red5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC337.13c gtr1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC337.13c gtr1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC337.14 rpb4 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPBC337.14 rpb4 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPBC337.14 rpb4 protein western blot evidence used in manual assertion decreased during(GO:0034605) PMID:11918671 4896 2015-11-26 SPBC337.14 rpb4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC337.14 rpb4 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPBC337.15c coq7 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC337.16 cho1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC337.16 cho1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC342.01c alg6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC342.02 qrs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC342.03 gas4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC342.03 gas4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC342.03 gas4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC342.03 gas4 RNA experimental evidence present during(GO:0000080) PMID:18410286 4896 2008-04-17 SPBC342.03 gas4 RNA experimental evidence present during(GO:0034293) PMID:18410286 4896 2008-04-17 SPBC342.04 rpn1301 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC342.06c rtt109 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC354.01 gtp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC354.02c sec61 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC354.02c sec61 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC354.03 swd3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC354.03 swd3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC354.04 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC354.05c sre2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC354.06 mrps16 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC354.07c osh42 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC354.07c osh42 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC354.07c osh42 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC354.07c osh42 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC354.08c rsn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC354.08c rsn1 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPBC354.08c rsn1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC354.09c tre1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC354.09c tre1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC354.10 def1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC354.12 gpd3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC354.12 gpd3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC354.12 gpd3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC354.13 rga6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC354.14c vac8 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC354.14c vac8 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC354.15 fap1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC354.15 fap1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC354.15 fap1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC359.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC359.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC359.02 alr2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC359.02 alr2 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC359.02 alr2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC359.02 alr2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC359.02 alr2 RNA expression microarray evidence increased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPBC359.03c aat1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC359.03c aat1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC359.03c aat1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC359.03c aat1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC359.03c aat1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC359.03c aat1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC359.03c aat1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC359.03c aat1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:28938) PMID:38780300 4896 2024-09-18 (Fig. 3) SPBC359.03c aat1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPBC359.04c pfl7 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-21 SPBC359.05 abc3 protein Western blot evidence increased during(GO:0010106) PMID:19915076 4896 2019-05-27 SPBC359.05 abc3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC359.05 abc3 RNA RNA protection assay evidence increased during(GO:0010106) PMID:19915076 4896 2019-05-27 SPBC359.05 abc3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC359.06 mug14 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC359.06 mug14 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC359.06 mug14 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC359.06 mug14 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC359.06 mug14 protein Western blot evidence increased during(GO:0042149) PMID:34086083 4896 2021-06-11 SPBC359.06 mug14 protein Western blot evidence increased during(GO:0006995) PMID:34086083 4896 2021-06-16 SPBC359.06 mug14 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC359.06 mug14 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC359.06 mug14 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC359.06 mug14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC359.06 mug14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC359.06 mug14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC359.06 mug14 RNA quantitative PCR increased during(GO:0042149) PMID:34086083 4896 2021-06-10 SPBC36.01c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36.01c RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC36.01c RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC36.01c RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC36.01c RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC36.01c RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC36.01c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC36.01c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC36.01c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36.02c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC36.02c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC36.02c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC36.02c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36.02c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC36.03c mfs3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC36.03c mfs3 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC36.03c mfs3 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC36.03c mfs3 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC36.03c mfs3 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC36.03c mfs3 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC36.03c mfs3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC36.03c mfs3 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC36.03c mfs3 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC36.03c mfs3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC36.04 cys11 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC36.04 cys11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC36.04 cys11 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC36.04 cys11 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC36.04 cys11 RNA expression microarray evidence increased during(GO:0071276) PMID:18637840 4896 2012-09-11 SPBC36.04 cys11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC36.06c spo9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC36.06c spo9 RNA northern assay evidence used in manual assertion decreased during(GO:0006995) PMID:17596513 4896 2015-07-30 SPBC36.06c spo9 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC36.06c spo9 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:17596513 4896 2015-07-30 SPBC36.07 elp1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC36.07 elp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC36.07 elp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36.10 ups2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC36.10 ups2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC36.11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC36.12c git7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC36.12c git7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC365.01 csr103 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC365.01 csr103 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC365.03c rpl2101 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC365.03c rpl2101 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC365.03c rpl2101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC365.03c rpl2101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC365.03c rpl2101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC365.04c nop6 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC365.04c nop6 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC365.05c slu7 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC365.06 pmt3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC365.06 pmt3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC365.08c der1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC365.08c der1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC365.09c kin17 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC365.10 arp5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC365.11 grp2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC365.11 grp2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC365.12c ish1 protein western blot evidence used in manual assertion increased during(GO:0071472) PMID:11751918 4896 2014-10-22 SPBC365.12c ish1 protein western blot evidence used in manual assertion increased during(GO:0034605) PMID:11751918 4896 2014-10-22 SPBC365.12c ish1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC365.12c ish1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC365.12c ish1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11751918 4896 2014-10-22 SPBC365.12c ish1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC365.12c ish1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC365.12c ish1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC365.12c ish1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC365.12c ish1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC365.12c ish1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC365.12c ish1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC365.12c ish1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC365.12c ish1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC365.12c ish1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC365.12c ish1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC365.12c ish1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC365.12c ish1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC365.12c ish1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC365.12c ish1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC365.15 alp4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC365.15 alp4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC365.16 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC365.20c pnc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC365.20c pnc1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC365.20c pnc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36B7.02 svf2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC36B7.02 svf2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC36B7.02 svf2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC36B7.02 svf2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC36B7.02 svf2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC36B7.02 svf2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36B7.03 sec63 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC36B7.03 sec63 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC36B7.03 sec63 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC36B7.03 sec63 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36B7.03 sec63 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC36B7.04 dus1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC36B7.04 dus1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36B7.05c pib1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC36B7.05c pib1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC36B7.05c pib1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC36B7.06c mug20 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC36B7.06c mug20 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC36B7.08c ccp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC36B7.09 gcn2 protein western blot evidence used in manual assertion present during(GO:0070314) PMID:23687372 4896 2014-02-24 SPBC36B7.09 gcn2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC36B7.09 gcn2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC36B7.09 gcn2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC3B8.01c arh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B8.02 php5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B8.02 php5 RNA quantitative PCR increased in presence of(CHEBI:29699) PMID:38360270 4896 2024-03-14 SPBC3B8.03 lys9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B8.03 lys9 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3B8.03 lys9 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC3B8.03 lys9 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC3B8.04c plt1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3B8.05 dph1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC3B8.05 dph1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC3B8.05 dph1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC3B8.05 dph1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC3B8.05 dph1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC3B8.05 dph1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3B8.05 dph1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC3B8.05 dph1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3B8.06 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B8.06 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3B8.06 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B8.07c dsd1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3B8.07c dsd1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3B8.07c dsd1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3B8.08 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B8.09 utp3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B8.09 utp3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B8.09 utp3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3B8.09 utp3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3B8.10c nem1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B8.10c nem1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3B8.10c nem1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B8.10c nem1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3B8.10c nem1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC3B8.10c nem1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC3B9.01 fes1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3B9.01 fes1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B9.01 fes1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3B9.01 fes1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC3B9.01 fes1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC3B9.01 fes1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3B9.01 fes1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC3B9.01 fes1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3B9.02c cwf28 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3B9.04 oms1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B9.04 oms1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3B9.06c atg3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3B9.06c atg3 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3B9.06c atg3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3B9.06c atg3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3B9.06c atg3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3B9.06c atg3 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC3B9.06c atg3 RNA quantitative PCR increased during(GO:0010438) PMID:33064910 4896 2020-10-28 SPBC3B9.07c rpa43 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3B9.07c rpa43 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3B9.07c rpa43 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B9.08c mnh1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B9.10 vti1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B9.11c ctf1 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:28567704 4896 2017-11-14 SPBC3B9.11c ctf1 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:28567704 4896 2017-11-14 SPBC3B9.13c rpp102 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B9.13c rpp102 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3B9.13c rpp102 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC3B9.15c scp1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3B9.15c scp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B9.16c nup120 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B9.16c nup120 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B9.17 isa2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3B9.17 isa2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC3B9.18c vma7 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3B9.19 mge1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3B9.19 mge1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3B9.19 mge1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3B9.19 mge1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC3B9.19 mge1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC3B9.22c dad4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3D6.02 but2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC3D6.02 but2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3D6.02 but2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC3D6.03c trz2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3D6.03c trz2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3D6.05 ptp4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3D6.05 ptp4 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3D6.05 ptp4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3D6.05 ptp4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3D6.06c prs5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3D6.06c prs5 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC3D6.07 gpi3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3D6.07 gpi3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3D6.07 gpi3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3D6.08c lsm1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3D6.12 dip2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3D6.12 dip2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3D6.12 dip2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3D6.13c pdi3 protein reporter gene assay evidence increased during(GO:0006995) PMID:20204527 4896 2014-05-20 SPBC3D6.13c pdi3 protein reporter gene assay evidence increased in presence of(CHEBI:29321) PMID:20204527 4896 2014-05-20 SPBC3D6.13c pdi3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3D6.13c pdi3 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC3D6.13c pdi3 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0006995) PMID:20204527 4896 2014-05-20 SPBC3D6.13c pdi3 RNA reverse transcription polymerase chain reaction transcription evidence increased in presence of(CHEBI:29321) PMID:20204527 4896 2014-05-20 SPBC3D6.15 rps2501 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3D6.15 rps2501 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3D6.15 rps2501 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3D6.15 rps2501 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC3D6.15 rps2501 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC3E7.01 fab1 RNA quantitative PCR decreased in presence of(CHEBI:52289) PMID:31657618 4896 2023-06-21 (Fig. 3) SPBC3E7.01 fab1 RNA experimental evidence increased during(GO:0006995) 4896 SPBC3E7.02c hsp16 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3E7.02c hsp16 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3E7.02c hsp16 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3E7.02c hsp16 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3E7.02c hsp16 protein Western blot evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPBC3E7.02c hsp16 protein microscopy evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPBC3E7.02c hsp16 protein Western blot evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPBC3E7.02c hsp16 protein microscopy evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 Furthermore, we analyzed whether DIA and HU were also engaging cytoplasmic chaperones. Indeed, we found that both treatments led to an increase in the levels of Hsp70/Ssa1-YFP, Hsp16-GFP, and the disaggregase Hsp104-GFP and their accumulation in cytoplasmic foci, suggesting defective folding in this compartment (Fig 4D–4F; for results, see S1 Data). SPBC3E7.02c hsp16 protein Western blot evidence increased during(GO:0034605) PMID:38269097 4896 2024-03-26 (Figure S2) SPBC3E7.02c hsp16 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBC3E7.02c hsp16 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3E7.02c hsp16 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC3E7.02c hsp16 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC3E7.02c hsp16 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC3E7.02c hsp16 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC3E7.02c hsp16 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC3E7.02c hsp16 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC3E7.02c hsp16 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3E7.02c hsp16 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3E7.02c hsp16 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPBC3E7.02c hsp16 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPBC3E7.02c hsp16 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC3E7.04c ric8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3E7.04c ric8 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3E7.04c ric8 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3E7.04c ric8 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3E7.05c mic60 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3E7.06c fnx2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3E7.07c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3E7.07c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3E7.07c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3E7.07c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3E7.09 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3E7.10 fma1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3E7.10 fma1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3E7.12c cfh4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3E7.12c cfh4 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3E7.12c cfh4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3E7.12c cfh4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3E7.12c cfh4 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC3E7.12c cfh4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3E7.12c cfh4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC3E7.13c syf2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3E7.13c syf2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3E7.14 smf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3E7.14 smf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3E7.15c lac1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3E7.15c lac1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3E7.15c lac1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3E7.15c lac1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3E7.15c lac1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3E7.15c lac1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3E7.15c lac1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3E7.16c leu3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3E7.16c leu3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3E7.16c leu3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3E7.16c leu3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC3E7.16c leu3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3E7.16c leu3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC3E7.17 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3E7.17 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3F6.01c hpp5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3F6.03 trr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3F6.03 trr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3F6.03 trr1 protein reporter gene assay evidence increased during(GO:0036245) PMID:16554715 4896 2014-11-06 SPBC3F6.03 trr1 protein reporter gene assay evidence increased during(GO:0071288) PMID:16554715 4896 2014-11-06 SPBC3F6.03 trr1 protein reporter gene assay evidence increased during(GO:0036245) PMID:15135546 4896 2014-11-20 SPBC3F6.03 trr1 protein reporter gene assay evidence increased during(GO:0071288) PMID:15135546 4896 2014-11-20 SPBC3F6.03 trr1 protein reporter gene assay evidence increased during(GO:0070301) PMID:15135546 4896 2014-11-20 SPBC3F6.03 trr1 protein reporter gene assay evidence increased during(GO:0071275) PMID:15135546 4896 2014-11-20 SPBC3F6.03 trr1 protein reporter gene assay evidence increased during(GO:0072715) PMID:15135546 4896 2014-11-20 SPBC3F6.03 trr1 protein reporter gene assay evidence increased during(GO:0071500) PMID:22279963 4896 2014-11-28 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:9585505 4896 2012-02-29 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23115244 4896 2012-02-20 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:18758731 4896 2013-09-17 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:10348908 4896 2014-07-02 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion increased during(GO:0036245) PMID:15135546 4896 2014-11-20 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion increased during(GO:0097238) PMID:16141205 4896 2015-01-25 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:18235227 4896 2015-12-17 SPBC3F6.03 trr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC3F6.03 trr1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3F6.03 trr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9585505 4896 2012-02-29 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10348908 4896 2014-07-02 SPBC3F6.03 trr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:18235227 4896 2015-12-17 SPBC3F6.04c nop14 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3H7.01 spo14 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3H7.01 spo14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC3H7.01 spo14 RNA northern assay evidence used in manual assertion unchanged during(GO:0006995) PMID:12631727 4896 2014-10-15 SPBC3H7.01 spo14 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12631727 4896 2014-10-15 SPBC3H7.02 sul1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC3H7.02 sul1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC3H7.02 sul1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC3H7.02 sul1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC3H7.02 sul1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC3H7.02 sul1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC3H7.02 sul1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3H7.02 sul1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3H7.02 sul1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC3H7.02 sul1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC3H7.02 sul1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC3H7.02 sul1 RNA Northern assay evidence increased during(GO:0010438) PMID:34279603 4896 2021-08-03 SPBC3H7.03c kgd1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3H7.03c kgd1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3H7.03c kgd1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3H7.03c kgd1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3H7.04 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3H7.05c acn1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3H7.05c acn1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC3H7.06c pof9 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3H7.07c ser2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3H7.07c ser2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3H7.07c ser2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3H7.07c ser2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3H7.07c ser2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3H7.07c ser2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3H7.08c mra2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3H7.08c mra2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC3H7.08c mra2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC3H7.09 erf2 protein western blot evidence used in manual assertion increased during(GO:0051321) PMID:23843742 4896 2013-08-08 SPBC3H7.09 erf2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3H7.09 erf2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC3H7.09 erf2 RNA quantitative PCR increased during(GO:0051321) PMID:23843742 4896 2013-08-08 SPBC3H7.09 erf2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3H7.09 erf2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC3H7.11 trm141 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3H7.11 trm141 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3H7.11 trm141 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC3H7.11 trm141 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC3H7.13 csc1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC3H7.13 csc1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC3H7.14 mug176 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC3H7.14 mug176 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC3H7.15 hhp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC3H7.15 hhp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC3H7.15 hhp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC4.01 dni2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4.01 dni2 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC4.01 dni2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC4.01 dni2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC4.03c sfb3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4.04c mcm2 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:9658174 4896 2015-06-10 SPBC4.04c mcm2 protein western blot evidence used in manual assertion decreased during(GO:0045023) PMID:16899242 4896 2014-11-06 SPBC4.04c mcm2 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:10888871 4896 2010-09-03 SPBC4.04c mcm2 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:10888871 4896 2010-09-03 SPBC4.04c mcm2 RNA northern assay evidence used in manual assertion present during(GO:0010458) PMID:12411492 4896 2015-10-14 SPBC4.06 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4.06 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC4.06 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC4.07c rpt2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC405.01 ade1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC405.01 ade1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC405.01 ade1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC405.01 ade1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC405.01 ade1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC405.01 ade1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC405.02c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC405.02c RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC405.02c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC405.03c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC405.04c ypt7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC405.04c ypt7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC405.05 atg16 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC405.05 atg16 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC405.06 xdj1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC405.07 rpl3602 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC405.07 rpl3602 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC405.07 rpl3602 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC405.07 rpl3602 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC409.03 swi5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC409.03 swi5 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC409.04c mis12 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC409.05 skp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC409.06 uch2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC409.07c wis1 RNA expression microarray evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC409.07c wis1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC409.07c wis1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:1756736 4896 2013-02-15 SPBC409.08 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC409.08 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC409.08 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC409.08 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC409.08 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC409.10 ade7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC409.10 ade7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC409.10 ade7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC409.10 ade7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC409.10 ade7 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC409.11 meu18 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC409.11 meu18 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPBC409.11 meu18 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC409.12c stn1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC409.12c stn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC409.13 rib4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC409.13 rib4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC409.13 rib4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC409.13 rib4 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC409.13 rib4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC409.13 rib4 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC409.14c mrps17 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC409.14c mrps17 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC409.15 tsr2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC409.15 tsr2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC409.15 tsr2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC409.15 tsr2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC409.15 tsr2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC409.17c duc2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC409.17c duc2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC409.18 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC409.19c mtx1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC409.21 sec66 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC409.23 mim2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC409.23 mim2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC409.23 mim2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC409.23 mim2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC418.01c his4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC418.01c his4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC418.01c his4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC418.01c his4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC418.01c his4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC418.01c his4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC418.01c his4 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC418.02 nat1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC418.02 nat1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC428.02c eca39 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.02c eca39 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC428.02c eca39 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC428.02c eca39 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC428.02c eca39 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC428.02c eca39 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC428.03c pho4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC428.03c pho4 RNA Northern assay evidence decreased during(GO:0071301) PMID:3536917 4896 2019-10-31 SPBC428.03c pho4 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC428.03c pho4 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC428.03c pho4 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC428.03c pho4 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC428.03c pho4 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC428.03c pho4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC428.03c pho4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC428.03c pho4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC428.03c pho4 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC428.04 apq12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC428.05c arg12 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC428.05c arg12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC428.05c arg12 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC428.05c arg12 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC428.07 meu6 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC428.07 meu6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.07 meu6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC428.07 meu6 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2008-09-08 SPBC428.07 meu6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC428.08c clr4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.08c clr4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC428.10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC428.10 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.10 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC428.10 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC428.10 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC428.10 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC428.10 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC428.10 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC428.10 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC428.10 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC428.10 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC428.10 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC428.10 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC428.10 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC428.10 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC428.10 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC428.10 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC428.11 met17 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC428.11 met17 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.11 met17 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC428.11 met17 RNA northern assay evidence used in manual assertion decreased during(GO:0036346) PMID:11754480 4896 2013-09-19 SPBC428.11 met17 RNA northern assay evidence used in manual assertion decreased during(GO:0061431) PMID:11754480 4896 2013-09-19 SPBC428.11 met17 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC428.11 met17 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC428.11 met17 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC428.11 met17 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC428.12c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC428.12c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC428.13c mob1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.13c mob1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC428.14 mlg1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.14 mlg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC428.15 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.15 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC428.15 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC428.15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC428.15 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC428.16c rhb1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.16c rhb1 RNA Northern assay evidence constant during(GO:0072690) PMID:10835385 4896 2021-01-22 SPBC428.16c rhb1 RNA Northern assay evidence constant during(GO:0006995) PMID:10835385 4896 2021-01-22 SPBC428.16c rhb1 RNA Northern assay evidence constant during(GO:0071472) PMID:10835385 4896 2021-01-22 SPBC428.18 cdt1 protein western blot evidence used in manual assertion absent during(GO:0000085) PMID:11606752 4896 2019-08-07 SPBC428.18 cdt1 protein western blot evidence used in manual assertion decreased during(GO:0006974) PMID:17039252 4896 2016-01-13 SPBC428.18 cdt1 protein western blot evidence used in manual assertion decreased during(GO:0000087) PMID:17039252 4896 2016-01-13 SPBC428.18 cdt1 protein western blot evidence used in manual assertion decreased during(GO:0000080) PMID:17039252 4896 2016-01-13 SPBC428.18 cdt1 protein western blot evidence used in manual assertion decreased during(GO:0000085) PMID:17531813 4896 2017-11-19 SPBC428.18 cdt1 protein western blot evidence used in manual assertion increased during(GO:0000093) PMID:10766248 4896 2015-04-24 SPBC428.18 cdt1 protein western blot evidence used in manual assertion present during(GO:0000080) PMID:11606752 4896 2019-08-07 SPBC428.18 cdt1 RNA northern assay evidence used in manual assertion absent during(GO:0000087) PMID:8313888 4896 2014-09-18 SPBC428.18 cdt1 RNA northern assay evidence used in manual assertion absent during(GO:0000085) PMID:8313888 4896 2014-09-18 SPBC428.18 cdt1 RNA northern assay evidence used in manual assertion absent during(GO:0000086) PMID:8313888 4896 2014-09-18 SPBC428.18 cdt1 RNA northern assay evidence used in manual assertion absent during(GO:0000084) PMID:8313888 4896 2014-09-18 SPBC428.18 cdt1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC428.18 cdt1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC428.18 cdt1 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:14648198 4896 2019-08-07 SPBC428.18 cdt1 RNA experimental evidence increased during(GO:0000080) 4896 SPBC428.18 cdt1 RNA experimental evidence increased during(GO:0000084) 4896 SPBC428.18 cdt1 RNA northern assay evidence used in manual assertion present during(GO:0000080) PMID:8313888 4896 2014-09-18 SPBC428.19c utp15 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC428.19c utp15 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC428.19c utp15 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC460.01c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC460.01c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC460.02c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC460.02c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC460.03 vba2 RNA expression microarray evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC460.03 vba2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC460.03 vba2 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:20944394 4896 2012-09-24 SPBC460.04c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC460.05 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC460.05 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC460.05 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC460.05 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC460.05 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4B4.01c ptk1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4B4.01c ptk1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC4B4.04 eif21 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4B4.07c usp102 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC4B4.07c usp102 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4B4.08 ght2 protein western blot evidence used in manual assertion decreased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPBC4B4.08 ght2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4B4.08 ght2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:25411338 4896 2015-08-17 SPBC4B4.08 ght2 RNA quantitative PCR decreased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPBC4B4.08 ght2 RNA reverse transcription polymerase chain reaction transcription evidence decreased during(GO:0071281) PMID:30730059 4896 2019-11-13 SPBC4B4.08 ght2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC4B4.08 ght2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4B4.08 ght2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC4B4.08 ght2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4B4.08 ght2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC4B4.08 ght2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC4B4.10c atg5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC4B4.12c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4B4.12c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC4C3.03 thr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4C3.03 thr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4C3.03 thr1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC4C3.04c dss4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC4C3.05c nuc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4C3.05c nuc1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4C3.05c nuc1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC4C3.05c nuc1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4C3.05c nuc1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4C3.07 tif306 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4C3.07 tif306 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4C3.07 tif306 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4C3.07 tif306 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4C3.07 tif306 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC4C3.08 otg2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC4C3.08 otg2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC4C3.08 otg2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC4C3.12 sep1 protein western blot evidence used in manual assertion increased during(GO:0000087) PMID:25908789 4896 2015-08-28 SPBC4C3.12 sep1 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:15302827 4896 2015-10-20 SPBC4C3.12 sep1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC4C3.12 sep1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4C3.12 sep1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC4F6.04 rpl2502 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4F6.04 rpl2502 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC4F6.04 rpl2502 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC4F6.06 kin1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:14596912 4896 2014-08-18 SPBC4F6.06 kin1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC4F6.06 kin1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC4F6.06 kin1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC4F6.06 kin1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4F6.06 kin1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4F6.07c mak5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4F6.07c mak5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4F6.07c mak5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4F6.08c mrpl39 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4F6.09 str1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC4F6.09 str1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC4F6.09 str1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4F6.09 str1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC4F6.09 str1 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:12888492 4896 2015-06-12 SPBC4F6.09 str1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12888492 4896 2015-06-12 SPBC4F6.09 str1 RNA northern assay evidence used in manual assertion present during(GO:0071281) PMID:12888492 4896 2015-06-12 SPBC4F6.10 vps901 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC4F6.11c asn2 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4F6.12 pxl1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:18272786 4896 2018-01-31 SPBC4F6.12 pxl1 protein western blot evidence used in manual assertion decreased during(GO:0051329) PMID:18256290 4896 2014-05-13 SPBC4F6.12 pxl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4F6.12 pxl1 protein Western blot evidence fluctuates during(GO:0098763) PMID:34133210 4896 2021-07-11 (Fig. 1) SPBC4F6.12 pxl1 protein western blot evidence used in manual assertion increased during(GO:0000087) PMID:18256290 4896 2014-05-13 SPBC4F6.12 pxl1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC4F6.12 pxl1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4F6.12 pxl1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4F6.13c erb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC4F6.13c erb1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4F6.14 nop4 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4F6.14 nop4 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC4F6.14 nop4 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC4F6.14 nop4 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC4F6.14 nop4 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC4F6.14 nop4 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC4F6.14 nop4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4F6.14 nop4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4F6.16c ero11 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4F6.16c ero11 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4F6.16c ero11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4F6.17c hsp78 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC4F6.17c hsp78 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC4F6.17c hsp78 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC4F6.17c hsp78 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC4F6.17c hsp78 RNA quantitative PCR increased in presence of(CHEBI:142517) PMID:35416247 4896 2022-07-04 SPBC4F6.17c hsp78 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC4F6.18c arf1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC530.01 gyp1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC530.01 gyp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC530.02 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC530.04 mod5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC530.04 mod5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC530.07c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC530.07c RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC530.07c RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC530.09c mrl1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC530.09c mrl1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC530.10c anc1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC530.10c anc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC530.10c anc1 RNA northern assay evidence used in manual assertion decreased during(GO:0071456) PMID:10082789 4896 2012-06-14 SPBC530.10c anc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC530.10c anc1 RNA northern assay evidence used in manual assertion increased during(GO:0006071) PMID:10082789 4896 2012-06-14 SPBC530.10c anc1 RNA northern assay evidence used in manual assertion increased during(GO:0033530) PMID:10082789 4896 2012-06-14 SPBC530.10c anc1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10082789 4896 2012-06-14 SPBC530.11c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC530.11c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC530.11c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC530.11c RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPBC530.13 lsc1 protein western blot evidence used in manual assertion unchanged during(GO:0006995) PMID:22144909 4896 2015-11-04 SPBC530.13 lsc1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:22144909 4896 2015-11-04 SPBC530.14c dsk1 protein western blot evidence used in manual assertion increased during(GO:0000087) PMID:22683458 4896 2013-11-12 SPBC530.14c dsk1 protein western blot evidence used in manual assertion present during(GO:0051329) PMID:22683458 4896 2013-11-12 SPBC530.14c dsk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC530.15c shp2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC530.15c shp2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC543.02c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC543.02c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC543.02c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC543.02c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC543.03c pku80 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC543.04 npr3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC543.05c bor1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC543.06c dbp8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC543.06c dbp8 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC543.08 fit1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC543.08 fit1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC543.09 yta12 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC543.10 get1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC557.02c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC557.02c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC557.03c pim1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC557.03c pim1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC557.04 ppk29 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC557.05 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC557.05 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC557.05 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC56F2.01 pof12 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC56F2.02 rpl1901 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC56F2.02 rpl1901 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.02 rpl1901 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC56F2.02 rpl1901 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC56F2.03 arp10 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC56F2.03 arp10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC56F2.04 utp20 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC56F2.04 utp20 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.05c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC56F2.05c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC56F2.05c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.05c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC56F2.05c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC56F2.06 mug147 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC56F2.06 mug147 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC56F2.06 mug147 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC56F2.06 mug147 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC56F2.06 mug147 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC56F2.06 mug147 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC56F2.06 mug147 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC56F2.06 mug147 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC56F2.06 mug147 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC56F2.06 mug147 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC56F2.06 mug147 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC56F2.06 mug147 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC56F2.06 mug147 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC56F2.06 mug147 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.06 mug147 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC56F2.06 mug147 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC56F2.06 mug147 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC56F2.06 mug147 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC56F2.06 mug147 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC56F2.08c puf1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC56F2.08c puf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC56F2.08c puf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC56F2.08c puf1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.08c puf1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC56F2.09c arg5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC56F2.09c arg5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC56F2.09c arg5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC56F2.09c arg5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC56F2.09c arg5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC56F2.09c arg5 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC56F2.10c alg5 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.10c alg5 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC56F2.10c alg5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC56F2.11 met6 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.11 met6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC56F2.12 ilv5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC56F2.12 ilv5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC56F2.12 ilv5 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.12 ilv5 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC56F2.12 ilv5 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC56F2.12 ilv5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC56F2.12 ilv5 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC56F2.14 mrpl44 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC56F2.15 tam13 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC56F2.15 tam13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC56F2.15 tam13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC56F2.15 tam13 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC56F2.15 tam13 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC56F2.15 tam13 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC56F2.15 tam13 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC56F2.15 tam13 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC577.02 rpl3801 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC577.02 rpl3801 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC577.02 rpl3801 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC577.02 rpl3801 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC577.02 rpl3801 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC577.02 rpl3801 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC577.02 rpl3801 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC577.04 tho5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC577.05c rec27 protein western blot evidence used in manual assertion decreased during(GO:0007135) PMID:18514516 4896 2017-08-02 SPBC577.05c rec27 protein western blot evidence used in manual assertion increased during(GO:0007128) PMID:18514516 4896 2017-08-02 SPBC577.05c rec27 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC577.05c rec27 protein western blot evidence used in manual assertion present during(GO:0006279) PMID:18514516 4896 2017-08-02 SPBC577.05c rec27 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC577.06c stt4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC577.07 ubp10 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC577.08c txl1 protein reporter gene assay evidence increased during(GO:0071500) PMID:22279963 4896 2014-11-28 SPBC577.08c txl1 protein reporter gene assay evidence increased during(GO:0036245) PMID:17668038 4896 2014-12-04 SPBC577.08c txl1 protein reporter gene assay evidence increased during(GO:0070301) PMID:17668038 4896 2014-12-04 SPBC577.08c txl1 RNA quantitative PCR increased during(GO:0036245) PMID:17668038 4896 2014-12-04 SPBC577.08c txl1 RNA quantitative PCR increased during(GO:0070301) PMID:17668038 4896 2014-12-04 SPBC577.08c txl1 RNA quantitative PCR increased during(GO:0072690) PMID:17668038 4896 2014-12-04 SPBC577.08c txl1 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0034605) PMID:21091378 4896 2013-08-28 SPBC577.08c txl1 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0070301) PMID:21091378 4896 2013-08-28 SPBC577.08c txl1 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0072709) PMID:21091378 4896 2013-08-28 SPBC577.08c txl1 RNA northern assay evidence used in manual assertion unchanged during(GO:0042149) PMID:17476701 4896 2014-10-27 SPBC577.08c txl1 RNA northern assay evidence used in manual assertion unchanged during(GO:0070301) PMID:17476701 4896 2014-10-27 SPBC577.08c txl1 RNA northern assay evidence used in manual assertion unchanged during(GO:0072735) PMID:17476701 4896 2014-10-27 SPBC577.08c txl1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:21091378 4896 2013-08-28 SPBC577.08c txl1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:17476701 4896 2014-10-27 SPBC577.10 pre4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC577.10 pre4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC577.11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC577.12 dph6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC577.12 dph6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC577.12 dph6 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC577.12 dph6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC577.13 syj2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC577.13 syj2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC577.13 syj2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC577.13 syj2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC577.13 syj2 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC577.14c spa1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC582.03 cdc13 protein fusion protein localization evidence absent during(GO:0007138) PMID:15791259 4896 2015-05-06 SPBC582.03 cdc13 protein western blot evidence used in manual assertion decreased during(GO:0000080) PMID:8799851 4896 2018-11-21 SPBC582.03 cdc13 protein western blot evidence used in manual assertion decreased during(GO:0006995) PMID:19366728 4896 2012-04-24 SPBC582.03 cdc13 protein western blot evidence used in manual assertion decreased during(GO:0000090) PMID:2665944 4896 2014-02-18 SPBC582.03 cdc13 protein immunofluorescence evidence decreased during(GO:0000087) PMID:2534559 4896 2014-02-18 SPBC582.03 cdc13 protein western blot evidence used in manual assertion decreased during(GO:0044838) PMID:20133687 4896 2014-10-02 SPBC582.03 cdc13 protein fusion protein localization evidence decreased during(GO:0007133) PMID:15791259 4896 2015-05-06 SPBC582.03 cdc13 protein fusion protein localization evidence decreased during(GO:0007137) PMID:15791259 4896 2015-05-06 SPBC582.03 cdc13 protein western blot evidence used in manual assertion decreased during(GO:0098765) PMID:11493649 4896 2015-07-16 SPBC582.03 cdc13 protein western blot evidence used in manual assertion decreased during(GO:0000090) PMID:28103117 4896 2017-04-03 SPBC582.03 cdc13 protein Western blot evidence decreased during(GO:0071444) PMID:9614176 4896 2018-06-08 SPBC582.03 cdc13 protein Western blot evidence decreased during(GO:0034644) PMID:29046339 4896 2018-10-05 SPBC582.03 cdc13 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC582.03 cdc13 protein Western blot evidence decreased during(GO:0010438) PMID:40395999 4896 2025-06-09 SPBC582.03 cdc13 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:8799851 4896 2018-11-21 SPBC582.03 cdc13 protein mass spectrometry evidence fluctuates during(GO:0000278) PMID:24763107 4896 2014-05-01 SPBC582.03 cdc13 protein western blot evidence used in manual assertion increased during(GO:0000085) PMID:8799851 4896 2018-11-21 SPBC582.03 cdc13 protein immunofluorescence evidence increased during(GO:0051329) PMID:2534559 4896 2014-02-18 SPBC582.03 cdc13 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:11493649 4896 2015-07-16 SPBC582.03 cdc13 protein western blot evidence used in manual assertion increased during(GO:0098764) PMID:11493649 4896 2015-07-16 SPBC582.03 cdc13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC582.03 cdc13 protein Western blot evidence unchanged in presence of(CHEBI:49703) PMID:11460168 4896 2024-04-16 (Fig. 3B) SPBC582.03 cdc13 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:19366728 4896 2012-04-24 SPBC582.03 cdc13 protein western blot evidence used in manual assertion present during(GO:0000085) PMID:2665944 4896 2014-02-18 SPBC582.03 cdc13 protein western blot evidence used in manual assertion present during(GO:0000088) PMID:2665944 4896 2014-02-18 SPBC582.03 cdc13 protein immunofluorescence evidence present during(GO:0000080) PMID:2534559 4896 2014-02-18 SPBC582.03 cdc13 protein immunofluorescence evidence present during(GO:0000085) PMID:2534559 4896 2014-02-18 SPBC582.03 cdc13 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:20133687 4896 2014-10-02 SPBC582.03 cdc13 protein fusion protein localization evidence present during(GO:0007128) PMID:15791259 4896 2015-05-06 SPBC582.03 cdc13 protein fusion protein localization evidence present during(GO:0007132) PMID:15791259 4896 2015-05-06 SPBC582.03 cdc13 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11493649 4896 2015-07-16 SPBC582.03 cdc13 protein western blot evidence used in manual assertion present during(GO:0000085) PMID:28103117 4896 2017-04-03 SPBC582.03 cdc13 protein Western blot evidence present during(GO:0072690) PMID:9614176 4896 2018-06-08 SPBC582.03 cdc13 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC582.03 cdc13 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC582.03 cdc13 RNA transcript expression level evidence unchanged during(GO:0071444) PMID:9614176 4896 2018-06-08 SPBC582.03 cdc13 RNA transcript expression level evidence present during(GO:0072690) PMID:9614176 4896 2018-06-08 SPBC582.05c brc1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC582.06c mcp6 protein Western blot evidence decreased during(GO:0098765) PMID:24838944 4896 2025-04-16 (Fig. 7A) SPBC582.06c mcp6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC582.06c mcp6 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC582.06c mcp6 RNA experimental evidence present during(GO:0007128) PMID:15654021 4896 2006-05-17 SPBC582.07c rpn7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC582.08 alt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC582.08 alt1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC582.08 alt1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC582.08 alt1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC582.08 alt1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC582.08 alt1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC582.08 alt1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC582.09 pex11 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC582.09 pex11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC582.09 pex11 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC609.01 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC609.01 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC609.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC609.01 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC609.01 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC609.01 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC609.02 ptn1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC609.03 iqw1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC609.03 iqw1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC609.03 iqw1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC609.04 caf5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC609.04 caf5 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC609.04 caf5 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23115244 4896 2012-02-20 SPBC609.04 caf5 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC609.04 caf5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC609.04 caf5 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC609.04 caf5 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC609.04 caf5 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPBC609.04 caf5 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPBC646.02 cwf11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC646.02 cwf11 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC646.03 gta1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC646.03 gta1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC646.05c erg9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC646.06c agn2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC646.06c agn2 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:15194814 4896 2015-01-08 SPBC646.06c agn2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC646.07c tsc13 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC646.07c tsc13 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC646.07c tsc13 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC646.08c oss1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC646.09c int6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC646.09c int6 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC646.09c int6 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC646.09c int6 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC646.09c int6 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:11071923 4896 2012-11-18 SPBC646.10c nop56 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC646.10c nop56 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC646.10c nop56 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC646.10c nop56 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC646.10c nop56 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC646.11 cct6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC646.11 cct6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC646.13 sds23 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC646.13 sds23 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC646.14c orc5 protein western blot evidence used in manual assertion unchanged during(GO:0000278) PMID:10523506 4896 2014-09-15 SPBC646.14c orc5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC646.14c orc5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC646.16 scl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC646.16 scl1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC646.17c dic1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC646.17c dic1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC646.17c dic1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC649.02 rps1902 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC649.02 rps1902 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC649.02 rps1902 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC649.03 rhp14 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC649.03 rhp14 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC649.04 uvi15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC649.04 uvi15 RNA northern assay evidence used in manual assertion increased during(GO:0009267) PMID:7898433 4896 2010-03-15 SPBC649.04 uvi15 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:7898433 4896 2010-03-15 SPBC649.04 uvi15 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:609827) PMID:7898433 4896 2010-03-15 SPBC649.04 uvi15 RNA Northern assay evidence increased during(GO:0034644) PMID:8048925 4896 2019-04-27 SPBC649.04 uvi15 RNA Northern assay evidence increased during(GO:0072703) PMID:8048925 4896 2019-04-27 SPBC649.04 uvi15 RNA Northern assay evidence increased in presence of(CHEBI:21759) PMID:8048925 4896 2019-04-27 SPBC649.04 uvi15 RNA Northern assay evidence increased during(GO:0034605) PMID:8048925 4896 2019-04-27 SPBC649.04 uvi15 RNA Northern assay evidence increased during(GO:0072711) PMID:8048925 4896 2019-04-27 SPBC649.04 uvi15 RNA Northern assay evidence increased during(GO:0042149) PMID:8048925 4896 2019-04-27 SPBC649.04 uvi15 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC649.04 uvi15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC649.04 uvi15 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC649.04 uvi15 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC649.04 uvi15 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC649.04 uvi15 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:7898433 4896 2010-03-15 SPBC649.05 cut12 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC649.05 cut12 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC651.01c nog1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC651.01c nog1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC651.01c nog1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC651.01c nog1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC651.01c nog1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC651.01c nog1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC651.01c nog1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC651.01c nog1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC651.03c gyp10 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC651.04 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC651.04 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC651.04 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC651.05c dot2 protein western blot evidence used in manual assertion increased during(GO:0051321) PMID:15992541 4896 2018-01-24 SPBC651.05c dot2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC651.06 mug166 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC651.07 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC651.08c rpc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC651.09c prf1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC651.09c prf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC651.09c prf1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC651.10 nse5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC651.12c dbl7 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC651.12c dbl7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC660.05 wwm3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC660.05 wwm3 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPBC660.05 wwm3 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC660.05 wwm3 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC660.05 wwm3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC660.05 wwm3 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC660.05 wwm3 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC660.05 wwm3 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC660.05 wwm3 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC660.05 wwm3 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC660.05 wwm3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC660.05 wwm3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC660.05 wwm3 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC660.05 wwm3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC660.05 wwm3 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC660.05 wwm3 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC660.05 wwm3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC660.06 wwm2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC660.06 wwm2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC660.06 wwm2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC660.06 wwm2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC660.06 wwm2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC660.06 wwm2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC660.06 wwm2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC660.06 wwm2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC660.06 wwm2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC660.06 wwm2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC660.06 wwm2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC660.06 wwm2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC660.06 wwm2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC660.06 wwm2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC660.07 ntp1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC660.07 ntp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC660.07 ntp1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:9729425 4896 2012-08-24 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:9729425 4896 2012-08-24 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:9495778 4896 2012-08-30 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:9495778 4896 2012-08-30 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion increased during(GO:0034599) PMID:9974219 4896 2012-08-30 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:12855726 4896 2014-06-19 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12855726 4896 2014-06-19 SPBC660.07 ntp1 RNA Northern assay evidence increased during(GO:0034605) PMID:15164362 4896 2019-10-29 SPBC660.07 ntp1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC660.07 ntp1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC660.07 ntp1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC660.07 ntp1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC660.07 ntp1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC660.07 ntp1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC660.07 ntp1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC660.07 ntp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC660.07 ntp1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC660.07 ntp1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC660.07 ntp1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC660.07 ntp1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC660.07 ntp1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC660.07 ntp1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9495778 4896 2012-08-30 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9974219 4896 2012-08-30 SPBC660.07 ntp1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12855726 4896 2014-06-19 SPBC660.08 atg38 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC660.09 mug168 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC660.09 mug168 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC660.09 mug168 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC660.10 gfm2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC660.11 tcg1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC660.11 tcg1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC660.11 tcg1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC660.11 tcg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC660.11 tcg1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC660.11 tcg1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC660.13c ssb1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC660.13c ssb1 protein western blot evidence used in manual assertion unchanged during(GO:0000278) PMID:17429064 4896 2016-06-15 SPBC660.13c ssb1 RNA experimental evidence increased during(GO:0000084) 4896 SPBC660.14 mik1 protein Western blot evidence increased in presence of(CHEBI:44423) PMID:9572736 4896 2024-04-11 (Fig. 3C) SPBC660.14 mik1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC660.14 mik1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC660.14 mik1 RNA experimental evidence increased during(GO:0000080) 4896 SPBC660.14 mik1 RNA experimental evidence increased during(GO:0000084) 4896 SPBC660.14 mik1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC660.14 mik1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC660.16 gnd1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC660.16 gnd1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC660.16 gnd1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC660.16 gnd1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC660.16 gnd1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC660.16 gnd1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC660.16 gnd1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPBC660.17c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC685.02 exo5 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC685.02 exo5 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBC685.03 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC685.03 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC685.03 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC685.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC685.06 rps001 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC685.06 rps001 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC685.06 rps001 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC685.06 rps001 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC685.06 rps001 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC685.07c rpl2701 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC685.07c rpl2701 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC685.07c rpl2701 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC685.07c rpl2701 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC685.07c rpl2701 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC685.07c rpl2701 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC685.07c rpl2701 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC691.01 pfa5 protein western blot evidence used in manual assertion constant during(GO:0051321) PMID:23843742 4896 2013-08-08 SPBC691.02c drp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC691.02c drp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC691.03c apl3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC691.03c apl3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC691.03c apl3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC691.04 mss116 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC691.04 mss116 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC691.04 mss116 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC691.05c ist2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC691.05c ist2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPBC6B1.02 ppk30 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC6B1.02 ppk30 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC6B1.03c pal2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC6B1.04 mde4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC6B1.04 mde4 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC6B1.04 mde4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC6B1.05c atg7 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC6B1.05c atg7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC6B1.05c atg7 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC6B1.05c atg7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC6B1.05c atg7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC6B1.07 prp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC6B1.08c ofd1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC713.02c ubp15 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC713.02c ubp15 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC713.02c ubp15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC713.02c ubp15 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC713.02c ubp15 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC713.03 dld2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC713.03 dld2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC713.04c pwp2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC713.04c pwp2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC713.04c pwp2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC713.04c pwp2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC713.05 wdr83 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC713.05 wdr83 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPBC713.06 adl1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC713.07c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC713.07c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC713.07c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC713.07c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC713.07c RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC713.08 mim1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC713.09 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC713.09 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC713.10 pam16 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC713.11c pmp3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC713.11c pmp3 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:16603158 4896 2014-08-18 SPBC713.11c pmp3 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:16603158 4896 2014-08-18 SPBC713.11c pmp3 RNA northern assay evidence used in manual assertion increased during(GO:0072709) PMID:16603158 4896 2014-08-18 SPBC713.11c pmp3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC713.11c pmp3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC713.11c pmp3 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC713.11c pmp3 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC713.12 erg1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC713.12 erg1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC713.12 erg1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC713.12 erg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC713.12 erg1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC713.14c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC725.01 maa1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC725.01 maa1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC725.01 maa1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC725.01 maa1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC725.01 maa1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC725.01 maa1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC725.02 mpr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC725.02 mpr1 protein reporter gene assay evidence increased during(GO:0071500) PMID:20563653 4896 2014-12-01 SPBC725.02 mpr1 protein reporter gene assay evidence increased during(GO:0006995) PMID:20563653 4896 2014-12-01 SPBC725.02 mpr1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071500) PMID:20563653 4896 2014-12-01 SPBC725.02 mpr1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0006995) PMID:20563653 4896 2014-12-01 SPBC725.02 mpr1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC725.02 mpr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC725.02 mpr1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC725.02 mpr1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC725.02 mpr1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC725.02 mpr1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC725.02 mpr1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC725.02 mpr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC725.02 mpr1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC725.02 mpr1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC725.02 mpr1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC725.02 mpr1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:20563653 4896 2014-12-01 SPBC725.03 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC725.03 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC725.03 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC725.03 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC725.03 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC725.03 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC725.03 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC725.03 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC725.03 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC725.03 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC725.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC725.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC725.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC725.03 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC725.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC725.03 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC725.03 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC725.03 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC725.04 hac1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC725.04 hac1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC725.05c npp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC725.05c npp1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC725.06c ppk31 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC725.06c ppk31 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC725.07 pex5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC725.07 pex5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC725.08 pir2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC725.08 pir2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC725.09c hob3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC725.09c hob3 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC725.10 tsp0 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC725.10 tsp0 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC725.10 tsp0 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC725.10 tsp0 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBC725.10 tsp0 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC725.10 tsp0 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC725.10 tsp0 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC725.10 tsp0 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC725.10 tsp0 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC725.10 tsp0 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC725.10 tsp0 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC725.10 tsp0 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC725.10 tsp0 RNA quantitative PCR increased in presence of(CHEBI:142517) PMID:35416247 4896 2022-07-04 SPBC725.10 tsp0 RNA quantitative PCR increased in presence of(CHEBI:192760) PMID:35416247 4896 2022-08-02 SPBC725.11c php2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC725.11c php2 RNA quantitative PCR increased in presence of(CHEBI:29699) PMID:38360270 4896 2024-03-14 SPBC725.12 nbl1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC725.12 nbl1 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBC725.13c psf2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC725.14 arg6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC725.14 arg6 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC725.15 ura5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC725.16 res1 RNA absent during(GO:0000085) PMID:7909513 4896 2014-07-29 SPBC725.16 res1 RNA absent during(GO:0000087) PMID:7909513 4896 2014-07-29 SPBC725.16 res1 RNA northern assay evidence used in manual assertion unchanged during(GO:0006279) PMID:14648198 4896 2019-08-07 SPBC725.16 res1 RNA present during(GO:0000080) PMID:7909513 4896 2014-07-29 SPBC725.16 res1 RNA present during(GO:0000084) PMID:7909513 4896 2014-07-29 SPBC725.17c rrn11 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC776.01 rpl29 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC776.01 rpl29 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC776.01 rpl29 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC776.01 rpl29 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC776.01 rpl29 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC776.01 rpl29 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC776.02c dis2 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:2170029 4896 2015-06-15 SPBC776.02c dis2 protein western blot evidence used in manual assertion decreased during(GO:0000093) PMID:25487150 4896 2015-12-04 SPBC776.02c dis2 protein western blot evidence used in manual assertion increased during(GO:0000089) PMID:25487150 4896 2015-12-04 SPBC776.02c dis2 protein western blot evidence used in manual assertion increased during(GO:0000090) PMID:25487150 4896 2015-12-04 SPBC776.02c dis2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC776.03 hom6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC776.03 hom6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC776.03 hom6 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC776.03 hom6 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC776.03 hom6 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC776.03 hom6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC776.04 sec2302 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC776.05 gpc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC776.05 gpc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC776.06c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC776.07 mam33 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC776.07 mam33 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC776.08c utp22 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC776.08c utp22 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC776.08c utp22 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC776.08c utp22 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC776.08c utp22 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC776.08c utp22 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC776.08c utp22 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC776.09 ste13 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC776.09 ste13 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC776.09 ste13 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8078473 4896 2014-05-02 SPBC776.11 rpl2801 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC776.11 rpl2801 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC776.11 rpl2801 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC776.11 rpl2801 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC776.12c hsk1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC776.12c hsk1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC776.12c hsk1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC776.12c hsk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC776.13 cnd1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC776.14 plh1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC776.14 plh1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC776.15c kgd2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC776.15c kgd2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC776.15c kgd2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC776.16 mis20 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC776.16 mis20 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC776.17 rrp7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC776.17 rrp7 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC776.17 rrp7 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC776.17 rrp7 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC776.17 rrp7 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC776.17 rrp7 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC776.17 rrp7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC776.17 rrp7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC776.17 rrp7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC800.02 whi5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC800.02 whi5 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBC800.02 whi5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC800.02 whi5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC800.03 clr3 protein mass spectrometry evidence fluctuates during(GO:0000278) PMID:24763107 4896 2014-05-01 SPBC800.04c rpl4301 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC800.04c rpl4301 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC800.04c rpl4301 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC800.04c rpl4301 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC800.04c rpl4301 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC800.05c atb2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC800.05c atb2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC800.05c atb2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:6327053 4896 2013-09-30 SPBC800.05c atb2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:3785193 4896 2013-10-16 SPBC800.06 brx1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC800.06 brx1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC800.06 brx1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC800.06 brx1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC800.06 brx1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC800.06 brx1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC800.06 brx1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC800.06 brx1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC800.06 brx1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC800.08 trm6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC800.09 sum2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC800.10c ede1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC800.11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC800.11 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC800.11 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC800.11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC800.11 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC800.11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC800.11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC800.14c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC800.14c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC800.14c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC800.14c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC800.14c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC800.14c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC83.02c rpl4302 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC83.02c rpl4302 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC83.02c rpl4302 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC83.02c rpl4302 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC83.03c tas3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC83.03c tas3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC83.04 apc15 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:12477395 4896 2014-07-21 SPBC83.04 apc15 protein western blot evidence used in manual assertion increased during(GO:0000087) PMID:28366744 4896 2017-04-28 SPBC83.04 apc15 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC83.04 apc15 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC83.05 yme2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC83.05 yme2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC83.05 yme2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC83.05 yme2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC83.05 yme2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC83.08 rvb2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC83.09c lin1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC83.09c lin1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC83.10 emc7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC83.10 emc7 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC83.11 pet2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC83.11 pet2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC83.12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC83.12 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC83.12 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC83.13 yhm2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC83.13 yhm2 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBC83.13 yhm2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC83.13 yhm2 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC83.13 yhm2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC83.15 wdr74 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC83.15 wdr74 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC83.15 wdr74 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC83.15 wdr74 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC83.15 wdr74 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC83.15 wdr74 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC83.15 wdr74 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC83.15 wdr74 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC83.15 wdr74 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC83.15 wdr74 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC83.16c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC83.16c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC83.16c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC83.17 mbf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC83.17 mbf1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC83.17 mbf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC83.17 mbf1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC83.17 mbf1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC83.17 mbf1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC83.17 mbf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC83.18c fic1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC839.02 aly1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC839.02 aly1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.02 aly1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC839.02 aly1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.02 aly1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.03c dcn1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC839.03c dcn1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC839.04 rpl803 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC839.04 rpl803 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC839.04 rpl803 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.04 rpl803 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.05c rps1701 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC839.05c rps1701 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC839.05c rps1701 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC839.05c rps1701 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.05c rps1701 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC839.06 cta3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC839.06 cta3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC839.06 cta3 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:10428498 4896 SPBC839.06 cta3 RNA northern assay evidence used in manual assertion increased during(GO:0071471) PMID:10428498 4896 SPBC839.06 cta3 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:12221110 4896 2015-12-16 SPBC839.06 cta3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC839.06 cta3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC839.06 cta3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.06 cta3 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC839.06 cta3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC839.06 cta3 RNA northern assay evidence used in manual assertion unchanged during(GO:0070301) PMID:12221110 4896 2015-12-16 SPBC839.06 cta3 RNA northern assay evidence used in manual assertion unchanged during(GO:0034605) PMID:12221110 4896 2015-12-16 SPBC839.06 cta3 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10428498 4896 2013-06-11 SPBC839.07 ibp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC839.07 ibp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC839.07 ibp1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC839.07 ibp1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC839.07 ibp1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC839.07 ibp1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC839.07 ibp1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC839.07 ibp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.07 ibp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.07 ibp1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC839.07 ibp1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC839.08c its8 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC839.08c its8 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.08c its8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC839.08c its8 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.08c its8 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC839.08c its8 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC839.09c mrp21 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC839.11c hut1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.11c hut1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.11c hut1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC839.11c hut1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC839.12 rpc31 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC839.13c rpl1601 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC839.13c rpl1601 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC839.13c rpl1601 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC839.13c rpl1601 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.13c rpl1601 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.14c efm4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC839.14c efm4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.15c tef103 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC839.15c tef103 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC839.15c tef103 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC839.15c tef103 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC839.15c tef103 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.15c tef103 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBC839.15c tef103 RNA northern assay evidence used in manual assertion increased during(GO:0034644) PMID:9099890 4896 2014-10-27 SPBC839.15c tef103 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:9099890 4896 2014-10-27 SPBC839.15c tef103 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9099890 4896 2014-10-27 SPBC839.16 thf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC839.16 thf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC839.16 thf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC839.16 thf1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC839.17c fkh1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC887.01 adi1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC887.01 adi1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC887.01 adi1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC887.01 adi1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC887.01 adi1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC887.01 adi1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC887.05c cwf29 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC887.05c cwf29 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC887.06c snx3 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-21 SPBC887.09c sog2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC887.12 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC887.12 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC887.12 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC887.13c cem1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC887.14c pfh1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC887.14c pfh1 RNA northern assay evidence used in manual assertion increased during(GO:0000082) PMID:12409464 4896 2014-09-11 SPBC887.15c sur2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC887.15c sur2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBC887.15c sur2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC887.15c sur2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC887.15c sur2 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBC887.15c sur2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC887.16 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC887.17 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC887.17 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC887.17 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC887.17 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC887.17 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC887.17 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC887.17 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC887.17 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC887.17 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC887.17 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC887.17 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC887.17 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC887.17 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC887.18c hfi1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC887.18c hfi1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC887.22 spc1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC8D2.01 gsk31 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC8D2.01 gsk31 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC8D2.01 gsk31 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC8D2.02c vps68 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC8D2.02c vps68 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC8D2.03c hhf2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC8D2.03c hhf2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC8D2.03c hhf2 RNA Northern assay evidence fluctuates during(GO:0098763) PMID:17452352 4896 2018-02-28 SPBC8D2.03c hhf2 RNA Northern assay evidence increased during(GO:0000084) PMID:17452352 4896 2018-02-28 SPBC8D2.03c hhf2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC8D2.04 hht2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC8D2.04 hht2 RNA Northern assay evidence constant during(GO:0098763) PMID:17452352 4896 2018-02-28 SPBC8D2.04 hht2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC8D2.04 hht2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC8D2.04 hht2 RNA Northern assay evidence unchanged during(GO:0000084) PMID:17452352 4896 2018-02-28 SPBC8D2.05c sfi1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC8D2.06 irs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC8D2.06 irs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC8D2.06 irs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC8D2.10c rmt3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC8D2.10c rmt3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC8D2.10c rmt3 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC8D2.10c rmt3 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC8D2.10c rmt3 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC8D2.10c rmt3 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC8D2.10c rmt3 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC8D2.10c rmt3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC8D2.10c rmt3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC8D2.10c rmt3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC8D2.11 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC8D2.12c tac1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC8D2.12c tac1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC8D2.13 shq1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC8D2.15 lip5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC8D2.17 gmh4 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPBC8D2.17 gmh4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC8D2.18c sah1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC8D2.18c sah1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC8D2.18c sah1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC8D2.18c sah1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC8D2.18c sah1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC8D2.18c sah1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC8D2.18c sah1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC8D2.19 mde3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC8D2.19 mde3 RNA experimental evidence increased during(GO:0051321) 4896 SPBC8D2.19 mde3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC8E4.01c pho84 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC8E4.01c pho84 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC8E4.01c pho84 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC8E4.01c pho84 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC8E4.01c pho84 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC8E4.01c pho84 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC8E4.01c pho84 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC8E4.01c pho84 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC8E4.01c pho84 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC8E4.01c pho84 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBC8E4.01c pho84 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC8E4.01c pho84 RNA RNA-sequencing evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC8E4.01c pho84 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBC8E4.01c pho84 RNA RNA-sequencing evidence decreased in presence of(CHEBI:27641),during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 3B) SPBC8E4.01c pho84 RNA quantitative PCR increased during(GO:0016036) PMID:21169418 4896 2015-02-16 SPBC8E4.01c pho84 RNA quantitative PCR increased during(GO:0036223) PMID:25547512 4896 2015-08-12 SPBC8E4.01c pho84 RNA quantitative polymerase chain reaction evidence used in manual assertion increased in presence of(CHEBI:53745) PMID:32499400 4896 2020-06-24 SPBC8E4.01c pho84 RNA quantitative polymerase chain reaction evidence used in manual assertion increased in presence of(CHEBI:168396) PMID:32499400 4896 2020-06-24 SPBC8E4.01c pho84 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC8E4.01c pho84 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC8E4.01c pho84 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC8E4.01c pho84 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBC8E4.01c pho84 RNA quantitative PCR increased during(GO:0010438) PMID:39105351 4896 2024-10-01 SPBC8E4.01c pho84 RNA Northern assay evidence present during(GO:0072690) PMID:29414789 4896 2018-08-16 SPBC8E4.03 agm3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC8E4.03 agm3 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC8E4.03 agm3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC8E4.03 agm3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC8E4.03 agm3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC8E4.04 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC8E4.04 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC8E4.04 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC8E4.04 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC8E4.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC8E4.05c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC8E4.05c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC8E4.05c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC8E4.05c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC8E4.12c ecl3 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:19352039 4896 2015-03-31 SPBC8E4.12c ecl3 RNA northern assay evidence used in manual assertion decreased during(GO:0036227) PMID:19352039 4896 2015-03-31 SPBC8E4.12c ecl3 RNA northern assay evidence used in manual assertion decreased during(GO:0034605) PMID:21072667 4896 2015-04-09 SPBC8E4.12c ecl3 RNA northern assay evidence used in manual assertion decreased during(GO:0070301) PMID:24696293 4896 2015-04-17 SPBC8E4.12c ecl3 RNA quantitative PCR increased during(GO:0010438) PMID:39105351 4896 2024-10-01 SPBC8E4.12c ecl3 RNA quantitative PCR increased during(GO:0016036) PMID:36779416 4896 2023-03-01 (Figure 1A, B) SPBC8E4.12c ecl3 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:19352039 4896 2015-03-31 SPBC8E4.12c ecl3 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:24696293 4896 2015-04-17 SPBC902.02c ctf18 protein western blot evidence used in manual assertion fluctuates during(GO:0000278) PMID:28567704 4896 2017-10-20 SPBC902.02c ctf18 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:28567704 4896 2017-10-20 SPBC902.02c ctf18 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC902.04 rmn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC902.04 rmn1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC902.04 rmn1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC902.05c idh2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC902.05c idh2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC902.05c idh2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC902.06 mto2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC947.01 knk1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC947.02 apl2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC947.04 pfl3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC947.04 pfl3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC947.04 pfl3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC947.04 pfl3 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC947.04 pfl3 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC947.04 pfl3 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC947.04 pfl3 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC947.04 pfl3 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC947.04 pfl3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC947.04 pfl3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC947.04 pfl3 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC947.04 pfl3 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC947.05c frp2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC947.05c frp2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC947.06c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC947.06c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC947.06c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC947.07 rrp1402 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC947.07 rrp1402 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC947.07 rrp1402 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC947.07 rrp1402 RNA RNA-sequencing evidence decreased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBC947.09 hsp3103 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC947.09 hsp3103 RNA quantitative PCR increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPBC947.09 hsp3103 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBC947.10 dsc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC947.11c elg1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC947.12 kms2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC947.12 kms2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC947.13 rba50 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC947.13 rba50 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC947.14c cbp6 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC947.15c ndi1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC947.15c ndi1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC947.15c ndi1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBC947.15c ndi1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC947.15c ndi1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBC947.15c ndi1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC947.15c ndi1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC9B6.02c Tf2-9 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBC9B6.02c Tf2-9 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC9B6.02c Tf2-9 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBC9B6.03 pib2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBC9B6.03 pib2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC9B6.03 pib2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBC9B6.03 pib2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC9B6.04c tuf1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC9B6.04c tuf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBC9B6.05c lsm3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC9B6.07 nop52 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC9B6.07 nop52 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBC9B6.07 nop52 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBC9B6.07 nop52 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBC9B6.07 nop52 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBC9B6.07 nop52 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBC9B6.07 nop52 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBC9B6.07 nop52 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBC9B6.07 nop52 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBC9B6.07 nop52 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC9B6.08 clc1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBC9B6.08 clc1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBC9B6.10 cdc37 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBC9B6.11c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBCPT2R1.01c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBCPT2R1.04c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBCPT2R1.07c RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBCPT2R1.08c tlh2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBCPT2R1.08c tlh2 RNA RNA-sequencing evidence increased during(GO:0036227) PMID:34464389 4896 2022-01-10 (Fig. S7A) A re-analysis of RNA-seq data from non-dividing cells [68] revealed a subtle increase in tlh2 expression during chronological ageing SPBCPT2R1.10 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBP16F5.02 mcs2 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:8467814 4896 2014-08-08 SPBP16F5.02 mcs2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP16F5.02 mcs2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP16F5.03c tra1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP16F5.04 ubc7 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP16F5.04 ubc7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP16F5.04 ubc7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP16F5.04 ubc7 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP16F5.05c yar1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP16F5.06 nop8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP16F5.06 nop8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP16F5.06 nop8 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP16F5.08c fmo1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP16F5.08c fmo1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP16F5.08c fmo1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP16F5.08c fmo1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP16F5.08c fmo1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBP16F5.08c fmo1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP18G5.02 pgs1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP18G5.02 pgs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP19A11.01 gcv3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP19A11.01 gcv3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP19A11.02c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBP19A11.02c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP19A11.03c mts4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP19A11.07c hid2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP22H7.02c mrd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP22H7.02c mrd1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP22H7.04 mrx15 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP22H7.06 nrk1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP22H7.08 rps1002 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP22H7.08 rps1002 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP22H7.08 rps1002 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP22H7.08 rps1002 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP22H7.08 rps1002 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP22H7.09c mis15 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBP23A10.04 apc2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP23A10.04 apc2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP23A10.04 apc2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP23A10.06 mtm1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP23A10.07 rpa2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP23A10.07 rpa2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP23A10.07 rpa2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP23A10.07 rpa2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP23A10.08 alp5 RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBP23A10.09 psf1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP23A10.10 ppk32 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:27191590 4896 2016-07-20 SPBP23A10.10 ppk32 protein western blot evidence used in manual assertion decreased during(GO:0034605) PMID:27191590 4896 2016-07-20 SPBP23A10.10 ppk32 protein western blot evidence used in manual assertion unchanged during(GO:0071238) PMID:27191590 4896 2016-07-20 SPBP23A10.10 ppk32 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:27191590 4896 2016-07-20 SPBP23A10.10 ppk32 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP23A10.11c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP23A10.11c RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBP23A10.11c RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBP23A10.11c RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBP23A10.11c RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBP23A10.11c RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBP23A10.11c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP23A10.11c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP23A10.11c RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBP23A10.11c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP23A10.12 frg1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP23A10.13 orc4 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:10077566 4896 2015-06-15 SPBP23A10.13 orc4 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBP23A10.14c ell1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP23A10.15c mas1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP23A10.16 sdh4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP23A10.16 sdh4 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPBP23A10.16 sdh4 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:16963626 4896 2019-05-24 SPBP23A10.16 sdh4 RNA quantitative PCR decreased in presence of(CHEBI:142517) PMID:35416247 4896 2022-07-04 SPBP23A10.16 sdh4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP23A10.16 sdh4 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBP26C9.02c car1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP26C9.02c car1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP26C9.02c car1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:29016) PMID:7985419 4896 2013-10-28 SPBP26C9.02c car1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP26C9.03c fet4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP26C9.03c fet4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP26C9.03c fet4 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBP26C9.03c fet4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP26C9.03c fet4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP35G2.02 txc1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP35G2.02 txc1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBP35G2.02 txc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP35G2.02 txc1 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0034605) PMID:21091378 4896 2013-08-28 SPBP35G2.02 txc1 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0070301) PMID:21091378 4896 2013-08-28 SPBP35G2.02 txc1 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0072709) PMID:21091378 4896 2013-08-28 SPBP35G2.02 txc1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:21091378 4896 2013-08-28 SPBP35G2.03c sgo1 protein Western blot evidence decreased during(GO:0007133) PMID:14730319 4896 2026-04-20 As reported previously [16], Sgo1 is degraded during anaphase I in part depending on Slp1 (Cdc20 homolog), a substrate-recognition subunit and activator of the APC/C. SPBP35G2.03c sgo1 protein Western blot evidence decreased during(GO:0007133) PMID:14972679 4896 2021-02-15 SPBP35G2.03c sgo1 protein Western blot evidence decreased during(GO:0007138) PMID:14972679 4896 2021-02-15 SPBP35G2.03c sgo1 protein Western blot evidence increased during(GO:0098764) PMID:14730319 4896 2021-02-16 SPBP35G2.03c sgo1 protein Western blot evidence increased during(GO:0098768) PMID:14972679 4896 2021-02-15 SPBP35G2.03c sgo1 protein Western blot evidence increased during(GO:0007137) PMID:14972679 4896 2021-02-15 SPBP35G2.03c sgo1 protein Western blot evidence present during(GO:0098764) PMID:14730319 4896 2021-02-16 SPBP35G2.03c sgo1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP35G2.04c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP35G2.05c cki2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP35G2.06c nup131 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP35G2.06c nup131 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP35G2.07 ilv1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP35G2.07 ilv1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP35G2.07 ilv1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP35G2.07 ilv1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP35G2.07 ilv1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP35G2.09 usp103 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP35G2.10 mit1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP35G2.11c nbr1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBP35G2.11c nbr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP35G2.12 ysa1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP35G2.12 ysa1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP35G2.12 ysa1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBP35G2.13c swc2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP35G2.13c swc2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBP35G2.14 puf2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP35G2.16c ecl2 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:19352039 4896 2015-03-31 SPBP35G2.16c ecl2 RNA northern assay evidence used in manual assertion decreased during(GO:0070301) PMID:24696293 4896 2015-04-17 SPBP35G2.16c ecl2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP35G2.16c ecl2 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:19352039 4896 2015-03-31 SPBP35G2.16c ecl2 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:21072667 4896 2015-04-09 SPBP35G2.16c ecl2 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:21072667 4896 2015-04-09 SPBP35G2.16c ecl2 RNA quantitative PCR increased during(GO:0010438) PMID:28388826 4896 2019-10-04 SPBP35G2.16c ecl2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP35G2.16c ecl2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP35G2.16c ecl2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBP35G2.16c ecl2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP35G2.16c ecl2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBP35G2.16c ecl2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBP35G2.16c ecl2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:19352039 4896 2015-03-31 SPBP35G2.16c ecl2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:24696293 4896 2015-04-17 SPBP35G2.17 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP35G2.17 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP4G3.02 pho1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP4G3.02 pho1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP4G3.02 pho1 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPBP4G3.02 pho1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP4G3.02 pho1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP4G3.02 pho1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:27641),during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 3C) SPBP4G3.02 pho1 RNA northern assay evidence used in manual assertion increased during(GO:0016036) PMID:4092931 4896 2012-05-18 SPBP4G3.02 pho1 RNA quantitative PCR increased during(GO:0016036) PMID:21169418 4896 2015-02-16 SPBP4G3.02 pho1 RNA quantitative PCR increased during(GO:0036223) PMID:25547512 4896 2015-08-12 SPBP4G3.02 pho1 RNA northern assay evidence used in manual assertion increased during(GO:0016036) PMID:24493644 4896 2017-10-26 SPBP4G3.02 pho1 RNA quantitative polymerase chain reaction evidence used in manual assertion increased in presence of(CHEBI:53745) PMID:32499400 4896 2020-06-24 SPBP4G3.02 pho1 RNA quantitative polymerase chain reaction evidence used in manual assertion increased in presence of(CHEBI:168396) PMID:32499400 4896 2020-06-24 SPBP4G3.02 pho1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP4G3.02 pho1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBP4G3.02 pho1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP4G3.02 pho1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP4G3.02 pho1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBP4G3.02 pho1 RNA quantitative PCR increased during(GO:0010438) PMID:39105351 4896 2024-10-01 SPBP4G3.02 pho1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:4092931 4896 2012-05-18 SPBP4G3.02 pho1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:24493644 4896 2017-10-26 SPBP4G3.03 fub2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBP4G3.03 fub2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBP4G3.03 fub2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP4H10.03 oxa102 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP4H10.03 oxa102 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10712694 4896 2014-10-21 SPBP4H10.04 ppb1 RNA Northern assay evidence increased during(GO:0000084) PMID:7559598 4896 2019-11-08 SPBP4H10.04 ppb1 RNA Northern assay evidence increased during(GO:0006995) PMID:7559598 4896 2019-11-08 SPBP4H10.04 ppb1 RNA Northern assay evidence increased during(GO:0036227) PMID:7559598 4896 2019-11-08 SPBP4H10.04 ppb1 RNA northern assay evidence used in manual assertion present during(GO:0010458) PMID:12411492 4896 2015-10-14 SPBP4H10.05c spe2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP4H10.05c spe2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP4H10.05c spe2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP4H10.05c spe2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP4H10.06c cut14 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBP4H10.06c cut14 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP4H10.08 qcr10 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP4H10.08 qcr10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP4H10.09 rsv1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP4H10.09 rsv1 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-21 SPBP4H10.09 rsv1 RNA quantitative PCR increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPBP4H10.09 rsv1 RNA Northern assay evidence increased during(GO:0036227) PMID:9372444 4896 2018-06-07 SPBP4H10.09 rsv1 RNA Northern assay evidence increased during(GO:0042149) PMID:9372444 4896 2018-06-07 SPBP4H10.09 rsv1 RNA Northern assay evidence increased during(GO:0006995) PMID:9372444 4896 2018-06-07 SPBP4H10.09 rsv1 RNA Northern assay evidence increased during(GO:0016036) PMID:9372444 4896 2018-06-07 SPBP4H10.09 rsv1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP4H10.09 rsv1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP4H10.09 rsv1 RNA Northern assay evidence unchanged during(GO:0034605) PMID:9372444 4896 2018-06-07 SPBP4H10.09 rsv1 RNA Northern assay evidence present during(GO:0072690) PMID:9372444 4896 2018-06-07 SPBP4H10.10 rbd3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP4H10.10 rbd3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP4H10.10 rbd3 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-21 SPBP4H10.10 rbd3 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBP4H10.10 rbd3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBP4H10.10 rbd3 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBP4H10.10 rbd3 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBP4H10.10 rbd3 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBP4H10.10 rbd3 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBP4H10.10 rbd3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP4H10.10 rbd3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP4H10.10 rbd3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP4H10.10 rbd3 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBP4H10.10 rbd3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP4H10.10 rbd3 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBP4H10.10 rbd3 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBP4H10.11c lcf2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP4H10.11c lcf2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP4H10.11c lcf2 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBP4H10.11c lcf2 RNA RNA-sequencing evidence increased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPBP4H10.12 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP4H10.13 rps2302 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP4H10.13 rps2302 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBP4H10.13 rps2302 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP4H10.13 rps2302 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP4H10.13 rps2302 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPBP4H10.14c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP4H10.14c RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP4H10.15 aco2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP4H10.15 aco2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP4H10.15 aco2 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBP4H10.15 aco2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP4H10.15 aco2 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP4H10.15 aco2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP4H10.15 aco2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP4H10.15 aco2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP4H10.16c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP4H10.17c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP4H10.17c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP4H10.17c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP4H10.19c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP4H10.20 nhm1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP8B7.01c pop7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.02 rng9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.02 rng9 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.03c rpl402 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.03c rpl402 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP8B7.03c rpl402 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP8B7.03c rpl402 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.03c rpl402 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.04 mug45 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.04 mug45 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPBP8B7.04 mug45 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.04 mug45 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP8B7.05c nce103 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.05c nce103 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.06 rpp201 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.06 rpp201 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP8B7.06 rpp201 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBP8B7.06 rpp201 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.06 rpp201 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP8B7.06 rpp201 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.06 rpp201 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP8B7.09c los1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.10c utp16 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.10c utp16 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.11 nxt3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP8B7.11 nxt3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.11 nxt3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP8B7.11 nxt3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.11 nxt3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.12c fta3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.13 vac7 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP8B7.14c dpb2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBP8B7.15c mpe1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.16c dbp2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.16c dbp2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP8B7.16c dbp2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP8B7.16c dbp2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBP8B7.16c dbp2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBP8B7.16c dbp2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBP8B7.16c dbp2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBP8B7.16c dbp2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBP8B7.16c dbp2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP8B7.16c dbp2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.18c thi201 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP8B7.18c thi201 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.18c thi201 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.18c thi201 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.20c nop2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.20c nop2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBP8B7.20c nop2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBP8B7.20c nop2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBP8B7.20c nop2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBP8B7.20c nop2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBP8B7.20c nop2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBP8B7.20c nop2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.20c nop2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.20c nop2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP8B7.20c nop2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.21 ubp3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.21 ubp3 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP8B7.21 ubp3 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.21 ubp3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.22 erd2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.22 erd2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.23 rnf10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.23 rnf10 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.23 rnf10 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.24c atg8 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBP8B7.24c atg8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBP8B7.24c atg8 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBP8B7.24c atg8 protein western blot evidence used in manual assertion unchanged during(GO:0006995) PMID:17295836 4896 2016-01-07 SPBP8B7.24c atg8 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:17295836 4896 2016-01-07 SPBP8B7.24c atg8 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP8B7.24c atg8 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBP8B7.24c atg8 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBP8B7.24c atg8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP8B7.24c atg8 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBP8B7.24c atg8 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.24c atg8 RNA quantitative PCR increased during(GO:0010438) PMID:33064910 4896 2020-10-28 SPBP8B7.25 cyp4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBP8B7.26 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBP8B7.27 mug30 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBP8B7.27 mug30 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBP8B7.28c stc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBP8B7.28c stc1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBP8B7.29 abz1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP8B7.29 abz1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBP8B7.30c thi5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBP8B7.31 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB10D8.01 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB10D8.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBPB10D8.01 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB10D8.01 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB10D8.01 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPB10D8.01 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBPB10D8.01 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB10D8.02c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB10D8.02c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBPB10D8.02c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB10D8.02c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBPB10D8.02c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBPB10D8.04c ssu1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB10D8.05c ssu2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB10D8.06c ssu3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB10D8.07c ssu4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB21E7.01c eno102 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB21E7.01c eno102 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB21E7.01c eno102 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBPB21E7.01c eno102 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB21E7.01c eno102 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB21E7.01c eno102 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB21E7.01c eno102 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBPB21E7.01c eno102 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB21E7.01c eno102 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBPB21E7.01c eno102 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBPB21E7.04c cmt2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB21E7.04c cmt2 RNA expression microarray evidence decreased during(GO:0042149) PMID:34460892 4896 2021-09-20 SPBPB21E7.04c cmt2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBPB21E7.04c cmt2 RNA transcript expression level evidence increased during(GO:0010446) PMID:31053915 4896 2019-05-17 SPBPB21E7.04c cmt2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB21E7.04c cmt2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB21E7.04c cmt2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPB21E7.07 aes1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB21E7.07 aes1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBPB21E7.07 aes1 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBPB21E7.07 aes1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBPB21E7.07 aes1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB21E7.07 aes1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB21E7.07 aes1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPB21E7.08 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBPB21E7.08 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB21E7.08 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB21E7.08 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBPB21E7.08 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB21E7.08 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPBPB21E7.08 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBPB21E7.09 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB21E7.09 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBPB21E7.09 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB21E7.09 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB21E7.09 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB21E7.09 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB21E7.11 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB21E7.11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB21E7.11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB21E7.11 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB21E7.11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB2B2.01 nrg1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB2B2.01 nrg1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBPB2B2.01 nrg1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBPB2B2.01 nrg1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB2B2.01 nrg1 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBPB2B2.01 nrg1 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPBPB2B2.01 nrg1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBPB2B2.01 nrg1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBPB2B2.01 nrg1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB2B2.01 nrg1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.02 say1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB2B2.02 say1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB2B2.02 say1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBPB2B2.02 say1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.02 say1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB2B2.02 say1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB2B2.05 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB2B2.05 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPB2B2.05 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPBPB2B2.05 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBPB2B2.05 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBPB2B2.05 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBPB2B2.05 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB2B2.05 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB2B2.05 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB2B2.06c efn1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB2B2.06c efn1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBPB2B2.06c efn1 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPBPB2B2.06c efn1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPBPB2B2.06c efn1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPBPB2B2.06c efn1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBPB2B2.06c efn1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB2B2.06c efn1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPBPB2B2.06c efn1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBPB2B2.06c efn1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.06c efn1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPBPB2B2.07c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB2B2.07c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBPB2B2.08 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB2B2.08 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB2B2.08 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBPB2B2.08 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB2B2.08 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBPB2B2.08 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB2B2.09c pan5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB2B2.09c pan5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB2B2.10c gal7 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB2B2.10c gal7 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBPB2B2.10c gal7 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBPB2B2.10c gal7 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBPB2B2.10c gal7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.10c gal7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB2B2.10c gal7 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPB2B2.11 gal102 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPBPB2B2.11 gal102 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.12c gal10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB2B2.12c gal10 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBPB2B2.12c gal10 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBPB2B2.12c gal10 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBPB2B2.12c gal10 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBPB2B2.12c gal10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBPB2B2.12c gal10 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB2B2.12c gal10 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.12c gal10 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB2B2.12c gal10 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBPB2B2.12c gal10 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB2B2.13 gal1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB2B2.13 gal1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPBPB2B2.13 gal1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPBPB2B2.13 gal1 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPBPB2B2.13 gal1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB2B2.13 gal1 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPBPB2B2.13 gal1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBPB2B2.13 gal1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.13 gal1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB2B2.13 gal1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB2B2.13 gal1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPB2B2.15 RNA northern assay evidence used in manual assertion decreased during(GO:0071294) PMID:24003116 4896 2014-01-03 SPBPB2B2.15 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.15 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB2B2.18 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB2B2.18 RNA expression microarray evidence decreased during(GO:0042149) PMID:34460892 4896 2021-09-22 SPBPB2B2.18 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPBPB2B2.19c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB2B2.19c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPBPB2B2.19c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB2B2.19c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB2B2.19c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPB7E8.01 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPBPB7E8.01 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB7E8.01 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPBPB7E8.01 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPBPB7E8.01 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPBPB7E8.01 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPBPB7E8.01 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPBPB7E8.01 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB7E8.01 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB7E8.01 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPBPB7E8.01 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPB7E8.01 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPBPB7E8.02 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPB7E8.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB7E8.02 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB7E8.02 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB8B6.02c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB8B6.03 fah1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPBPB8B6.04c grt1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB8B6.04c grt1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB8B6.05c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB8B6.05c ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPBPB8B6.05c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPBPB8B6.05c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPBPB8B6.05c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPBPB8B6.05c RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPB8B6.06c fex2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPBPJ4664.01 dps1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPJ4664.01 dps1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPBPJ4664.02 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPJ4664.03 mfm3 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0006995) PMID:8196631 4896 2012-02-08 SPBPJ4664.03 mfm3 RNA northern assay evidence used in manual assertion increased in(CL:0002674),during(GO:0071444) PMID:8196631 4896 2012-02-08 SPBPJ4664.03 mfm3 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPBPJ4664.04 cop1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPBPJ4664.05 aig1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPBPJ4664.06 gpt1 RNA increased during(GO:0033554) PMID:8631292 4896 SPBPJ4664.06 gpt1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8631292 4896 2012-05-28 SPBPJ4664.06 gpt1 RNA northern assay evidence used in manual assertion increased during(GO:0072705) PMID:8631292 4896 2012-05-28 SPBPJ4664.06 gpt1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:29699) PMID:8631292 4896 2012-05-28 SPBPJ4664.06 gpt1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:22986) PMID:8631292 4896 2012-05-28 SPBPJ4664.06 gpt1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:15866) PMID:8631292 4896 2012-05-28 SPBPJ4664.06 gpt1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8631292 4896 2012-05-28 SPCC1020.01c pma2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1020.01c pma2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1020.01c pma2 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-21 SPCC1020.03 mmt1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1020.04c rpb6 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPCC1020.04c rpb6 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPCC1020.04c rpb6 protein western blot evidence used in manual assertion decreased during(GO:0034605) PMID:11918671 4896 2015-11-26 SPCC1020.04c rpb6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1020.04c rpb6 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPCC1020.04c rpb6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1020.04c rpb6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1020.05 dcr2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1020.05 dcr2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1020.05 dcr2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC1020.05 dcr2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC1020.05 dcr2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1020.06c tal1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1020.06c tal1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1020.06c tal1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC1020.07 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1020.07 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1020.07 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPCC1020.09 gnr1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1020.09 gnr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1020.10 oca2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1020.10 oca2 protein Western blot evidence increased in presence of(CHEBI:16134) PMID:20404084 4896 2025-09-23 In addition, oca2 cells are resistant to rapamycin in minimal medium with ammonia (even though growth is already slow), another similarity to S. cerevisiae Npr1 (40) (see Fig. S2A in the supplemental material). SPCC1020.10 oca2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC1020.10 oca2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1020.10 oca2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1020.10 oca2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1020.10 oca2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1020.10 oca2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1020.10 oca2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1020.10 oca2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1020.10 oca2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1020.10 oca2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1020.10 oca2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1020.10 oca2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1020.10 oca2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1020.11c emc6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1020.11c emc6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1020.12c xap5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1020.13c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1020.14 Tf2-12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1020.14 Tf2-12 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC10H11.01 prp11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC10H11.01 prp11 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC10H11.01 prp11 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPCC10H11.02 cwf23 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1183.01 sec15 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1183.01 sec15 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1183.02 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1183.03c fxn1 RNA northern assay evidence used in manual assertion present during(GO:0071456) PMID:23115244 4896 2013-02-20 SPCC1183.05c lig4 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1183.06 ung1 ribosomal density ribosome profiling evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1183.07 rrp5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1183.07 rrp5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1183.07 rrp5 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1183.07 rrp5 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1183.07 rrp5 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1183.07 rrp5 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1183.07 rrp5 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1183.07 rrp5 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1183.07 rrp5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1183.07 rrp5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1183.08c rpl101 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1183.08c rpl101 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1183.08c rpl101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1183.08c rpl101 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1183.09c pmp31 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1183.09c pmp31 RNA northern assay evidence used in manual assertion constant during(GO:0070301) PMID:16603158 4896 2014-08-18 SPCC1183.09c pmp31 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1183.09c pmp31 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:16603158 4896 2014-08-18 SPCC1183.09c pmp31 RNA northern assay evidence used in manual assertion increased during(GO:0072709) PMID:16603158 4896 2014-08-18 SPCC1183.09c pmp31 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1183.09c pmp31 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1183.09c pmp31 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1183.09c pmp31 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1183.10 wtf10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1183.10 wtf10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1183.10 wtf10 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1183.11 msy1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1183.11 msy1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071474) PMID:22910366 4896 2013-04-24 SPCC1183.11 msy1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071476) PMID:22910366 4896 2013-04-24 SPCC1183.11 msy1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1183.11 msy1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1183.11 msy1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1183.11 msy1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1183.11 msy1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1183.11 msy1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1183.11 msy1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1183.11 msy1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1183.11 msy1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1183.11 msy1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1183.11 msy1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1183.12 spo13 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1183.12 spo13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1183.12 spo13 RNA experimental evidence absent during(GO:0000278) PMID:18367542 4896 2010-10-20 SPCC1183.12 spo13 RNA experimental evidence decreased during(GO:0007135) PMID:18367542 4896 2010-10-20 SPCC1183.12 spo13 RNA experimental evidence increased during(GO:0007127) PMID:18367542 4896 2010-10-20 SPCC1183.12 spo13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC11E10.01 cbl1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC11E10.01 cbl1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC11E10.01 cbl1 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC11E10.01 cbl1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPCC11E10.01 cbl1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC11E10.01 cbl1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC11E10.01 cbl1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC11E10.01 cbl1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC11E10.03 jnm1 RNA quantitative PCR absent during(GO:0072690) PMID:25736293 4896 2021-01-22 SPCC11E10.03 jnm1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC11E10.03 jnm1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC11E10.03 jnm1 RNA quantitative PCR present during(GO:0051321) PMID:25736293 4896 2021-01-22 SPCC11E10.05c ynd1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC11E10.05c ynd1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC11E10.07c gcn3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC11E10.07c gcn3 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC11E10.07c gcn3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC11E10.08 rik1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC11E10.09c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC11E10.09c protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC11E10.09c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC11E10.09c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1223.01 rqt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1223.02 nmt1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1223.02 nmt1 RNA northern assay evidence used in manual assertion absent in presence of(CHEBI:26948) PMID:2358444 4896 2014-05-26 SPCC1223.02 nmt1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1223.02 nmt1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1223.02 nmt1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC1223.03c gut2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1223.03c gut2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1223.03c gut2 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPCC1223.03c gut2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC1223.03c gut2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1223.03c gut2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1223.03c gut2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1223.03c gut2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1223.03c gut2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1223.03c gut2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1223.03c gut2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1223.03c gut2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1223.03c gut2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1223.03c gut2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1223.03c gut2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1223.03c gut2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1223.04c set11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1223.04c set11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1223.05c rpl3702 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1223.05c rpl3702 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1223.05c rpl3702 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1223.05c rpl3702 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1223.05c rpl3702 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1223.05c rpl3702 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC1223.07c drs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1223.07c drs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1223.07c drs1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1223.07c drs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1223.08c dfr1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1223.08c dfr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1223.09 uro1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1223.09 uro1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1223.09 uro1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1223.09 uro1 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPCC1223.09 uro1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC1223.09 uro1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1223.09 uro1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1223.10c eaf1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1223.10c eaf1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1223.10c eaf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1223.11 ptc2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1223.12c meu10 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1223.12c meu10 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1223.12c meu10 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1223.12c meu10 RNA Northern assay evidence absent during(GO:0098763) PMID:11895484 4896 2024-06-12 SPCC1223.12c meu10 RNA experimental evidence increased during(GO:0051321) 4896 2010-03-17 SPCC1223.12c meu10 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC1223.12c meu10 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1223.12c meu10 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1223.12c meu10 RNA Northern assay evidence present during(GO:0098765) PMID:11895484 4896 2024-06-12 SPCC1223.13 cbf12 RNA quantitative PCR increased during(GO:0036227) PMID:19101542 4896 2012-08-16 SPCC1223.13 cbf12 RNA quantitative PCR increased during(GO:0051321) PMID:19101542 4896 2012-08-16 SPCC1223.13 cbf12 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPCC1223.14 aro2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1223.14 aro2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1223.14 aro2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1223.14 aro2 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1223.14 aro2 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1223.14 aro2 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1223.14 aro2 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1223.14 aro2 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1223.14 aro2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1223.15c spc19 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPCC1235.01 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1235.01 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1235.01 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1235.01 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1235.01 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1235.01 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1235.01 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1235.01 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC1235.01 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1235.01 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1235.01 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1235.01 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1235.01 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1235.02 bio2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1235.02 bio2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1235.02 bio2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1235.02 bio2 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPCC1235.02 bio2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1235.02 bio2 RNA quantitative PCR fluctuates during(GO:0000278) PMID:27687771 4896 2016-12-06 SPCC1235.02 bio2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1235.02 bio2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1235.02 bio2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1235.02 bio2 RNA RNA-sequencing evidence increased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPCC1235.03 cue2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1235.03 cue2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1235.03 cue2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1235.03 cue2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1235.05c fft2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1235.07 fta7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1235.08c pdh1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1235.09 hif2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1235.09 hif2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1235.10c sec6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1235.11 mpc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1235.11 mpc1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1235.11 mpc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1235.11 mpc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1235.11 mpc1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1235.12c mug146 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1235.13 ght6 protein western blot evidence used in manual assertion increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPCC1235.13 ght6 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1235.13 ght6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1235.13 ght6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1235.13 ght6 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1235.13 ght6 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1235.13 ght6 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPCC1235.13 ght6 RNA quantitative PCR increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPCC1235.13 ght6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1235.13 ght6 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0071281) PMID:30730059 4896 2019-11-13 SPCC1235.14 ght5 protein western blot evidence used in manual assertion increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPCC1235.14 ght5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1235.14 ght5 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1235.14 ght5 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:25411338 4896 2015-08-17 SPCC1235.14 ght5 RNA reverse transcription polymerase chain reaction transcription evidence decreased during(GO:0071281) PMID:30730059 4896 2019-11-13 SPCC1235.14 ght5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1235.14 ght5 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1235.14 ght5 RNA quantitative PCR decreased in presence of(CHEBI:142517) PMID:35416247 4896 2022-07-04 SPCC1235.14 ght5 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPCC1235.14 ght5 RNA quantitative PCR increased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPCC1235.14 ght5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1235.14 ght5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1235.14 ght5 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC1235.15 dga1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1235.16 vma21 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1235.18 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPCC1259.01c rps1802 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1259.01c rps1802 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1259.01c rps1802 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1259.01c rps1802 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1259.01c rps1802 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1259.01c rps1802 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC1259.02c erm1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1259.03 rpa12 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1259.03 rpa12 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1259.03 rpa12 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1259.05c cox9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1259.05c cox9 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1259.05c cox9 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1259.06 taf8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1259.06 taf8 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1259.07 rxt3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1259.08 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1259.08 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1259.09c pdx1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1259.09c pdx1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1259.09c pdx1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1259.12c gid1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1259.12c gid1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1259.12c gid1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1259.13 chk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1259.14c meu27 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1259.14c meu27 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1259.14c meu27 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPCC1259.14c meu27 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1259.15c ubc11 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1259.15c ubc11 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1259.15c ubc11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1259.15c ubc11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC126.01c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC126.01c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC126.02c pku70 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC126.02c pku70 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC126.03 pus1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC126.03 pus1 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC126.03 pus1 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC126.03 pus1 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC126.03 pus1 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC126.03 pus1 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC126.03 pus1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC126.03 pus1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC126.03 pus1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC126.03 pus1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC126.04c sgf73 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC126.04c sgf73 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC126.06 twf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC126.06 twf1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC126.07c asr1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC126.07c asr1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC126.08c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC126.09 zip2 RNA expression microarray evidence unchanged during(GO:0071276) PMID:18637840 4896 2012-09-11 SPCC126.10 iah1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC126.10 iah1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC126.10 iah1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC126.11c RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1281.01 ags1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1281.01 ags1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1281.01 ags1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC1281.04 akr7 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1281.04 akr7 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1281.04 akr7 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1281.04 akr7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1281.04 akr7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1281.04 akr7 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1281.06c ole1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1281.06c ole1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1281.06c ole1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC1281.06c ole1 RNA quantitative PCR increased during(GO:0071456) PMID:27053105 4896 2016-08-03 SPCC1281.06c ole1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1281.06c ole1 RNA RNA-sequencing evidence increased in presence of(CHEBI:171741) PMID:38780300 4896 2024-09-18 (Fig. 3) SPCC1281.07c gst4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1281.07c gst4 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1281.07c gst4 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1281.08 wtf11 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1281.08 wtf11 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-06-05 SPCC1281.08 wtf11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1281.08 wtf11 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1281.08 wtf11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1281.08 wtf11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC132.02 hst2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC132.03 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC132.03 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC132.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC132.04c gdh2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC132.04c gdh2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC132.04c gdh2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC132.05c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1322.01 rpm1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1322.02 pxd1 protein western blot evidence used in manual assertion decreased during(GO:0000084) PMID:32692737 4896 2020-09-03 SPCC1322.03 trp1322 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1322.03 trp1322 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1322.03 trp1322 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1322.04 fyu1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1322.04 fyu1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1322.04 fyu1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1322.04 fyu1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC1322.04 fyu1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1322.04 fyu1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1322.04 fyu1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1322.05c lap2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1322.06 kap113 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1322.07c mug150 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1322.08 srk1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1322.08 srk1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1322.08 srk1 RNA western blot evidence used in manual assertion constant during(GO:0000278) PMID:15629716 4896 2015-01-21 SPCC1322.08 srk1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12080074 4896 2014-12-04 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:0070301) PMID:12080074 4896 2014-12-04 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:0034605) PMID:12080074 4896 2014-12-04 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:0071471) PMID:12080074 4896 2014-12-04 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1322.08 srk1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1322.08 srk1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1322.08 srk1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1322.08 srk1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1322.08 srk1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1322.08 srk1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1322.08 srk1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1322.08 srk1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1322.08 srk1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1322.08 srk1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1322.09 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1322.10 knh2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1322.10 knh2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC1322.10 knh2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC1322.10 knh2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1322.11 rpl2302 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1322.11 rpl2302 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1322.11 rpl2302 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1322.11 rpl2302 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1322.12c bub1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1322.13 ade6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1322.13 ade6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1322.13 ade6 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1322.13 ade6 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1322.14c vtc4 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC1322.14c vtc4 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPCC1322.15 rpl3402 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1322.15 rpl3402 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1322.16 phb2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1322.16 phb2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1393.02c spt2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1393.03 rps1501 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1393.03 rps1501 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1393.04 fta4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1393.06c ipi1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1393.07c mug4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1393.07c mug4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1393.07c mug4 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC1393.07c mug4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1393.08 fil1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1393.08 fil1 protein Western blot evidence increased during(GO:1990253) PMID:33534698 4896 2021-06-28 Indeed, we observed that, after leucine starvation, the Fil1 protein increased, which was dependent on Gcn2 and the phosphorylation of eIF2a (Figure 4—Figure supplement 1H). SPCC1393.08 fil1 protein Western blot evidence increased during(GO:0034605) PMID:33313903 4896 2021-02-15 SPCC1393.08 fil1 protein Western blot evidence increased in presence of(CHEBI:48775),during(GO:0071276) PMID:33313903 4896 2021-02-15 SPCC1393.08 fil1 protein Western blot evidence increased in presence of(CHEBI:16240),during(GO:0034599) PMID:33313903 4896 2021-02-15 SPCC1393.08 fil1 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1393.08 fil1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1393.08 fil1 ribosomal density ribosome profiling evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1393.08 fil1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1393.08 fil1 ribosomal density ribosome profiling evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1393.08 fil1 ribosomal density ribosome profiling evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1393.08 fil1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1393.08 fil1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1393.08 fil1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1393.08 fil1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S4) SPCC1393.09c gir2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1393.09c gir2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1393.10 ctr4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1393.10 ctr4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1393.10 ctr4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1393.10 ctr4 RNA RNA protection assay evidence absent during(GO:0071280) PMID:22558440 4896 2013-01-22 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion decreased during(GO:0071280) PMID:12244050 4896 2014-04-03 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion decreased during(GO:0071280) PMID:10593913 4896 2014-11-25 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion decreased during(GO:0071280) PMID:11274192 4896 2015-07-14 SPCC1393.10 ctr4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1393.10 ctr4 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1393.10 ctr4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1393.10 ctr4 RNA RNA protection assay evidence increased during(GO:0035874) PMID:22558440 4896 2013-01-22 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:12244050 4896 2014-04-03 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:10593913 4896 2014-11-25 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:11274192 4896 2015-07-14 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion increased during(GO:0051328) PMID:24569997 4896 2017-09-14 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:24569997 4896 2017-09-14 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion increased during(GO:0072690) PMID:28572514 4896 2017-09-16 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion increased during(GO:0035874) PMID:28572514 4896 2017-09-16 SPCC1393.10 ctr4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1393.10 ctr4 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC1393.10 ctr4 RNA RNA protection assay evidence present during(GO:0072690) PMID:22558440 4896 2013-01-22 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12244050 4896 2014-04-03 SPCC1393.10 ctr4 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10593913 4896 2014-11-25 SPCC1393.12 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1393.12 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1393.12 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1393.12 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1393.12 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1393.12 ribosomal density ribosome profiling evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1393.12 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1393.12 ribosomal density ribosome profiling evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1393.12 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1393.12 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1393.12 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1393.12 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1393.12 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1393.12 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1393.12 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1393.12 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC1393.12 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1393.12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1393.12 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1393.12 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1393.12 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1393.12 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1393.12 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1393.12 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC1393.13 duf89 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPCC1393.14 ten1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC13B11.01 adh1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC13B11.01 adh1 RNA expression microarray evidence decreased during(GO:0034224) PMID:23223230 4896 2023-03-16 In the array analysis, one of the most repressed genes in response to zinc deficiency was adh1, whereas one of the most highly expressed transcripts under this condition was an antisense transcript at this locus (Fig. 1A). SPCC13B11.01 adh1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC13B11.01 adh1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC13B11.01 adh1 RNA expression microarray evidence increased in presence of(CHEBI:27365) PMID:23223230 4896 2023-03-16 Taken together, the Northern and array analyses indicate that adh1AS transcripts preferentially accumulate in zinc-limited cells, whereas adh1 mRNAs accumulate in zinc-replete cells. SPCC13B11.02c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC13B11.02c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1442.01 ste6 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1442.01 ste6 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1442.01 ste6 RNA Northern assay evidence increased during(GO:0006995) PMID:12052869 4896 2018-04-29 SPCC1442.01 ste6 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC1442.01 ste6 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1442.01 ste6 RNA Northern assay evidence present during(GO:0072690) PMID:12052869 4896 2018-04-29 SPCC1442.04c rmr1 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1442.04c rmr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1442.05c mic26 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1442.05c mic26 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1442.05c mic26 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1442.05c mic26 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC1442.06 pre8 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1442.07c wss2 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1442.07c wss2 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1442.07c wss2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1442.07c wss2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1442.07c wss2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1442.08c cox12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1442.09 trp3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1442.09 trp3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1442.09 trp3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1442.09 trp3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1442.09 trp3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1442.10c rpb3 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:11918671 4896 2015-11-26 SPCC1442.10c rpb3 protein western blot evidence used in manual assertion decreased during(GO:0009267) PMID:11918671 4896 2015-11-26 SPCC1442.10c rpb3 protein western blot evidence used in manual assertion unchanged during(GO:0034605) PMID:11918671 4896 2015-11-26 SPCC1442.10c rpb3 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11918671 4896 2015-11-26 SPCC1442.12 pps1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1442.12 pps1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1442.12 pps1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1442.12 pps1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1442.13c sqs2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1442.13c sqs2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1442.14c hnt1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1442.15c cox18 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:16911509 4896 2014-08-21 SPCC1442.16c zta1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1442.16c zta1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1442.16c zta1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1442.16c zta1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1442.17c ist1 protein microscopy evidence present during(GO:0000092) PMID:37783794 4896 2023-10-05 Fig. 2 SPCC1442.17c ist1 protein microscopy evidence present during(GO:0000080) PMID:37783794 4896 2023-10-05 Fig. 2 SPCC1442.19 mrp49 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1450.01c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC1450.02 bdf1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:22095079 4896 2018-06-26 SPCC1450.03 utp502 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1450.03 utp502 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1450.03 utp502 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1450.04 tef5 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1450.04 tef5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1450.04 tef5 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1450.04 tef5 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1450.04 tef5 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1450.04 tef5 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1450.04 tef5 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1450.04 tef5 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1450.04 tef5 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1450.04 tef5 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1450.04 tef5 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1450.04 tef5 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1450.04 tef5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1450.04 tef5 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC1450.05c rox3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1450.05c rox3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1450.06c grx3 protein reporter gene assay evidence increased during(GO:0071276) PMID:16258244 4896 2014-11-06 SPCC1450.06c grx3 protein reporter gene assay evidence increased during(GO:0071275) PMID:16258244 4896 2014-11-06 SPCC1450.06c grx3 protein reporter gene assay evidence increased during(GO:0071732) PMID:16258244 4896 2014-11-06 SPCC1450.06c grx3 protein reporter gene assay evidence increased during(GO:0042149) PMID:16258244 4896 2014-11-06 SPCC1450.06c grx3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1450.07c dao1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1450.07c dao1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1450.07c dao1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1450.07c dao1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC1450.07c dao1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1450.07c dao1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1450.08c wtf16 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1450.08c wtf16 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1450.10c nar1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1450.10c nar1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1450.10c nar1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1450.10c nar1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1450.10c nar1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1450.12 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1450.12 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1450.13c rib5 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1450.13c rib5 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1450.13c rib5 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1450.13c rib5 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1450.13c rib5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1450.13c rib5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1450.13c rib5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1450.13c rib5 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1450.14c ero12 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1450.14c ero12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1450.15 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1450.15 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1450.16c ptl1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1450.16c ptl1 RNA quantitative PCR increased during(GO:0071456) PMID:27053105 4896 2016-08-03 SPCC1450.16c ptl1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1494.01 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1494.01 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1494.01 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1494.01 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1494.01 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC1494.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1494.03 arz1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1494.03 arz1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1494.03 arz1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1494.03 arz1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1494.03 arz1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1494.03 arz1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1494.03 arz1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1494.03 arz1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1494.03 arz1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1494.03 arz1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1494.03 arz1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1494.03 arz1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1494.05c ubp12 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1494.07 trm732 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1494.07 trm732 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1494.07 trm732 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1494.07 trm732 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1494.07 trm732 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1494.08c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1494.08c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1494.08c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1494.09c tfb6 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1494.10 adn3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1494.11c Tf2-13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1494.11c Tf2-13 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC14G10.01 cab5 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC14G10.01 cab5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC14G10.01 cab5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC14G10.02 urb1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC14G10.03c ump1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC14G10.03c ump1 protein Western blot evidence increased during(GO:0034605) PMID:39473973 4896 2025-03-21 (Fig. 1D) SPCC14G10.03c ump1 protein Western blot evidence increased in presence of(CHEBI:609827) PMID:39473973 4896 2025-03-21 (Fig. 1F) SPCC1529.01 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC162.01c snp27 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC162.02c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC162.02c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC162.03 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC162.03 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC162.03 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC162.04c wtf13 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC162.04c wtf13 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC162.04c wtf13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC162.04c wtf13 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC162.05 coq3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC162.05 coq3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC162.06c vps60 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC162.06c vps60 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC162.06c vps60 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC162.06c vps60 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC162.07 ent1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC162.07 ent1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC162.09c hmg1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC162.09c hmg1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC162.09c hmg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC162.10 ppk33 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC162.10 ppk33 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC162.10 ppk33 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC162.10 ppk33 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC162.10 ppk33 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC162.10 ppk33 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC162.11c urk1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC162.11c urk1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC162.12 tco89 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1620.01c lsm2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1620.02 wtf23 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1620.02 wtf23 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1620.02 wtf23 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1620.02 wtf23 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1620.03 mug163 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1620.03 mug163 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1620.03 mug163 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1620.04c fzr3 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC1620.06c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1620.06c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1620.06c ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1620.06c ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC1620.06c ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1620.06c ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1620.07c lnp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1620.07c lnp1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1620.07c lnp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1620.08 lsc2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1620.09c tfg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1620.09c tfg1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1620.11 nup97 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1620.11 nup97 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1620.13 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1672.01 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1672.02c sap1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1672.03c gud1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1672.03c gud1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC1672.03c gud1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1672.03c gud1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1672.03c gud1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1672.03c gud1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1672.04c cox19 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1672.05c yrs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1672.05c yrs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1672.05c yrs1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1672.05c yrs1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1672.05c yrs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1672.06c asp1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPCC1672.07 utp21 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1672.07 utp21 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1672.07 utp21 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1672.08c tfa2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1672.09 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1672.10 mis16 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1682.01 qcr9 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1682.01 qcr9 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1682.01 qcr9 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1682.01 qcr9 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1682.01 qcr9 RNA quantitative PCR decreased in presence of(CHEBI:52289) PMID:31657618 4896 2023-06-21 (Fig. 3) SPCC1682.02c mcm3 protein western blot evidence used in manual assertion absent during(GO:0006995) PMID:9705504 4896 2012-08-17 SPCC1682.02c mcm3 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:9705504 4896 2015-06-10 SPCC1682.02c mcm3 protein western blot evidence used in manual assertion decreased during(GO:0045023) PMID:16899242 4896 2014-11-06 SPCC1682.02c mcm3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1682.02c mcm3 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:10888871 4896 2010-09-03 SPCC1682.02c mcm3 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:10888871 4896 2010-09-03 SPCC1682.03c mug174 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1682.03c mug174 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1682.04 cdc31 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1682.06 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1682.06 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1682.06 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1682.07 ssl1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1682.08c mpf2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1682.08c mpf2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1682.08c mpf2 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:16896214 4896 2014-07-17 SPCC1682.08c mpf2 RNA quantitative PCR increased during(GO:0051321) PMID:16896214 4896 2014-07-17 SPCC1682.08c mpf2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1682.08c mpf2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1682.09c ggc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1682.09c ggc1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1682.11c ctl1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1682.11c ctl1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1682.11c ctl1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1682.11c ctl1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1682.12c ubp16 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1682.12c ubp16 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1682.13 laf2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1682.13 laf2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1682.13 laf2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1682.13 laf2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1682.14 rpl1902 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1682.14 rpl1902 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1682.15 mug122 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1682.15 mug122 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1682.16 rpt4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1682.16 rpt4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC16A11.01 sfk1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC16A11.01 sfk1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC16A11.01 sfk1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC16A11.01 sfk1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC16A11.01 sfk1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16A11.01 sfk1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC16A11.01 sfk1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC16A11.02 utp13 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC16A11.02 utp13 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC16A11.02 utp13 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16A11.04 snx12 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC16A11.04 snx12 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC16A11.06c gpi10 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC16A11.06c gpi10 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16A11.07 coq10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC16A11.07 coq10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC16A11.08 atg20 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC16A11.08 atg20 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC16A11.08 atg20 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC16A11.08 atg20 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC16A11.08 atg20 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC16A11.08 atg20 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16A11.08 atg20 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC16A11.08 atg20 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC16A11.08 atg20 RNA quantitative PCR increased during(GO:0010438) PMID:33064910 4896 2020-10-28 SPCC16A11.09c tim23 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC16A11.09c tim23 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC16A11.10c oca8 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC16A11.12c ubp1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC16A11.15c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC16A11.15c ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC16A11.15c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC16A11.15c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC16A11.15c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC16A11.15c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC16A11.15c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC16A11.15c RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC16A11.15c RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC16A11.15c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC16A11.15c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC16A11.15c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC16A11.15c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC16A11.15c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16A11.15c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC16A11.15c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC16A11.15c RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC16A11.16c rpn1302 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC16A11.17 mcm4 protein western blot evidence used in manual assertion decreased during(GO:0045023) PMID:16899242 4896 2014-11-06 SPCC16A11.17 mcm4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC16A11.17 mcm4 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:10888871 4896 2010-09-03 SPCC16A11.17 mcm4 protein western blot evidence used in manual assertion present during(GO:0000278) PMID:9658174 4896 2015-06-10 SPCC16A11.17 mcm4 protein western blot evidence used in manual assertion present during(GO:0051321) PMID:10888871 4896 2010-09-03 SPCC16C4.01 sif2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC16C4.02c asi1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC16C4.03 pin1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC16C4.03 pin1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16C4.04 pex26 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC16C4.04 pex26 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC16C4.04 pex26 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16C4.07 scw1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC16C4.07 scw1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC16C4.07 scw1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC16C4.07 scw1 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPCC16C4.07 scw1 protein Western blot evidence decreased in presence of(GO:0036227) PMID:34464389 4896 2022-01-05 . Figure 6C In fact, the protein levels of Scw1 markedly decreased in ageing cells. SPCC16C4.08c skb15 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC16C4.08c skb15 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC16C4.08c skb15 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16C4.13c rpl1201 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC16C4.13c rpl1201 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC16C4.13c rpl1201 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC16C4.17 mug123 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC16C4.17 mug123 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC16C4.19 rpp21 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC16C4.19 rpp21 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC16C4.20c hap2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1739.01 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1739.01 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1739.02c mrpl22 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1739.02c mrpl22 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1739.04c dms1 protein western blot evidence used in manual assertion present during(GO:0007127) PMID:29259000 4896 2017-12-22 SPCC1739.04c dms1 protein western blot evidence used in manual assertion present during(GO:0007135) PMID:29259000 4896 2017-12-22 SPCC1739.04c dms1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1739.04c dms1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1739.04c dms1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1739.04c dms1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1739.04c dms1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC1739.05 set5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1739.05 set5 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1739.05 set5 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1739.05 set5 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC1739.06c met1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1739.06c met1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1739.06c met1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1739.06c met1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1739.06c met1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1739.07 cti1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1739.07 cti1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1739.07 cti1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1739.08c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1739.08c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1739.08c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC1739.08c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1739.08c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1739.09c cox13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1739.09c cox13 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1739.09c cox13 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1739.10 mug33 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1739.10 mug33 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC1739.10 mug33 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC1739.10 mug33 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1739.11c cdc11 protein Western blot evidence decreased during(GO:0098765) PMID:24838944 4896 2025-04-16 (Fig. 4B) SPCC1739.11c cdc11 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1739.11c cdc11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1739.12 ppe1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1739.12 ppe1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1739.13 ssa2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1739.13 ssa2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1739.13 ssa2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1739.13 ssa2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC1739.13 ssa2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1739.13 ssa2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1739.15 wtf21 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1739.15 wtf21 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1739.15 wtf21 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1742.01 gsf2 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1742.01 gsf2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1742.01 gsf2 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:22180499 4896 2017-10-20 SPCC1742.01 gsf2 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1753.02c git3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1753.02c git3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1753.02c git3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1753.02c git3 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1753.02c git3 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1753.03c rec7 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:11447128 4896 2015-05-27 SPCC1753.03c rec7 RNA experimental evidence increased during(GO:0051321) PMID:1339382 4896 SPCC1753.03c rec7 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:11447128 4896 2015-05-27 SPCC1753.03c rec7 RNA Northern assay evidence increased during(GO:0051321) PMID:9671035 4896 2019-11-07 SPCC1753.03c rec7 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC1753.03c rec7 RNA northern assay evidence used in manual assertion present during(GO:0007127) PMID:1339382 4896 2013-08-12 SPCC1753.04 tol1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1753.04 tol1 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1753.04 tol1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1753.04 tol1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1753.05 rsm1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC1795.01c mad3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1795.03 gms1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1795.03 gms1 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC1795.03 gms1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1795.06 map2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1795.06 map2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1795.06 map2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC1795.06 map2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1795.07 sws2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1795.07 sws2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1795.08c vid21 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1795.09 yps1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC1795.09 yps1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1795.10c svp26 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1795.11 sum3 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:11711540 4896 2015-07-17 SPCC1795.11 sum3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1795.11 sum3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1795.11 sum3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1795.11 sum3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1795.11 sum3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1795.12c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1795.12c RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC18.01c adg3 protein Western blot evidence increased during(GO:0016036) PMID:39660919 4896 2024-12-12 Protein content of supernant medium from wild-type cells that were starved for phosphate for 12 hours was analyzed by UHPLC-MS SPCC18.01c adg3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC18.01c adg3 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC18.01c adg3 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC18.01c adg3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC18.03 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC18.03 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC18.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC18.04 pof6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC18.05c rsa4 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC18.05c rsa4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC18.07 rpc53 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC18.08 msk1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC18.08 msk1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC18.09c hnt3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC18.09c hnt3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC18.09c hnt3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC18.09c hnt3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC18.09c hnt3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC18.10 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC18.11c sdc1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC18.12c utp23 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC18.12c utp23 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC18.12c utp23 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC18.12c utp23 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC18.12c utp23 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC18.12c utp23 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC18.12c utp23 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC18.13 trm82 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC18.13 trm82 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC18.14c rpp0 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC18.14c rpp0 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC18.14c rpp0 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC18.14c rpp0 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC18.14c rpp0 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC18.14c rpp0 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC18.15 dph7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC18.15 dph7 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC18.16c fmn1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC18.16c fmn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC18.16c fmn1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC18.16c fmn1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC18.17c hsm3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC18.18c fum1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC18.18c fum1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1827.01c utp25 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1827.01c utp25 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC1827.01c utp25 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC1827.01c utp25 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC1827.01c utp25 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC1827.01c utp25 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC1827.01c utp25 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1827.01c utp25 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1827.01c utp25 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1827.02c pcy1 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC1827.02c pcy1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1827.03c pcs60 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1827.03c pcs60 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1827.03c pcs60 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1827.03c pcs60 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1827.03c pcs60 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1827.03c pcs60 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1827.05c protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1827.05c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1827.05c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1827.05c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1827.06c hom2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1827.06c hom2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1827.06c hom2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1827.06c hom2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1827.06c hom2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1827.06c hom2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1827.06c hom2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1827.06c hom2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1827.07c spx2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1827.07c spx2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1840.02c bgs4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1840.02c bgs4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1840.02c bgs4 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC1840.03 sal3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1840.03 sal3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1840.03 sal3 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1840.04 pca1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:16240) PMID:12597774 4896 2013-05-03 SPCC1840.04 pca1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:35456) PMID:12597774 4896 2013-05-03 SPCC1840.04 pca1 RNA northern assay evidence used in manual assertion increased in presence of(CHEBI:29321) PMID:12597774 4896 2013-05-03 SPCC1840.04 pca1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0036227) PMID:17898859 4896 2014-12-02 SPCC1840.04 pca1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071500) PMID:17898859 4896 2014-12-02 SPCC1840.04 pca1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071276) PMID:17898859 4896 2014-12-02 SPCC1840.04 pca1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0070301) PMID:17898859 4896 2014-12-02 SPCC1840.04 pca1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1840.05c pgm2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1840.05c pgm2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1840.05c pgm2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1840.05c pgm2 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1840.05c pgm2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1840.06 atp5 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1840.06 atp5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1840.06 atp5 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC1840.06 atp5 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC1840.07c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1840.07c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1840.08c pdi5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1840.08c pdi5 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC1840.08c pdi5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1840.09 coq11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1840.09 coq11 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1840.11 csl4 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1840.11 csl4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1840.11 csl4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1840.12 opt3 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC1840.12 opt3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1840.12 opt3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1840.12 opt3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC188.02 par1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:10757751 4896 2015-01-14 SPCC188.02 par1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC188.02 par1 protein western blot evidence used in manual assertion unchanged during(GO:0036227) PMID:10757751 4896 2015-01-14 SPCC188.02 par1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:10757751 4896 2015-01-14 SPCC188.03 cnd3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC188.03 cnd3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC188.06c srp54 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC188.07 ccq1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC188.07 ccq1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC188.08c ubp5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC188.09c pfl4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC188.12 spn6 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC188.12 spn6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC188.12 spn6 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC188.12 spn6 RNA experimental evidence increased during(GO:0034293) 4896 SPCC188.12 spn6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC188.12 spn6 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC188.13c dcr1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC1884.02 nic1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC18B5.01c bfr1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC18B5.01c bfr1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:9585505 4896 2012-02-29 SPCC18B5.01c bfr1 RNA reverse transcription polymerase chain reaction transcription evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-17 SPCC18B5.01c bfr1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071409) PMID:22840777 4896 2012-10-17 SPCC18B5.01c bfr1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC18B5.01c bfr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC18B5.01c bfr1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC18B5.01c bfr1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC18B5.01c bfr1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC18B5.01c bfr1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC18B5.01c bfr1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC18B5.01c bfr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9585505 4896 2012-02-29 SPCC18B5.01c bfr1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9532803 4896 2012-08-30 SPCC18B5.01c bfr1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:22840777 4896 2012-10-17 SPCC18B5.02c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC18B5.03 wee1 protein western blot evidence used in manual assertion decreased during(GO:0000090) PMID:28103117 4896 2017-04-03 SPCC18B5.03 wee1 protein reporter gene assay evidence unchanged during(GO:0000085) PMID:28479325 4896 2022-01-31 SPCC18B5.03 wee1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC18B5.03 wee1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC18B5.03 wee1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC18B5.03 wee1 RNA differential hybridization evidence unchanged during(GO:0000085) PMID:28479325 4896 2022-01-31 SPCC18B5.04 rsm18 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC18B5.06 dom34 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC18B5.07c nup61 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC18B5.07c nup61 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC18B5.07c nup61 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC18B5.11c cds1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1902.01 gaf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1902.01 gaf1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:22900017 4896 2014-07-31 SPCC1902.01 gaf1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1902.02 mug72 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1902.02 mug72 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1902.02 mug72 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPCC1906.01 mpg1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1906.01 mpg1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1906.01 mpg1 protein western blot evidence used in manual assertion increased during(GO:0000910) PMID:16049679 4896 2013-01-25 SPCC1906.01 mpg1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:16049679 4896 2013-01-25 SPCC1906.01 mpg1 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:16049679 4896 2013-01-25 SPCC1906.01 mpg1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1906.01 mpg1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1906.01 mpg1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:16049679 4896 2013-01-25 SPCC1906.03 wtf19 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1906.03 wtf19 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1906.03 wtf19 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1906.03 wtf19 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1906.03 wtf19 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1906.04 wtf20 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1906.04 wtf20 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1906.04 wtf20 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1906.04 wtf20 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1906.04 wtf20 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1906.04 wtf20 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC191.01 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC191.01 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC191.01 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC191.01 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC191.01 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC191.01 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC191.01 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC191.01 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC191.01 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC191.01 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC191.01 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC191.01 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC191.01 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC191.01 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC191.01 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC191.01 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC191.01 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC191.02c acs1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC191.02c acs1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC191.02c acs1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC191.02c acs1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC191.03c ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC191.03c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC191.03c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC191.04c RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC191.04c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC191.05c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC191.05c RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC191.05c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC191.06 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC191.06 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC191.06 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC191.07 cyc1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPCC191.07 cyc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC191.07 cyc1 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC191.07 cyc1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC191.08 lto1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC191.08 lto1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC191.08 lto1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC191.08 lto1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC191.09c gst1 protein reporter gene assay evidence increased during(GO:0036245) PMID:11513961 4896 2014-11-03 SPCC191.09c gst1 protein reporter gene assay evidence increased during(GO:0070301) PMID:11513961 4896 2014-11-03 SPCC191.09c gst1 protein reporter gene assay evidence increased during(GO:0071276) PMID:11513961 4896 2014-11-03 SPCC191.09c gst1 protein reporter gene assay evidence increased during(GO:0071288) PMID:11513961 4896 2014-11-03 SPCC191.09c gst1 protein reporter gene assay evidence increased during(GO:0034605) PMID:11513961 4896 2014-11-03 SPCC191.09c gst1 protein reporter gene assay evidence increased during(GO:0071500) PMID:15650330 4896 2014-11-20 SPCC191.09c gst1 protein reporter gene assay evidence present during(GO:0072690) PMID:11513961 4896 2014-11-03 SPCC191.09c gst1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12063243 4896 2014-11-20 SPCC191.09c gst1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC191.09c gst1 RNA northern assay evidence used in manual assertion unchanged during(GO:0036227) PMID:12063243 4896 2014-11-20 SPCC191.11 inv1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC191.11 inv1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC191.11 inv1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC191.11 inv1 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPCC191.11 inv1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC191.11 inv1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC191.11 inv1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC191.11 inv1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC1919.01 ckk2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1919.02 pbn1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1919.03c amk2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1919.04 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1919.04 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1919.04 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1919.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC1919.06c wtf25 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1919.08c mrpl33 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1919.09 tif6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1919.09 tif6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC1919.09 tif6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC1919.09 tif6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1919.10c myo52 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1919.10c myo52 RNA expression microarray evidence increased PMID:21148300 4896 2021-03-19 SPCC1919.10c myo52 RNA expression microarray evidence increased PMID:21148300 4896 2021-03-19 SPCC1919.11 mug137 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC1919.11 mug137 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC1919.12c erm2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC1919.14c bdp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC1919.14c bdp1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC1919.14c bdp1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC1919.15 brl1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC23B6.01c osh6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC23B6.01c osh6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC23B6.01c osh6 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC23B6.02c ecm1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC23B6.02c ecm1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC23B6.03c tel1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC23B6.04c pdr16 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC23B6.04c pdr16 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC23B6.05c ssb3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC24B10.02c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC24B10.02c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC24B10.02c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC24B10.02c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC24B10.02c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC24B10.02c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC24B10.02c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC24B10.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC24B10.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC24B10.05 tim9 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC24B10.05 tim9 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC24B10.06 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC24B10.07 gad8 protein Western blot evidence increased during(GO:0044838) PMID:31315658 4896 2020-11-03 SPCC24B10.07 gad8 RNA western blot evidence used in manual assertion unchanged during(GO:0006995) PMID:23551936 4896 2013-02-13 SPCC24B10.07 gad8 RNA western blot evidence used in manual assertion unchanged during(GO:0071242) PMID:23551936 4896 2013-02-13 SPCC24B10.07 gad8 RNA western blot evidence used in manual assertion present during(GO:0072690) PMID:23551936 4896 2013-02-13 SPCC24B10.08c ada2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC24B10.08c ada2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC24B10.08c ada2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC24B10.08c ada2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC24B10.09 rps1702 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC24B10.09 rps1702 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC24B10.09 rps1702 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC24B10.09 rps1702 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC24B10.09 rps1702 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC24B10.09 rps1702 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC24B10.09 rps1702 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC24B10.10c yta4 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC24B10.10c yta4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC24B10.11c tho7 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC24B10.11c tho7 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC24B10.11c tho7 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC24B10.11c tho7 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC24B10.11c tho7 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC24B10.12 cgi121 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC24B10.12 cgi121 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC24B10.14c xlf1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC24B10.14c xlf1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC24B10.15 swt1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC24B10.15 swt1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC24B10.16c pac4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC24B10.16c pac4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC24B10.16c pac4 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC24B10.16c pac4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC24B10.16c pac4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC24B10.17 emp24 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC24B10.17 emp24 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC24B10.17 emp24 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC24B10.17 emp24 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC24B10.18 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC24B10.18 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC24B10.18 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC24B10.18 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC24B10.20 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC24B10.20 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC24B10.21 tpi1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC24B10.21 tpi1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC24B10.22 pog1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC24B10.22 pog1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC24B10.22 pog1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC24B10.22 pog1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC285.03 dbp6 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC285.04 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC285.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC285.05 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC285.05 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC285.05 ribosomal density ribosome profiling evidence decreased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC285.05 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC285.05 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC285.05 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPCC285.05 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC285.05 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC285.06c wtf17 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC285.06c wtf17 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC285.07c wtf18 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC285.07c wtf18 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC285.07c wtf18 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC285.07c wtf18 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC285.07c wtf18 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC285.08 ret2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC285.09c cgs2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC285.09c cgs2 RNA quantitative PCR increased during(GO:0006995) PMID:15448137 4896 2017-07-20 SPCC285.09c cgs2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC285.09c cgs2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC285.09c cgs2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC285.09c cgs2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC285.09c cgs2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC285.10c ear1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC285.10c ear1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC285.10c ear1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC285.10c ear1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC285.10c ear1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC285.11 dsc5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC285.11 dsc5 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC285.11 dsc5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC285.11 dsc5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC285.11 dsc5 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC285.11 dsc5 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC285.11 dsc5 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC285.11 dsc5 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC285.12 lsm7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC285.12 lsm7 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC285.13c nup60 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC285.13c nup60 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC285.14 trs130 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC285.14 trs130 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC285.14 trs130 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC285.15c rps2802 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC285.15c rps2802 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC285.15c rps2802 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC285.15c rps2802 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC285.16c msh6 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC285.16c msh6 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC285.17 spp27 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC285.17 spp27 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC285.17 spp27 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC290.02 rpc34 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC290.02 rpc34 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC290.02 rpc34 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC290.02 rpc34 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC290.02 rpc34 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC290.02 rpc34 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC290.02 rpc34 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC290.03c nup186 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC290.04 ams2 protein Western blot evidence decreased during(GO:0000085) PMID:12535531 4896 2018-02-28 SPCC290.04 ams2 protein Western blot evidence fluctuates during(GO:0098763) PMID:17452352 4896 2018-02-28 SPCC290.04 ams2 protein northern assay evidence used in manual assertion increased during(GO:0000084) PMID:17452352 4896 2012-01-30 SPCC290.04 ams2 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:23314747 4896 2015-10-01 SPCC290.04 ams2 protein Western blot evidence increased during(GO:0000084) PMID:12535531 4896 2018-02-28 SPCC290.04 ams2 protein Western blot evidence increased during(GO:0000080) PMID:12535531 4896 2018-02-28 SPCC290.04 ams2 protein Western blot evidence increased during(GO:0000084) PMID:17452352 4896 2018-02-28 SPCC290.04 ams2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC290.04 ams2 RNA Northern assay evidence fluctuates during(GO:0098763) PMID:17452352 4896 2018-02-28 SPCC290.04 ams2 RNA Northern assay evidence increased during(GO:0000084) PMID:17452352 4896 2018-02-28 SPCC290.04 ams2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC297.03 ssp1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC297.04c set7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC297.04c set7 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC297.04c set7 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC297.04c set7 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC297.04c set7 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC297.04c set7 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC297.04c set7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC297.04c set7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC297.04c set7 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC297.05 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC297.05 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC297.06c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC2H8.02 pho843 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC306.02c yip3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC306.02c yip3 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC306.02c yip3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC306.02c yip3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC306.03c cnd2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC306.04c set1 protein Western blot evidence fluctuates during(GO:0034605) PMID:38181050 4896 2024-05-07 In wild-type cells, we observed a significantly increased amount of Set1 at 37 ̊C (Fig 6A), indicating that Set1 is also stabilized during heat stress. SPCC306.04c set1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC306.05c ins1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC306.05c ins1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC306.05c ins1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC306.05c ins1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC306.05c ins1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC306.05c ins1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC306.05c ins1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC306.06c big1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC306.07c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC306.07c RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC306.07c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC306.08c mdh1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC306.08c mdh1 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPCC306.08c mdh1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC306.08c mdh1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC306.08c mdh1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC306.08c mdh1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC306.08c mdh1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC306.08c mdh1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC306.08c mdh1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC306.08c mdh1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC306.08c mdh1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC306.08c mdh1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC306.08c mdh1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC306.09c cap1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC306.10 wtf8 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC306.11 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC306.11 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC306.11 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC31H12.02c mug73 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC31H12.02c mug73 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC31H12.02c mug73 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC31H12.04c rpl1202 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC31H12.04c rpl1202 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC31H12.04c rpl1202 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC31H12.04c rpl1202 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC31H12.04c rpl1202 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC31H12.04c rpl1202 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC31H12.06 mug111 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC31H12.06 mug111 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC31H12.06 mug111 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC31H12.08c ccr4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC31H12.08c ccr4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC320.03 rgt1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC320.03 rgt1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC320.03 rgt1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC320.03 rgt1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC320.03 rgt1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC320.03 rgt1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC320.03 rgt1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC320.03 rgt1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC320.03 rgt1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.03 rgt1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC320.03 rgt1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC320.05 sul3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC320.05 sul3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC320.05 sul3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.05 sul3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC320.05 sul3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.05 sul3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC320.06 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC320.06 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC320.06 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.07c mde7 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC320.07c mde7 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC320.07c mde7 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC320.08 qtp1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC320.08 qtp1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC320.08 qtp1 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC320.08 qtp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.09 hem15 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC320.09 hem15 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.09 hem15 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC320.09 hem15 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC320.10 srp72 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC320.11c nip7 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC320.11c nip7 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC320.11c nip7 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC320.11c nip7 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC320.11c nip7 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC320.11c nip7 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC320.11c nip7 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC320.11c nip7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC320.11c nip7 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC320.11c nip7 RNA RNA-sequencing evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC320.11c nip7 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.11c nip7 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC320.12 atp23 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.13c ark1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.13c ark1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC320.14 sry1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC320.14 sry1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC320.14 sry1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC330.01c rhp16 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC330.01c rhp16 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC330.01c rhp16 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC330.01c rhp16 RNA northern assay evidence used in manual assertion increased during(GO:0071494) PMID:8879272 4896 2013-02-05 SPCC330.01c rhp16 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC330.01c rhp16 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC330.01c rhp16 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC330.01c rhp16 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC330.01c rhp16 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC330.01c rhp16 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8879272 4896 2013-02-05 SPCC330.02 rhp7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC330.02 rhp7 RNA northern assay evidence used in manual assertion increased during(GO:0034644) PMID:10446227 4896 2015-04-13 SPCC330.02 rhp7 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC330.02 rhp7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC330.02 rhp7 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC330.02 rhp7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC330.02 rhp7 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10446227 4896 2015-04-13 SPCC330.03c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC330.03c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC330.03c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC330.03c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC330.03c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC330.04c tdk1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC330.04c tdk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC330.04c tdk1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC330.05c ura4 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC330.05c ura4 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC330.05c ura4 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC330.05c ura4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC330.05c ura4 RNA experimental evidence increased in presence of(CHEBI:17234) PMID:12521309 4896 SPCC330.05c ura4 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC330.06c pmp20 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC330.06c pmp20 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC330.06c pmp20 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC330.06c pmp20 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC330.06c pmp20 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC330.06c pmp20 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC330.06c pmp20 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC330.06c pmp20 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC330.06c pmp20 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC330.06c pmp20 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC330.06c pmp20 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC330.06c pmp20 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC330.06c pmp20 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC330.07c RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC330.07c RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC330.07c RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC330.07c RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC330.07c RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC330.07c RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC330.07c RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC330.08 alg11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC330.09 enp2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC330.09 enp2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC330.09 enp2 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC330.12c sdh3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC330.12c sdh3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC330.12c sdh3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC330.12c sdh3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC330.12c sdh3 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPCC330.12c sdh3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC330.14c rpl2402 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC330.14c rpl2402 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC330.14c rpl2402 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC330.14c rpl2402 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC330.14c rpl2402 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC330.20 tam14 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC330.21 new25 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC330.21 new25 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC330.21 new25 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC338.02 mug112 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC338.02 mug112 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC338.02 mug112 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC338.04 mix23 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC338.06c hsp20 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC338.06c hsp20 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC338.06c hsp20 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC338.06c hsp20 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC338.07c naa15 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC338.07c naa15 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC338.07c naa15 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC338.07c naa15 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC338.08 ctp1 protein western blot evidence used in manual assertion absent during(GO:0000080) PMID:17936710 4896 2016-06-23 SPCC338.08 ctp1 protein western blot evidence used in manual assertion increased in presence of(CHEBI:22907) PMID:18378696 4896 2016-08-18 SPCC338.08 ctp1 protein western blot evidence used in manual assertion present during(GO:0000084) PMID:17936710 4896 2016-06-23 SPCC338.08 ctp1 protein western blot evidence used in manual assertion present during(GO:0000085) PMID:17936710 4896 2016-06-23 SPCC338.08 ctp1 protein western blot evidence used in manual assertion present during(GO:0090549) PMID:17936710 4896 2016-06-23 SPCC338.08 ctp1 RNA quantitative PCR increased during(GO:0000084) PMID:17936710 4896 2016-06-23 SPCC338.08 ctp1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC338.10c cox5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC338.10c cox5 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC338.10c cox5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC338.11c efm2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC338.11c efm2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC338.11c efm2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC338.11c efm2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC338.11c efm2 RNA Northern assay evidence decreased during(GO:0042149) PMID:11861905 4896 2021-01-28 (Figure 1a) SPCC338.11c efm2 RNA Northern assay evidence fluctuates during(GO:0000085) PMID:12442907 4896 2021-01-28 SPCC338.11c efm2 RNA increased in presence of(CHEBI:17234) PMID:11861905 4896 SPCC338.11c efm2 RNA Northern assay evidence increased during(GO:0034644) PMID:8048925 4896 2019-04-27 SPCC338.11c efm2 RNA Northern assay evidence increased during(GO:0072703) PMID:8048925 4896 2019-04-27 SPCC338.11c efm2 RNA Northern assay evidence increased in presence of(CHEBI:21759) PMID:8048925 4896 2019-04-27 SPCC338.11c efm2 RNA Northern assay evidence increased in presence of(CHEBI:17234) PMID:11861905 4896 2021-01-28 (Figure 1a) SPCC338.11c efm2 RNA Northern assay evidence increased during(GO:0000087) PMID:12442907 4896 2021-01-28 SPCC338.12 pbi2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC338.12 pbi2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC338.12 pbi2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC338.12 pbi2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC338.12 pbi2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC338.12 pbi2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC338.12 pbi2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC338.12 pbi2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC338.12 pbi2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC338.12 pbi2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC338.12 pbi2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC338.12 pbi2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC338.12 pbi2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC338.12 pbi2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC338.12 pbi2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC338.12 pbi2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC338.12 pbi2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC338.13 cog4 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC338.14 ado1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC338.14 ado1 RNA northern assay evidence used in manual assertion decreased during(GO:0036227) PMID:12827445 4896 2013-09-20 SPCC338.14 ado1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC338.15 wbp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC338.16 pof3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC338.16 pof3 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC338.17c rad21 RNA northern assay evidence used in manual assertion increased during(GO:0000080) PMID:7706319 4896 2013-09-20 SPCC338.17c rad21 RNA northern assay evidence used in manual assertion increased during(GO:0000084) PMID:7706319 4896 2013-09-20 SPCC338.18 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC338.18 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC338.18 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC338.18 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC338.18 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC338.18 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC338.18 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC338.18 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC338.18 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC338.18 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC338.18 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC338.18 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC338.18 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC338.18 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC338.18 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC338.18 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC364.01 cif1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC364.01 cif1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC364.01 cif1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC364.02c bis1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC364.02c bis1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC364.02c bis1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC364.02c bis1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC364.03 rpl1702 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC364.03 rpl1702 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC364.03 rpl1702 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC364.03 rpl1702 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC364.03 rpl1702 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC364.03 rpl1702 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC364.04c coy1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC364.04c coy1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC364.06 nap1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC364.06 nap1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC364.07 ser3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC364.07 ser3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC364.07 ser3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC364.07 ser3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC364.07 ser3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC364.07 ser3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC364.07 ser3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC364.07 ser3 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC417.02 dad5 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC417.02 dad5 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC417.05c cfh2 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC417.05c cfh2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC417.05c cfh2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC417.05c cfh2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC417.05c cfh2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC417.05c cfh2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC417.05c cfh2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC417.05c cfh2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC417.05c cfh2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC417.05c cfh2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC417.05c cfh2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC417.05c cfh2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC417.05c cfh2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC417.05c cfh2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC417.05c cfh2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC417.06c mug27 protein microscopy evidence absent during(GO:0072690) PMID:18562696 4896 2024-08-16 (Fig. 2A) SPCC417.06c mug27 protein Western blot evidence increased during(GO:0098764) PMID:18397994 4896 2024-08-15 (Fig. 2B) SPCC417.06c mug27 protein experimental evidence present during(GO:0007127) PMID:18411246 4896 2008-04-16 SPCC417.06c mug27 RNA experimental evidence increased during(GO:0051321) PMID:18411246 4896 2008-04-16 SPCC417.06c mug27 RNA experimental evidence increased during(GO:0051321) PMID:18397994 4896 2008-04-16 SPCC417.06c mug27 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC417.06c mug27 RNA Northern assay evidence increased during(GO:0098764) PMID:18397994 4896 2024-08-15 (Fig. 2A) SPCC417.08 tef3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC417.08 tef3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC417.08 tef3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC417.08 tef3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC417.08 tef3 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC417.08 tef3 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC417.08 tef3 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC417.08 tef3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC417.09c sdr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC417.10 dal51 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC417.10 dal51 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC417.10 dal51 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC417.10 dal51 RNA quantitative PCR increased during(GO:0010438) PMID:39105351 4896 2024-10-01 SPCC417.11c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC417.11c RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC417.11c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC417.12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC417.12 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC417.16 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC417.16 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC417.16 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4B3.01 tum1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC4B3.01 tum1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC4B3.01 tum1 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPCC4B3.02c got1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC4B3.02c got1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC4B3.02c got1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4B3.03c mam301 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC4B3.03c mam301 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4B3.03c mam301 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4B3.04c nte1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC4B3.04c nte1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4B3.04c nte1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC4B3.04c nte1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4B3.04c nte1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4B3.05c hem12 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4B3.06c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC4B3.06c RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC4B3.07 nro1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC4B3.07 nro1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4B3.07 nro1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC4B3.07 nro1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC4B3.07 nro1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4B3.08 lsg1 protein western blot evidence used in manual assertion unchanged during(GO:0006995) PMID:22144909 4896 2015-11-04 SPCC4B3.08 lsg1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:22144909 4896 2015-11-04 SPCC4B3.09c mrpl12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4B3.09c mrpl12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4B3.09c mrpl12 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC4B3.12 set9 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4B3.13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4B3.13 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4B3.14 cwf20 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4B3.14 cwf20 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC4B3.14 cwf20 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4B3.15 mid1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4B3.15 mid1 RNA northern assay evidence used in manual assertion present during(GO:0010458) PMID:12411492 4896 2015-10-14 SPCC4B3.16 tip41 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4B3.17 cbp3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4B3.17 cbp3 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC4B3.18 ppc1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC4E9.01c rec11 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4E9.01c rec11 RNA Northern assay evidence absent during(GO:0072690) PMID:9076725 4896 2018-06-07 SPCC4E9.01c rec11 RNA northern assay evidence used in manual assertion increased during(GO:0006279) PMID:14648198 4896 2019-08-07 SPCC4E9.01c rec11 RNA Northern assay evidence increased during(GO:0051321) PMID:9076725 4896 2018-06-07 SPCC4E9.01c rec11 RNA Northern assay evidence increased during(GO:0051321) PMID:9671035 4896 2019-11-07 SPCC4E9.01c rec11 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC4E9.01c rec11 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC4E9.02 cig1 protein western blot evidence used in manual assertion absent during(GO:0098765) PMID:11493649 4896 2015-07-16 SPCC4E9.02 cig1 protein western blot evidence used in manual assertion decreased during(GO:0098764) PMID:11493649 4896 2015-07-16 SPCC4E9.02 cig1 protein western blot evidence used in manual assertion increased during(GO:0006279) PMID:11493649 4896 2015-07-16 SPCC4E9.02 cig1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:11493649 4896 2015-07-16 SPCC4E9.02 cig1 RNA northern assay evidence used in manual assertion constant during(GO:0000278) PMID:1829983 4896 2013-03-19 SPCC4E9.02 cig1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4E9.02 cig1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC4F11.02 ptc1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC4F11.02 ptc1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:8196617 4896 2014-08-04 SPCC4F11.02 ptc1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4F11.02 ptc1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC4F11.02 ptc1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC4F11.02 ptc1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC4F11.02 ptc1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC4F11.02 ptc1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC4F11.02 ptc1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC4F11.02 ptc1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC4F11.02 ptc1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC4F11.02 ptc1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4F11.02 ptc1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC4F11.02 ptc1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC4F11.02 ptc1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:8196617 4896 2014-08-04 SPCC4F11.03c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4F11.03c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4F11.04c imt2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4F11.04c imt2 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC4F11.04c imt2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC4F11.04c imt2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4F11.04c imt2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC4F11.04c imt2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4F11.04c imt2 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC4G3.02 aph1 protein western blot evidence used in manual assertion absent during(GO:0044838) PMID:31538680 4896 2019-10-14 SPCC4G3.02 aph1 protein western blot evidence used in manual assertion decreased during(GO:0071456) PMID:31538680 4896 2019-10-14 SPCC4G3.02 aph1 protein western blot evidence used in manual assertion decreased during(GO:0042149) PMID:31538680 4896 2019-10-14 SPCC4G3.02 aph1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC4G3.02 aph1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC4G3.02 aph1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:31538680 4896 2019-10-14 SPCC4G3.03 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC4G3.03 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC4G3.03 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC4G3.03 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC4G3.03 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC4G3.03 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC4G3.03 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC4G3.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC4G3.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC4G3.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC4G3.03 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC4G3.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4G3.03 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC4G3.03 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC4G3.03 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC4G3.04c coq5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4G3.04c coq5 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4G3.05c mus81 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC4G3.06c mrpl4 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC4G3.06c mrpl4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4G3.07c phf1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC4G3.07c phf1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4G3.08 psk1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4G3.08 psk1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4G3.08 psk1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4G3.09c gyp3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4G3.10c rhp42 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC4G3.11 nur1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4G3.11 nur1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC4G3.11 nur1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4G3.12c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC4G3.12c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC4G3.12c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC4G3.13c cue1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC4G3.13c cue1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4G3.14 mdj1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4G3.14 mdj1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC4G3.14 mdj1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC4G3.17 hdd1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC4G3.17 hdd1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC4G3.17 hdd1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC4G3.17 hdd1 RNA northern assay evidence used in manual assertion decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4G3.17 hdd1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC4G3.17 hdd1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC4G3.18 rix1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC548.02c wtf3 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC548.03c wtf4 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC548.03c wtf4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC548.04 urm1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC548.06c ght8 protein western blot evidence used in manual assertion decreased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPCC548.06c ght8 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC548.06c ght8 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC548.06c ght8 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC548.06c ght8 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:25411338 4896 2015-08-17 SPCC548.06c ght8 RNA quantitative PCR decreased during(GO:0042149) PMID:25411338 4896 2015-08-17 SPCC548.06c ght8 RNA reverse transcription polymerase chain reaction transcription evidence decreased during(GO:0071281) PMID:30730059 4896 2019-11-13 SPCC548.06c ght8 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC548.06c ght8 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC548.06c ght8 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC548.07c ght1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC548.07c ght1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC548.07c ght1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC548.07c ght1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC548.07c ght1 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPCC548.07c ght1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC548.07c ght1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC548.07c ght1 RNA expression microarray evidence increased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC548.07c ght1 RNA reverse transcription polymerase chain reaction transcription evidence unchanged during(GO:0071281) PMID:30730059 4896 2019-11-13 SPCC548.07c ght1 RNA northern assay evidence used in manual assertion present during(GO:0071333) PMID:9090050 4896 2012-11-27 SPCC550.03c ski2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC550.05 nse1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC550.05 nse1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC550.05 nse1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC550.06c hsp10 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC550.06c hsp10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC550.06c hsp10 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC550.06c hsp10 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC550.06c hsp10 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC550.07 fah2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC550.07 fah2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC550.07 fah2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC550.08 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC550.09 pex32 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC550.10 atd3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC550.10 atd3 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPCC550.10 atd3 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC550.10 atd3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC550.11 nmd5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC550.11 nmd5 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC550.13 dfp1 protein western blot evidence used in manual assertion absent during(GO:0000080) PMID:10411894 4896 2012-09-03 SPCC550.13 dfp1 protein western blot evidence used in manual assertion decreased during(GO:0000086) PMID:10411894 4896 2012-09-03 SPCC550.13 dfp1 protein western blot evidence used in manual assertion decreased during(GO:0000087) PMID:10411894 4896 2012-09-03 SPCC550.13 dfp1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC550.13 dfp1 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:10409743 4896 2012-09-03 SPCC550.13 dfp1 protein western blot evidence used in manual assertion increased during(GO:0000085) PMID:10411894 4896 2012-09-03 SPCC550.13 dfp1 protein western blot evidence used in manual assertion increased during(GO:0000084) PMID:10411894 4896 2012-09-03 SPCC550.13 dfp1 RNA northern assay evidence used in manual assertion absent during(GO:0000087) PMID:10411894 4896 2012-09-03 SPCC550.13 dfp1 RNA northern assay evidence used in manual assertion decreased during(GO:0000080) PMID:10411894 4896 2012-09-03 SPCC550.13 dfp1 RNA northern assay evidence used in manual assertion increased during(GO:0000087) PMID:10409743 4896 2012-09-03 SPCC550.13 dfp1 RNA northern assay evidence used in manual assertion increased during(GO:0000080) PMID:10409743 4896 2012-09-03 SPCC550.13 dfp1 RNA northern assay evidence used in manual assertion increased during(GO:0000082) PMID:10411894 4896 2012-09-03 SPCC550.13 dfp1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC550.14 vgl1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC550.14 vgl1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC550.14 vgl1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC550.15c rei1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC550.15c rei1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC553.02 qns1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC553.03 pex1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC553.05c wtf6 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC553.06 swp1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC553.06 swp1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC553.07c kpa1 protein western blot evidence used in manual assertion increased during(GO:0006974) PMID:12514100 4896 2014-03-03 SPCC553.07c kpa1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC553.07c kpa1 RNA northern assay evidence used in manual assertion increased during(GO:0006974) PMID:12514100 4896 2014-03-03 SPCC553.07c kpa1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC553.08c ria1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC553.09c spb70 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC553.10 knh3 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC553.10 knh3 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC553.10 knh3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC569.01c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC569.01c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC569.01c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC569.01c protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC569.01c protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPCC569.01c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC569.01c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC569.01c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC569.01c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC569.03 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC569.03 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC569.03 protein high throughput evidence used in manual assertion increased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPCC569.03 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC569.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC569.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC569.03 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC569.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC569.05c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC569.05c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC569.05c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC569.05c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC569.05c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC569.06 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC569.06 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC569.06 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC569.07 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC569.07 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC569.07 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC569.08c ade5 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC569.08c ade5 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC569.09 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC569.09 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC569.09 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC576.01c xan1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC576.01c xan1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC576.01c xan1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC576.01c xan1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC576.01c xan1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC576.02 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC576.02 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC576.03c tpx1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23115244 4896 2012-02-20 SPCC576.03c tpx1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC576.03c tpx1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC576.03c tpx1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC576.03c tpx1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC576.03c tpx1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC576.03c tpx1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC576.03c tpx1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC576.03c tpx1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC576.03c tpx1 RNA quantitative PCR increased in presence of(CHEBI:142517) PMID:35416247 4896 2022-07-04 SPCC576.03c tpx1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23115244 4896 2012-02-20 SPCC576.04 bxi1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC576.04 bxi1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC576.04 bxi1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC576.04 bxi1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC576.04 bxi1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC576.04 bxi1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC576.04 bxi1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC576.04 bxi1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC576.04 bxi1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC576.04 bxi1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC576.04 bxi1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC576.04 bxi1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC576.04 bxi1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC576.04 bxi1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC576.08c rps2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC576.08c rps2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC576.08c rps2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC576.08c rps2 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC576.08c rps2 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC576.08c rps2 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC576.09 rps20 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC576.09 rps20 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC576.09 rps20 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC576.11 rpl15 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC576.11 rpl15 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC576.11 rpl15 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC576.11 rpl15 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC576.11 rpl15 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC576.12c mhf2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC576.12c mhf2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC576.13 swc5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC576.14 dph5 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC576.14 dph5 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC576.16c wtf22 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC576.17c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC576.17c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC576.17c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC576.17c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC576.17c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC576.17c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC576.19c RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPCC584.01c met10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC584.01c met10 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC584.01c met10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC584.01c met10 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC584.02 cuf2 protein Western blot evidence increased during(GO:0098765) PMID:23628763 4896 2019-10-11 SPCC584.02 cuf2 RNA RNA protection assay evidence absent during(GO:0072690) PMID:22558440 4896 2013-01-22 SPCC584.02 cuf2 RNA RNA protection assay evidence absent during(GO:0035874) PMID:22558440 4896 2013-01-22 SPCC584.02 cuf2 RNA RNA protection assay evidence absent during(GO:0071280) PMID:22558440 4896 2013-01-22 SPCC584.02 cuf2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC584.04 sup35 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC584.04 sup35 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC584.04 sup35 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC584.11c svf1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC584.12 mug42 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC584.13 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC584.13 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC584.13 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC584.13 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC584.13 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC584.13 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC584.13 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC584.13 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC584.13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC584.14 mug160 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC584.14 mug160 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC584.14 mug160 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC584.15c aly3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC584.15c aly3 RNA quantitative PCR increased during(GO:0006995) PMID:34028542 4896 2021-06-17 After cultivation in low glucose MM for 10 h, medium was replaced with low-glucose nitrogen-starved MM, and cells were further cultivated for 4 h. SPCC584.15c aly3 RNA quantitative PCR unchanged during(GO:0042149) PMID:34028542 4896 2021-06-17 (Fig. 5) SPCC584.16c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC584.16c RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC584.16c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC584.16c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC594.02c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC594.02c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC594.04c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC594.04c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC594.04c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC594.04c ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC594.04c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC594.04c ribosomal density ribosome profiling evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC594.04c ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC594.04c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC594.04c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC594.04c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC594.04c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC594.04c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC594.04c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC594.06c vsl1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC594.07c bqt3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC594.07c bqt3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC594.07c bqt3 RNA expression microarray evidence increased during(GO:0006995) PMID:19948484 4896 2015-09-25 SPCC594.07c bqt3 RNA expression microarray evidence increased during(GO:0071444),during(GO:0006995) PMID:19948484 4896 2015-09-25 SPCC594.07c bqt3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC594.07c bqt3 RNA expression microarray evidence present during(GO:0072690) PMID:19948484 4896 2015-09-25 SPCC5E4.03c taf5 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC5E4.03c taf5 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC5E4.05c mgl1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC5E4.07 rpl2802 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC5E4.07 rpl2802 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC5E4.07 rpl2802 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC5E4.07 rpl2802 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC5E4.10c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC61.01c str2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC61.01c str2 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC61.01c str2 RNA northern assay evidence used in manual assertion decreased during(GO:0071281) PMID:12888492 4896 2015-06-12 SPCC61.01c str2 RNA northern assay evidence used in manual assertion increased during(GO:0010106) PMID:12888492 4896 2015-06-12 SPCC61.01c str2 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC61.01c str2 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:12888492 4896 2015-06-12 SPCC61.02 spt3 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPCC61.03 nnr2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC61.03 nnr2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC61.03 nnr2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC61.03 nnr2 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC61.03 nnr2 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC61.03 nnr2 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC61.03 nnr2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC61.03 nnr2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC61.03 nnr2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC61.03 nnr2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC61.03 nnr2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC61.03 nnr2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC61.03 nnr2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC61.03 nnr2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC61.04c yip1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC61.05 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC61.05 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC61.05 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC61.05 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC613.01 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC613.01 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC613.02 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC613.02 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC613.04c rng3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC613.04c rng3 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC613.05c rpl35 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC613.05c rpl35 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC613.05c rpl35 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC613.05c rpl35 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC613.05c rpl35 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC613.05c rpl35 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC613.06 rpl902 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC613.06 rpl902 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC613.06 rpl902 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC613.06 rpl902 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC613.07 bcd1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC613.08 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC613.08 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC613.08 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC613.08 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC613.08 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC613.08 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC613.09 sen54 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC613.09 sen54 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPCC613.10 qcr2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC613.10 qcr2 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC613.11c meu23 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC613.11c meu23 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC613.11c meu23 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPCC613.11c meu23 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC613.12c raf1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC622.03c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC622.06c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC622.06c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC622.07 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC622.08c hta1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC622.09 htb1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC622.09 htb1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC622.09 htb1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC622.10c sec5 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC622.11 lmb1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC622.11 lmb1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC622.11 lmb1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC622.11 lmb1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC622.12c gdh1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC622.12c gdh1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC622.12c gdh1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC622.12c gdh1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC622.14 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC622.14 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC622.14 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC622.15c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC622.15c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC622.15c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC622.15c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC622.16c epe1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC622.16c epe1 protein Western blot evidence decreased during(GO:0042149) PMID:35171902 4896 2022-02-26 SPCC622.16c epe1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC622.16c epe1 RNA quantitative PCR increased during(GO:0042149) PMID:35171902 4896 2022-02-26 SPCC622.16c epe1 RNA quantitative PCR unchanged in presence of(CHEBI:27732) PMID:32908306 4896 2021-04-13 SPCC622.18 rpl6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC622.18 rpl6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC622.18 rpl6 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC622.18 rpl6 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC622.18 rpl6 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC622.18 rpl6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC622.18 rpl6 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC622.19 jmj4 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC622.21 wtf12 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC622.21 wtf12 RNA experimental evidence increased during(GO:0051321) 4896 2010-03-17 SPCC63.02c aah3 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC63.03 mib1 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPCC63.04 mok14 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC63.04 mok14 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC63.04 mok14 RNA Northern assay evidence absent during(GO:0072690) PMID:16420355 4896 2020-10-21 SPCC63.04 mok14 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC63.04 mok14 RNA Northern assay evidence increased during(GO:0030437) PMID:16420355 4896 2020-10-21 SPCC63.05 tap42 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC63.06 wdr89 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC63.07 thg1 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC63.08c atg1 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC63.08c atg1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC63.08c atg1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC63.08c atg1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC63.08c atg1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC63.08c atg1 RNA quantitative PCR increased during(GO:0010438) PMID:33064910 4896 2020-10-28 SPCC63.11 prp28 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC63.11 prp28 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC63.11 prp28 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC63.12c pup3 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC63.13 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC63.13 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC63.13 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC63.13 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC63.14 eis1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC63.14 eis1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC63.14 eis1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC63.14 eis1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC63.14 eis1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC63.14 eis1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC63.14 eis1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC63.14 eis1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC63.14 eis1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC63.14 eis1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC63.14 eis1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC63.14 eis1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC63.14 eis1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC63.14 eis1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC63.14 eis1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC645.02 gep4 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC645.02 gep4 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPCC645.03c isa1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC645.03c isa1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC645.03c isa1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPCC645.03c isa1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:16963626 4896 2019-05-24 SPCC645.03c isa1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC645.03c isa1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC645.03c isa1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC645.03c isa1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC645.06c rgf3 RNA Northern assay evidence increased during(GO:0000093) PMID:15546915 4896 2022-03-30 SPCC645.07 rgf1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC645.07 rgf1 protein microscopy evidence decreased in presence of(CHEBI:32588) PMID:39509469 4896 2025-01-30 (Fig. 5E) SPCC645.07 rgf1 protein microscopy evidence decreased in presence of(CHEBI:17924) PMID:39509469 4896 2025-01-30 (Fig. 5E) SPCC645.07 rgf1 protein microscopy evidence decreased during(GO:0034605) PMID:39509469 4896 2025-01-30 (Fig. 5E) SPCC645.07 rgf1 protein microscopy evidence decreased in presence of(CHEBI:69136) PMID:39509469 4896 2025-01-30 (Fig. S5D) SPCC645.08c snd1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC645.08c snd1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC645.08c snd1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC645.09 mrpl37 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC645.09 mrpl37 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC645.11c mug117 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC645.11c mug117 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC645.14c sti1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC645.14c sti1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC645.14c sti1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC645.14c sti1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC645.14c sti1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC645.14c sti1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC663.02 wtf14 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC663.02 wtf14 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC663.03 pmd1 protein high throughput evidence used in manual assertion decreased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC663.03 pmd1 protein mass spectrometry evidence fluctuates during(GO:0000278) PMID:24763107 4896 2014-05-01 SPCC663.03 pmd1 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:9585505 4896 2012-02-29 SPCC663.03 pmd1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:9585505 4896 2012-02-29 SPCC663.03 pmd1 RNA reverse transcription polymerase chain reaction transcription evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-17 SPCC663.03 pmd1 RNA reverse transcription polymerase chain reaction transcription evidence increased during(GO:0071409) PMID:22840777 4896 2012-10-17 SPCC663.03 pmd1 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC663.03 pmd1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC663.03 pmd1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC663.03 pmd1 RNA reverse transcription polymerase chain reaction transcription evidence present during(GO:0072690) PMID:22840777 4896 2012-10-17 SPCC663.04 rpl39 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC663.04 rpl39 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC663.04 rpl39 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC663.04 rpl39 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC663.04 rpl39 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC663.05c asf1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC663.06c osr1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC663.06c osr1 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC663.06c osr1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC663.07c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC663.07c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC663.07c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC663.08c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC663.08c RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23115244 4896 2012-02-20 SPCC663.08c RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC663.08c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC663.08c RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPCC663.08c RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPCC663.08c RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPCC663.09c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC663.09c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC663.11 saf1 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC663.12 cid12 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC663.13c naa50 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC663.13c naa50 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC663.13c naa50 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC663.13c naa50 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC663.13c naa50 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC663.14c trp663 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC663.14c trp663 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC663.14c trp663 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC663.15c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC663.15c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC663.17 wtf15 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC663.18 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC663.18 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC663.18 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC70.02c inh1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC70.02c inh1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC70.02c inh1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC70.02c inh1 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC70.02c inh1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC70.02c inh1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC70.03c put1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC70.03c put1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC70.03c put1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC70.04c npr1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC70.04c npr1 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC70.04c npr1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC70.04c npr1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC70.06 sac32 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC70.07c tmp1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC70.08c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC70.08c RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC70.08c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC70.08c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC70.08c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC70.09c gsr2 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC70.10 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC70.10 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC70.10 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC70.10 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC70.10 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC70.10 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC70.12c ecl1 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:21307597 4896 2015-03-31 SPCC70.12c ecl1 protein western blot evidence used in manual assertion decreased during(GO:0036227) PMID:18422613 4896 2014-08-21 SPCC70.12c ecl1 protein western blot evidence used in manual assertion increased during(GO:0036227) PMID:21307597 4896 2015-03-31 SPCC70.12c ecl1 protein western blot evidence used in manual assertion increased during(GO:0006995) PMID:21307597 4896 2015-03-31 SPCC70.12c ecl1 protein fusion protein localization evidence increased during(GO:0010438) PMID:28388826 4896 2019-10-04 SPCC70.12c ecl1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:18422613 4896 2014-08-21 SPCC70.12c ecl1 protein western blot evidence used in manual assertion present during(GO:0072690) PMID:21307597 4896 2015-03-31 SPCC70.12c ecl1 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:18422613 4896 2014-08-21 SPCC70.12c ecl1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:21307597 4896 2015-03-31 SPCC70.12c ecl1 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:21072667 4896 2015-04-09 SPCC70.12c ecl1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:24696293 4896 2015-04-17 SPCC70.12c ecl1 RNA quantitative PCR increased during(GO:0010438) PMID:28388826 4896 2019-10-04 SPCC70.12c ecl1 RNA quantitative PCR increased during(GO:0034198) PMID:31456006 4896 2019-10-24 SPCC70.12c ecl1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC70.12c ecl1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC70.12c ecl1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC70.12c ecl1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC70.12c ecl1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC70.12c ecl1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC70.12c ecl1 RNA quantitative PCR increased during(GO:0010350) PMID:33970532 4896 2021-05-21 SPCC70.12c ecl1 RNA northern assay evidence used in manual assertion unchanged during(GO:0034605) PMID:21072667 4896 2015-04-09 SPCC70.12c ecl1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:18422613 4896 2014-08-21 SPCC70.12c ecl1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:24696293 4896 2015-04-17 SPCC736.02 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC736.02 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC736.04c gma12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC736.04c gma12 protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC736.05 wtf7 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC736.05 wtf7 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC736.05 wtf7 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC736.06 dar2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC736.08 cbf11 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC736.08 cbf11 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC736.08 cbf11 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC736.09c tfx1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC736.10c mrps8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC736.12c mmi1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC736.12c mmi1 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:16823445 4896 2014-01-09 SPCC736.12c mmi1 RNA northern assay evidence used in manual assertion increased during(GO:0051321) PMID:16823445 4896 2014-01-09 SPCC736.13 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC736.13 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC736.13 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC736.13 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCC736.13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC736.14 dis1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC736.14 dis1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC736.14 dis1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC736.15 pil1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC736.15 pil1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC736.15 pil1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC736.15 pil1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC736.15 pil1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC736.15 pil1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC736.15 pil1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC736.15 pil1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC736.15 pil1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC736.15 pil1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC736.15 pil1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC737.02c qcr7 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC737.02c qcr7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC737.02c qcr7 RNA expression microarray evidence decreased during(GO:0071456) PMID:22235339 4896 2015-09-16 SPCC737.03c ima1 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC737.04 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC737.04 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC737.04 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCC737.04 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC737.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC737.04 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC737.05 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC737.05 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC737.05 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC737.06c gcs2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC737.07c RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC737.08 mdn1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC737.09c hmt1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC737.09c hmt1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC737.09c hmt1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC737.09c hmt1 RNA RNA protection assay evidence unchanged during(GO:0010106) PMID:19915076 4896 2019-05-27 SPCC737.09c hmt1 RNA RNA protection assay evidence unchanged during(GO:0071281) PMID:19915076 4896 2019-05-27 SPCC74.01 sly1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC74.04 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC74.04 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC74.04 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC74.05 rpl2702 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC74.05 rpl2702 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC74.05 rpl2702 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC74.05 rpl2702 ribosomal density ribosome profiling evidence decreased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC74.05 rpl2702 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC74.05 rpl2702 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC74.05 rpl2702 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC74.06 mak3 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC74.09 mug24 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC74.09 mug24 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC74.09 mug24 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC74.09 mug24 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC74.09 mug24 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC757.02c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC757.02c RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC757.02c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 protein high throughput evidence used in manual assertion decreased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCC757.03c hsp3101 protein western blot evidence used in manual assertion increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPCC757.03c hsp3101 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC757.03c hsp3101 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC757.03c hsp3101 ribosomal density ribosome profiling evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC757.03c hsp3101 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 ribosomal density ribosome profiling evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 ribosomal density ribosome profiling evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 RNA quantitative PCR increased during(GO:0036227) PMID:26624998 4896 2015-01-28 SPCC757.03c hsp3101 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC757.03c hsp3101 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC757.03c hsp3101 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC757.03c hsp3101 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC757.03c hsp3101 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC757.03c hsp3101 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC757.03c hsp3101 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC757.03c hsp3101 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC757.03c hsp3101 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC757.03c hsp3101 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC757.04 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC757.05c dug2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC757.07c ctt1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC757.07c ctt1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC757.07c ctt1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:9585505 4896 2012-02-29 SPCC757.07c ctt1 RNA RNA protection assay evidence decreased during(GO:0010106) PMID:18223116 4896 2019-05-23 SPCC757.07c ctt1 RNA quantitative PCR increased in presence of(CHEBI:142517) PMID:29900664 4896 2018-11-13 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:9585505 4896 2012-02-29 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:8537298 4896 2012-05-28 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0071475) PMID:8537298 4896 2012-05-28 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0071471) PMID:8537298 4896 2012-05-28 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0071494) PMID:8537298 4896 2012-05-28 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0036245) PMID:8537298 4896 2012-05-28 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:18758731 4896 2013-09-17 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:23874237 4896 2013-03-10 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:24118096 4896 2014-04-20 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:10348908 4896 2014-07-02 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:9450957 4896 2014-12-09 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0072709) PMID:8824588 4896 2015-01-07 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0034644) PMID:9154834 4896 2015-05-13 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0071472) PMID:12221110 4896 2015-12-16 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12221110 4896 2015-12-16 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion increased during(GO:0034605) PMID:12221110 4896 2015-12-16 SPCC757.07c ctt1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC757.07c ctt1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC757.07c ctt1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC757.07c ctt1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC757.07c ctt1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC757.07c ctt1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC757.07c ctt1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC757.07c ctt1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC757.07c ctt1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC757.07c ctt1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC757.07c ctt1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC757.07c ctt1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC757.07c ctt1 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC757.07c ctt1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC757.07c ctt1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC757.07c ctt1 RNA quantitative PCR increased in presence of(CHEBI:192760) PMID:35416247 4896 2022-08-02 SPCC757.07c ctt1 RNA quantitative PCR increased during(GO:0071447) PMID:33410907 4896 2021-01-12 (Figure 1) SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion unchanged during(GO:0070417) PMID:8537298 4896 2013-10-01 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion unchanged during(GO:0071287) PMID:8537298 4896 2013-10-01 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion unchanged during(GO:0071276) PMID:8537298 4896 2013-10-01 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion unchanged during(GO:0071493) PMID:8537298 4896 2013-10-01 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:23874237 4896 2013-03-10 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:10348908 4896 2014-07-02 SPCC757.07c ctt1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9154834 4896 2015-05-13 SPCC757.08 rrp45 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC757.08 rrp45 RNA expression microarray evidence increased in presence of(CHEBI:46345) PMID:24223771 4896 2024-12-06 (Table 1) SPCC757.09c rnc1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC757.09c rnc1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC757.10 vph2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC757.11c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC757.11c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC757.11c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC757.11c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC757.11c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC757.11c RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC757.12 aah1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC757.12 aah1 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC757.13 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC757.13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC777.03c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC777.05 gtr2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC777.05 gtr2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC777.05 gtr2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC777.06c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC777.07 omh3 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC777.07 omh3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC777.09c arg1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC777.09c arg1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC777.09c arg1 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC777.09c arg1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC777.09c arg1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC777.10c ubc12 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC777.10c ubc12 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC777.10c ubc12 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC777.12c protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC777.13 vps35 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC777.13 vps35 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC777.14 prp4 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC777.15 dus4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC777.15 dus4 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC777.15 dus4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC777.17c protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC777.17c RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC777.17c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC790.03 rbd2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC790.03 rbd2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC794.01c gcd1 protein western blot evidence used in manual assertion increased during(GO:0034224) PMID:28667014 4896 2017-07-28 SPCC794.01c gcd1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC794.01c gcd1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC794.01c gcd1 RNA expression microarray evidence decreased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPCC794.01c gcd1 RNA northern assay evidence used in manual assertion increased during(GO:0034224) PMID:28667014 4896 2017-07-28 SPCC794.01c gcd1 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPCC794.01c gcd1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC794.02 wtf5 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC794.02 wtf5 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC794.03 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC794.03 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC794.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC794.03 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC794.04c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC794.04c protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC794.04c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC794.04c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC794.04c RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC794.04c RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC794.04c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC794.04c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC794.04c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC794.04c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC794.04c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC794.04c RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC794.04c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC794.07 lat1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC794.07 lat1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC794.08 efr3 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC794.08 efr3 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC794.08 efr3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC794.09c tef101 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC794.09c tef101 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC794.09c tef101 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC794.09c tef101 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC794.09c tef101 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC794.09c tef101 RNA northern assay evidence used in manual assertion decreased during(GO:0034644) PMID:9099890 4896 2014-10-27 SPCC794.09c tef101 RNA northern assay evidence used in manual assertion decreased during(GO:0034605) PMID:9099890 4896 2014-10-27 SPCC794.09c tef101 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC794.09c tef101 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:9099890 4896 2014-10-27 SPCC794.12c mae2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC794.12c mae2 protein western blot evidence used in manual assertion increased during(GO:0071333) PMID:11453251 4896 2013-09-03 SPCC794.12c mae2 protein western blot evidence used in manual assertion increased during(GO:0071456) PMID:11453251 4896 2013-09-03 SPCC794.12c mae2 RNA northern assay evidence used in manual assertion increased during(GO:0071333) PMID:11453251 4896 2013-09-03 SPCC794.12c mae2 RNA northern assay evidence used in manual assertion increased during(GO:0071456) PMID:11453251 4896 2013-09-03 SPCC794.12c mae2 RNA reporter gene assay evidence increased during(GO:0071333) PMID:11453251 4896 2013-09-03 SPCC794.12c mae2 RNA reporter gene assay evidence increased during(GO:0071456) PMID:11453251 4896 2013-09-03 SPCC794.12c mae2 RNA reporter gene assay evidence increased during(GO:0071333) PMID:10187772 4896 2013-09-03 SPCC794.12c mae2 RNA reporter gene assay evidence increased during(GO:0071456) PMID:10187772 4896 2013-09-03 SPCC794.12c mae2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC794.12c mae2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC794.12c mae2 RNA reporter gene assay evidence unchanged during(GO:0072709) PMID:11453251 4896 2013-09-03 SPCC794.12c mae2 RNA reporter gene assay evidence unchanged during(GO:0071472) PMID:11453251 4896 2013-09-03 SPCC825.01 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC825.01 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC825.01 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC825.03c psy1 RNA experimental evidence increased during(GO:0034293) 4896 SPCC825.03c psy1 RNA northern assay evidence used in manual assertion increased during(GO:0007135) PMID:11739793 4896 2015-03-31 SPCC825.03c psy1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC825.03c psy1 RNA northern assay evidence used in manual assertion present during(GO:0072690) PMID:11739793 4896 2015-03-31 SPCC825.04c naa40 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC825.05c pwi1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC830.03 grc3 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC830.04c mug128 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC830.04c mug128 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC830.05c epl1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC830.07c psi1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC830.07c psi1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC830.07c psi1 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC830.07c psi1 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC830.07c psi1 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC830.07c psi1 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC830.07c psi1 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC830.07c psi1 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC830.07c psi1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC830.07c psi1 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC830.07c psi1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC830.08c yop1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC830.08c yop1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC830.08c yop1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC830.08c yop1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC830.08c yop1 RNA quantitative PCR decreased in presence of(CHEBI:29699) PMID:38360270 4896 2024-03-14 SPCC830.08c yop1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC830.08c yop1 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC830.08c yop1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC830.10 ham1 RNA RNA-sequencing evidence increased during(GO:0016036) PMID:36794724 4896 2023-08-11 (Figure 2) SPCC830.11c fap7 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC895.04c ufe1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC895.05 for3 protein Western blot evidence decreased during(GO:0034599) PMID:32915139 4896 2020-10-21 We found that total For3 levels also decline in S. pombe wild-type cells in response to stimuli that activate Sty1, like heat shock (40 ̊C), osmotic saline (0.6 M KCl), and oxidative stress (1 mM H2O2) (Pe ́rez and Cansado, 2010) in a MAPK-dependent manner (Figure 5—Figure supplement 3). SPCC895.05 for3 protein Western blot evidence decreased during(GO:0034605) PMID:32915139 4896 2020-10-21 We found that total For3 levels also decline in S. pombe wild-type cells in response to stimuli that activate Sty1, like heat shock (40 ̊C), osmotic saline (0.6 M KCl), and oxidative stress (1 mM H2O2) (Pe ́rez and Cansado, 2010) in a MAPK-dependent manner (Figure 5—Figure supplement 3). SPCC895.05 for3 protein Western blot evidence decreased during(GO:0071475) PMID:32915139 4896 2020-10-21 We found that total For3 levels also decline in S. pombe wild-type cells in response to stimuli that activate Sty1, like heat shock (40 ̊C), osmotic saline (0.6 M KCl), and oxidative stress (1 mM H2O2) (Pe ́rez and Cansado, 2010) in a MAPK-dependent manner (Figure 5—Figure supplement 3). SPCC895.05 for3 protein Western blot evidence decreased during(GO:0120306) PMID:32915139 4896 2020-10-26 SPCC895.05 for3 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC895.05 for3 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC895.05 for3 RNA quantitative PCR increased during(GO:0120306) PMID:32915139 4896 2020-10-26 SPCC895.06 elp2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC895.06 elp2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC895.06 elp2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC895.08c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC895.08c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC895.08c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC895.08c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC895.09c ucp12 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC962.01 tcb1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC962.01 tcb1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC962.01 tcb1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC962.02c bir1 protein reporter gene assay evidence increased during(GO:0071500) PMID:17473896 4896 2014-12-03 SPCC962.02c bir1 protein reporter gene assay evidence increased during(GO:0006995) PMID:17473896 4896 2014-12-03 SPCC962.02c bir1 protein reporter gene assay evidence increased during(GO:0042149) PMID:17205051 4896 2014-12-03 SPCC962.02c bir1 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC962.02c bir1 RNA quantitative PCR increased during(GO:0072690) PMID:17473896 4896 2014-12-03 SPCC962.02c bir1 RNA quantitative PCR increased during(GO:0071500) PMID:17473896 4896 2014-12-03 SPCC962.02c bir1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC962.03c cut15 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCC962.04 rps1201 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC962.04 rps1201 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC962.04 rps1201 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC962.04 rps1201 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC962.04 rps1201 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCC962.05 ast1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC962.05 ast1 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC962.05 ast1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC965.04c yme1 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC965.04c yme1 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC965.05c thp1 ribosomal density ribosome profiling evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC965.06 osr2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC965.06 osr2 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC965.06 osr2 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC965.06 osr2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC965.06 osr2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC965.06 osr2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC965.06 osr2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC965.06 osr2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC965.06 osr2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC965.06 osr2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC965.06 osr2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC965.06 osr2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC965.06 osr2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC965.07c gst2 protein reporter gene assay evidence increased during(GO:0036245) PMID:11997110 4896 2014-11-03 SPCC965.07c gst2 protein reporter gene assay evidence increased during(GO:0071288) PMID:11997110 4896 2014-11-03 SPCC965.07c gst2 protein reporter gene assay evidence increased during(GO:0071732) PMID:11997110 4896 2014-11-03 SPCC965.07c gst2 protein reporter gene assay evidence increased during(GO:0036245) PMID:12521308 4896 2014-11-03 SPCC965.07c gst2 protein reporter gene assay evidence increased during(GO:0071732) PMID:12521308 4896 2014-11-03 SPCC965.07c gst2 protein reporter gene assay evidence increased during(GO:0071288) PMID:12521308 4896 2014-11-03 SPCC965.07c gst2 protein reporter gene assay evidence increased during(GO:0036245) PMID:15650330 4896 2014-11-20 SPCC965.07c gst2 protein reporter gene assay evidence increased during(GO:0071500) PMID:15650330 4896 2014-11-20 SPCC965.07c gst2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC965.07c gst2 protein reporter gene assay evidence unchanged during(GO:0042149) PMID:15650330 4896 2014-11-20 SPCC965.07c gst2 protein reporter gene assay evidence present during(GO:0072690) PMID:15650330 4896 2014-11-20 SPCC965.07c gst2 RNA northern assay evidence used in manual assertion increased during(GO:0036245) PMID:15650330 4896 2014-11-20 SPCC965.07c gst2 RNA northern assay evidence used in manual assertion increased during(GO:0071500) PMID:15650330 4896 2014-11-20 SPCC965.07c gst2 RNA northern assay evidence used in manual assertion increased during(GO:0036227) PMID:12063243 4896 2014-11-20 SPCC965.07c gst2 RNA northern assay evidence used in manual assertion increased during(GO:0070301) PMID:12063243 4896 2014-11-20 SPCC965.07c gst2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC965.07c gst2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCC965.07c gst2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC965.07c gst2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC965.07c gst2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCC965.07c gst2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCC965.07c gst2 RNA RNA-sequencing evidence increased in presence of(CHEBI:44423) PMID:41259369 4896 2026-02-06 SPCC965.07c gst2 RNA RNA-sequencing evidence increased in presence of(CHEBI:48958) PMID:41259369 4896 2026-02-12 SPCC965.07c gst2 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPCC965.08c alr1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC965.09 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC965.11c agp3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC965.11c agp3 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC965.11c agp3 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC965.11c agp3 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPCC965.12 dpe2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC965.12 dpe2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC965.12 dpe2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC965.12 dpe2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCC965.13 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC965.13 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC965.13 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCC965.13 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCC965.13 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCC965.13 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCC965.13 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCC965.13 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC965.13 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC965.13 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCC965.13 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCC965.13 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC965.14c fcy1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC965.14c fcy1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC970.02 dcw1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPCC970.03 cbr1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC970.04c mob2 protein western blot evidence used in manual assertion constant during(GO:0000278) PMID:12456722 4896 2017-08-15 SPCC970.05 rpl3601 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCC970.05 rpl3601 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCC970.05 rpl3601 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC970.05 rpl3601 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCC970.05 rpl3601 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCC970.06 erv29 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCC970.06 erv29 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCC970.10c brl2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCC970.11c wtf9 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCC970.11c wtf9 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCC970.12 mis18 RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-20 SPCP1E11.02 ppk38 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP1E11.03 mug170 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP1E11.03 mug170 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCP1E11.04c pal1 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCP1E11.05c are2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCP1E11.05c are2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCP1E11.05c are2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCP1E11.05c are2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCP1E11.05c are2 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCP1E11.06 apl4 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCP1E11.08 nsa2 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCP1E11.08 nsa2 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP1E11.08 nsa2 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCP1E11.08 nsa2 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCP1E11.09c rpp103 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP1E11.09c rpp103 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCP1E11.09c rpp103 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCP1E11.10 dhm1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP1E11.11 puf6 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP1E11.11 puf6 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCP1E11.11 puf6 RNA expression microarray evidence decreased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCP1E11.11 puf6 RNA expression microarray evidence decreased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCP1E11.11 puf6 RNA expression microarray evidence decreased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCP1E11.11 puf6 RNA expression microarray evidence decreased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCP1E11.11 puf6 RNA expression microarray evidence decreased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCP1E11.11 puf6 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCP1E11.11 puf6 RNA RNA-sequencing evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCP1E11.11 puf6 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCP20C8.01c protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCP20C8.01c protein high throughput evidence used in manual assertion increased during(GO:0031142) PMID:39705284 4896 2025-04-04 SPCP20C8.01c RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCP20C8.01c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCP20C8.02c RNA expression microarray evidence increased in presence of(CHEBI:17634) PMID:34460892 4896 2021-09-22 SPCP25A2.02c rhp26 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP31B10.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCP31B10.02 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCP31B10.03c med31 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP31B10.03c med31 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCP31B10.04 psg2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP31B10.04 psg2 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCP31B10.04 psg2 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCP31B10.05 tdp1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCP31B10.06 tcb2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCP31B10.06 tcb2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCP31B10.06 tcb2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCP31B10.06 tcb2 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCP31B10.06 tcb2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPCP31B10.06 tcb2 RNA expression microarray evidence increased during(GO:0034599) PMID:12529438 4896 2021-11-30 SPCP31B10.06 tcb2 RNA expression microarray evidence increased during(GO:0034605) PMID:12529438 4896 2021-11-30 SPCP31B10.06 tcb2 RNA expression microarray evidence increased during(GO:0071470) PMID:12529438 4896 2021-11-30 SPCP31B10.06 tcb2 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCP31B10.06 tcb2 RNA expression microarray evidence increased in presence of(CHEBI:25255) PMID:12529438 4896 2021-11-30 SPCP31B10.06 tcb2 RNA expression microarray evidence increased during(GO:0016036) PMID:23231582 4896 2021-02-03 SPCP31B10.06 tcb2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCP31B10.06 tcb2 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCP31B10.06 tcb2 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCP31B10.06 tcb2 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCP31B10.06 tcb2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCP31B10.06 tcb2 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCP31B10.06 tcb2 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCP31B10.07 eft202 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCP31B10.07 eft202 protein western blot evidence used in manual assertion unchanged during(GO:0071470) PMID:18065650 4896 2017-09-29 SPCP31B10.07 eft202 protein western blot evidence used in manual assertion unchanged during(GO:0034599) PMID:18065650 4896 2017-09-29 SPCP31B10.07 eft202 protein western blot evidence used in manual assertion unchanged during(GO:0006995) PMID:18065650 4896 2017-09-29 SPCP31B10.07 eft202 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCP31B10.07 eft202 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCP31B10.07 eft202 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCP31B10.07 eft202 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCP31B10.07 eft202 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCP31B10.08c rpl35A01 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCP31B10.08c rpl35A01 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCP31B10.08c rpl35A01 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCP31B10.08c rpl35A01 RNA RNA-sequencing evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCPB16A4.02c opy1 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCPB16A4.03c ade10 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCPB16A4.03c ade10 protein high throughput evidence used in manual assertion decreased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCPB16A4.03c ade10 protein high throughput evidence used in manual assertion decreased during(GO:0000747) PMID:39705284 4896 2025-04-04 SPCPB16A4.03c ade10 ribosomal density ribosome profiling evidence decreased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCPB16A4.03c ade10 ribosomal density ribosome profiling evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCPB16A4.03c ade10 ribosomal density ribosome profiling evidence decreased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCPB16A4.03c ade10 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCPB16A4.03c ade10 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCPB16A4.03c ade10 RNA RNA-sequencing evidence decreased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPCPB16A4.04c trm8 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCPB16A4.04c trm8 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCPB16A4.06c protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCPB16A4.06c ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCPB16A4.06c RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCPB16A4.06c RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCPB16A4.06c RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCPB16A4.06c RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCPB16A4.06c RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCPB16A4.07 smp4 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCPB16A4.07 smp4 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCPB16A4.07 smp4 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCPB16A4.07 smp4 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCPB16A4.07 smp4 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCPB16A4.07 smp4 RNA RNA-sequencing evidence increased during(GO:0042542) PMID:33313903 4896 2021-01-11 SPCPB16A4.07 smp4 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCPB16A4.07 smp4 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCPB16A4.07 smp4 RNA RNA-sequencing evidence increased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCPB16A4.07 smp4 RNA RNA-sequencing evidence increased in presence of(CHEBI:40036) PMID:36478272 4896 2025-05-21 SPCPB1C11.01 amt1 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCPB1C11.01 amt1 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCPB1C11.01 amt1 RNA RNA-sequencing evidence decreased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCPB1C11.01 amt1 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCPB1C11.01 amt1 RNA quantitative PCR decreased in presence of(CHEBI:142517) PMID:35416247 4896 2022-07-04 SPCPB1C11.01 amt1 RNA expression microarray evidence decreased in presence of(CHEBI:29016) PMID:32896087 4896 2020-12-09 SPCPB1C11.01 amt1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCPB1C11.02 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCPB1C11.02 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCPB1C11.02 ribosomal density ribosome profiling evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCPB1C11.02 RNA expression microarray evidence increased in presence of(CHEBI:47600) PMID:22840777 4896 2012-10-18 SPCPB1C11.02 RNA expression microarray evidence increased during(GO:0006995) PMID:12161753 4896 2025-12-04 SPCPB1C11.02 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCPB1C11.02 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCPB1C11.02 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCPB1C11.02 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPCPB1C11.02 RNA RNA-sequencing evidence increased during(GO:0006974) PMID:33313903 4896 2021-01-11 SPCPB1C11.03 protein mass spectrometry evidence decreased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCPB1C11.03 protein high throughput evidence used in manual assertion decreased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPCPB1C11.03 RNA expression microarray evidence decreased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCPB1C11.03 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPCPB1C11.03 RNA expression microarray evidence increased in presence of(CHEBI:50292) PMID:12529438 4896 2021-11-30 SPCPB1C11.03 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCPB1C11.03 RNA expression microarray evidence increased during(GO:1903832) PMID:29432178 4896 2018-03-09 SPCPB1C11.03 RNA RNA-sequencing evidence increased during(GO:0071276) PMID:33313903 4896 2021-01-11 SPCPJ732.02c xks1 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPCPJ732.02c xks1 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPCPJ732.02c xks1 RNA expression microarray evidence increased during(GO:0071456) PMID:16537923 4896 2020-12-07 SPCPJ732.02c xks1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPCPJ732.03 meu15 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPCPJ732.03 meu15 protein high throughput evidence used in manual assertion increased during(GO:0007135) PMID:39367033 4896 2024-11-01 SPCPJ732.03 meu15 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPCPJ732.03 meu15 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPMIT.01 cox1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPMIT.01 cox1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.02 cox1-I1b protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPMIT.02 cox1-I1b RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.03 cox1-I2b RNA RNA-sequencing evidence increased in presence of(CHEBI:9168) PMID:38269097 4896 2024-03-27 Table S3 SPMIT.04 cox3 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPMIT.04 cox3 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.04 cox3 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPMIT.05 cob1 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPMIT.05 cob1 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPMIT.05 cob1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.06 cob1-I1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.07 atp6 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPMIT.07 atp6 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.08 var1 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.08 var1 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPMIT.09 atp8 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.10 atp9 RNA expression microarray evidence increased during(GO:0043935) PMID:12161753 4896 2025-12-04 SPMIT.11 cox2 protein mass spectrometry evidence increased in presence of(CHEBI:15361),in absence of(CHEBI:17234) PMID:31626996 4896 2021-01-31 SPMIT.11 cox2 protein high throughput evidence used in manual assertion increased during(GO:0007127) PMID:39367033 4896 2024-11-01 SPMIT.11 cox2 protein high throughput evidence used in manual assertion increased during(GO:0006995) PMID:39705284 4896 2025-04-04 SPMTR.01 mat2-Pc RNA northern assay evidence used in manual assertion increased in(CL:0002675),during(GO:0006995) PMID:2792737 4896 2012-02-17 SPMTR.01 mat2-Pc RNA RNA protection assay evidence increased during(GO:0006995) PMID:2900761 4896 2014-06-18 SPMTR.01 mat2-Pc RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPMTR.01 mat2-Pc RNA northern assay evidence used in manual assertion present in(CL:0002675),during(GO:0072690) PMID:2792737 4896 2012-02-17 SPMTR.01 mat2-Pc RNA RNA protection assay evidence present during(GO:0072690) PMID:2900761 4896 2014-06-18 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion absent in(CL:0002675),during(GO:0072690) PMID:2792737 4896 2012-02-17 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:1435723 4896 2013-02-19 SPMTR.02 mat2-Pi RNA RNA protection assay evidence absent during(GO:0072690) PMID:2900761 4896 2014-06-18 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:2300054 4896 2014-06-18 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion absent during(GO:0072690) PMID:15713656 4896 2014-12-02 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion increased in(CL:0002675),during(GO:0042149) PMID:8001162 4896 2012-02-21 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion increased in(CL:0002675),during(GO:0006995) PMID:2792737 4896 2012-02-17 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion increased in(CL:0002675),during(GO:0006995) PMID:8001162 4896 2012-02-21 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:7651414 4896 2012-02-24 SPMTR.02 mat2-Pi RNA RNA protection assay evidence increased during(GO:0006995) PMID:2900761 4896 2014-06-18 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:2300054 4896 2014-06-18 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:15713656 4896 2014-12-02 SPMTR.02 mat2-Pi RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPMTR.02 mat2-Pi RNA northern assay evidence used in manual assertion present during(GO:0006995) PMID:1435723 4896 2013-02-19 SPNCRNA.07 meu3 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPNCRNA.07 meu3 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPNCRNA.1021 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1029 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.103 sme2 RNA northern assay evidence used in manual assertion increased during(GO:0006995) PMID:7520368 4896 2014-05-07 SPNCRNA.103 sme2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1030 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1033 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1055 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1068 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1069 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1072 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1079 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1083 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1086 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1087 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1091 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1100 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.111 rse1 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1111 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1116 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1126 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1137 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1164 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1174 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1177 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1180 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1190 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1197 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1202 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1206 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1212 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1214 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1215 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1216 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1234 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1257 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1261 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1278 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1280 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.130 omt3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1307 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1312 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1316 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1319 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1320 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1327 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1348 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1352 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1360 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1362 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1364 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1374 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1376 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1404 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1405 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1408 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1417 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1431 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1437 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1443 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1447 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1448 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1451 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1457 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1465 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1471 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1472 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1473 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1483 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1488 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1489 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1492 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1525 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1530 aal1 RNA quantitative PCR increased during(GO:0044838) PMID:39358553 4896 2024-10-21 (Fig. 1) SPNCRNA.1544 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1548 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1550 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1557 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1563 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1564 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1573 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1575 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1588 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1591 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1599 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1601 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1606 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1609 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1617 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1643 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1656 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1671 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1682 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1690 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1691 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1695 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1696 nam3 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1697 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.1698 nc-tgp1 RNA quantitative polymerase chain reaction evidence used in manual assertion decreased during(GO:0016036) PMID:32499400 4896 2020-06-24 SPNCRNA.1698 nc-tgp1 RNA RNA-sequencing evidence decreased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S3) SPNCRNA.17 meu11 RNA experimental evidence increased during(GO:0051321) PMID:11376151 4896 2010-01-03 SPNCRNA.17 meu11 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPNCRNA.1710 adh1AS RNA expression microarray evidence decreased in presence of(CHEBI:27365) PMID:23223230 4896 2023-03-16 In the array analysis, one of the most repressed genes in response to zinc deficiency was adh1, whereas one of the most highly expressed transcripts under this condition was an antisense transcript at this locus (Fig. 1A). SPNCRNA.1710 adh1AS RNA expression microarray evidence increased during(GO:0034224) PMID:23223230 4896 2023-03-16 In the array analysis, one of the most repressed genes in response to zinc deficiency was adh1, whereas one of the most highly expressed transcripts under this condition was an antisense transcript at this locus (Fig. 1A). SPNCRNA.1712 nc-pho1 RNA RNA-sequencing evidence decreased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S3) SPNCRNA.178 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.214 ter1 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.231 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.269 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.29 meu19 RNA experimental evidence increased during(GO:0051321) 4896 2010-03-17 SPNCRNA.29 meu19 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPNCRNA.301 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.304 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.380 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.451 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.519 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.520 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.530 sno530 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.577 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.584 lncRNA584 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.587 meu20 RNA experimental evidence increased during(GO:0051321) 4896 2010-03-17 SPNCRNA.587 meu20 RNA expression microarray evidence increased during(GO:0051332) PMID:12161753 4896 2025-12-04 SPNCRNA.600 nc-tco1 RNA northern assay evidence used in manual assertion absent in presence of(CHEBI:15379) PMID:18276645 4896 2020-09-24 SPNCRNA.600 nc-tco1 RNA northern assay evidence used in manual assertion increased during(GO:0071456) PMID:18276645 4896 2020-09-24 SPNCRNA.602 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.607 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.610 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.617 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.622 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.623 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.626 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.639 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.652 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.688 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.706 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.708 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.711 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.712 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.724 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.728 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.737 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.739 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.742 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.752 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.772 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.789 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.791 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.80 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPNCRNA.812 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.815 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.821 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.829 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.834 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.836 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.839 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.84 IRC1-L RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPNCRNA.853 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.857 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.863 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.864 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.865 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.866 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.870 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.887 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.900 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.9001 prt2 RNA Northern assay evidence absent during(GO:0072690) PMID:29414789 4896 2018-08-16 SPNCRNA.9001 prt2 RNA RNA-sequencing evidence decreased during(GO:0006970) PMID:33313903 4896 2021-01-11 SPNCRNA.9001 prt2 RNA RNA-sequencing evidence decreased during(GO:0016036) PMID:36794724 4896 2023-08-21 (Figure S3) SPNCRNA.9001 prt2 RNA expression microarray evidence increased during(GO:0051321) PMID:12161753 4896 2025-12-04 SPNCRNA.9001 prt2 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.9001 prt2 RNA RNA-sequencing evidence increased during(GO:0009408) PMID:33313903 4896 2021-01-11 SPNCRNA.909 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.920 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.928 meu16 RNA experimental evidence increased during(GO:0051321) 4896 2010-01-03 SPNCRNA.928 meu16 RNA expression microarray evidence increased during(GO:0051327) PMID:12161753 4896 2025-12-04 SPNCRNA.934 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.935 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.936 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.949 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.953 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.957 RNA RNA-sequencing evidence decreased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.96 RNA expression microarray evidence increased during(GO:0035874) PMID:21828039 4896 2024-07-01 (Table 2) SPNCRNA.980 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.984 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.987 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.992 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.993 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14 SPNCRNA.995 RNA RNA-sequencing evidence increased during(GO:0044838) PMID:27984744 4896 2021-07-14